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iAbstract
Salmonella are major food-borne pathogens responsible for causing a broad
spectrum of human disease, ranging from mild gastroenteritis to life-threatening
systemic disease. We are interested in analysing the function of the putative mrd
operon in Salmonella, whose gene products include PBP2 and RodA; two proteins
which are involved in longitudinal cell wall synthesis and essential for rod shape-
maintenance in Salmonella. Although PBP2 is fairly well described, surprisingly
little is known about the function of RodA or the other mrd operon proteins.
This study aimed to characterise the mrd operon, elucidating its contribution to the
biology and pathogenicity of Salmonella. Possible links between the structural
integrity of the cell wall and the functionality of wall-spanning virulence organelles
were also examined. Precise knockout mutations of the mrd operon genes were
constructed in Salmonella enterica serovars Typhi and Typhimurium. A range of
subsequent phenotypic analyses have revealed that the round-cell ΔpbpA (PBP2)
and ΔrodA mutants, though viable and able to stably propagate, are defective in
the expression of flagella and the Salmonella pathogenicity island 1 (SPI-1) type III
secretion system (T3SS), although the SPI-2 T3SS remains active. These
virulence defects were successfully complemented by expressing the major SPI-1
and flagella regulators in trans from inducible promoters. A transposon
mutagenesis screen was subsequently developed to search for global regulators
of the SPI-1 and motility phenotypes in round-cell mutants. This led to the
identification of several candidate regulators, which ongoing work seeks to further
analyse. This study has demonstrated that round-cell mrd mutants almost
completely down-regulate the expression of key invasion-associated virulence
genes, although the cell wall in these mutants remains sufficiently robust to enable
the assembly and functioning of wall-spanning multi-protein complexes.
Collectively these data provide important insights into both the physiological state
of mrd operon mutants, and the function of mrd operon genes.
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1Chapter 1. General Introduction
1.1 Salmonella enterica as an enteric pathogen
1.1.1 Introduction to Salmonella enterica
Salmonella enterica is one of only 2 recognised species of Salmonella. It is a
Gram-negative bacterial pathogen responsible for widespread disease in humans
and animals. The Salmonella enterica species itself comprises over 2500 closely
related serovars, many of which are responsible for enteric disease, ranging from
mild gastroenteritis to life threatening illness (1-4). The major disease-causing
serovars in humans include Salmonella enterica serovar Typhimurium (S.
Typhimurium), S. Enteritidis, S. Typhi and S. Paratyphi (4-7).
S. Typhimurium and S. Enteritidis generally cause mild self-limiting gastroenteritis
in humans, which remains localised to the gut. Salmonella is a common cause of
gastroenteritis, being responsible for approximately 1.4 million cases annually in
the US, for example. Of these cases, approximately 26% are caused by S.
Typhimurium (4, 8). Aside from gastroenteritis, S. Enteritidis, and more commonly
S. Typhimurium, can also cause a serious systemic infection in an
immunocompromised host. This disease is distinct from typhoid fever, being often
more serious, invasive and recurrent (9). Systemic non-typhoidal salmonellosis
(NTS) disease is increasingly becoming a major problem in parts of sub-Saharan
Africa, particularly in AIDS patients, where NTS bacteraemia is associated with a
mortality rate of up to 47%. In many countries where HIV infection is particularly
prevalent, NTS accounts for the most common cause of bacteraemia (9-11).
Unlike S. Typhimurium and S. Enteritidis, which have a broad host range and
hence retain a large reservoir outside humans, S. Typhi and S. Paratyphi
infections are restricted to humans (4, 12). S. Typhi is the major cause of typhoid
fever, a serious invasive disease in which the bacteria are able to evade host
immune responses and survive inside macrophages, enabling them to spread
beyond the gut, through the lymphoid tissues and the blood. Ultimately the
bacteria set up a systemic infection in organs such as the liver, spleen and bone
marrow. Around 22 million cases of typhoid fever are recorded worldwide, annually.
2Of these cases, approximately 200,000 are fatal, although if untreated the fatality
rate for typhoid fever is approximately 10-20% (1, 9, 11, 13, 14). A further problem
associated with S. Typhi infections is the recent emergence of multidrug-resistant
strains, which are now prevalent and endemic throughout Asia and South East
Asia.  A study conducted in 2008 found that of 204 clinical isolates taken from
seven South Asian countries where typhoid fever is endemic, 41.2% were
multidrug-resistant (resistant to at least 3 antimicrobials) (11, 15-18).
1.1.2 Major virulence determinants of Salmonella enterica and mechanisms
of pathogenesis
Salmonella infections are acquired through the ingestion of contaminated food or
water. In order to establish an infection in the host gut, Salmonella deploys a
number of important virulence factors, many of which are essential for
pathogenesis. Fundamentally, Salmonella infections involve the invasion of and
survival inside intestinal epithelial cells or M cells. The establishment of a systemic
infection is dependent upon intracellular survival and replication within adapted
phagosomes, the so-called Salmonella-containing vacuoles (SCV), inside
intestinal epithelial cells and macrophages (4, 19-21).
Salmonella Type 3 secretion systems (T3SSs)
A number of essential virulence factors have been recognised in Salmonella. Two
of these encompass pathogenicity islands, each of around 40kb; Salmonella
Pathogenicity Island 1 and 2 (SPI-1 and SPI-2), which both encode the apparatus
and effector proteins of two type 3 secretion systems (T3SS) (12, 22, 23). The
SPI-1 T3SS is essential in the initial stages of infection, enabling the bacteria to
invade the host intestinal epithelium. SPI-1 effector proteins are injected directly
into host epithelial cells, where they interfere with signal transduction and
reorganise host cell actin filaments, therefore inducing phagocytosis of the
bacterium. They also play a major role in assisting with colonisation of the intestine
and modulating the host immunity to induce inflammatory responses, therefore
causing gastroenteritis (4, 24, 25-28).
3The roles of the major secreted SPI-1 effector proteins are fairly well characterised.
Among the most significant SPI-1 effectors are the Sip proteins (SipA, SipB, SipC
and SipD), the Sop proteins (SopA, SopB, SopD, SopE and SopE2), AvrA and
SptP (4). The Sip proteins are SPI-1-encoded effectors. SipB, SipC and SipD
together form the translocon element of the T3SS needle, which inserts into and
thus form a pore in the host cell membrane, permitting the injection of effectors
into the host cell cytoplasm (4, 29). SipA and SipC also function by directly binding
host cell actin and promoting actin filament stability and polymerisation (4, 30, 31).
In addition, SipB has been shown to activate the host inflammatory response, by
inducing IL-18 and IL-1β (4, 32). The Sop effector proteins are encoded outside of
SPI-1 (29). SopB, SopE and SopE2 function by activating host cell Rho GTPases.
This results in the rearrangement of actin filaments, which in concert with the
action of the Sip proteins causes subsequent membrane ruffling and induced
phagocytosis of the bacterium (4, 29). The Sop proteins are also able to disrupt
the tight junctions between epithelial cells, allowing Salmonella to gain access
beyond the apical surface (4, 33). The SPI-1-encoded AvrA and SptP effectors
also have roles in modulating the host inflammatory response. However, in
contrast to the Sop proteins, AvrA suppresses the inflammatory response by
inhibiting NF-κB and stabilising tight junctions between epithelial cells (34, 35).
SptP encodes a tyrosine phosphatase, which also acts in opposition to the Sop
proteins, reversing their effects on actin polymerisation after bacterial
internalisation and reducing the inflammatory responses (4, 36).
Expression of the SPI-2 T3SS is induced after bacterial internalisation (between 2-
24 hours after infection), possibly in response to the detection of, among other
factors, a low magnesium concentration and a low pH, indicative of an intracellular
phagosome environment (23, 37-39). The SPI-2 T3SS is therefore active at a later
stage than SPI-1, and is required to help the bacterium survive and multiply
intracellularly, in both epithelial cells and macrophages (4, 22, 23, 40-42). After
phagocytosis into the host cell, Salmonella cells remain inside the uptake
phagosomes, which are modified to form the Salmonella-containing vacuole (SCV).
Maturation of the SCV may initially be implemented by SPI-1 effector proteins,
although as the SPI-1 genes are downregulated shortly after internalisation, the
majority of SCV maturation is thought to be directed by SPI-2 effectors (20, 21, 43).
4The essentiality of the SPI-2 T3SS for infection has been widely demonstrated and
SPI-2 mutants are severely attenuated for infection in vivo (11, 19, 23, 44, 45). In
spite of this and despite recent advances in knowledge of the later stages in
Salmonella infection, little remains known about the mechanisms involved to
permit intracellular survival, and the precise roles of SPI-2 effector proteins (11, 23,
43). Some of the major functions of the SPI-2 effectors are thought to include
promoting replication within the SCV, inducing changes in the SCV membrane to
help it mature, and directing trafficking and fusion of vesicles towards/with the SCV,
and trafficking of the SCV through the host cell (4, 11, 20, 43). Some research has
indicated that additional functions of the SPI-2 effector proteins may include
inducing delayed cell death of the host macrophage cell, avoidance of the
oxidative burst or oxidative stress resistance, bringing about actin accumulation
and polymerisation close to the SCV membrane, and recruiting cholesterol to the
SCV membrane (4, 38, 41, 44, 46). Some research has indicated that SCVs may
be able to fuse with lysosomes, suggesting the importance of resistance to
lysosomal contents by Salmonella (4, 43). However, this remains disputed. Recent
data suggests that SPI-2 and its effectors do not assist in bacterial resistance
against host defence mechanisms, but rather aid specifically in bacterial
replication inside the salmonella-containing vacuole (SCV) (19).
It was originally thought that the SPI-1 and SPI-2 systems acted in isolation, at
separate stages of infection, with little if any overlap in gene expression or function.
Only recently has it become clear that this model is too simplistic and that there is
significant cross-talk between the two T3SSs (4, 20, 43). For instance, mutations
in SPI-2 T3SS apparatus proteins were found to result in the downregulation of a
number of SPI-1 T3SS genes (47). Also, a number of SPI-1 effector proteins are
now known to persist and continue to be expressed long after bacterial
internalisation. These effectors have a role in SCV maturation, a process originally
attributed just to SPI-2 effectors. SipA is a SPI-1 effector protein involved in
inducing internalisation of the bacterium through the binding and polymerisation of
actin. However, Brawn et al. demonstrated that this effector protein persists on the
cytosolic side of the SCV membrane after phagocytosis (20). From here it acts in
concert with a major SPI-2 effector, SifA, to help direct the positioning of the SCV
5within host cells. SipA is also important for bacterial replication within the SCV (4,
20, 43, 48).
Both T3S needles comprise multi-protein complexes made up of over 20 proteins,
which span the cell wall (4, 29) (Figure 1.1). The complexity of these needle
structures means that they must be expressed in an organised manner to ensure
proper assembly. The assembly of both needles is tightly controlled at a number of
levels and by several pathways (29). Work by Pucciarelli and Portillo showed that
PrgH and PrgK, membrane components of the SPI-1 needle, were present in
purified peptidoglycan fractions, suggesting that these proteins associate with
peptidoglycan. These interactions were also necessary for correct assembly of the
SPI-1 needle (49). T3SS assembly occurs in a sequential manner, and the needle
components can only be assembled once the base and export apparatus of the
structure are in place, as these are secreted in a Type 3-dependent manner (29).
Motility of Salmonella
Salmonella express peritrichous flagella, which although not essential for virulence,
are recognised as virulence factors due to the observation that flagella-expressing
Salmonella strains are more invasive than those lacking flagella (50-53). The
bacterial flagellum is structurally related to the T3SSs, being made up of over 20
proteins which associate in a large cell wall-spanning multi-protein complex (4, 54,
55) (Figure 1.1). The assembly of this structure is also very tightly regulated, with
over 50 genes involved in some aspect of assembly or function. The correct
assembly of the flagellum is essential for its function (11, 56-59). Salmonella
express between 5 and 10 flagella per cell, which are distributed all around the cell
(42, 59, 60).
The flagellum apparatus structure itself can be divided into several distinct portions.
At the base of the macromolecular structure is the cell-wall spanning basal body.
This forms the T3SS-like structure, which is responsible for secreting the more
distal structural components of the flagellum during flagellum assembly, including
the hook proteins and the filament flagellin proteins. The basal body is also
required to relay the rotational force generated by the motor, to the flagellum
filament. It is made up of the MS, C, P and L rings, which reside in the inner
6bacterial membrane, cytoplasm, periplasm and outer bacterial membrane
respectively, as well as a central rod. These rings anchor the flagellum into the cell
envelope (61, 62).
The MS ring, made up of FliF monomers, is the primary structure to be assembled
into the cell wall. After this the C ring is built up, associating with the MS ring. The
rod component connects to the MS ring of the basal body and spans the periplasm.
This structure helps to transfer torque to the hook and filament structures as well
as providing a central channel through which flagellar proteins are exported. Once
assembled, the P and L rings form around the central rod, with the P ring
physically associating with the peptidoglycan cell wall (61, 62).
The hook is assembled once the basal body structures are in place. This structure
acts as a hinge and transfers torque from the basal body to the filament. The 120
FlgE monomers which make up the hook, along with the hook capping protein and
three hook-associated proteins (HAPs) are secreted through the basal body T3S
channel. The hook self assembles to the required length, at which point the cap
protein is replaced by the HAPs, of which HAP2 forms the cap of the filament and
is required for filament assembly. When the hook reaches a length of ~55nm, the
T3SS specificity is switched irreversibly and filament assembly begins with the
export of FliC flagellin monomers. Like the hook, FliC monomers self assemble
into the filament, which grows from the tip to a length of up to 10-15µm (61, 62).
The stator region of the flagellum consists of a complex of the MotA and MotB
proteins. This assembles around the flagellum rotor region in the cell cytoplasm.
Rotational torque is generated through the interactions of the stator and rotor,
formed by the C-ring. The stator itself is thought to be anchored to the
peptidoglycan, through the C-terminus of the MotB protein, whilst MotA is involved
in generating torque (62-65). The inner membrane-spanning Mot proteins are the
final proteins to assemble into the flagellar structure, since rotational torque is only
generated once the whole flagellar structure has been successfully assembled.
Mutants of the motA or motB genes are able to assemble complete flagellum
structures, but remain non-motile, whilst missense mutations in either protein are
known to cause slow-rotation defects (65-68).
7Figure 1.1: Molecular structure of bacterial flagella and type 3 secretion systems
(T3SS): Schematic diagram to demonstrate molecular structure, and structural similarity
of flagella and T3SSs. T3SS needle based on that of Yersinia.  Both structures comprise
complex wall-spanning macromolecular organelles, produced in many bacterial species
including Salmonella.  Figure taken from “The Type III Injectisome” (84).
1.1.3 Additional virulence determinants of Salmonella Typhi and Salmonella
Typhimurium
Salmonella deploy a number of additional virulence determinants during the
course of an infection, which although not essential, may play important additional
roles in pathogenesis (1, 2, 12, 23, 69). These virulence determinants are directly
involved in pathogenesis, being important for invasion or intracellular survival. The
majority of these are encoded within one of the 14 horizontally acquired
Salmonella pathogenicity islands (SPIs), that have to date been identified (12, 42).
A brief overview of several significant factors which contribute directly to virulence
in Salmonella is given below.
In addition, many factors could be described which are sometimes considered as
virulence determinants due to their nature as housekeeping genes, nutrient
acquisition genes, or stress response genes. These are needed to enable
Salmonella to adapt and survive in a range of rapidly-changing environmental
8conditions encountered in the host. However, in reality these factors are only
indirectly related to virulence, and they play roles in the normal physiology of both
Salmonella and many other non-pathogenic enteric bacteria (12).
Salmonella Typhi Vi capsular polysaccharide
The extracellular polysaccharide capsule, the Vi antigen, is expressed by S. Typhi
almost exclusively among Salmonella enterica serovars (70). It is recognised as
an important virulence factor, although not all clinical isolates of S. Typhi express
Vi, and it is not essential for survival and spread within the host (70, 71). The
capsule helps protect the bacteria from the host immunity, owing to its anti-
phagocytic and anti-opsonic nature. It also may serve to reduce the inflammatory
response of the host (11, 23, 72, 73). Genes for the regulation, synthesis and
export of the Vi capsule are all located within SPI-7, a genomic pathogenicity
island unique to Typhi.
Adhesins/Fimbriae
Salmonella express a number of types of cell surface fimbriae which are important
for adhesion to and hence invasion of host epithelial cells. 14 separate fimbrial
operons have been identified in Salmonella; these include the bcf, csg (agf), fim,
saf (SPI-6), sef (SPI-10), sta, stb, stc, std, ste, stg, sth and tcf operons, as well as
the pil operon within SPI-7, encoding type IV pili (1, 12, 23, 42, 74. 75). 12 are
present within the S. Typhi genome, although Typhimurium lacks the sef, sta, ste,
stg, tcf, and pil operons (23, 76). The specific complement of adhesive fimbriae
expressed by Typhi may contribute to the host specificity of this serovar (3, 76, 77).
Virulence plasmids
Virulence genes and traits are often carried on virulence plasmids in bacterial
pathogens. Serovars of Salmonella enterica belonging to Subspecies I (including
S. Typhimurium, Enteritidis, and Paratyphi C but excluding Typhi, Paratyphi A and
Paratyphi B) carry a self-transmissible plasmid termed Salmonella virulence
plasmid, or pSLT. Contained within this plasmid are the genes for a fimbrial
operon pef (plasmid-encoded fimbriae), and the spv locus; a 7.8kb region
encoding 5 genes which plays a role in replication for intracellular Salmonella. This
region is also known to be required for bacterial survival and replication within the
9reticuloendothelial system. Aside from these genes, a number of other loci may
also be present on pSLT which play various roles in infection. For example, the rck
and rsk loci have roles in resistance to complement killing and serum killing
respectively (42, 78-80).
Two plasmids harbouring multiple drug-resistance genes have been characterised
in the CT18 strain of S. Typhi, including a large cryptic plasmid pHCM2, which has
significant homology to a virulence plasmid of Yersinia pestis, and pHCM1 (1, 42).
However, both pHCM1 and pHCM2 are absent from the majority of S. Typhi
isolates, including the widely studied Ty2 strain, and the role of these plasmids in
virulence remains unclear (1, 3, 42).
Toxins
Salmonella express a number of cytotoxins and enterotoxins which may play roles
in virulence, although the complement of toxins expressed varies between
serovars. Several Salmonella serovars express a variety of heat- and protease-
sensitive cytotoxins, with recognised ability to kill mammalian cells. The most well
characterised toxin of Salmonella is Stn, a heat-labile enterotoxin which is
produced by several serovars, including Typhi and Typhimurium. Its exact role in
virulence remains unclear, although Stn is known to bring about an increase in
cAMP levels, as well as the synthesis and release of prostaglandins. Stn also
causes an increase in fluid secretion into the gut lumen (42). This toxin displays
homology at the amino acid level to both Escherichia coli (E. coli) LT-1 toxin, and
the Cholera toxin subunits CT-A and CT-B (42, 81).
Serovars Typhi and Paratyphi A produce a pore-forming cytotoxin ClyA,
sometimes termed ‘salmolysin’ due to its haemolytic activity (81). Several toxin or
toxin-like genes have also been identified within a cluster on the S. Typhi genome,
which are absent from other serovars. These pltA, cdtB, and pltC genes encode
the A/B toxin ‘Typhoid toxin’, a cytolethal distending toxin which causes DNA
damage, possibly bringing about cell death to fast-growing host cells (11, 82, 83).
In addition Salmonella Typhi expresses at least 2 proteins with homology to RTX-
like toxins (RTX: repeats in the structural toxin) along with T1SS apparatus
proteins, which are encoded on SPI-4 and SPI-9 (1).
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1.1.4 Comparisons between Salmonella enterica serovars Typhi and
Typhimurium at the molecular level
Comparisons of the genome sequences of S. Typhimurium LT2 and S. Typhi
CT18 or Ty2 strains have demonstrated a number of significant differences, in
terms of both genome structure and the cohort of virulence genes (3, 80). The
~4.81 and ~4.86 mega base genomes of S. Typhi and S. Typhimurium,
respectively, share over 90% of their DNA content. Within these conserved
regions of the genome (including conserved SPI regions) the sequence identity
between the two serovars is 97.6%, on average, at the DNA level. However ~10-
12% (0.5-0.6 mega base pairs) of the Salmonella genome is generally unique to a
given serovar. It is thought that these regions of the genomes are responsible for
establishing the variable host specificities of different serovars, as well as bringing
about different disease characteristics and stimulating specific immune responses
within the host (1, 2, 11, 12, 18, 80).
Significant portions of the S. Typhi genome have, however, diversified from S.
Typhimurium, as a result of major gene rearrangements, inactivations and
insertions. Most significantly, of the 4599 genes of the S. Typhi genome, 204 are
pseudogenes (~5%), resulting from single frame-shift mutations or the introduction
of stop codons in the middle of open reading frames. 46 Typhi pseudogenes are
known or at least thought to have been involved in virulence or host interactions
prior to their inactivation. These include genes for several T3SS effector proteins
such as sseJ (SPI-2), sopE2, and sopA (SPI-1), a flagellar methylation gene fliB,
and several fimbrial operon genes. Of particular importance may be the slrP
pseudogene of Typhi, encoding a T3SS-secreted protein which is involved in
determining the host specificity. The S. Typhimurium genome shares only 23
pseudogenes with S. Typhi (1, 3). It is thought that the presence of such a large
number of pseudogenes in S. Typhi, and particularly those involved in virulence or
host interactions, is the major factor contributing to the host specificity and disease
presentation of S. Typhi (1).
In addition to pseudogenes, S. Typhi possesses just over 600 unique genes.
These appear to have been introduced as a result of the insertion of either
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individual genes or whole blocks of genes. Significant insertions in Typhi include at
least two additional pathogenicity islands, SPI-7 and SPI-10, several fimbrial
operons (including one on SPI-10), homologues of E. coli and Campylobacter
toxins haemolysin E and cdtB respectively, and toxin genes ptxA and ptxB from
Bordetella pertussis. SPI-7 contains the Vi polysaccharide capsule biosynthesis
and export genes, as well as the genes for a type IV pilus, as previously discussed.
These may be significant factors involved in determining the presentation of
clinical disease and host immune responses, particularly as the Vi capsule is
known to dull the immune inflammatory responses (3). This may be directly
through the expression of Vi itself, or through the downregulation of flagella
expression by the SPI-7 regulatory protein TviA. Differing immune responses are
made evident by the fact that the incubation period for S. Typhi can be up to 2
weeks, by which point the bacteria have spread beyond the gut. This is compared
with an incubation period of 12-72 hours for Typhimurium infections, with
subsequent sickness and diarrhoea (1, 3, 11, 12, 85).
1.2 Regulation of virulence in Salmonella Typhi and Typhimurium
Virulence gene expression in Salmonella is tightly controlled at a number of levels.
In addition to specific virulence gene regulators (which, if inactivated, render the
bacteria attenuated or avirulent) many upstream global gene regulators are
involved in the control of virulence gene expression in response to environmental
signals. The resulting regulatory networks, which are not yet fully defined, are
highly complex, involving multiple factors and multiple levels of control.
1.2.1 Regulation of virulence gene expression
SPI-1 gene regulation: hilA, hilC, hilD, and rtsA
The regulatory pathways involved in the control of SPI-1 gene expression are as
shown (Figure 1.2). Expression of SPI-1 genes is controlled by the HilA master
regulator protein, a ToxR/OmpR family protein. HilA activates expression of the
SPI-1 T3SS prg/org and inv/spa (encoding T3SS apparatus proteins), and sic/sip
(encoding effector proteins) operons, as well as negatively regulating itself by an
uncharacterised mechanism (86-88). In addition, HilA induces the expression of
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further SPI-1 encoded transcriptional activators invF and sicA, which together
activate the expression of the sip operon. InvF can also act independently of HilA
to induce expression of important non-SPI-1-encoded effector protein genes sopB
and sopE (87, 89, 90). That HilA is required for SPI-1 gene expression is
illustrated by the fact that hilA mutants show a 10-fold decrease in SPI-1 gene
expression, resulting in a massive reduction in both invasion (~150-fold), and in
virulence in a mouse (~60-fold) (89).
hilA expression itself is induced by 3 upstream AraC-like positive transcriptional
regulators, HilC, HilD and RtsA, which bind to the promoter region of hilA to
activate it. Unlike the hil genes, rtsA is encoded outside of SPI-1. As well
contributing in a feedback loop to positively regulate both their own expression and
that of the other two AraC-like regulators, and inducing hilA expression, these
regulators are able to induce SPI-1 activity independently of HilA. They activate
expression of both the SlrP effector protein and a periplasmic disulphide bond
isomerase which is needed for SPI-1 T3SS functionality (86-91).
Global regulation of SPI-1 gene expression
hilC, hilD and rtsA expression is controlled upstream both directly and indirectly by
a number of global regulator proteins and systems encoded outside of SPI-1.
These systems both activate and repress SPI-1 expression. The HilD protein is the
most crucial regulatory factor in the activation of SPI-1 gene expression;
environmental signals and global regulators which alter SPI-1 expression seem to
converge on HilD. The regulation of HilD expression (and hence ultimately SPI-1
expression) appears to be predominantly post-transcriptional, brought about by
altering translation or hilD mRNA stability. By comparison, hilC and rtsA
expression (resulting from hilD activation) appear to amplify the HilD signal and
further induce hilA expression. For instance, hilD mutants were found to be non-
invasive (53-fold reduction in invasion of HEp-2 cells), lacking hilA expression (14-
fold decrease in expression), whereas hilC mutants only displayed minor invasion
defects, although the overexpression of hilC can increase SPI-1 expression and
help compensate for the loss of hilD (87-89). hilA expression was decreased ~2-
fold in both rtsA and hilC mutants (88, 89). Finally, although hilC and rtsA are able
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to increase hilD expression, hilD expression is not reduced as a result of the loss
of either hilC or rtsA (88).
A major global activator of SPI-1 expression is the BarA/SirA two-component
system. Activated SirA binds directly to the hilA and hilC promoters to activate
transcription. However, BarA/SirA is also known to post-transcriptionally regulate
HilD expression through the csr system. This system comprises two small RNAs;
csrB and csrC, which together are thought to bind and regulate the CsrA protein.
CsrA post-transcriptionally regulates SPI-1 by binding to hilD mRNA near to the
ribosome binding site and in doing so altering its translation. The concentrations of
CsrA are thought to determine whether CsrA-mediated regulation is positive or
negative; csrA is required for SPI-1 expression, although overexpression of CsrA
causes a decrease in SPI-1 gene expression. In addition, csrB and csrC are
needed for full SPI-1 expression. When phosphorylated, SirA activates csrB and
csrC expression, which in turn tightly control and sequester CsrA, thereby de-
repressing hilD translation and inducing SPI-1 gene expression (87, 89, 92).
A number of additional global regulators (encoded outside of SPI-1) feed in to the
network to regulate SPI-1, including the PhoP/PhoQ and EnvZ/OmpR two-
component systems, the ferric uptake regulator protein, Fur, CpxA, a flagellar
protein FliZ, and HilE. These factors act upon hilD expression post-
transcriptionally to regulate the expression of downstream SPI-1 genes. In addition,
the flagella gene master regulator proteins FlhD and FlhC have been shown to
activate hilA transcription (92). Whilst BarA/SirA, EnvZ/OmpR, Fur, and FliZ also
all activate SPI-1, HilE appears to be the major repressor of SPI-1. HilE strongly
represses HilD, potentially by binding directly to HilD, such that HilD-mediated
SPI-1 expression is only brought about once activating signals are strong enough
to overcome a threshold set by HilE suppression (93). Several global
transcriptional regulators act directly through HilE to repress SPI-1 expression,
including the PhoP/PhoQ and PhoR/PhoB two-component systems, and FimZY
(87-89, 92, 94).
Other important repressors of SPI-1 virulence gene expression include several
PhoP-activated genes (pag genes), the Lon protease which may digest HilD, the
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DNA binding protein hha which binds hilA DNA and the Rcs phosphorelay system.
In addition, the small secondary messenger molecule c-di-GMP suppresses SPI-1
effector protein secretion (95). The latter two factors are both involved in
seemingly independent regulatory pathways which in response to environmental
factors suppress invasion associated genes (e.g. SPI-1/flagella) and activate
genes such as Vi and SPI-2, which are important for intracellular survival, as well
as several colanic acid biosynthesis pathways (50, 86, 89, 95-97).
At the apex of these regulatory networks are environmental signals which are
detected by various global regulators, such as osmolarity (EnvZ/OmpR), pH
(EnvZ/OmpR, PhoP/PhoQ and Fur), Mg2+/Ca2+ concentration (PhoP/PhoQ), bile,
and nutrient starvation, which all indicate to the bacterium the nature of the
environment and whether to express or repress invasion-associated genes (87, 89,
96, 98).
Figure 1.2: Regulation of SPI-1 gene expression: Diagram showing current models of
the multiple levels of regulation involved in activating and repressing SPI-1 gene
expression, along with major transcriptional regulator proteins. Taken from “Adaptation to
the host environment: regulation of the SPI1 type III secretion system in Salmonella
enterica serovar Typhimurium” (88).
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SPI-2 gene regulation: the SsrA/B two-component system
Expression of both SPI-2 T3SS apparatus and effector protein genes is controlled
by and dependent upon the SPI-2-encoded two component system SsrA/SsrB (11,
99, 100). In current models of SPI-2 gene regulation, the response regulator SsrB
directly binds SPI-2 promoters to activate transcription of SPI-2 genes as well as
the transcription of several effector proteins encoded outside of SPI-2, and other
genes (11, 99-102) (Figure 1.3). SsrB is able to bind and thus activate
transcription at all gene clusters within SPI-2, as well as auto-regulating itself. It
has been demonstrated that the two components, SsrA and SsrB are divergently
expressed. Also, the overexpression of SsrB is sufficient to stimulate SPI-2 gene
expression, even with a lack of SsrA (101-104).
The mechanism of action of the SsrB response regulator is thought to differ from
that of classical transcription factors. Analysis of SsrB DNA binding sites has
shown that the location of these sites compared to the transcriptional start sites
varies considerably at different gene clusters, being located either upstream,
downstream or even overlapping the transcriptional start sites. In addition, a
consensus sequence for the binding of the SsrB has been difficult to identify.
Analysis of genes regulated by SsrB, including over 100 genes outside of SPI-2,
revealed that the majority of SsrB-regulated genes appear to be horizontally
acquired (11, 100, 102).
H-NS is a nucleoid-associated inhibitory protein which preferentially binds to A/T-
rich regions of the genome, such as horizontally-acquired clusters of DNA. It is
thought that this protein functions to protect the bacteria by suppressing the
expression of foreign DNA. It is known that H-NS suppresses SPI-2 gene
expression. However, recent work has shown that SsrB-mediated activation of
SPI-2 genes is H-NS dependent; SsrB stimulates SPI-2 gene expression to a
much lesser extent in hns mutants. Recent work has established that SsrB is likely
to act by competitively inhibiting H-NS from binding to target DNA, and therefore
relieving the DNA silencing brought about by this inhibitory nucleoid-associated
protein. The authors suggested that when stimulated, SsrB competitively binds to
SPI-2 DNA, causing the release of H-NS and therefore a relief in gene inhibition
(11, 100, 102, 105).
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Global regulation of SPI-2 gene expression
The expression of SsrAB is controlled by at least two upstream global regulators:
SlyA and the OmpR/EnvZ two component system. These regulators are thought to
respond to several environmental signals that are indicative of an intracellular
environment, and go on to activate SPI-2 gene expression in an SsrA/B-
dependent manner (Figure 1.3). OmpR directly binds to the ssrAB promoter,
activating gene expression. The nature of the environmental signals which activate
OmpR/SlyA-mediated SPI-2 activation remain elusive. in vivo data providing
evidence on such signals is lacking, and much work in vitro has produced
conflicting results. In vitro, SPI-2 gene expression is stimulated in stationary phase
Salmonella cultures grown in minimal media (90). It has been variously suggested
that the signals that induce SPI-2 gene expression include low osmolarity, low pH,
and low Ca2+, phosphate and Mg2+ concentrations. However more recent work has
been unable to reproduce the effects of a low Mg2+ concentration on SPI-2 gene
expression. Given that OmpR/EnvZ is known to be stimulated in response to
osmolarity and pH changes, it is likely that these factors at least are important (38,
99, 102, 104, 106).
In addition to OmpR/EnvZ and SlyA, several other major regulators are thought to
be involved in stimulating ssrAB expression, including the PhoP/PhoQ two
component system, the major virulence gene global regulatory system which is
essential for intracellular survival. This system directly activates genes (including
ssrAB) needed for intracellular survival. PhoP/PhoQ also positively regulates the
expression of SlyA (38, 96, 100, 102, 107). Negative regulators of SPI-2 gene
expression are known to include nucleoid associated proteins H-NS and Fis, as
well as YdgT (102). In general, much about the regulatory pathways involved in
controlling SPI-2 gene expression remains to be fully elucidated.
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Figure 1.3: Regulation of SPI-2 gene expression: Diagram showing the major
regulators, environmental signals and pathways involved in controlling the activation and
repression of SPI-2 genes. Taken from “The roles of SsrA–SsrB and OmpR–EnvZ in the
regulation of genes encoding the Salmonella typhimurium SPI-2 type III secretion system”
(99).
Flagellar gene regulation: flhDC
The expression and assembly of the flagellar apparatus is highly complex,
involving the tightly regulated and hierarchical expression of over 50 different
genes contained within at least 17 operons. These operons, containing genes for
the regulatory proteins, chaperones, basal body apparatus proteins and secreted
flagellin subunits, are grouped into three separate gene classes according to the
temporal regulation of their expression. Flagellar gene expression is tightly
coupled with the assembly of the flagella structure. Flagellar genes are expressed
in the order of their assembly into the flagellum structure, with each gene class
corresponding to a distinct assembly stage. The expression of downstream
classes of flagellar genes is completely dependent upon the successful expression
and assembly of the preceding class of proteins. Hence, the so called ‘late genes’
encoding the secreted flagellin filament subunits are only expressed once the
basal body structure of the flagellum is completely assembled. A schematic
diagram demonstrating the hierarchical assembly of the flagellar structure is
demonstrated below (Figure 1.4) (56, 58, 62).
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Figure 1.4: Hierarchical regulation of flagella gene expression: Schematic diagram
showing the hierarchical control of flagella gene regulation and coupling of gene
expression to flagella assembly, along with major transcriptional regulators involved in
controlling flagella gene expression. Taken from “Bringing order to a complex molecular
machine: The assembly of the bacterial flagella” (62).
At the peak of this temporal hierarchy is class 1, or the ‘early’ genes, comprising
solely of flhDC. These genes encode the flagellar gene master transcriptional
regulator, formed by a hetero-oligomer complex FlhD4C2. Transcription of the
flhDC genes is induced in response to numerous signals involving both direct and
indirect regulation from a number of global regulators. Environmental signals that
regulate flhDC include temperature, osmolarity, carbohydrate and alcohol
concentrations, and cell physiological signals such as cell cycle stage, the
presence of certain heat shock proteins, growth phase and DNA supercoiling. A
major regulator of flhDC expression is the cAMP-receptor protein CRP, which
senses the cell state and activates flhDC. Other positive regulators of flhDC
include H-NS, QseBC and several heat shock response proteins (DnaK, DnaJ and
GrpE), whilst flhDC is negatively regulated by global regulators such as
OmpR/EnvZ, HdfR, LrhA and the Rcs phosphorelay. All such factors signal directly
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through FlhDC. flhDC expression is vital for the expression of all downstream
flagellar genes and hence motility (56, 58, 62, 108-111).
The FlhD4C2 complex directly binds to class 2 gene promoters and interacts with
RNA polymerase to activate transcription. Class 2 genes include those encoding
the cell wall-spanning basal-body and hook components of the flagellum structure
(Figure 1.4). The basal body elements together form a type 3 secretion structure
through which the hook and filament protein subunits are secreted. Contained
amongst the class 2 gene operons are also the transcriptional regulators for the
class 3 genes, including fliA encoding the alternative sigma factor subunit of RNA
polymerase, σ28, and the anti-sigma factor anti-σ28, FlgM. FliA (σ28) is essential for
class 3 gene expression. In order to ensure that the class 3 genes are not
expressed until the hook-basal body structure is completed, however, FliA is
repressed by FlgM until this stage. Upon completion of basal body assembly, the
flagellar T3SS is able to secrete not only the flagellin filament subunits, but also
the FlgM anti-σ28. It is thought that the secretion of FlgM causes the de-repression
of FliA, leaving it free to bind to and activate class 3 promoters. In this way, FlgM
acts as a checkpoint, enabling the cell to sense completion of basal body
assembly and switch to flagellin production (56, 58, 62).
Genes encoding the flagellin filament subunits, FliC and FljB (the latter being
absent from S. Typhi), as well as chemotaxis genes and the motor proteins MotA
and MotB, are all class 3 or ‘late stage’ genes. The expression of these genes is
dependent upon σ28. Flagellin proteins are then secreted through the flagellar
T3SS and incorporated into the growing flagellum filament tail (56, 58, 62, 112).
In addition to the regulatory elements described here, more complex regulatory
mechanisms and feedback loops are involved in fine-tuning flagellar gene
expression. For instance, many flagellar genes are expressed from both FlhDC-
regulated and σ28–regulated promoters, albeit from different transcriptional start
sites. FliA has been shown to activate transcription of both flhDC and class 2
genes when overexpressed. Under normal growth circumstances FlhDC
negatively regulates itself, and so the presence of FliA is needed to increase flhDC
expression. The FliZ protein, encoded within the same operon as fliA, is thought to
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bind to the FlhD4C2 complex and increase its effect on class 2 gene activation (56,
58, 62, 111).
The regulation of flagella assembly also involves post-transcriptional regulatory
mechanisms to bring about efficient, tight levels of control. In addition,
mechanisms are in place to control both the length and number of flagella
expressed on a cell. Further work remains to be carried out to fully delineate the
flagellar gene regulatory complex (56, 113).
Vi capsule regulation
Genes responsible for the expression and assembly of the Vi capsule are located
predominantly within the viaB locus. viaB is located on SPI-7 of the S. Typhi
chromosome, a large 134kb pathogenicity island which is absent from S.
Typhimurium (23, 70, 114). The locus consists of 11 genes, including tviA, a major
regulatory gene, and other genes necessary for both the synthesis (tviB-E genes),
and export (vexA-E genes) of the Vi polysaccharide subunits (23, 115, 116).
Upstream to tviA, which activates the tvi and vex genes, at least two other global
regulators are involved in activating viaB locus expression, including OmpR/EnvZ,
a two-component system that regulates gene expression in response to changes
in osmolarity and pH (98, 116, 117). RcsB, the response regulator of the RcsCDB
two component system (the Rcs phosphorelay), also positively regulates Vi
capsule expression. These regulators both form important components regulating
the stress responses in Salmonella, and respond to multiple environmental signals
to regulate levels of Vi capsule production. TviA is also thought to form an auxiliary
protein of the Rcs phosphorelay system, helping to regulate the expression of SPI-
1 and flagella genes in S. Typhi in response to changes in osmolarity (85, 98, 114,
116-118). RpoS, another major stress response gene in Salmonella, may also be
involved in Vi capsule regulation (85).
1.2.2 The role of global gene regulators in virulence gene regulation
As alluded to previously, many global regulators are involved in the direct
activation or repression of SPI-1, SPI-2 and flagella genes. Many of these
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regulators act conversely on SPI-1/flagella and SPI-2 genes, since they regulate
genes involved in two very different states of infection. These global regulators are
commonly found in both pathogenic and non-pathogenic Enterobacteriaceae.
Their primary roles are not directly virulence-related, but in fact related chiefly in
detecting environmental conditions and subsequently controlling physiological
responses to external environmental stress. Thus these signalling pathways
enable the bacteria to quickly respond and adapt to, and hence survive in rapidly
changing conditions (98, 119-121).
The major Salmonella regulators which are responsible for controlling responses
to environmental stress include the PhoP/PhoQ, OmpR/EnvZ and RcsCDB two-
component systems, Fur, RpoE and RpoS. In addition, the Typhi-specific regulator
TviA feeds into these regulatory networks. It is evident that in order to successfully
establish an infection Salmonella must be able to detect and respond appropriately
to environmental changes. This enables them to express virulence genes at the
correct stages of infection, so that invasion-associated genes are expressed in the
gut lumen, whereas genes essential for intracellular-survival are expressed after
uptake into host cells. Thus the environmental stress response and virulence gene
regulation in Salmonella are intimately linked and should not be considered in
isolation of each other (98, 107, 116, 119).
The genetic networks are wired such that the environmental conditions which,
through global regulators, stimulate SPI-1 expression (namely nutrient rich
conditions, high osmolarity, low oxygen and a neutral pH) and SPI-2 expression
(namely low Ca2+/Mg2+, low phosphate, low osmolarity and low pH) are those
which are reminiscent of conditions found in the gut and intracellularly,
respectively (87, 96, 98).
1.3 Cell shape determination and cell wall synthesis in rod-shaped bacteria
The mechanisms by which bacteria such as E. coli, Bacillus and Salmonella form
and maintain a distinct rod shape have been the subject of considerable interest
and debate in recent years. Much work remains to be done to fully elucidate these
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mechanisms, although to date several models have been formulated. These will
be discussed.
1.3.1 Bacterial cell shape determination
The bacterial peptidoglycan layer (sacculus) plays an essential role in providing
mechanical support to the cell, both maintaining a distinct shape and resisting
turgor pressure. The sacculus is a large macromolecule which surrounds the
whole bacterial cell. It is made up of long glycan strands cross-linked by short
peptide side chains. In Gram-negative bacteria the sacculus forms a fairly thin
layer (~4-6nm thick), made up of 1-3 layers of peptidoglycan, which resides
between the inner and outer membranes (122-125). Evidence suggests that the
glycan strands and peptide cross-links are positioned so that they run
perpendicular and parallel to the long axis of the cell, respectively. The peptide
cross-links are fairly flexible, and thus thought to give the cell wall elastic
properties, helping it to withstand external pressures and cell growth. Relaxed
sacculi can be stretched up to 3-fold without breakage, because of the elastic
nature of the molecule (125). When purified from the other cell components, the
sacculus retains the distinct cell morphology, demonstrating that this molecule
must be involved in physically constraining cell shape (125-127).
1.3.2 Cell wall synthesis in rod-shaped bacteria and Salmonella
Questions remain, however, as to how the cell walls in bacteria such as E. coli and
Salmonella are synthesised, specifically with regard to the precise identity and
functions of factors that must be involved in directing synthesis of the
peptidoglycan sacculus during cell growth and division, so that it adopts a specific
shape (122). After the translocation of peptidoglycan subunits across the inner
membrane into the periplasm, the integration and polymerisation of peptidoglycan
into the existing cell wall is brought about by the combined hydrolysis,
transglycosylation and transpeptidation reactions. Current models hypothesise that
the insertion of new wall material is brought about by the insertion of new glycan
strands between existing strands, followed by the subsequent hydrolysis of old
links, thus permitting growth of the cell wall without introducing breakages which
may de-stabilise the cell wall (125, 126).
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Cell shape determinant proteins of Salmonella
Whatever the mechanisms involved in cell wall synthesis, several proteins are now
known to play essential roles in cell shape maintenance, through their direction of
cell wall synthesis, by either their involvement in the control of peptidoglycan
synthesis or by their nature as cytoskeletal elements (128, 129). The inactivation
of any one of these proteins causes rod-shaped bacteria to become spheroid, and
without compensatory mutations, to eventually lyse (95, 96). To date six such
proteins have been identified; MreB, MreC, MreD, PBP2, RodA, and RodZ (122,
128, 130-132). That there are functional links between MreBCD, RodZ and
PBP2/RodA is clear; cells treated with either the MreB-targetting A22 or PBP2-
targetting mecillinam drugs exhibit exactly the same phenotypes in terms of the
biochemical changes brought about in the sacculus structure and round-cell
mutants also show identical phenotypes (126, 130).
The cytoplasmic MreB protein is now known to form a major cytoskeletal protein in
non-spheroid bacteria (122, 132). This protein is highly structurally homologous to
eukaryotic actin, despite lacking significant homology at the amino acid level.
Electron microscopy (EM) studies demonstrated the ability of MreB (unlike
eukaryotic actin) to self-polymerise in an ATP-dependent manner, into long
filaments and filamentous bundles, and also form curved structures and rings, in
vitro (126, 133). Fluorescent light microscopy in several rod-shaped bacterial
species expressing GFP-MreB fusions have demonstrated that MreB localises just
beneath the inner bacterial membrane, forming spirals or helices along the
longitudinal axis of the cell (126, 132, 134, 135).
The mreC and mreD genes are located alongside mreB, within the same operon
(131, 136). MreC and MreD are both integral membrane proteins. MreD is
polytopic, whilst MreC is bitopic, possessing a large periplasmic domain. Both
proteins have been observed to localise in a helical pattern along the length of the
cell, MreC doing so independently of MreB (although long-term, the loss of MreB
affects the localisation of MreC) (136, 137). Although some work has shown that
MreC and MreB helices do not co-localise (138), bacterial two-hybrid and affinity
chromatography experiments conversely demonstrated that MreC directly interacts
with MreB, MreD and several high molecular weight peptidoglycan synthetic
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enzymes, including PBP2 (131, 137, 139, 140). MreD and MreB did not, however,
directly associate (84, 96). Furthermore, the helical localisation of MreB has been
shown to be dependent upon the MreC and MreD proteins, as well as RodA, as
depletion of either protein brings about the mislocalisation of MreB (126, 131). It
was proposed that MreC and MreD may assist in anchoring MreB to the
cytoplasmic membrane, although more recently, RodZ has emerged as a more
likely candidate for this (141).
The pbpA gene encodes Penicillin-binding protein 2 (PBP2), the major
transpeptidase enzyme involved in lateral cell wall synthesis in rod-shaped
bacteria (130, 142-145). The 66 kDa PBP2 protein is a class B high molecular
weight PBP, which catalyses the cross-linking transpeptidation reactions to link
adjacent glycan strands by a pentapeptide bridge within the growing cell wall.
PBP2 is the only transpeptidase known to be essential for lateral cell wall
synthesis (125, 130, 146-149). The transpeptidation activity is contained within the
large C-terminal penicillin-binding periplasmic domain of PBP2, whilst the protein
is anchored into the cytoplasmic membrane via the transmembrane N-terminus of
the protein. The N-terminal portion may also determine the localisation of PBP2
and interact with other proteins involved in elongation (130, 145, 150).
Transglycosylation activity has not been detected in the PBP2 enzyme (126, 130).
The enzymatic activity of PBP2 is dependent upon the RodA protein (127, 143,
146). The rodA gene lies directly downstream of pbpA, within the same operon in
many rod-shaped bacteria including E. coli and Salmonella. Given the contiguous
nature of the two genes, and the dependence of PBP2 on RodA, it is likely that the
two proteins directly interact (122, 146, 151-153). RodA is a 40 kDa polytopic
membrane protein, containing at least 9 membrane-spanning helices (143, 153,
154). Various roles for RodA have been speculated, although none have been
definitively demonstrated (126, 153, 155). Among the most widely recognised is
the hypothesis that RodA forms the so-called flippase, responsible for the
translocation of the lipid II peptidoglycan precursor across the cytoplasmic
membrane into the periplasm, particularly given its structure. However, this
process is thought to be coupled closely to transglycosylation, and it may be that
the translocation of lipid II is coordinated by RodA as well as a number of
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associated integral membrane proteins (126, 152, 156). It also remains unknown
whether RodA possesses any enzymatic activity, although it has been speculated
that RodA may have transglycosylase activity (127, 146).
As with the inactivation of other cell shape determinant proteins, treatment of
Gram-negative rods such as E. coli and Salmonella with the PBP2-inhibiting
antibiotic mecillinam, or the genetic inactivation of pbpA or rodA, results in the
formation of spheroid cells, which divide asymmetrically and eventually lyse (127,
145). It is generally reported that growth of Δmre, ΔpbpA or ΔrodA mutants is
permitted in minimal media and at low temperatures (30°C), but that these cells
are unable to grow and divide at high growth rates (i.e. in rich medium and at 37°C)
unless the FtsA and FtsZ proteins, or the alarmone ppGpp are overproduced (126,
127, 130, 157). Similarly to the inactivation of pbpA, overexpression of pbpA in E.
coli caused cells to become large and spheroid, and eventually lyse, although this
effect was shown to be dependent upon the presence of the N-terminal membrane
anchor, and not the transpeptidase domain (158).
The subcellular localisation of both PBP2 and RodA is helical, reminiscent of MreB,
although PBP2 helices at least, are dependent upon MreB, MreC and MreD, and
PBP2 co-localises with MreC (135-137, 159-161). Previous bacterial two hybrid
work has also provided evidence that MreB and RodA directly interact, and that
MreB localisation is dependent upon RodA, but not PBP2 (126, 131, 162, 163).
The well conserved RodZ protein was recently identified as an additional protein
required for maintenance of rod-shape in bacteria, although one study has since
suggested that RodZ is not necessary for this (128, 164-166).  Both depletion and
over-expression of RodZ, as with the other cell shape determinant proteins, cause
a loss of rod-shape (128, 165). RodZ, encoded by the rodZ gene (formerly yfgA) is
a bitopic membrane protein, containing both periplasmic and cytoplasmic domains.
It was found to both directly bind and colocalise with MreB independently of all
other cell shape determinants except MreB (141, 164). Bendezu et al.
demonstrated that colocalisation of the RodZ and MreB helices was
interdependent. In addition, a correct ratio of MreB:RodZ was shown to be
important in maintaining cell shape (128, 164, 165, 167). However, another group
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found that RodZ could localise helically independently of MreB (128, 164, 167).
RodZ is also thought to interact with other cell shape determinants in the
periplasm (128, 167). Although its precise function is still unknown, RodZ may be
important in directing MreB localisation by anchoring MreB to the cytoplasmic
membrane, and physically bridging MreB to the peptidoglycan synthetic enzymes
(141). A recent study also brought to light a possible secondary role for RodZ, as
an mRNA-binding protein which assists in post-transcriptional regulation (168).
1.3.3 Current models of peptidoglycan synthetic multi-protein complexes
All 6 cell shape determinant proteins have been shown to localise with a helical or
banding pattern in the lateral cell wall of rod-shaped bacteria, in a manner
reminiscent of MreB (126, 132, 135, 136, 163, 164). A number of protein
interaction studies incorporating data from bacterial two-hybrid assays, affinity
chromatography and X-Ray crystallography studies have also revealed that many
of these proteins may directly interact. Thus, combined data from a number of
studies has led to the formulation of a model, whereby cell wall synthesis in rod-
shaped bacteria is coordinated by two separate multi-protein complexes, which
are responsible for lateral and polar cell wall synthesis during cell elongation and
cell division, respectively. These complexes contain the periplasmic penicillin-
binding proteins (PBPs) and related proteins which coordinate the transpeptidation
and transglycosylation reactions, integral membrane proteins, and associated
cytoskeletal proteins. The latter components may form a track or a scaffold to
direct the localisation of the complexes (Figure 1.5). It is thought that these
complexes, and in particular the cytoskeletal elements, are responsible for
determining cell shape (131, 136, 169, 122, 170, 171).
In terms of lateral cell wall synthesis specifically, all 6 cell shape determinant
proteins along with other associated proteins, including lipid II synthesis enzymes
(MraY and MurG), additional cell wall synthetic enzymes (PBP1A or PBP1B), and
cell wall hydrolase enzymes, at least, may form a multiprotein complex to
specifically coordinate longitudinal cell wall synthesis (125, 126, 139) (Figure 1.5).
The cytoskeletal MreB protein may help determine cell shape by associating with
this complex and forming a track to position the peptidoglycan synthesis
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machinery in the cell membrane.  This allows peptidoglycan to be synthesised in a
spatially coordinated manner, permitting longitudinal cell wall growth (130, 131,
135, 169, 172). In this model, other cell shape determinants such as the
membrane proteins MreC and MreD, or RodZ may tether MreB to the cytoplasmic
membrane, or form the bridge between the MreB cytoskeleton and the
peptidoglycan biosynthesis machinery, including PBP2 and RodA (Figure 1.5)
(122, 130, 131, 169, 173). In support of this model, the incorporation of new
peptidoglycan subunits into the cell wall occurs evenly and in a helical pattern
across the lateral cell wall, in a manner which is disrupted upon the inactivation of
MreB and the cell division protein FtsZ (122, 169, 171, 172, 174).
The protein complex responsible for bringing about septal cell wall synthesis and
hence cell division, is coordinated by the tubulin homologue FtsZ. This protein
forms a characteristic ring structure around the cell septum which contracts to
bring about cell division. A large number of associated proteins, including at least
10 essential division proteins comprising the septal cell wall synthesis machinery
are sequentially recruited by FtsZ to the septal ring before cell division (169, 172,
175-179) (Figure 1.5). Many of these proteins are essential for cell division, and
their inactivation results in the formation of non-dividing filamentous cells. In this
complex the PBP3 and FtsW proteins form the equivalents of the PBP2 and RodA
proteins, coordinating septal peptidoglycan synthesis as the septal ring contracts
(172, 175, 180). Experiments have demonstrated that the majority of PBPs form
part of either the elongation or division complexes (126, 185).
The MreB- and FtsZ-coordinated multi-protein complexes involved in the direction
of lateral and polar cell wall synthesis were originally thought to act independently
of one another, and at different stages in cell growth (169, 181). The relative
simplicity of this model has been brought into question by recent studies. Both
FtsZ and MreB are dynamic proteins, with varying localisation patterns (122).
MreB and associated proteins, for instance were shown to rearrange prior to cell
division to form ring-structures flanking the mid-cell position, in a manner
dependent upon FtsZ (135, 159, 160).  This suggests an involvement of MreB and
associated proteins in cell division. In non-dividing cells FtsZ re-localises, forming
helices extending along the length of the cell (122, 182, 183). MreB and FtsZ may
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potentially serve to re-localise cell wall synthetic complexes according to the
required location of peptidoglycan synthesis (159, 182, 183). Furthermore, Varma
et al. demonstrated that FtsZ may play a role in directing the incorporation of new
peptidoglycan into the side wall of E.coli; inhibiting FtsZ brought about a significant
reduction in the incorporation of peptidoglycan into sections of the side wall
adjacent to the cell poles as well as alterations in the composition of the peptide
side chains (172). This phenotype was exacerbated by the simultaneous inhibition
of MreB (159, 169, 172). More recently the group demonstrated that the even
distribution of peptidoglycan insertion into the E. coli side wall was disrupted with
the inhibition of both MreB and FtsZ, but not MreB alone. The same disruption of
insertion was also observed in pbpA mutants, suggesting that MreB and FtsZ may
both act upon PBP2 to direct the localisation of the cell wall synthases (159, 169).
Furthermore, FtsZ in Caulobacter crescentus contributes to cell elongation by
mediating localisation of the lipid II synthase MurG, a protein that was
coimmunoprecipitated with MreB and is recognised to form a part of the elongation
complex, as well as localising to a mid-cell position prior to cell division (126, 184).
These pieces of evidence demonstrate that the two systems responsible for cell
growth and division have significant overlaps in function which are necessary to
bring about smooth transitions between cell elongation and division, and ultimately
direct formation of rod-shaped cells (159). The complexes are highly dynamic,
moving and relocalising according to the stage of growth. A number of proteins,
including PBP1A, PBP1B, PBP2, MurG and MraY are also likely to form part of
both complexes (122, 126).
Further questions about cell shape maintenance
MreB is thought to control cell shape by directly positioning cell wall synthetic
complexes. However, it remains unclear as to precisely what directs the helical
localisation of MreB, and hence which factors are involved first and foremost in
determining rod-shape (122, 159). Some data suggests that contained within the
MreB protein is the innate ability to rapidly self-polymerise into long filaments as
required and direct cell shape (133). However, MreB helices are disrupted with the
depletion of MreC, MreD, or RodA, but not PBP2 (131). Most recently, MreB
localisation has been shown to require RodZ, although seemingly conflicting data
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about the dependence of MreB localisation upon MreC and RodZ has been
published (131, 138, 164). Thus, although the inter-dependence of the various
protein complex constituents remains confusing, the localisation of MreB appears
to be dependent on other cell shape determinants.
It also remains unclear as to precisely which proteins directly interact (or indeed
how they associate) and form part of the proposed lateral cell wall synthetic
complex (126, 135). The majority of data from protein interaction studies have
come from bacterial two hybrid assays and co-immunoprecipitation studies, and
hence do not provide definitive proof of actual protein interactions (126). It may be
that the nature of the upstream factor(s) responsible for overall cell shape
determination has yet to be realised, or that the models in place at present need to
be refined as a result of further research.
An alternative model for the control of lateral cell wall synthesis
Recently the work of Swulius et al. has raised further questions about this widely
accepted model of cell shape maintenance (134). This group used
electroncryotomography to attempt to visualise MreB filaments residing near to the
cytoplasmic membrane in various species of rod-shaped bacteria. This method
provides a means of visualising cell ultrastructures at a high-resolution, whilst
maintaining cells in a ‘near-native state’. Whilst FtsZ filaments were clearly visible,
helical MreB filaments could not be detected despite a number of combinations
and permutations tested. The authors concluded that long helical filaments of
MreB do not form in vivo, as previously thought, suggesting that the observed
helices from fluorescence microscopy studies may have resulted from the sample
preparation method constraining soluble monomeric proteins including MreB and
associated proteins into the available space between the nucleoid and cell
membrane; hence the localisation of these proteins would appear helical because
of the twisted morphology of the nucleoid. Alternatively, it was suggested that the
observed helices may have resulted from small MreB complexes moving through
the cell, combined with a long exposure time. However, Swulius et al. also
recognised the possibility, if unlikely, of sample preparation in the cryotomography
process causing long MreB filaments to depolymerise (134).
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The group proposed an alternative model where the peptidoglycan cell wall itself
forms a scaffold for further cell wall synthesis. They suggested that freely moving
MreB-linked enzyme complexes may provide additional support to newly-
synthesised sections of cell wall, lengthening and straightening them as they are
incorporated into the existing cell wall. In addition, short filaments of polymerised
MreB may play a role in forming a bridge between glycan strands (134).
However, this model does not explain several observations, including that of new
wall insertion, which occurs in a helical fashion reminiscent of the proposed MreB
localisation. In addition, the helical localisation of MreB and associated proteins is
often seen to be dependent on at least one other cell shape-determinant protein,
the absence of which causes the proteins to mislocalise, seemingly forming arcs
and random linear filaments across the cell cytoplasm. A22 treatment also causes
the observed helices to dissipate. Furthermore, MreB and associated proteins are
known to re-localise to the cell septum before cell division. It is questionable as to
whether these phenotypes would be detected if helical localisation was purely an
artefact of sample preparation. Whatever the reason for the inability of Swulius et
al. to detect MreB helices, both models warrant further investigation to more
comprehensively elucidate the mechanisms of cell shape control in rod-shaped
bacteria.
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Figure 1.5: Putative multiprotein complexes responsible for lateral and septal cell
wall synthesis: A and B taken from “Morphogenesis of rod-shaped sacculi” (126).
Putative interactions (as shown) are based on data from bacterial two-hybrid assays and
coimmunoprecipitation studies. Two alternative models of elongation complex given in A.
C – additional model of elongation complex, adapted from figure in “The morphogenetic
MreBCD proteins of E. coli form an essential membrane-bound complex” (131), to include
RodZ.
1.4 The mrd operon of Salmonella
The cell shape determinant proteins PBP2 and RodA are encoded by the pbpA
(mrdA) and rodA (mrdB) genes, respectively (155). These genes lie contiguously
within the putative mrd (murein D) operon in many rod-shaped bacteria including
Escherichia coli, and Salmonella (122, 142, 155). Studies show that the mrd
operon is likely to consist of at least three other genes: ybeB, ybeA, and rlpA
(Figure 1.6). The contiguous nature of pbpA, rodA and rlpA, along with the lack of
transcriptional termination sequences between the pbpA and rodA genes, and the
functional relationship of pbpA and rodA at least, suggests that these three genes
are co-transcribed (142-144, 186). In addition, potential promoter sequences for
this operon have been identified in the inter-genic region upstream of ybeB. Hence
the two ybe genes may also form part of the operon (142).
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Figure 1.6: The putative mrd operon of Salmonella enterica serovar Typhi:
Schematic diagram showing layout of mrd operon in S. Typhi, including gene sizes,
spacing between genes, and position of putative mrd operon promoter upstream of ybeB.
Operon layout as shown is identical in both Typhi and Typhimurium serovars, except for
rlpA gene; length in S. Typhimurium is 1146 bp.
However, some evidence suggests that rodA and rlpA may be independently
expressed. Putative promoter sequences were identified upstream of rodA, within
the pbpA gene, although the activity of the promoter upstream of ybeB was much
greater than that from the rodA promoter as shown by expression levels of a rodA-
lacZ fusion construct, leading the authors to conclude that pbpA and rodA were
likely to be co-expressed (143, 144). In addition, transposon mutagenesis of the
pbpA gene did not have a polar effect on rodA expression, as would be expected
for co-transcribed genes (144). Promoter-like sequences have also been identified
upstream of the rlpA gene, within rodA although these may not constitute an actual
active promoter, and rlpA is generally recognised as being co-transcribed with
rodA (179, 186, 187).
ybeB encodes YbeB, a common, highly conserved protein (188, 189, 190).
Relatively little is known about the function of YbeB, although it is homologous to
Iojap, a plant protein required to maintain the stability of chloroplast ribosomes
(189, 191). In 2007 Jiang et al. showed that YbeB is a 50S subunit ribosome-
associated protein, possibly involved in ribosome biogenesis (189, 192, 193).
Double mutants of ybeB and the minCDE genes were also isolated with a
synthetic lethal phenotype in E. coli. The Min proteins are responsible for directing
formation of the FtsZ ring at a mid-cell position, by inhibiting FtsZ polymerisation
elsewhere. Double mutants isolated with a lethal or sick phenotype were therefore
indicative of proteins potentially involved in cell division. However, the ΔybeB Min-
double mutants also harboured shape defects which were complemented with the
recovery of pbpA/rodA expression in trans. The authors therefore suggested that
the observed phenotypes were most likely due to a polar effect of the ybeB
mutation on the expression of the downstream pbpA and rodA genes (188). YbeB
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is not essential in E. coli, although given its highly conserved nature it is likely that
this protein has some important function (188). That a ybeB mutation may have
had a polar effect on pbpA and rodA expression also suggests that ybeB is indeed
part of the mrd operon.
The ybeA gene is highly conserved in many bacterial species, and also present in
archaeal and plant genomes (196). Recent work has identified YbeA (RlmH) as a
methyltransferase involved in what is thought to be the final stage of ribosome
assembly, which occurs as translation begins. In E. coli, dimeric YbeA specifically
methylates a pseudouridine residue m3Ψ1915, located within stem-loop 69 of the
23S ribosome subunit rRNA (194-196). This hairpin loop of rRNA is specifically
important to ribosome function, playing a role in the initiation, elongation and
accuracy of translation, as well as ribosome recycling. The three highly conserved
pseudouridine residues contained within stem-loop 69 are important for translation
termination in particular (195-197). Purta et al. speculated that YbeA may act as a
checkpoint, indicating that translation initiation has proceeded (194). Aside from
the effects on pseudouridine methylation in a ΔybeA mutant strain, minor growth
defects were reported for this strain when grown in rich medium at 37°C. However,
the presence of additional morphogical defects, or polar effects on downstream
gene expression in this mutant was either not noted or simply not reported (194,
196). It is therefore unknown whether ybeB and ybeA are in any way functionally
related to the other mrd operon genes.
rlpA was found to encode a rare outer membrane lipoprotein (RlpA) (179, 186,
198). Due to close homology of the signal peptide sequence of rlpA with those of
other peptidoglycan-associating lipoproteins including Braun lipoprotein (Lpp), it
was suggested that RlpA may also associate with peptidoglycan in some way (124,
186). Further evidence supporting this came from analysis of the RlpA amino acid
sequence using the SMART database (163, 199, 200). This identified a 70-amino
acid sporulation-related (SPOR) domain close to the C-terminal of RlpA, which is
found in several cell division proteins and may be involved in binding
peptidoglycan. This domain is absent from the Lpp sequence. Gerding et al.
demonstrated more recently that isolated SPOR domains from RlpA, as well as
three other proteins (FtsN, DamX and DedD), bound peptidoglycan and localised
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to the cell septum in E. coli, suggesting these domains are sufficient to direct
septal accumulation. However, the full-length RlpA was found to localise at distinct
foci along the side walls of both dividing and non-dividing cells, as well as at the
cell septum, as has been observed in Salmonella (163, 179, 201). The authors
concluded that SPOR domain proteins may form part of the septal cell division ring,
although the precise role of RlpA in cell division, or other cell processes, remains
unknown, since ΔrlpA mutants did not display any obvious growth or division
defects in E. coli or Salmonella. It is possible, however, that some functional
redundancy may exist, masking the effects of an rlpA mutation (163, 179, 201).
RlpA is one of only two outer membrane lipoproteins so far recognised to localise
at the cell septum. The outer membrane protein Pal is required for invagination of
the outer membrane during cell division, and so it has been proposed that RlpA
may bridge the outer membrane and peptidoglycan, playing a similar role to Pal,
although this does not explain the side-wall localisation patterns. Given its
presence within the mrd operon, it may also play a role linked with that of PBP2
and RodA (179, 186, 201, 202).
A study in 2002 also found that expression of rlpA was highly induced with
hyperosmotic stress in E. coli, suggesting that RlpA may be involved to some
extent in resistance to external stresses (203). Finally, Prc is a periplasmic
protease which cleaves the cell division transpeptidase enzyme, PBP3. It is also
important for resistance to both thermal and osmotic shock, since Δprc mutants
are lethal when cells are grown above 40°C in hypotonic media. A truncated RlpA
(retaining just the N-terminal 102 amino acids of the full length protein) was able to
suppress this lethality when overexpressed, potentially indirectly through the
induction of another protease HtrA (198). This may point to another link, if indirect,
between RlpA and cell division or stress resistance.
Another gene located 138 bp downstream of rlpA, dacA, may also form part of the
operon (145, 204, 205). dacA encodes a non-essential D-alanine
carboxypeptidase enzyme (PBP5), whose inactivation brings about morphological
defects in E. coli (204, 206-208). Overproduction of PBP5 also caused E. coli cells
to become spheroid and prone to lysis, and these cells had an altered
peptidoglycan structure similar to that in ∆pbpA cells (209). This suggests a
35
functional link with other mrd operon cell shape genes. PBP5 has also been
shown to localise both septally and in the lateral cell wall (126). However, PBP5 is
the most abundant penicillin-binding protein expressed in bacterial cells, a feature
which would not be expected for a gene located towards the 3' end of an operon
(207, 210). In fact, PBP5 is much more highly expressed than PBP2, suggesting
that expression of dacA is independent of pbpA, although this theory does not take
into account the possible post-transcriptional regulation mechanisms to regulate
both PBP2 and PBP5 protein levels (210). However, mutations in the mrd operon
genes in E. coli did not affect PBP5 expression, and ΔrlpA mutants did not
possess the morphological defects displayed by ΔdacA mutants, both suggesting
that dacA is not co-transcribed along with the upstream mrd operon genes (179,
201, 211).
The precise complement of genes contained within the mrd operon is still not
known and further experimental work is required to establish this. However, it is
generally accepted that the ybeB-rlpA genes are likely to form one transcriptional
unit, the putative promoter for the mrd operon being located upstream of the ybeB
gene (142, 186, 187, 212).
1.5 Rationale for studying cell shape determinants and the mrd operon in
Salmonella
The aims of this study focus on the further delineation of both the structure of the
mrd operon, and the function of its constituent genes, within the enteric pathogen
Salmonella Typhi specifically. In particular investigations will assess the potential
wider roles of the mrd operon genes in the pathogenesis, as well as the general
biology, of Salmonella. The rationale for studying the mrd operon in Salmonella is
discussed below.
1.5.1 Cell shape determinant inactivation and effects on cell wall structure,
integrity and general physiology in Salmonella
The peptidoglycan sacculus is widely recognised as the stress-bearing molecule of
the cell, helping maintain cell shape and resist internal turgor pressure to prevent
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cell lysis (124, 125, 213). Hence, disruptions to the cell wall structure caused by
the genetic or drug-mediated inactivation of cell wall synthetic complexes, cause a
loss of cell shape and eventual cell lysis. With the presence of additional
compensatory mutations however, round cells are able to grow and divide
indefinitely, although cell wall growth appears to be dependent upon the septal-
specific peptidoglycan synthesis complex in cell shape determinant mutants (127).
In addition, the cell wall integrity in these cells appears to be significantly affected.
Several studies have noted increased sensitivity to various external stresses in cell
shape-determinant mutants, including osmotic pressure, oxidative stress, drugs
and antibiotics (211, 214). In mecillinam-treated cells, whilst growth and division
rates remained at the same level as wild-type for at least one mass doubling, a
50% reduction in the rate of peptidoglycan synthesis was observed (127). This
evidence suggests that the lateral cell walls of pbpA (and rodA) mutants have a
significantly compromised cell wall structure, lacking both the physical strength to
withstand osmotic pressure, and the structural integrity to act as an effective
barrier against external stresses. Perturbations to the cell wall integrity are unlikely
to be due to the constitutive synthesis of septal peptidoglycan, since the
differences between septal and lateral cell wall peptidoglycan structure are very
small (122, 201).
1.5.2 Cell shape determinant inactivation and effects on cell wall-spanning
organelles
Besides the observed defects in cell wall structure and integrity, and cell
morphology, the effects of mre, mrd and rodZ mutations upon the assembly and
functioning of other cell wall components, including large cell wall-spanning multi-
protein organelles, has not been widely considered (118, 166, 215). This has
important implications in terms of virulence, since many major virulence
determinants in pathogens such as Salmonella encompass such organelles,
including flagella and type 3 secretion systems (T3SSs) (4, 11, 12, 216). Although
two studies have noted motility defects in round-cell mutants, few, if any, have
comprehensively analysed the effects of cell shape determinant inactivation upon
flagella and T3SS function in Salmonella or other bacterial pathogens (118, 166).
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The study of possible links between cell wall synthesis/integrity and wall-spanning
organelle functionality could be significant for a number of reasons.
Involvement of peptidoglycan in assembly, stability and positioning of cell
wall organelles
Cell wall-spanning multiprotein complexes such as flagella and T3SSs both
traverse the peptidoglycan layer, directly associating with it. Such associations
with the peptidoglycan may be necessary to help stabilise the flagellum/T3SS
structures in the wall, and assist their function (213). For instance, the P ring of the
flagellum basal body is a rigid, non-rotating structure consisting of 26 FlgI
monomers. It is thought to specifically interact with the peptidoglycan layer,
connecting the basal body to the cell wall, and in doing so, providing physical
support and stability to the rotor (62, 217). Sequential regulation of flagellum
assembly means that downstream elements of the flagellum structure are not
expressed and assembled until the preceding elements are successfully
assembled. Consequently, disruptions of FlgI cause flagellum assembly to halt at
the assembly of the P ring (218). It may be that peptidoglycan-binding via the P
ring is an important feature in flagella assembly. Flagellar rotation is extremely fast,
having been measured at 100Hz. Such forces may make it necessary for the
flagellum to be tightly secured within the cell wall (213). In addition to the P ring,
the MotB flagellar protein is also involved in peptidoglycan binding. The C-
terminus of MotB is thought to bind peptidoglycan in order to anchor and help
stabilise the stator structure around the basal body (213, 63, 64). Amino acid
substitutions in regions of the MotB protein within or close to the peptidoglycan-
binding domain cause motility defects (213).
The loss of peptidoglycan-binding through mutations in peptidoglycan-binding
regions of proteins within several bacterial wall-spanning secretion systems
(including the SPI-1 T3SS, T2SSs and T6SSs) is linked with a loss of function (49).
The PrgH, PrgK and InvH proteins of the SPI-1 T3SS also bind peptidoglycan
directly. PrgH and PrgK are membrane proteins, forming part of the base of the
SPI-1 needle structure, whereas InvH is an outer membrane lipoprotein which
appears to form more stable cross-links with peptidoglycan. It was proposed that
InvH, and its association with peptidoglycan, plays an important role in initiating
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assembly of the SPI-1 needle, although InvH is not essential for needle assembly
(49). In the same study, altered peptidoglycan structure caused an inhibition of
these protein-peptidoglycan interactions along with a subsequent decrease in the
number of SPI-1 needle complexes per cell, and hence decreased secretion and
invasion. The peptidoglycan structural changes were brought about by the
incorporation of D-methionine into the cell wall, resulting in changes including a
significant reduction in the number of peptide cross-links (49, 219). SPI-1
structural protein expression however, was unaffected, and the same
peptidoglycan modifications did not affect flagella assembly.
These data together demonstrate the importance of peptidoglycan-binding
proteins and the integrity of the cell wall on the assembly and consequently the
function of cell wall-spanning organelles. Peptidoglycan itself may function as a
physical scaffold in the anchoring of such structures into the cell wall. Defects in
the cell wall could therefore significantly affect organelle assembly and function
(64, 67, 213, 220). The effects seen with alterations in peptidoglycan structure in
these studies may be similar or amplified in cells with cell wall defects caused by
the inactivation of the cell shape determinants.
Putative positioning of cell wall complexes by bacterial cytoskeletal proteins
Current models hypothesise that the MreB cytoskeleton and associated proteins
act by directly positioning cell wall synthetic complexes within the cell wall to bring
about spatially organised cell wall synthesis. It is therefore reasonable to consider
that the same cytoskeletal elements may also be directly involved in the
positioning and localisation of other multi-protein structures within the cell wall,
including flagellar and T3SS basal body proteins. If this is the case, perturbations
in the MreB cytoskeleton and/or associated proteins (since MreB localisation may
be dependent on other cell shape determinant proteins) are likely to affect both the
assembly and localisation of cell wall-spanning organelles.
Evidence to support this hypothesis has come from a study showing that the
bacterial actin homologue, MreB, is involved in directing the polar localisation of
several proteins, including, for example, secretion system proteins, virulence
related proteins and cell surface receptors (173). In another example, motility in
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the Gram-negative bacteria Myxococcus xanthus was shown to require MreB.
Motility in this organism is mediated not by flagella, but using two separate motility
systems to move across surfaces: S-Motility and A-motility. S-motility involves
polar type-IV pili, which attach to surface polysaccharides and then retract to move
the bacterium forward. A-motility is less well characterised but may comprise
motor systems and adhesion complexes which display distinct localisation patterns
along the length of the cell. Recently, Mauriello et al. demonstrated that treatment
of M Xanthus cells with the MreB inhibitor, A22, blocked both A- and S-motility.
Furthermore, localisation of the A-motility and S-motility protein complexes was
disrupted in A22-treated cells. AglZ, a protein involved in A-motility, was localised
in clusters along the length of the cell, in a manner reminiscent of MreB. Taking
the results together, Mauriello et al. hypothesised that MreB is specifically involved
in the localisation of motility complexes in this bacterium (221). Recently, another
study in Pseudomonas aeruginosa found that the MreB cytoskeleton was directly
involved in the polar localisation of type IV pili. In cells treated with A22, both the
pili themselves and an important protein involved in pilus retraction mislocalised
(222).
These studies are amongst the few that have considered both the importance of
virulence determinant localisation in pathogens, and the possible role of the
bacterial cytoskeletal elements in virulence determinant localisation (222). They
provide clear evidence that the MreB cytoskeleton in particular may play an
important role in the localisation and hence function of such systems.
Several cell wall-spanning organelles in Salmonella are known to have distinct
localisation patterns. Wild-type S. enterica serovars are known to express between
4 and 8 flagella per cell, although some studies have reported numbers of
between 6-10 flagella, or up to 15 per cell (113, 223-225). These peritrichous
flagella are distributed around the whole of the cell surface, including the lateral
cell walls and the poles (226). Nikolaus et al. demonstrated that SPI-2 needles
have a polar localisation, with apparently few, or only one needle complex per cell
(227, 228). By comparison, the SPI-1 T3SS appears to be distributed diffusely
across the whole bacterial cell surface, with up to 200 needle complexes per cell
(54, 227). It remains to be investigated whether the localisation of flagella, SPI-1
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and SPI-2 organelles in Salmonella is coordinated by bacterial cell shape genes or
the cytoskeleton, although their localisation is clearly significant for function (227).
1.5.3 Cell shape determinant inactivation and global effects on cell biology
The inactivation of cell shape determinant brings about stark defects in cell wall
synthesis and integrity, indicated by morphological defects and increased
sensitivity to external stress (229). Aside from these specific effects, the global
effects in bacteria such as Salmonella have not been studied in detail. In particular,
the increased exposure of mrd, mre or rodZ mutants to external stresses would
have a potentially massive impact on global transcriptional and translational
profiles. This would also be relevant in terms of virulence, given that virulence
gene expression is tightly regulated by multiple environmental signals, so that
virulence properties are expressed when the bacteria are in a particular state or
environment. Increased exposure to certain environmental stresses which may
trigger the activation of global regulatory pathways could certainly alter virulence
gene regulation.
Hence there is a need to further investigate the global downstream effects of cell
shape determinant inactivation. Doing so would provide a broader picture of both
the general physiology and the responses involved in bacteria with cell wall
defects, as well as providing further clues into the precise roles of both the cell wall,
cell shape determinant proteins, and cell wall associated synthetic complexes.
1.5.4 The mrd operon in relation to the biology and virulence of Salmonella
The mrd operon genes are known to play an important role in lateral cell wall
synthesis. However, the structure and regulation of the operon, as well as the
precise roles of the constituent genes, are not well characterised. Much work is
needed to delineate the functions of the cell shape determinant proteins PBP2 and
RodA not only in cell wall synthesis, but also in the broader biology of rod-shaped
bacteria such as Salmonella. Furthermore, the roles of the ybe and rlpA genes
should be further investigated. ybeB and ybeA are known to be involved in
ribosome assembly and stability, but whether their roles are linked with those of
pbpA and rodA remains to be realised. Bacterial ribosomes in B. subtilis are
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localised around the periphery of the cytoplasm and particularly at the cell poles
(230, 231). If the same is true in Salmonella it is plausible that cell-shape
determinant proteins may be involved in directing the localisation of ribosomes and
associated proteins including YbeB and YbeA. An association between cell wall
synthetic complexes and ribosomes may hint at a functional link between the mrd
operon proteins (230). It was recently recognised that RlpA has a role in
peptidoglycan binding, and may localise in a pattern reminiscent of the PBP2 and
RodA helices, as well as at the division septum (163, 179, 201). These findings
also may indicate a functional relationship between the pbpA, rodA, and rlpA
genes which should be further investigated.
The high level of operon conservation suggests that there may be some
conserved function between all 5 genes, that has until now not been recognised.
That the conserved operon contains genes with seemingly unrelated functions
may also point to the PBP2 and RodA proteins fulfilling more complex functions
than currently proposed.
Finally, along with investigating the role of mrd operon genes in the functionality of
important virulence determinants in Salmonella, it is important to establish whether
mrd operon mutants of Salmonella remain not only viable, but virulent.
1.6 Outline of aims, progress and major results from this study
In conclusion, the major aims of this thesis were to systematically analyse the role
of the mrd operon in the biology and pathogenicity of Salmonella enterica serovar
Typhi. Specifically, this entailed the primary analysis of the mrd operon structure,
followed subsequently by the construction of precise knockout mutants of each
gene in S. enterica serovar Typhi, and comprehensive phenotypic analyses of
these mutants. A wide range of phenotypic analyses were to be utilised to enable
investigation of both the general physiology and biology of mutant cells, and the
pathogenicity of these strains. This would be done with the hope of gaining a
better understanding of the function of this operon, and in particular establishing
whether there are any links between the function of these genes and pathogenicity
in Salmonella. This aspect may be particularly significant, given the nature of
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many major Salmonella virulence determinants as cell wall-spanning organelles,
which may be dependent upon a certain level of cell wall integrity for their function,
as previously discussed.
As work has progressed, initial results demonstrated clear effects of mrd gene
inactivation on some but not all aspects of pathogenicity, due to the
downregulation of invasion-associated virulence genes. As such, the focus of this
project was developed, with additional aims of elucidating the regulatory
mechanisms responsible for controlling the observed phenotypes and the overall
behaviour of the mutants.
Work of this thesis has followed the aims closely, bringing about significant
insights into the mrd operon genes. To date, the results of this work have shown
that round-cell pbpA and rodA mutants, but not ybeB, ybeA, and rlpA mutants,
have severe defects in invasion-associated virulence, such as SPI-1 and motility,
whereas virulence factors involved in intracellular survival remained active in these
mutants. More recent work has demonstrated that virulence can be recovered in
round-cell mutants through the restored expression of the major SPI-1 and motility
transcriptional regulators. Furthermore, several putative regulators of these
phenotypes have been identified, suggesting that envelope stress response
pathways are activated in round-cell mutants, as well as at least one other novel
regulator. Together these regulators play a major role in controlling virulence gene
expression in response to the inactivation of pbpA or rodA. The roles of the
remaining 3 mrd operon genes have been investigated, and some data highlights
potential functional links between the mrd operon genes.
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Chapter 2. Materials and Methods
2.1 Materials
2.1.1 Chemicals, kits and reagents
General laboratory chemicals and antibiotics were acquired from Sigma-Aldrich®
(Dorset, UK), or BDH® Chemicals (VWR International, Leicestershire, UK).
Bacto™ Growth media was obtained from BD (Oxford, UK).
Restriction endonuclease enzymes and T4 DNA ligase used in this study were
purchased from Promega UK (Southampton, UK) and Fermentas UK (York, UK).
GoTaq® DNA Polymerase and Phusion® High-Fidelity DNA Polymerase were
purchased from Promega UK (Southampton, UK) and Finnzymes (NEB UK, Herts,
UK) respectively. RT-PCR reactions were performed using the Access RT-PCR
System (Promega, Southampton, UK).
The Qiagen DNeasy Blood and Tissue Kit was used for genomic DNA preparation
(West Sussex, UK). Additional DNA purification kits used in this study were
obtained from Invitrogen™ (Life Technologies co., California, US), including the
following: the Purelink™ Quick Plasmid Miniprep Kit, the PureLink™ PCR
Purification Kit, and the PureLink™ Quick Gel Extraction Kit. The Ambion®
Ribopure™-Bacteria Kit was used for RNA isolation (Life Technologies co.,
California, US). Lipopolysaccharide (LPS) extraction kits were obtained from
iNtRON Biotechnology (Gyeonggi-do, Korea).
The NBS Biologicals SafeView Nucleic Acid Stain was used for detecting
DNA/RNA in agarose gels (Cambridgeshire, UK). GeneRuler™1kb DNA Ladder
and PageRuler™ Prestained Protein Ladder molecular weight markers were
purchased from Fermentas UK (York, UK). Alternatively, 1kb DNA Ladder was
purchased from Promega UK (Southampton, UK).
Finally, the “SilverSNAP” Pierce Silver Stain kit was obtained from Pierce Protein
Research (Thermo Fisher Scientific, Illinois, US).
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2.1.2 Antisera
Polyclonal horseradish peroxidise (HRP)-conjugated goat anti-rabbit and goat anti-
mouse immunoglobulins, routinely used in western blotting, were purchased from
Dako UK Ltd. (Cambridgeshire, UK). Alexa Fluor® 488 dye-labelled goat anti-rabbit
IgG antibodies, for use in immunofluorescence microscopy, were purchased from
Invitrogen™ (Life Technologies co., US).
HA.11 monoclonal IgG antibody was obtained from Covance Inc. (New Jersey,
US).
Salmonella agglutinating sera for use with slide agglutination assays and
immunofluorescence microscopy were obtained from Murex Biotech Ltd. (Dartford,
UK).
The SPI-1 anti-SipA, anti-SipC and anti-SipD rabbit polyclonal antibodies used in
western blots and immunofluorescence microscopy were kindly donated by
Vassilis Koronakis (Cambridge University, UK).  The SPI-2 anti-SseB rabbit
polyclonal antibody was kindly donated by David Holden (Imperial College
London).
2.1.3 Buffers, stock solutions, antibiotics and media
Buffers and stock solutions were prepared as follows. Final concentrations or
working concentrations are shown in brackets. All growth media was sterilised
before use by autoclaving. Buffers and solutions were sterilised as required, by
autoclaving or filter sterilisation (pore size: 0.2 µm).
10x Phosphate-buffered saline (PBS)
80 g NaCl, 2 g KCl and 11.5 g Na2HPO4 made up to 1 litre with dH2O, adjusted to
pH 7.5.
10x SDS-PAGE running buffer
30.3 g Trizma® base (250 mM), 187.7 g glycine (2.5 M) and 10 g sodium dodecyl
sulphate (SDS) (1%), made up to 1 litre with dH2O.
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6x SDS-PAGE sample buffer
100 μl 0.5 M Tris-HCl pH 6.8 (50 mM), 60 μl 10% SDS (0.6%), 50 μl 2%
bromophenol blue (0.1%) and 400 μl glycerol (40%), made up to 1 ml with dH2O.
10% 2-mercaptoethanol added before use.
2x SDS-PAGE sample buffer
200 μl 0.5 M Tris-HCl pH 6.8 (100 mM), 400 μl 10% SDS (4%), 100 μl 2%
bromophenol blue (0.2%) and 200 μl glycerol (20%), made up to 1 ml with dH2O.
10% 2-mercaptoethanol added before use.
Transfer buffer for western blotting
14.4 g glycine, 3.06 g Trizma® base and 200 ml methanol, made up to 1 litre with
dH2O. Freshly prepared and cooled to 4ºC before use.
Blocking solution for western blotting
3% bovine serum albumin dissolved in PBS-Tween (0.1% Tween). Freshly
prepared before use.
Chloro-naphthol developer solution for western blotting
30 mg 4-chloro-1-naphthol, 10 ml methanol, 30 ml PBS and 60 µl hydrogen
peroxide (30% w/w). Freshly prepared before use.
Coomassie® Brilliant Blue stain solution
0.2 g Coomassie® Brilliant Blue R, 80 ml methanol and 10 ml acetic acid, made up
to 200 ml with dH2O.
Coomassie® de-stain solution
300 ml methanol and 100 ml acetic acid, made up to 1 litre with dH2O.
50x TAE buffer
242 g Trizma® base, 57.1 ml acetic acid and 100 ml 0.5 M EDTA, made up to 1
litre with dH2O and adjusted to pH 8.0.
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6x DNA loading buffer
1.25 ml 2% bromophenol blue (~0.25%), 4 ml glycerol (~40%) and 5 ml dH2O
(~50%).
4% Paraformalydehyde fixing solution
4% paraformaldehyde (PFA) dissolved in PBS.
1000x Ampicillin stock solution
100 mg ampicillin sodium salt dissolved in 1 ml dH2O. Working concentration: 100
µg/ml.
1000x Kanamycin stock solution
50 mg kanamycin sulphate salt dissolved in 1 ml dH2O. Working concentration: 50
µg/ml.
1000x Chloramphenicol stock solution
25 mg chloramphenicol dissolved in 1 ml 70% ethanol. Working concentration: 25
µg/ml.
100x Tetracycline stock solution
5 mg tetracycline hydrochloride dissolved in 1 ml 70% ethanol. Working
concentration: 50 µg/ml.
100x Aromatic amino acid mix stock solution (Aro mix)
80 mg L-phenylalanine (40 µg/ml), 80 mg L-tryptophan (40 µg/ml), 20 mg 4-
aminobenzoic acid (PABA) (10 µg/ml) and 20 mg 2,3-dihydroxybenzoic acid
(DHBA) (10 µg/ml), dissolved in 20 ml dH20.
100x Tyrosine stock solution (Tyr mix)
80 mg L-tyrosine dissolved in 20 ml 0.1 M HCl. Working concentration: 40 µg/ml.
100x Congo red solution
10 mg congo red dissolved in 1 ml 70% ethanol.  Working concentration: 100
µg/ml.
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Luria-Bertani (LB) broth
10 g tryptone, 5 g yeast extract and 10 g NaCl, made up to 1 litre with dH2O.  For
1.5% LB agar, 15 g of agar was added to 1 litre LB broth.
SOC media
20 g tryptone, 5 g yeast extract, 0.5 g NaCl and 10 ml 250 mM potassium chloride,
adjusted to pH 7.0 and made up to 1 litre with dH2O. 10 ml sterile 1 M MgCl2 and
10 ml sterile 1 M glucose added before use.
M5.8 SPI-2-inducing minimal media
15.76 g Tris-HCl (100 mM), 0.1% casamino acids and 1.6 ml glycerol (0.16%),
adjusted to pH 5.8 and made up to 1 litre with dH2O. 10 μl sterile 1 M MgCl2 (10
μM) and 10 ml sterile 4 mg/ml histidine (40 μg/ml) added before use.
Motility agar (0.3% agar)
10 g tryptone, 5 g NaCl and 3 g agar, made up to 1 litre with dH2O.
2.1.4 Molecular size markers
DNA molecular size markers for agarose gels
The Fermentas GeneRuler™ 1 kb DNA Ladder (York, UK) or the Promega 1 kb
DNA Ladder (Southampton, UK) were used as DNA molecular size markers for
the separation of DNA in agarose gels (Figure 2.1).
Protein molecular size markers for SDS-PAGE
The Fermentas PageRuler™ Prestained Protein Ladder (York, UK) was used as a
molecular weight marker during the separation of proteins by SDS-PAGE (Figure
2.2).
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Fermentas GeneRuler™1 kb DNA Ladder Promega 1 kb DNA Ladder
10000 bp 10000 bp
8000 bp 8000 bp
6000 bp 6000 bp
5000 bp 5000 bp
4000 bp 4000 bp
3500 bp 3000 bp
3000 bp 2500 bp
2500 bp 2000 bp
2000 bp 1500 bp
1500 bp 1000 bp
1000 bp 750 bp
750 bp 500 bp
500 bp 250 bp
250 bp
Figure 2.1: DNA molecular size markers: Indication of DNA fragment sizes for
Fermentas and Promega DNA molecular size markers, as used in agarose gel
electrophoresis with DNA.
Fermentas PageRuler™ Prestained Protein Ladder
~170 kDa
~130 kDa
~100 kDa
~70 kDa (red)
~55 kDa
~40 kDa
~35 kDa
~25 kDa
~15 kDa
~10 kDa (green)
Figure 2.2: Protein molecular size markers: Indication of protein fragment sizes for the
Fermentas PageRuler™ molecular size marker, as used in the separation of proteins by
SDS-PAGE.
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2.1.5 Bacterial strains and plasmids
The bacterial strains and plasmids used in this work, along with any relevant
information, are outlined in Table 2.1.
Bacterial strains
Species Strain Genotype/relevant information Source/reference
S. enterica serovar
Typhi
BRD948 Derivative of Ty2 strain; ∆aroC,
∆aroD, ∆htrA
G. Dougan
(Sanger institute,
Cambridge) (232,
233)
BRD948 ∆ybeB This study
BRD948 ∆ybeA This study
BRD948 ∆pbpA This study
BRD948 ∆rodA This study
BRD948 ∆rlpA (163)
BRD948 pagN::cat (Henceforth: ΔpagN) This study
BRD948 rcsC::cat (Henceforth: ΔrcsC) This study
BRD948 ∆rodA ΔpagN This study
BRD948 ∆pbpA ΔrcsC This study
BRD948 ∆rodA ΔrcsC This study
S. enterica serovar
Typhimurium
SL1344 Wild-type, derivative of LT2 (234)
SL1344 ∆spi1 (235)
NCTC 12023 ∆ssaV SPI-2 non-secretor DW. Holden (47)
SL1344 ∆ssaV SPI-2 non-secretor Transduced from
the above
SL1344 ybeB::kan (Henceforth: ΔybeB) This study
SL1344 pbpA::kan (Henceforth: ΔpbpA) This study
SL1344 rodA::kan (Henceforth: ΔrodA) (163)
SL1344 rlpA::kan (Henceforth: ΔrlpA) (163)
SL1344 TPA14 (PflhDC5451::Tn10[del-25]) This study;
transduced from
phage stock given
by PD. Aldridge
(236)
SL1344 ΔpbpA TPA14 This study; as
above
SL1344 ΔrodA TPA14 This study; as
above
SL1344 Tn10d(Tc) H. Spencer
(ICAMB,
Newcastle)
SL1344 pagN10a::Tn10d(Tc) This study
SL1344 rcsC4a::Tn10d(Tc) This study
SL1344 rcsC9a::Tn10d(Tc) This study
SL1344 rodA::kan, pagN10a::Tn10d(Tc) This study
SL1344 rodA::kan, rcsC4a::Tn10d(Tc) This study
SL1344 rodA::kan, rcsC9a::Tn10d(Tc) This study
SL1344 pagN::cat (Cmr) (Henceforth:
ΔpagN)
This study
SL1344 rcsC::cat (Henceforth: ΔrcsC) This study
SL1344 ΔpbpA ΔpagN This study
SL1344 ΔrodA ΔpagN This study
SL1344 ΔpbpA ΔrcsC This study
SL1344 ΔrodA ΔrcsC This study
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SL5338 galE r – m + (Rough LPS mutant) (237)
E. coli TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC)
φ80lacZΔM15 ΔlacX74 recA1
araD139 Δ(araleu) 7697 galU galK
rpsL (StrR) endA1 nupG
Invitrogen™ (Life
Technologies co.,
California, US)
MC1000 e14 araD139 Δ(araA-leu)7697
galE15 galK16 Δ(codB-lac)3
rpsL150 mcrB1 relA1 spoT1
L. Rothfield
(University of
Connecticut, US)
(135)
Plasmids
Name Genotype/relevant information Source/reference
pKD46 Red helper plasmid. Derivative of pINT-ts, araC-ParaBand γ β exo, tL3 terminator downstream of exo.
Encodes λ Red Recombinase gene. Ampicillin resistant
(ampR), temperature sensitive
(238)
pKD13 Template plasmid.   Derivative of pANTSγ with
kanamycin resistance (kanR) gene flanked by FLP
recognition target (FRT) sites, ampr
(238)
pKD3 Template plasmid.   Derivative of pANTSγ with
chloramphenicol resistance (CmR) gene flanked by FLP
recognition target (FRT) sites, ampR
(238)
pCP20 FLP+, λ cI857+, λ PR Repts, ampR, CmR, temperaturesensitive
(238, 239)
pMK1lux Transcriptional luminescence reporter plasmid. pBR322
cloning vector with promoter-less luxCDABE operon
(taken from pSB377) downstream of MCS. ampR
(240-242)
pMK1lux–PcobC 499bp region, 27bp upstream of BRD948 cobC gene
cloned into pMK1lux MCS between 5’ ecoR1 and 3’
BamH1 restriction sites
This study
pMK1lux–PybeB 499bp region, 29bp upstream of BRD948 ybeB gene
cloned into pMK1lux MCS between 5’ ecoR1 and 3’
BamH1 restriction sites
This study
pMK1lux–PybeA* 496bp region, 30bp upstream of BRD948 ybeA gene
cloned into pMK1lux MCS between 5’ ecoR1 and 3’
BamH1 restriction sites
This study
pMK1lux–PybeA 289bp region, 30bp upstream of BRD948 ybeA gene
cloned into pMK1lux MCS between 5’ ecoR1 and 3’
BamH1 restriction sites
This study
pMK1lux–PpbpA 499bp region, 33bp upstream of BRD948 pbpA gene
cloned into pMK1lux MCS between 5’ ecoR1 and 3’
BamH1 restriction sites
This study
pMK1lux–ProdA 501bp region, 31bp upstream of BRD948 rodA gene
cloned into pMK1lux MCS between 5’ ecoR1 and 3’
BamH1 restriction sites
This study
pMK1lux–PrlpA 500bp region, 30bp upstream of BRD948 rlpA gene
cloned into pMK1lux MCS between 5’ ecoR1 and 3’
BamH1 restriction sites
This study
pMK1lux–fliF Promoter region of fliF gene (499bp upstream of fliF,
including first 18bp of fliF) cloned into pMK1lux MCS
between 5’ ecoR1 and 3’ BamH1 restriction sites
This study
pMK1lux–hilD Promoter region of hilD gene (504bp upstream of hilD,
including first 24bp of hilD) cloned into pMK1lux MCS
between 5’ ecoR1 and 3’ BamH1 restriction sites
This study
pRG38 (flhD) Transcriptional luminescence reporter plasmid. flhD
promoter cloned into promoter-less pSB401-based
luxCDABE fusion plasmid to generate flhD::luxCDABE.
(TetR)
BMM. Ahmer
(Ohio State
University, US)
(243)
pWSK-sseJ2HA sseJ (SPI-2 effector protein) and haemagglutinin (HA) DW. Holden (244)
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tag sequences cloned into pWSK29 to generate C-
terminal Haemagglutin-tagged (HA-tagged) SseJ
pLE7 N-terminal Yfp fusion plasmid encoding E. coli MreB-
YFP (Plac-yfp::mreB). (ampR)
L. Rothfield
(University of
Connecticut, US)
(135)
pVP6 N-terminal Yfp fusion plasmid encoding E. coli PBP2-
YFP (Plac-yfp::pbpA). Digested XbaI/HindIII site-flanked
pbpA cloned into XbaI/HindIII-digested pLE7
L. Rothfield (135)
pVP3 N-terminal Yfp fusion plasmid encoding E. coli RodA-
YFP (Plac-yfp::rodA). Digested XbaI/HindIII site-flanked
rodA cloned into XbaI/HindIII-digested pLE7
L. Rothfield (135)
pLE-ybeB N-terminal Yfp fusion plasmid encoding S. Typhi YbeB-
YFP (Plac-yfp::ybeB). Digested XbaI/HindIII site-flanked
ybeB cloned into XbaI/HindIII-digested pLE7
This study
pLE-ybeA N-terminal Yfp fusion plasmid encoding S. Typhi YbeA-
YFP (Plac-yfp::ybeA). Digested XbaI/HindIII site-flanked
ybeA cloned into XbaI/HindIII-digested pLE7
This study
pJBT Cloning vector derived from pBR322. 8 amino acid
epitope tag ‘Strep-tag®‘ encoded downstream of MCS,
all under control of an arabinose inducible pBAD
promoter. Used to generate C-terminal Strep-tag®
fusion proteins. ampR
IBA International
(Louvain-la-Neuve,
Belgium) (241)
pJBT-rlpA pJBT C-terminal Strep-tag® fusion plasmid encoding
RlpA-Strep-tag®. Digested EcoRI/HindIII site-flanked
rlpA cloned into EcoRI/HindIII-digested pJBT
(163)
pBAD24 Arabinose-inducible expression vector. Plasmid gene
expression from MCS under control of arabinose
operon PBAD promoter. MCS contains optimised shine-delgarno (SD) sequence for efficient translation. ampR
(245)
pBAD-hilD pBAD24 expression vector encoding S. Typhimurium
HilD protein under control of arabinose-inducible PBADpromoter. Digested ecoRI/xbaI site-flanked hilD cloned
into ecoRI/xbaI-digested pBAD24
DM. Bulmer
(ICAMB,
Newcastle, UK)
pBAD-yciR- Strep-
tag®,
pBAD24 expression vector encoding N-terminal S.
Typhi YciR- Strep-tag® fusion protein under control of
arabinose-inducible PBAD promoter. Digested ncoI/xbaIsite-flanked yciR cloned into ncoI/xbaI-digested
pBAD24-StrepN
This study
Table 2.1: List of bacterial strains and plasmids: Details and sources of bacterial
strains and plasmids used in this study.
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2.1.6 Synthetic oligonucleotide primers
Synthetic oligonucleotide primers were designed and then purchased from (Life
Technologies co., US). Upon delivery, oligonucleotides were reconstituted in
nuclease-free dH2O to a final concentration of 100µM and stored at -20ºC till use.
A comprehensive list of the primers used in this study, along with information on
their usage, is given below (Table 2.2).
Primer name Nucleotide sequence (5’ 3’ direction) Usage, reference
Check primers
ybeB 5 ttataacgcaattattcacc 5’ ybeB check primer
ybeB 3 cgacaagttgcagcttcacg 3’ ybeB check primer
ybeA 5 gaactggaaaaactctggag 5’ ybeA check primer
ybeA 3 ctgcttaatcttctcaagac 3’ ybeA check primer
pbpA 5 gtaccgggcgtggagcatcac 5’ pbpA check primer
pbpA 3 gatcgatatgaattttatccc 3’ pbpA check primer
rodA 5 caacaacacccatttgcctg 5’ rodA check primer (163)
rodA 3 agtagtactatccctgccgc 3’ rodA check primer (163)
pagN 5 gggcttcgtttatgtaatcg 5’ pagN check primer
pagN 3 ggcgcaggagtattcattac 3’ pagN check primer
rcsC 5 cgtcatttaccgctacctta 5’ rcsC check primer
rcsC 3 ggcctaccagtcgactcatc 3’ rcsC check primer
Knockout primers
ybeB P1 ttgcagggtaaagcactccaggattttgttatcgataaaa
gtgtaggctggagctgcttc
P1 ybeB knockout primer
ybeB P4 agagtttttccagttcatacaggcggcgactttcttcctg
attccggggatccgtcgacc
P4 ybeB knockout primer
ybeA P1 aagctgcaacttgtcgctgtcggcacgaagatgcccgact
gtgtaggctggagctgcttc
P1 ybeA knockout primer
ybeA P4 tcacggtgataagggtggttggttgtgatgctccacgccc
attccggggatccgtcgacc
P4 ybeA knockout primer
pbpA P1 aacgacaaaattcttttcgtgactatacggctgagtccgc
gtgtaggctggagctgcttc
P1 pbpA knockout primer
pbpA P4 caggcaaatgggtgttgttgtcgcccagcatgatgtgatc
attccggggatccgtcgacc
P4 pbpA knockout primer
rodA P1 catgacggataatccgaacaaaaaaaccttctgggataaa
gtgtaggctggagctgcttc
P1 rodA knockout primer
(163)
rodA P4 gacgcagattacaggcaactgcttacgcattgcgcacccc
attccggggatccgtcgacc
P4 rodA knockout primer
(163)
pagN P1 gaaacttgtcttttagcccaatattaaggcaggttctgaa
gtgtaggctggagctgcttc
P1 pagN knockout primer
(246)
pagN P2 cttcgggaacccacaggaccagctattttaccgatagtgt
atgggaattagccatggtcc
P2 pagN knockout primer
(246)
rcsC P1 gtcacactctatttacatcctgaggcggagcttcgcccct
gtgtaggctggagctgcttc
P1 rcsC knockout primer
(246)
rcsC P2 ttttacaggccggacaggcgacgccgccatccggcatttt
atgggaattagccatggtcc
P2 rcsC knockout primer
(246)
Mutant sequencing
primers
SEQybeB5 cacggcgtcccgccggaagg 5’ ΔybeB sequencing primer
SEQybeB3 atcagctcaaagggcatatc 3’ ΔybeB sequencing primer
SEQybeA5 tgactggattgtcgtcgatc 5’ ΔybeA sequencing primer
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SEQybeA3 gcgaccagcgcccgacgcac 3’ ΔybeA sequencing primer
SEQpbpA5 gcgttaacgctccctcaccc 5’ ΔpbpA sequencing primer
SEQpbpA3 gtcctggccgctggcgctcc 3’ ΔpbpA sequencing primer
SEQrodA5 cggcgcaggcccggcagtag 5’ ΔrodA sequencing primer
(163)
SEQrodA3 cattacataccgcaggttgc 3’ ΔrodA sequencing primer
(163)
pMK1lux cloning
primers
pMK1lux-PcobC 5
ecoRI
gcggaattcgtcaacgcctcaagaatggc 5’ PcobC pMK1lux cloning
primer
pMK1lux-PcobC 3
bamHI
gcgggatccaaacatgataatgcccctga 3’ PcobC pMK1lux cloning
primer
pMK1lux-PybeB 5
ecoRI
gcggaattccgttcagcgattgccagaac 5’ PybeB pMK1lux cloningprimer
pMK1lux-PybeB 3
bamHI
gcgggatcctaacgatagaaaaaaggcca 3’ PybeB pMK1lux cloning
primer
pMK1lux-PybeA* 5
ecoRI
gcggaattcggcgatgctttctgtgacgtg 5’ PybeA* pMK1lux cloning
primer
pMK1lux-PybeA 5
ecoRI
gcggaattcgcagggtaaagcactccagg 5’ PybeA pMK1lux cloningprimer
pMK1lux-PybeA 3
bamHI
gcgggatcccaggcggcgactttcttcct 3’ PybeA pMK1lux cloning
primer
pMK1lux-PpbpA 5
ecoRI
gcggaattccctgtatgaactggaaaaac 5’ PpbpA pMK1lux cloning
primer
pMK1lux-PpbpA 3
bamHI
gcgggatccctcacggtgataagggtggt 3’ PpbpA pMK1lux cloning
primer
pMK1lux-ProdA 5
ecoRI
gcggaattcggacggcaacgccgattcag 5’ ProdA pMK1lux cloning
primer
pMK1lux-ProdA 3
bamHI
gcgggatccggttttccgcaggcaaatgg 3’ ProdA pMK1lux cloning
primer
pMK1lux-PrlpA 5
ecoRI
gcggaattcgtggtttttcctgatgcacg 5’ PrlpA pMK1lux cloning
primer
pMK1lux-PrlpA 3
bamHI
gcgggatcctttttctgtgggtgtggatc 3’ PrlpA pMK1lux cloning
primer
pMK1lux-PdacA 5
ecoRI
gcggaattccgaccacgctggcgcctggc 5’ PdacA pMK1lux cloning
primer
pMK1lux-PdacA 3
bamHI
gcgggatccccctactatagcaaaagcat 3’ PdacA pMK1lux cloning
primer
pMK1lux-hilD 5
ecoRI
gcggaattctatatcagggagttgacctg 5’ PhilD pMK1lux cloning
primer
pMK1lux-hilD 3
BamHI
gcgggatccacttacaaaggttacattttc 3’ PhilD pMK1lux cloningprimer
pMK1lux-fliF 5 ecoRI gcggaattcgcacctgaatccccatttgc 5’ PfliF pMK1lux cloning primer
pMK1lux-fliF 3
BamHI
gcgggatcccgatgcagtcgcactcatctc 3’ PfliF pMK1lux cloning primer
pMK1lux check
primers
Lux F ctataaaaataggcgtatcac 5’ pMK1lux check primer
Lux R ctggccgttaataatgaatg 3’ pMK1lux check primer
pBAD24 check
primers
pBAD-F ggcgtcacactttgctatgc 5’ pBAD24 check primer
pBAD-R ctgatttaatctgtatcagg 3’ pBAD24 check primer
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pLE7 cloning
primers
pLE–ybeB 5 gcgtctagattgcagggtaaagcactccag 5’ pLE-ybeB cloning primer
pLE–ybeB 3 gcgaagcttttaactccagagtttttccag 3’ pLE-ybeB cloning primer
pLE–ybeA 5 gcgtctagagtgaagctgcaacttgtcgc 5’ pLE-ybeA cloning primer
pLE–ybeA 3 gcgaagctttcactcacggtgataaggg 3’ pLE-ybeA cloning primer
pLE7 check
primers
pLE7-F gagagaccacatggtccttc 5’ pLE7 & derivatives check
primer
pLE7-R gggttttcccagtcacgacg 3’ pLE7 & derivatives check
primer
RT-PCR primers
RT cobD-C F gtccgggtagcgctcaatgc 5’ cobD-cobC primer
RT cobD-C R ttctggcaatcgctgaacgc 3’ cobD-cobC primer
RT cobC-ybeB F tagaacagggatgctggagc 5’ cobC-ybeB primer
RT cobC-ybeB R taccctgaacatctaaggcg 3’ cobC-ybeB primer
RT ybeB-A F gcagggtaaagcactccagg 5’ ybeB-ybeA primer
RT ybeB-A R gtaacaatgcgattcttacc 3’ ybeB-ybeA primer
RT ybeA-pbpA F gcaaacgcggcaagaacgcg 5’ ybeA-pbpA primer
RT ybeA-pbpA R caaggggaatgccgttgcgg 3’ ybeA-pbpA primer
RT pbpA-rodA F ccaacgaaacgtacaatgcg 5’ pbpA-rodA primer
RT pbpA-rodA R cttggatattgcgccgaagg 3’ pbpA-rodA primer
RT rodA-rlpA F agagcgcaaactacatttgg 5’ rodA-rlpA primer
RT rodA-rlpA R ggaggcggttaaattactgc 3’ rodA-rlpA primer
RT rlpA-dacA F gccgtcagcgatcaaacgcg 5’ rlpA-dacA primer
RT rlpA-dacA R ccagaactttgccggagttg 3’ rlpA-dacA primer
RT dacA-ybeD F cgctgggcgtcgataaagac 5’ dacA-ybeD primer
RT dacA-ybeD R tttaccgtcggagagtaatc 3’ dacA-ybeD primer
Tn10d(Tc) arbitrary
PCR primers
Tn10 arb1 ccacgcgtcgactagtacNNNNNNNNNNNgatat Arbitrary primer 1 (1st round)
(247)
Tn10 arb2 ccacgcgtcgactagtac Arbitrary primer 2 (2nd round)
(247)
Tn10-R acctttggtcaccaacgctt 1st round Tn10d(Tc)-specific
primer (248)
Tn10-I gacaagatgtgtatccac 2nd round Tn10d(Tc)-specific
primer (248)
Table 2.2: List of oligonucleotide primers: Details, sequences and sources of
oligonucleotide primers used in this study.
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2.2 Methods
2.2.1 Bacterial growth conditions
Bacteria were routinely cultured in LB broth at 37ºC with shaking (200 rpm). Where
appropriate, culture media was supplemented with ampicillin, kanamycin,
chloramphenicol or tetracycline at concentrations of 100 µg/ml, 50 µg/ml, 25 µg/ml
and 50 µg/ml respectively. At these conditions SPI-1 and flagella genes are
expressed whilst cells are actively growing. To induce SPI-2 gene expression,
cells were cultured in M5.8 minimal media at 37ºC and 200 rpm, for at least 16
hours. Salmonella Typhi BRD948 was cultured in media supplemented with
aromatic amino acids and tyrosine as described (163, 232). In addition, where
appropriate growth media was supplemented with MgCl2 to a final concentration of
20 mM, to facilitate growth of round-cell ∆pbpA and ∆rodA mutants.
2.2.2 Genomic DNA purification
Bacterial genomic DNA was isolated and purified using the Qiagen DNeasy Blood
and Tissue Kit (West Sussex, UK). DNA purification was done according to the kit
instructions. 5 ml of overnight culture (stationary phase cells) was harvested by
centrifugation (4000 x g, 15 minutes, 4ºC) and the pellet resuspended in 180 µl
Buffer ATL. 20 µl proteinase K was added to the suspension and mixed thoroughly
by vortexing. Samples were then incubated at 56ºC for several minutes until the
cells had lysed. After vortexing the samples for 15 seconds, 200 µl Buffer AL was
added and mixed thoroughly. 200 µl 100% ethanol was subsequently added and
mixed thoroughly. Samples were then transferred to DNeasy Mini spin columns,
each in a collection tube, and centrifuged at ≥6000 x g for 1 minute. After replacing
the collection tubes and discarding the contents, columns were washed with 500 µl
Buffer AW1 and centrifuged as previously. The flow-through was discarded and
the column washed in 500 µl Buffer AW2. Columns were then centrifuged at
~17000 x g for 3 minutes to dry the membranes, and transferred to clean 1.5 ml
microcentrifuge tubes. Finally, 200 µl sterile dH2O was pipetted onto the centre of
each column and incubated at room temperature (~22°C unless stated otherwise)
for 1 minute, before centrifuging for 1 minute at ≥6000 x g to elute the genomic
DNA. Genomic DNA was stored at 4ºC until use.
56
2.2.3 RNA extraction and purification
The Ambion® Ribopure™-Bacteria Kit was used to isolate and purify DNA-free
RNA for use in downstream reverse transcriptase PCR (RT-PCR). Work areas
were thoroughly cleaned before commencing any RNA work, and all steps were
done in using gloves, clean equipment and nuclease-free filter tips, to help prevent
DNase or RNase contamination.
Bacteria were cultured to mid-log phase (OD600 ~1.2) and 10 ml each culture was
harvested by centrifugation (4000 x g, 15 minutes, 4ºC). After completely removing
the culture supernatants, cell pellets were resuspended in 350 µl RNAWIZ by
pipetting or vortexing. Cells were then transferred to individual screw-cap tubes
containing 250 µl ice-cold Zirconia beads and vortexed at maximum speed for 10
minutes to lyse the cells. Lysates were centrifuged at ~17000 x g for 5 minutes to
pellet the beads, then transferred to clean nuclease-free 1.5 ml tubes. 0.2 volumes
of chloroform was added to each lysate, shaken vigorously for 30 seconds, and
then incubated at room-temperature for 10 minutes. A further 5 minute
centrifugation step at ~17000 x g enabled the aqueous phase (top layer) to be
removed and transferred to a clean nuclease-free 1.5 ml tube. In the final RNA
purification steps, 0.5 volumes 100% ethanol was added to the recovered aqueous
phase and mixed well. Samples were then transferred to individual filter cartridges
placed inside collection tubes, and centrifuged at maximum speed for 1 minute.
After discarding the flow-through, columns were washed with 700 µl Wash
Solution 1, and centrifuged as before. The flow-through was discarded, and the
columns washed twice with 500 µl Wash Solution 2/3 and centrifuged as before.
Cartridge membranes were finally dried by centrifugation at maximum speed for 1
minute. Columns were then placed into clean nuclease-free 2 ml collection tubes.
To elute the RNA 25 µl preheated Elution Solution was added to the centre of
each column and centrifuged at maximum speed for 1 minute. This elution step
was repeated to obtain ~50 µl RNA.
An additional DNase treatment step was performed to remove any contaminating
DNA. 4 µl DNase I and 5.5 µl 10x DNase buffer were added to the eluted DNA,
before incubating at 37ºC for 30 minutes. 10 µl DNase Inactivation Reagent was
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then added to each sample and incubated at room temperature for 2 minutes.
Finally, samples were centrifuged at maximum speed for 1 minute, and the
supernatants containing purified RNA were transferred to clean nuclease-free 1.5
ml tubes. Purified RNA was stored at -80ºC until use.
2.2.4 Plasmid DNA purification
Plasmid DNA was purified using the Invitrogen™ Purelink™ Quick Plasmid
Miniprep Kit, according to kit instructions (Life Technologies co., California, US). 5
ml overnight cultures were first harvested by centrifugation (4000 x g, 15 minutes,
4ºC). After completely removing the supernatants, cell pellets were resuspended in
250 µl Resuspension Buffer and transferred to clean 1.5 ml microcentrifuge tubes.
250 µl Lysis Buffer was then added and mixed gently, and samples were
incubated at room temperature for exactly 5 minutes. 350 µl Precipitation Buffer
was added to each sample, shaken vigorously to mix, and samples were
centrifuged at ~12000 x g for 10 minutes. Sample supernatants were then
transferred onto individual spin columns placed within collection tubes. After
centrifuging for 1 minute at ~12000 x g, 500 µl Wash Buffer W10 was added to
each column and incubated for a minute at room temperature. The columns were
centrifuged as previously, the flow-through discarded, and 700 µl Wash Buffer W9
added to each column. After centrifuging as before, the flow-through was again
discarded and the columns centrifuged at maximum speed for 2 minutes to dry the
membranes. The columns were then transferred to clean 1.5 ml elution tubes. 40-
50 µl sterile dH2O was pipetted onto the centre of each column and incubated at
room temperature for 1 minute. Finally the columns were centrifuged at maximum
speed for 1 minute to elute the purified plasmid DNA. Plasmid DNA was stored at -
20ºC until use.
2.2.5 Purification of PCR products
The Invitrogen™ Purelink™ PCR Purification Kit was used to purify PCR products
and other short linear DNA fragments, for use with downstream applications (Life
Technologies co., California, US). Initially 4 volumes Binding Buffer with
isopropanol was added to each DNA/PCR reaction mixture. After mixing, samples
were transferred to individual spin columns and centrifuged at ~10000 x g for 1
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minute. The flow-through was discarded, and then the spin columns washed with
600 µl Wash Buffer 1 before centrifuging as previously. The flow-through was
again discarded and the spin columns were centrifuged at maximum speed for 1
minute to dry the membranes. The columns were then transferred to clean 1.5 ml
microcentrifuge tubes. 40-50 µl sterile dH2O was pipetted onto the centre of each
column and incubated at room temperature for 1 minute. The columns were finally
centrifuged at maximum speed for 1 minute to elute the DNA. Purified DNA was
stored at -20ºC until use.
2.2.6 Purification of DNA fragments from agarose gels
DNA fragments excised from agarose gels were purified using the Invitrogen™
PureLink™ Quick Gel Extraction Kit (Life Technologies co., California, US).
Purification of DNA was done according to the kit instructions with the exception of
the initial solubilisation stage. After excision, gel slices of ~100 mg were solubilised
by adding 300 µl Buffer QG (QIAquick Gel Extraction Kit, Qiagen) and incubating
at 50ºC until fully dissolved. Once solubilised, samples were loaded onto individual
Quick Gel Extraction Columns and centrifuged at ~12000 x g for 1 minute. The
flow-through was discarded and the columns washed by adding 600 µl Wash
Buffer W1 and centrifuging as previously. After discarding the flow-through, the
column membranes were dried by centrifugation at ~12000 x g for 2 minutes. The
columns were then transferred to clean 1.5 ml elution tubes and 40-50 µl sterile
dH2O was applied to the centre of each column. Purified DNA was eluted by
centrifuging the columns at ~12000 x g for 1 minute.
2.2.7 Polymerase chain reaction (PCR)
A wide range of polymerase chain reaction (PCR) applications have been used in
the course of this study.  Each PCR technique is described below. In the case of
all PCR applications, reaction mixtures were prepared on ice, in sterile nuclease-
free 1.5 ml, 0.5 ml or 0.2 ml tubes. All reagents were added in order, as described.
Thermal cycling conditions were also carried out as described. Where appropriate,
PCR products were analysed by agarose gel electrophoresis and imaging, DNA
sequencing, or restriction enzyme digestion.
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GoTaq® PCR reactions
For standard non-fastidious PCR reactions, GoTaq® DNA polymerase, a
formulation of the low fidelity Taq DNA polymerase, was used (Promega,
Southampton, UK). Reaction mixtures were prepared according to kit instructions,
as described.
Reaction mix:
Reagent (final concentration) Volume
5x Green or Colourless GoTaq® Reaction Buffer (1x) 10 µl
Nuclease-free dH2O Up to final vol. of 50 µl10 mM dNTPs (0.2 mM each dNTP) 1 µl
Upstream primer (1 µM) 0.5 µl
Downstream primer (1 µM) 0.5 µl
Template DNA (<0.5 µg/50 µl) X µl
GoTaq® DNA polymerase 5 u/µl (1.25 u) 0.25 µl
Final reaction volume: 50 µl
Thermal cycling conditions:
Step Temperature Time
Initial denaturation 98ºC 5 minutes
Denaturation 98ºC 30 seconds
Annealing 55ºC 30 seconds x30
Extension 72ºC 1 minute/kb
Final Extension 72ºC 5 minutes
Table 2.3: Reaction mix preparation and thermal cycling conditions for standard
GoTaq® PCR
Colony PCR
Colony PCRs were performed by picking a small amount (<1 mg) of a bacterial
colony with a sterile tip and transferring it to the bottom of a nuclease-free 0.2 µl
PCR tube, for use as template DNA. The remainder of the colony was then
patched onto LB agar containing relevant antibiotics, and cultured at 37ºC
overnight. The thermal cycling conditions were done as for a standard GoTaq®
PCR.
Reagent (final concentration) Volume
5x Green or Colourless GoTaq® Reaction Buffer (1x) 10 µl
Nuclease-free dH2O 37.75 µl10 mM dNTPs (0.2 mM each dNTP) 1 µl
Upstream primer (1 µM) 0.5 µl
Downstream primer (1 µM) 0.5 µl
<1 mg Bacterial colony -
GoTaq® DNA polymerase 5 u/µl (1.25 u) 0.25 µl
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Final reaction volume: 50 µl*
*For colony PCR, 50 µl reaction mixtures were generally divided between 4 individual
tubes to give ~12 µl reactions
Table 2.4: Reaction mix preparation for standard colony PCR
Phusion® polymerase PCR
Finnzymes Phusion® High-Fidelity DNA Polymerase (NEB UK, Herts, UK) was
used to generate PCR products for applications such as cloning, to ensure a high
quality PCR product. Reaction mixtures and cycling conditions were prepared
according to the kit instructions, as described.
Reaction mix:
Reagent (final concentration) Volume
5x Phusion® HF/GC Buffer 10 µl
Nuclease-free dH2O Up to final vol. of 50 µl10 mM dNTPs (0.2 mM each dNTP) 1 µl
Upstream primer (1 µM) 0.5 µl
Downstream primer (1 µM) 0.5 µl
Template DNA (<0.5 µg/50 µl) X µl
Phusion® DNA polymerase (0.02 u/µl) 0.5 µl
Final reaction volume: 50 µl
Thermal cycling conditions:
Step Temperature Time
Initial denaturation 98ºC 30 seconds
Denaturation 98ºC 10 seconds
Annealing 58ºC 30 seconds x30-35
Extension 72ºC 0.5 minutes/kb
Final Extension 72ºC 10 minutes
Table 2.5: Reaction mix preparation and thermal cycling conditions for standard
Phusion® polymerase PCR
Arbitrary PCR
Arbitrary PCR allows the amplification of DNA from a region where only part of the
target sequence is known, using arbitrary primers in two separate rounds of PCR,
as described by Knobloch et al. (247).
In this study arbitrary PCR was used to identify the insertion sites of the Tn10d(Tc)
transposon during a mutagenesis screen, where only the TN10d(Tc) transposon
sequence was known. The method was based on those from studies by Knobloch
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et al., and O’Toole and Kolter (247, 249). The method used a specially designed
forward arbitrary primer consisting of a specific 20 bp nucleotide ‘tail’ sequence at
the 5’ end, a mid-section containing a random 11 bp nucleotide sequence, and a
specific 5 bp sequence at the 3’ end (Figure 2.3, Table 2.2). The primer was
designed such that on average the random sequence would anneal at sites within
the template DNA at a given frequency. The arbitrary primer was coupled with a
reverse primer complementary to a known target sequence within the 5’ end of
Tn10d(Tc). Thus the first round of PCR generated a mixture of products of varying
lengths, all containing the 5’ 20 bp tail sequence generated from the arbitrary
primer. This was sometimes observed as a faint smear of DNA on agarose gels
(Figure 2.3). In a second round of PCR, the products from the first round formed
the template DNA. A second arbitrary primer was used consisting just of the 20 bp
5’ tail sequence; this was coupled with another reverse primer complementary to a
section of the Tn10d(Tc) sequence upstream from the first primer binding site
(Table 2.2). The second round of PCR therefore generated several distinct
products, typically of ~500-1000 bp in length, which were detected as distinct
bands on an agarose gel. These products were purified and sequenced to
determine the site of Tn10d(Tc) transposon insertion.
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Figure 2.3 Arbitrary PCR to amplify regions of unknown sequence: Schematic
diagram illustrating the arbitrary PCR method to amplify DNA, whereby only part of the
target sequence is known. PCR products from successive rounds of PCR, as typically
visualised on 1% agarose gels, are shown.
Arbitrary PCR reactions were performed using GoTaq® polymerase, with individual
mutant colonies forming the template for the first round PCR reactions. After
completion of the first round of PCR, 1 µl of the first round reaction mixture was
directly transferred into the second round reaction mix as template DNA. PCR
reaction mixtures were prepared and run as follows (Table 2.6).
Reaction mix:
Reagent Round 1 Round 2
5x Green or Colourless GoTaq®
Reaction Buffer
5 µl 10 µl
Nuclease-free dH2O 18.875 µl 36.75 µl10 mM dNTPs 0.5 µl 1 µl
Upstream primer 0.25 µl 0.5 µl
Downstream primer 0.25 µl 0.5 µl
Template DNA <1 mg Colony 1 µl Round 1 product
GoTaq® DNA polymerase 5 u/µl 0.125 µl 0.25 µl
Final reaction volume: 25 µl Final reaction volume: 50 µl
63
Round 1 - Thermal cycling conditions:
Step Temperature Time
Initial denaturation 95ºC 5 minutes
Denaturation 95ºC 1 minute
Annealing 30ºC 1 minute x6
Extension 72ºC 1 minute 30
seconds
Denaturation 95ºC 30 seconds
Annealing 50ºC 30 seconds x30
Extension 72ºC 1 minute 30
seconds
Final Extension 72ºC 7 minutes
Round 2 - Thermal cycling conditions:
Step Temperature Time
Initial denaturation 95ºC 5 minutes
Denaturation 95ºC 30 seconds
Annealing 55ºC 30 seconds x30
Extension 72ºC 1 minute
Final Extension 72ºC 7 minutes
Table 2.6: Reaction mix preparation and thermal cycling conditions for arbitrary
PCR
Reverse transcriptase PCR (RT-PCR)
The Promega Access RT-PCR System (Southampton, UK) was used to detect the
presence of certain RNA transcripts within Salmonella Typhi. The two-step system
permits the generation and then amplification of cDNA from template RNA
transcripts, with both AMV reverse transcriptase and Tfl DNA polymerase
contained within one reaction mix.  The resulting cDNA products can be detected
by gel electrophoresis.
Reaction mixtures were prepared on ice in nuclease-free tubes, using clean
equipment and work areas, according to the kit instructions. First and second
strand synthesis steps were carried out as detailed in the kit protocol (Table 2.7).
Reaction mix:
Reagent (final concentration) Volume
AMV/Tfl 5x Reaction Buffer 10 µl
Nuclease-free dH2O Up to final vol. of 50 µl10 mM dNTPs (0.2 mM each dNTP) 1 µl
Upstream primer (1 µM) 0.5 µl
Downstream primer (1 µM) 0.5 µl
25 mM MgSO4 (1 mM) 2 µlAMV Reverse Transcriptase (0.1 u/µl) 1 µl
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Tfl DNA Polymerase (0.1 u/µl) 1 µl
Template RNA (1 ng-1 µg) X µl
Final reaction volume: 50 µl
Thermal cycling conditions:
Step Temperature Time
Reverse transcription 45ºC 45 minutes 1st strand cDNA synthesis
AMV RT inactivation,
RNA/cDNA denaturation
94ºC 2 minutes
Denaturation 94ºC 30 seconds 2nd strand synthesis &
cDNA amplificationAnnealing 60ºC 1 minute x40-45
Extension 68ºC 1 minute 50
seconds
Final Extension 68ºC 7 minutes
Table 2.7: Reaction mix preparation and thermal cycling conditions for reverse
transcriptase PCR (RT-PCR)
2.2.8 Agarose gel electrophoresis
Nucleic acids were separated and analysed by gel electrophoresis. Agarose gels
were prepared with TAE buffer and SafeView Nucleic Acid Stain (1:10000 dilution)
(NBS Biologicals). To ensure good separation, 1% agarose gels were generally
prepared for DNA fragments of ~250-2000 bp, whilst 0.7% agarose gels were
prepared for larger fragments, or plasmid DNA. Gels were loaded with ~5 µl
sample DNA or DNA molecular size marker per well (both mixed with loading
buffer). Electrophoresis was performed at 100 V for 20-40 minutes, in TAE buffer.
Gels were visualised under ultraviolet (UV) light and analysed using the GelDoc
Molecular Analyst™ software (Bio-Rad, California, US).
2.2.9 Restriction enzyme digestion of DNA
Restriction enzyme digestion was generally performed at 37ºC for 1-2 hours.
Reactions were prepared according to kit instructions, with recommended reaction
buffers (Promega/Fermentas). Typical reaction mixtures comprised 40-50 µl DNA
(0.5-1 µg/µl) and nuclease-free dH2O, 4 µl 10x reaction buffer, and 1 µl restriction
enzyme(s). For double-digest reactions with two restriction enzymes, 10x
Fermentas Buffer Tango™ was routinely used. These reactions were performed in
optimal conditions for the enzymes used, as recommended (Fermentas
DoubleDigest™: http://www.fermentas.com/en/tools/doubledigest).
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2.2.10 Ligation of DNA fragments
Ligation of restriction enzyme-digested DNA fragments was performed using T4
DNA ligase (Promega/Fermentas). Sticky-end ligation reactions typically consisted
of 2 µl 10x T4 DNA Ligase Buffer, 20-100 ng digested DNA, 1 µl T4 DNA ligase,
and dH2O up to a total volume of 20 µl. Digested DNA fragments were added such
that the molar ratio of vector to insert was approximately 3:1. Ligation reactions
were incubated at 16-22ºC for 30 minutes.
2.2.11 DNA sequencing and mapping, and calculations of DNA/RNA
concentration
DNA sequencing was carried out using the GATC Biotech and Dundee DNA
sequencing services (www.gatc-biotech.com Germany, and www.dnaseq.co.uk,
Dundee, respectively). in silico analyses and mapping of genes, operons, cloned
plasmid constructs and mutants were performed with the aid of VectorNTI® version
10 software.
The concentration and purity of RNA/DNA samples were routinely measured using
a Tecan Infinite® 200 PRO NanoQuant microplate reader. Concentrations were
deduced from the average of at least two readings per sample.
2.2.12 Transformation of DNA into competent bacterial cells
Transformation of DNA into E. coli supercompetent cells (TOP10 cells)
Supercompetent One Shot® TOP10 chemically competent E. coli cells were
obtained from Invitrogen™ (Life Technologies co., California, US).
Transformations were carried out according to kit instructions. Briefly, vials of
TOP10 cells were thawed on ice. 1-5 µl DNA or DNA ligation reaction mix (1 pg-
100ng) was then added to each vial and mixed gently. Vials were incubated on ice
for 30 minutes. After heat-shocking at 42ºC for 30 seconds, 250 µl sterile SOC
medium was then added to each vial. Cells were recovered by incubating for 1
hour at 37ºC with shaking, before spreading 200 µl of each transformation mix
onto agar plates containing the relevant antibiotics, and incubating overnight at
37ºC.
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Transformation of DNA into electro-competent Salmonella
To create electro-competent cells for the transformation of plasmids and linear
DNA fragments, 50 ml of LB broth was inoculated with a bacterial strain at 1:100
from an overnight culture, and incubated at 37ºC and 200 rpm till cells reached
early log phase (OD600 ~0.4-0.5). Cultures were then incubated on ice for 30
minutes before harvesting by centrifugation (4000 x g, 20 minutes, 4ºC). The cells
were washed 3-4 times by centrifugation and resuspension in decreasing volumes
of sterile ice-cold dH2O, before being finally resuspended in 400 µl sterile ice-cold
10% glycerol and divided into 100 µl aliquots.
To 100 µl of electro-competent cells, 5-10 µl plasmid/linear DNA was added and
mixed gently. The cells were then incubated on ice for 30 minutes before
electroporating at 2500 V and immediately adding 600 µl warm nutrient-rich SOC
media. The cells were recovered by incubating at 37ºC for at least one hour,
before spreading 100-200 µl cells onto agar plates containing the relevant
antibiotics and incubating overnight.
In the generation of electro-competent ∆pbpA or ∆rodA mutants, cells were
washed in decreasing volumes of sterile dH2O with 20 mM MgCl2. In addition,
electroporation was carried out at 1800 V, and cells were recovered in SOC media
containing 20 mM MgCl2.
2.2.13 One-step gene disruption using the lambda-red system
Specific gene knockouts were created using the Lambda-red recombinase
technique, as described by Datsenko and Wanner, and illustrated below (Figure
2.4) (238).
In order to create specific knockout mutants, short DNA cassettes containing
kanamycin- or chloramphenicol-resistance genes were generated by PCR, for
insertion into the parent strain genome. Upstream and downstream primers were
designed, consisting of 40 bp of sequence from the 5’ or 3’ end of the target gene,
alongside a 20 bp sequence from the template plasmid sequence, from which the
antibiotic resistance gene-harbouring cassettes were amplified (Table 2.2). Hence,
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the resulting DNA cassettes contained antibiotic resistance genes, flanked by
short regions of homology to the target gene. Template plasmids pKD13 and
pKD3 were used to create kanamycin-resistant mrd operon mutants, and
chloramphenicol-resistant ∆rcsC/∆pagN mutants respectively.
To generate mutants, the knockout cassettes containing kanamycin or
chloramphenicol resistance genes flanked by short regions of specificity to the
target gene, were introduced by transformation into parent strains expressing the
Lambda-red recombinase enzyme (from the pKD46 plasmid). The cassettes were
designed to insert specifically into the target gene by homologous recombination,
resulting in the disruption and inactivation of the target gene (238). Where possible,
knockout strains were then transformed with the FLP-recombinase enzyme-
expressing plasmid, pCP20, which caused recombination to occur between the
two FRT (FLP recognition target) sites. This resulted in the removal of the
antibiotic resistance gene (238). This additional step had the advantage of
decreasing any potential polar effects of the mutation on downstream genes. The
creation of specific knockouts was checked by PCR and DNA sequencing.
Figure 2.4: Generation of specific gene knockouts using the one-step gene
disruption technique: Schematic diagram to illustrate the Lambda-red recombinase
gene knock-out method, used to generate specific mrd operon knockouts. Adapted from
“One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR
products” (238).
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2.2.14 Transduction with P22 phage
P22 lysate production
To reduce the risk of secondary mutations arising in the mutant strains, specific
mutants were transduced into a fresh wild-type background. Lysates of the strains
bearing the specific mutations were created by adding 10 µl P22 phage lysate to a
10 ml culture of the mutant strain, culturing overnight, and then lysing the cells with
chloroform to harvest P22 phage harbouring the genetic lesion, as described (163).
Transduction of genetic lesions
To carry out transduction, 1 ml of overnight culture of wild-type Salmonella
Typhimurium strain SL1344 was harvested by centrifugation and resuspended in
100 µl LB broth. To this, 10 µl of P22 lysate containing the genetic lesion was
added. The cells were incubated at room temperature for 30 minutes before the
addition of 1 ml warm LB and a further incubation at 37ºC for 30 minutes. The cells
were then harvested and resuspended in 100 µl fresh LB before being spread onto
agar plates containing the relevant antibiotic to select for transductants, and
cultured overnight at 37oC. All mutants created in S. Typhimurium SL1344 were
transduced into a wild-type SL1344 background. However, due to the inability to
transduce between S. Typhimurium and S. Typhi, this was not possible in the S.
Typhi BRD948 mutants (439).
2.2.15 Transposition with Tn10d(Tc)
The Tn10d(Tc) mini transposon was used in the global mutagenesis screen to
identify regulators of flagella gene expression. Initially a phage lysate was created
from a parent donor strain of Salmonella which contained both Tn10d(Tc) and a
plasmid-borne transposase, since Tn10d(Tc) alone is transposition-defective (251,
252). This initial phage lysate was kindly provided by Philip Aldridge (Newcastle
University, UK), and was transduced into the wild-type S. Typhimurium SL1344.
Transduced cells were grown overnight on plates containing tetracycline, to select
for transductants where Tn10d(Tc) had randomly inserted into the genome by
homologous recombination. 12000 transductant colonies were pooled into 10 ml
fresh LB broth, and to this, 10 μl P22 phage stock was added. After incubating
overnight at 37ºC, a P22 phage lysate was made, resulting in a phage pool
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containing Tn10d(Tc) elements randomly inserted throughout the SL1344 genome
(previous work of this lab). The phage pool consisted of Tn10d(Tc) insertions from
the 12000 original transductant colonies so as to be sure of having complete
coverage of the Salmonella genome. The global Tn10d(Tc) mutagenesis screen of
this study was carried out using this P22 phage pool.
Global mutagenesis screen with Tn10d(Tc) P22 lysate
SL1344 ∆rodA cells expressing the transcriptional luminescence reporter plasmid
pMK1lux–fliF were used in the global mutagenesis screen to identify transposon
mutants with recovered fliF expression, as evident from a recovery in
luminescence. The transduction method was the same as for the transduction of
genetic lesions, although the process was scaled up; 5 ml of SL1344 ∆rodA
pMK1lux–fliF overnight culture was transduced with 100 µl of the P22 Tn10d(Tc)
lysate, and later recovered in 5 ml warm LB. Cells were then concentrated by
centrifugation (4000 x g for 15 minutes, 4ºC) and resuspension in 500 µl LB. Cells
were divided between and plated out on LB agar containing tetracycline, and
grown overnight to select for ∆rodA mutants harbouring Tn10d(Tc).
The level of luminescence emitted from SL1344 wild-type (WT) cells expressing
pMK1lux–fliF was such that it could be detected by eye, and by exposure to light-
sensitive film. Thus, to conduct the screen to recover luminescent SL1344 ∆rodA
pMK1lux–fliF Tn10d(Tc) mutants, transductant colonies and relevant WT/∆rodA
controls were patched in duplicate onto fresh LB agar containing ampicillin. After
growth overnight, one of the two duplicate plates was blotted onto damp filter
paper. This was covered in cling film and exposed to light-sensitive film in the dark
for 20-30 seconds. The film was then developed to visualise luminescent colonies
(Figure 2.5). Luminescent ∆rodA revertant colonies were re-patched from the
second of the duplicate plates, so luminescence could be verified. Arbitrary PCR
was then performed as described, from the re-patched colonies. PCR products
were finally sequenced to identify the location of the Tn10d(Tc) insertions. In this
way ~7000 mutant colonies have been screened to date.
70
Figure 2.5: Tn10d(Tc) global mutagenesis screen: Schematic representation of the
Tn10d(Tc) global mutagenesis screen method to identify luminescent revertants, and
image of a typical film after exposure to patched Tn10d(Tc) mutant colonies. Controls and
luminescent revertant colonies are indicated by arrows and red circles, respectively.
2.2.16 Analysis of bacterial growth and temperature sensitivity
Measurements of culture optical density (OD600) and generation of growth
curves
To analyse the growth of mrd operon mutants as compared to wild-type (WT), WT
and ∆mrd strains were subcultured 1:100 from overnight cultures into 50 ml fresh
LB with the addition of relevant antibiotics, aro mix and tyrosine in the case of the
S. Typhi BRD948 strain, and 20 mM MgCl2. Strains were cultured in 250 ml flasks
at 37ºC with shaking (200 rpm). Growth was assessed by measuring the optical
density of the cultures at an absorbance of 600nm (OD600), every hour for at least
8 hours. The sensitivity of mrd mutants to growth at low temperatures was
analysed by culturing WT and mutant strains at 30ºC with shaking (200 rpm), and
measuring the OD600 every hour for at least 8 hours. Growth curves were
produced by plotting growth (OD600) against time.
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Haemocytometer counts
Total cell counts were carried out using a haemocytometer. Cells of a known wet
weight, taken from agar plate cultures, were transferred to sterile microcentrifuge
tubes and resuspended in 1 ml 4% paraformaldehyde (PFA) for around 15-20
minutes to fix. Cells were then centrifuged and carefully resuspended in 1 ml
sterile dH2O. Meanwhile a coverslip was fixed onto a clean haemocytometer slide,
to ensure a depth of 0.1 mm between the slide and coverslip. ~5-10 µl of a fixed
cell suspension, diluted 1:10, was then loaded into the prepared haemocytometer
slide. The number of individual bacterial cells within a medium-sized
haemocytometer square (comprising 16 small squares) was then carefully counted.
This number was subsequently multiplied by 25 to attain the number of cells in 1
large haemocytometer square (equivalent to the number of cells x104 per ml).
When multiplied by the dilution factor this gave the number of cells per ml of
culture. Haemocytometer counts were each performed in triplicate per cell
suspension, thoroughly cleaning and re-setting the haemocytometer slide between
counts. Counts were then repeated 3 times with fresh cell suspensions. Averages
of these counts were used to plot the number of cells per ml. The initial weighing
of the cells, along with optical density (OD600) measurements of the cell
suspensions enabled graphs to be produced, comparing wet weight, cell number,
and OD600.
2.2.17 Analysis of bacterial motility
Motility of both the SL1344 and BRD948 WT and mrd mutants was investigated by
measuring migration upon growth in semi-solid agar. 1-2 µl of overnight culture
was inoculated into the centre of a petri dish containing semi-solid motility agar
(0.3%).  After incubation at 37ºC of 5-6 hours, the extent of culture spread
(diameter) from the centre of the plate was measured as an indication of motility.
Alongside motility assays, cells were observed by phase microscopy for signs of
motility.
2.2.18 Analysis of Vi antigen expression in S. Typhi cells
Slide agglutination assays were performed to determine whether S. Typhi BRD948
cultures expressed the Vi capsular polysaccharide. 10 µl of culture was mixed on a
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clean microscope slide, with 5-10 µl Vi-agglutinating serum and 5-10 µl PBS. After
several minutes’ incubation at room temperature, slides were observed for signs of
agglutination, demonstrative of Vi capsule expression. S. Typhimurium SL1344
cultures were used as a negative control.
2.2.19 Analysis of antibiotic sensitivity
Antibiotic disc diffusion assays
Antibiotic disc diffusion assays were carried out to test the sensitivity of different
bacterial strains to particular antibiotics. Molten LB agar (~46ºC) was inoculated
with the required bacterial strains at 1:100 from an overnight culture. 5 ml of
inoculated molten agar was then immediately poured into individual petri dishes
containing 20 ml solid LB agar and cooled. Once set, sterile 5 mm filter paper
discs were placed onto the agar surface and inoculated with 5 µl sterile dH2O, or
antibiotic stock solution, typically at a concentration of 10 mg/ml and 1 mg/ml. After
growth overnight at 37ºC, zones of clearance in the bacterial lawns were
measured. In this way, the sensitivities of both WT and mrd mutant strains to
mecillinam, A22, rifampicin, erythromycin and streptomycin, were compared.
Antibiotic/oxidative stress sensitivity growth assays
Growth of both WT and mrd mutant strains in the presence of particular antibiotics
or oxidative stress, was measured by inoculating LB broth containing the relevant
antibiotics or hydrogen peroxide (30% w/w) 1:1000 from an overnight culture. The
fresh cultures were then aliquoted between at least 3 wells of a sterile 96-well
plate (200 µl per well) and cultured for 15-16 hours at 37ºC, with shaking, in a
Tecan Infinite 200® spectrophotometer. The cycling conditions were set to
measure the OD600 of each culture every 15-20 minutes. Growth curves were
then constructed from the averages of OD600 values to compare growth of the
different strains.
2.2.20 Luciferase transcriptional reporter assays
In order to test transcription levels of various genes in S. Typhi and S.
Typhimurium, ~500 bp regions just upstream of the required genes, containing the
gene promoter regions, were PCR amplified complete with appropriate restriction
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enzyme sites and cloned into the promoterless luciferase transcriptional reporter
plasmid, pMK1lux, between EcoR1 and BamH1 restriction enzyme sites (Table
2.1). Accurate cloning was checked by PCR and sequencing, and the newly
constructed reporter plasmids were introduced into SL1344 and BRD948 wild-type
and mutant strains. In this way, the following luminescence reporter plasmids were
constructed in this study: pMK1lux-fliF, pMK1lux-hilD, pMK1lux-PcobC, pMK1lux-
PybeB, pMK1lux-PybeA, pMK1lux-PpbpA, pMK1lux-ProdA, and pMK1lux-PrlpA
(other pMK1lux plasmids were constructed previously – Table 2.1).
Luminesence and optical density (OD600) levels of cultures expressing the
pMK1lux reporters were measured in 96-well plates in a Tecan Infinite 200®
spectrophotometer. Fresh LB broth containing ampicillin was inoculated 1:1000
from overnight cultures expressing pMK1lux and aliquoted into individual wells, at
least in triplicate. The plates were then cultured at 37ºC overnight, with shaking.
The OD600 and luminescence values of the cultures in each well were measured
every 15-20 minutes. Averages from triplicate wells were calculated before
deducing the relative luminescence (luminescence units per optical density) for
each culture and plotting this as a function of time.
2.2.21 Preparation of proteins for analysis of protein expression
Preparation of total cell protein and secreted protein fractions
In order to prepare total cell protein and secreted protein samples for analysis,
bacteria were routinely subcultured in 25-50 ml LB with appropriate additives,
1:100 from an overnight culture, and incubated at 37ºC and 200 rpm till cultures
reached mid-log phase (OD600: ~1.1-1.2). Cells were then harvested by
centrifugation (4000 x g, 15 minutes, 4ºC) and cell pellets were frozen at -20ºC
until use. Meanwhile, secreted proteins were precipitated by adding 10%
trichloroacetic acid to filter-sterilised (pore size: 0.2 µm) culture supernatants and
incubating overnight at 4ºC. Secreted protein was then concentrated by
centrifuging at 12000 x g for 30 minutes (4ºC), and resuspending in 300 µl 2%
sodium dodecyl sulphate (SDS). 1.2 ml acetone was added to each protein
sample and mixed before being stored at -80ºC overnight. The following morning,
the secreted proteins were pelleted by centrifugation for 20 minutes at ~12000 x g.
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The purified secreted protein and total cell protein pellets were finally resuspended
in ≥25 µl or ≥500 µl PBS respectively, according to the optical densities of the
cultures upon harvest so as to make sure the protein concentrations of each
sample were standardised. This enabled comparisons to be made between the
levels and composition of various protein preparations.
2.2.22 Preparation of bacterial lipopolysaccharide (LPS) from Salmonella
Bacterial lipopolysaccharide (LPS) was isolated from Salmonella cells using the
iNtRON Biotechnology LPS extraction kit (Gyeonggi-do, Korea). This kit provided
a rapid and effective method for preparing crude LPS from Salmonella cultures.
LPS extraction was done according to kit instructions. Salmonella strains were
grown at 37ºC till mid-log phase (OD600: ~1.1-1.2). 3 ml from each culture was
then harvested by centrifugation (4000 x g, 15 minutes, 4ºC). The culture
supernatants were completely removed, and the cell pellets were resuspended in
1 ml Lysis Buffer and vortexed well to mix. Cell lysates were transferred to clean
1.5 ml microcentrifuge tubes and 200 µl chloroform was added to each lysate, and
mixed well by vortexing for 20 seconds. After 5 minutes’ incubation at room
temperature, samples were centrifuged for 10 minutes at ~17000 x g to separate
the organic and aqueous phases. 400 µl from the aqueous phase (top layer) of
each sample was then transferred to a clean 1.5 ml microcentrifuge tube. 800 µl
Purification Buffer was added, and samples were incubated at -20ºC for 10
minutes. Samples were finally centrifuged at ~17000 x g for 15 minutes to pellet
the purified LPS. After removing all of the supernatant, LPS pellets were washed
by adding 1 ml 70% ethanol and inverting the tubes gently 2-3 times. LPS samples
were then centrifuged at ~17000 x g for 3 minutes. The supernatant was
completely removed, and the LPS pellets were allowed to dry. LPS samples were
resuspended in 30-50 μl 10 mM Tris-HCl (pH 8.0), according to the original culture
OD600 values upon harvest, in order to standardise the LPS concentration for
each sample. The LPS pellets were dissolved by boiling the resuspended samples
for ~2 minutes.
To further purify the LPS, removing any traces of protein, samples were treated
with 2.5 µg proteinase K per 1 µg LPS. Assuming a yield of up to 45 µg LPS from
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3 ml culture, samples were treated with 112.5 µg proteinase K from a 20 mg/ml
stock solution. After adding proteinase K, the LPS samples were incubated at
50ºC for 30 minutes. Samples were finally boiled for 20-30 minutes to inactivate
the proteinase K, and stored at -80ºC until use.
2.2.23 Separation of proteins/LPS by Sodium Dodecyl Sulphate-
Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Protein and LPS preparations from S. Typhi and S. Typhimurium cultures were
analysed by SDS-PAGE.
12% Acrylamide gels were prepared as standard to enable the clear separation of
proteins and LPS by SDS-PAGE. 12% separating gels and stacking gels were
prepared as detailed (Table 2.8), thoroughly mixing the solution after the addition
of successive reagents. Gels were cast immediately upon preparation. After
casting the separating gels, 0.5 ml dH2O was pipetted onto the top of each gel to
remove any air bubbles and ensure the formation of a flat gel surface. When
completely set excess water was removed from the top of each separating gel.
The stacking gels were then prepared and immediately poured onto the separating
gels. The required comb was also inserted into the stacking gel, avoiding the
introduction of any air bubbles in the process. Stacking gels were continually
topped up until the gels had set.
12% separating gels 4x 3 ml 10-well mini gels
(~9 cm)
1x large 30 ml 1 mm 15-
well gel (~18 cm)
Sterile dH2O 5 ml 11 ml1.5 M Tris-HCl (pH 8.8) 3.75 ml 8.25 ml
30% Acrylamide/bis-acrylamide 6 ml 13.2 ml
10% SDS 150 µl 330 µl
Fresh 10% Ammonium persulphate
(APS)
75 µl 165 µl
N,N,N′,N′-
Tetramethylethylenediamine
(TEMED)
7.5 µl 16.5 µl
Stacking gels 10 ml: 4x10-well mini gels or 1x large 1 mm 15-well gel
Sterile dH2O 6.35 ml0.5 M Tris-HCl (pH 6.8) 2.5 ml
30% Acrylamide/bis-acrylamide 1 ml
Fresh 10% APS 50 µl
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TEMED 10 µl
Table 2.8 Preparation of 12% acrylamide gels for separation of proteins and
bacterial lipopolysaccharide (LPS)
After mounting the cast gels onto the gel electrophoresis apparatus, and filling the
tank with 1x SDS running buffer (~300-500 ml for mini gels or 1.5 l for large gels),
proteins were loaded onto the gels. 6x SDS loading buffer (with mercaptoethanol)
was added to each sample, to a final concentration of 1x. 15 µl or 40 µl of each
protein sample per well was then boiled for ~10 minutes, and loaded onto the mini
and large 12% acrylamide gels respectively. 5 µl or 10 µl PageRuler™ Prestained
Protein Ladder (Fermentas) was loaded alongside the samples, onto a mini or a
large gel, respectively.
For the separation of LPS preparations by SDS-PAGE, 2x SDS loading buffer
(without mercaptoethanol) was added to each LPS sample, to a final concentration
of 1x. 30-40 µl sample per well was then loaded straight onto a large 12%
acrylamide gel, alongside 10 µl PageRuler™ Prestained Protein Ladder.
Electrophoresis was carried out at 100 V for 1-1.5 hours for a mini gel, or overnight
at 3-5 mA and 4ºC for a large SDS-PAGE gel.
2.2.24 Staining and analysis of SDS-PAGE gels
Staining with Coomassie® Brilliant Blue
After the separation of protein samples by SDS-PAGE, gels were carefully
transferred to a clean dish and soaked in Coomassie® Brilliant Blue R stain
solution for 1 hour at room temperature. The Coomassie® dye was removed and
replaced with Coomassie® de-stain solution. Gels were incubated in de-stain until
the protein bands became clearly visible.
Silver staining SDS-PAGE gels
LPS gels were stained using the “SilverSNAP” Pierce Silver Stain kit (Pierce
Protein Research). Staining was carried out according to kit instructions; all steps
were performed at room temperature. After electrophoresis, the gel was carefully
removed from the casting plates, transferred to a large glass dish, and washed
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twice in 50-100 ml sterile dH2O for 5 minutes each. After removing the water, the
gel was fixed in 100 ml 30% ethanol:10% acetic acid solution twice, for 15 minutes
each. The fixing solution was discarded and the gel washed twice in 100 ml 10%
ethanol, for 5 minutes each, then twice in 50-100 ml sterile dH2O, for 5 minutes
each. The gel was incubated in 50 ml freshly prepared Sensitizer Working Solution
for 1 minute, before immediately washing twice in 50-100 ml sterile dH2O for 1
minute per wash. 50 ml Stain Working Solution was then freshly prepared and
applied. The gel was incubated in stain solution for at least 30 minutes. Prior to
washing the gel again, the Developer Solution and 5% acetic acid stop solution
were both pre-prepared. The gel was then briefly washed twice in 50-100 ml sterile
dH2O (20 seconds each), and developed by adding the Developer solution and
incubating for 1-2 minutes. When the LPS bands reached the desired intensity,
100 ml 5% acetic acid stop solution was immediately added to the developer
solution, until bubbles appeared in the solution. The developer solution was then
replaced with a fresh 100 ml of stop solution and incubated for 10 minutes. The gel
was finally washed in 50-100 ml sterile dH2O for several minutes.
Western blotting
Proteins separated by SDS-PAGE were blotted onto nitrocellulose membranes.
The 12% acrylamide gels were sandwiched together with nitrocellulose membrane
between several layers of filter paper and sponge soaked in transfer buffer, set in
a tank containing transfer buffer, and run at 150-200 V for 30 minutes on ice.  After
blotting, membranes were washed briefly in PBS and blocked in 3% bovine serum
albumin (BSA) in PBS-Tween for 45 minutes. Primary antibody was then added to
the block solution at 1:1000-10000 and the nitrocellulose membranes were
incubated overnight in the block-antibody solution at 4ºC. The following morning,
the membranes were incubated at room temperature for 30-40 minutes before
washing 3 times in PBS (5 minutes per wash). Secondary antibody was then
added to 20 ml fresh PBS at 1:10000. After 2 hours’ incubation at room
temperature, the membranes were washed as before and developed in chloro-
naphthol developer solution. Freshly prepared developer solution was applied to
the membranes, and incubated in the dark for 10-20 minutes until the protein
bands reached the desired intensity. Membranes were then rinsed in water and
dried.
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2.2.25 Phase contrast, epifluorescence and electron microscopy
Preparation of cells and slides for microscopy
Both live and fixed bacterial cells were routinely viewed by phase contrast
microscopy. Cells were fixed with 4% PFA for 30-60 minutes, before washing and
resuspending in PBS, and storing at 4ºC until use.
Samples were mounted onto thin 1% agarose beds for viewing by microscopy.
The agarose mounts were prepared by pipetting 500-750 µl melted 1% agarose (in
PBS) onto the slide surface, and covering with another glass microscope slide to
allow the agarose to form a thin gel layer. After 1-2 minutes, the covering slide was
gently removed. 0.5 µl each sample was pipetted onto the surface of the agarose.
Once dried, coverslips were placed over the samples.
Phase contrast microscopy
Cells were viewed by phase contrast microscopy at a 100x magnification, using a
Nikon Plan 100x/1.25 Ph3 DL oil objective, on a Nikon Inverted Microscope
Eclipse Ti-E model microscope.
Epifluorescence microscopy
For immunofluorescence microscopy, 1-5 ml bacterial cultures were harvested and
fixed as above. After washing thoroughly in PBS, cells were resuspended in 100 µl
PBS containing the primary antibody; cells were probed with rabbit anti-SipD
(kindly provided by Vassilis Koronakis, Cambridge), or rabbit anti-SseB (kindly
provided by David Holden, UCL) at a 1:1000 dilution, or with rabbit anti-flagellin
(Typhi/Typhimurium-specific) Salmonella agglutinating serum at a 1:20 dilution.
Samples were then incubated for 1 hour at room temperature, washed as before,
and probed with the secondary goat anti-rabbit antibody conjugated to the green-
fluorescent Alexa Fluor® dye (Invitrogen, UK) at 1:1000 in 100 µl PBS. Samples
were incubated in secondary antibody for 2 hours at room temperature, in the dark.
After washing again in PBS, cells were finally resuspended in 100-300 µl 10%
glycerol and stored at 4ºC, in the dark, until use.
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Immunofluorescence microscopy samples or live cells expressing Green
Fluorescent Protein (GFP) derivatives were viewed by epifluorescence microscopy
at 100x magnification, using a Nikon Plan 100x/1.25 Ph3 DL oil objective.
Image processing
Images were captured using NIS-Elements Advanced Research (version 2.3)
software. All image processing was done using NIS-Elements 2.3 and the ImageJ
image processing software.
Electron microscopy
Scanning electron microscopy images were taken of S. Typhi BRD948 WT and
mutant cells in collaboration with Newcastle University Electron Microscopy
Research Services (Newcastle, UK). Appropriate strains were cultured to mid-log
phase (OD600: 1.1-1.2) and harvested by centrifugation. After carefully removing
all of the culture supernatant, cell pellets were resuspended in Sorenson’s
phosphate buffer with 2% gluteraldehyde. Samples were then taken to the
Electron Microscopy Unit and processed further, to prepare them for scanning
electron microscopy.
2.2.26 DNA Microarrays
NimbleGen gene expression microarrays were used to compare global gene
expression between S. Typhimurium SL1344 wild-type and ΔrodA strains (Roche
NimbleGen Inc., Wisconsin, US). 4x72000 multiplex arrays were used, consisting
of 4 arrays per slide, and 72000 S. Typhimurium LT2-specific probes per array.
These enabled the analysis of the gene expression of 4504 S. Typhimurium genes
in both wild-type and mutant strains.
Strains were grown to mid-log phase (OD600 of ~1.0-1.2) in LB broth (without
antibiotic or MgCl2 supplementation) and harvested. The mRNA was then purified,
processed and applied to the arrays. Statistical analysis of the array data was
done using the DNASTAR ArrayStar® software. This work was kindly conducted
by David Bulmer (ICAMB, Newcastle University).
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2.2.27 Quantification of c-di-GMP by HPLC/Mass spectrometry (LC/MS/MS)
In order to directly quantify c-di-GMP levels from both wild-type and ΔrodA
cultures of S. Typhi BRD948 a high pressure liquid chromatography (HPLC)-
coupled mass spectrometry (MS) method (LC/MS/MS) was developed with the
help of Joe Gray (Pinnacle, Newcastle University).
Cell lysates were initially prepared as follows. Overnight cultures of BRD948 wild-
type and ΔrodA were subcultured into 25 ml fresh LB broth containing aro/tyr mix
and 20 mM MgCl2. Each strain was then cultured at 37°C and 200 rpm, till mid-log
phase (OD600 of ~1.1-1.2). The two cultures were harvested by centrifugation
(4000 x g, 20 minutes, RT) at an equal optical density. After thoroughly removing
all culture medium, cell pellets were each resuspended in volumes of HPLC-grade
dH2O to standardise cell suspensions at an OD600 value of 2 (equivalent to 1010
wild-type/ΔrodA cells per ml). Cells were then cooled to 4°C, and lysed thoroughly
by sonication (7-8 pulses, for 30 seconds each, at 10 microns). Optical densities
were measured after sonication to ensure equal lysis. Cell lysates were
subsequently centrifuged at 4000 x g, for ~20 minutes at room temperature to
pellet the cell debris. 2 ml of supernatant from each strain was then transferred to
an Amicon® Centriplus® centrifuge 10 kDa filter and centrifuged at 2000 x g until
sufficient lysate had passed through the filters. This filtration step removed large
molecules of >10 kDa, including proteins and genomic DNA, which may have
interfered with the LC/MS/MS analysis. 1ml of each lysate was then recovered and
stored in a sterile bijoux tube, at 4°C, until use. An additional 1 ml of filtered lysate
from the wild-type strain was recovered and spiked with 10 pmoles of pure c-di-
GMP, as a control.
The following steps were kindly carried out by Joe Gray (Pinnacle, Newcastle
University). For LC/MS/MS analysis, 1ml lysates were dried in vacuo and
reconstituted in 100 µl HPLC buffer A (5 mM dibutylamine acetate (DBAA) / 0.1%
acetic acid). 5 µl sample was then injected onto the MS-coupled HPLC trap &
column at a flow rate of 10 µl/minute for 2 minutes.  The HPLC column used was a
Waters Symmetry C18 Trapping Column, 5µm particle, dimensions 180 µm x 20
mm. This trap was then switched in-line with a resolving column; a self-packed
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Reprosil™ C18-AQ, 5 µm capillary, dimensions 150 µm x 120 mm. A flow-rate of
2.5 µl/minute was used, along with a gradient of: T=0 - 2.5% Buffer B (80%
Methanol (aqueous) with 5 mM DBAA/0.1% acetic acid), T=5 - 5.0% Buffer B,
T=25 - 100% Buffer B, T=25.5 - 100% Buffer B, T=26 – 2.5% Buffer B. This was
followed by a 10 minute re-equilibration step with 2.5% Buffer B. The eluate from
the column was then sprayed directly into an LTQ FT Ultra mass spectrometer in
negative ion mode (Thermo Fisher Scientific, Illinois, US). Scanning was done at a
mass range of 300-1100 m/z. The c-di-GMP peak was detected at a m/z value of
689.17.
A calibration curve over a range of 0.05-5 pmoles (on-column loading) was initially
constructed using integrated mass peak areas of a reference solution of c-di-GMP
(BIOLOG Life Science Institute, Bremen, Germany). The calibration curve was
used to determine unknown c-di-GMP concentrations from the MS response
signals of biological samples. All measurements, both in the construction of the
calibration curve, and measurement of wild-type/ΔrodA c-di-GMP levels, were
performed in triplicate. Measured c-di-GMP levels in the spiked wild-type BRD948
sample were close to 10 pmoles (9.65 pmoles), verifying the accuracy of the
calibration curve.
2.2.28 in vivo virulence assays
In order to study the virulence of the round-cell mrd operon mutants in vivo,
C57BL/6 mice were each inoculated intravenously with 104 cells of either S.
Typhimurium SL1344 wild-type or ΔrodA strains. S. Typhimurium infections in
mice encompass a useful model of typhoid fever (250). The in vivo growth of both
wild-type and ΔrodA strains was characterised by measuring the liver/spleen
bacterial loads 6 hours, 1 day, 3 days, 6 days, 14 days and 28 days post-infection
(colony-forming units (CFU) per organ). Data was based on the average bacterial
load counts from 4 mice. This work was carried out in collaboration with Andrew
Grant and Pietro Mastroeni (University of Cambridge, UK).
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2.3 Statistical analyses of data
To ensure reproducibility and significance of results, assays in this study where
possible were routinely conducted on at least three separate occasions, done in
duplicate or triplicate where applicable. Data was then analysed with the
calculation of both mean and standard deviation values, as presented on graphs.
In order to test the statistical significance of data generated in this study, student t-
tests were carried out using Microsoft® Excel. Un-paired 2-tailed t-tests with
unequal variance were routinely done to compare data generated from wild-type
and mutant strains, whilst equivalent paired student t-tests were carried out to
analyse the significance of differences between data from the same strain.
2.4 General definitions
Unless otherwise stated, the following definitions apply to the work carried out in
this study:
‘Room temperature’ – equivalent to ~22-25°C
‘Overnight’ – 16 hours
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Chapter 3. Analyses of the mrd operon structure
3.1 Introduction
The putative mrd operon is thought to consist of the 3 contiguous genes pbpA,
rodA, and rlpA, as well as two upstream genes ybeB and ybeA, due to the
presence of potential promoter sequences upstream of ybeB. However, the
position of rlpA is in doubt and further experimental analyses are needed to
characterise the promoter, and show whether rlpA and the downstream dacA gene
form part of the operon (142, 143, 186, 187, 205). In this study, both experimental
and in silico analyses were therefore implemented to enable characterisation of
both the co-transcribed mrd operon genes and also the location(s) of mrd operon
promoter(s).
3.2 in silico analyses of the mrd operon
3.2.1 Conservation of the mrd operon transcriptional unit
The mrd operon is thought to consist of 5 genes: ybeB, ybeA (rlmH), pbpA (mrdA),
rodA (mrdB), and rlpA (142, 143, 186). Sequence analysis using the online “Kyoto
Encyclopedia of Genes and Genomes” database demonstrated that the operon as
a single unit is conserved in structure across Gram-negative species of both
pathogenic and non-pathogenic bacteria, including Escherichia coli, Shigella,
Yersinia, Pseudomonas, Caulobacter, Vibrio, and even the deep-sea marine
bacteria Photobacterium profundum (253, 254). However, this is not so in Gram-
positive organisms such as Bacillus subtilis, where pbpA and rodA, as well as
homologues of ybeB, ybeA and rlpA (yqeL, yydA, and lytD respectively), are each
encoded at completely separate loci within the genome. Furthermore, the rodA
gene was shown to be monocistronic in B. subtilis (154, 253).
The structure of the mrd operon, in both open reading frames and intergenic
regions, is well conserved between Salmonella enterica serovars Typhi and
Typhimurium, as shown (Figure 3.1) (163). Basic Local Alignment Search Tool
(BLASTn/megablast) comparisons of the relatedness of serovars Typhi and
Typhimurium, in a previous study, showed that the 5 putative mrd operon genes
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Figure 3.1: Putative mrd operon structure in S. enterica serovar Typhi: Layout of the
mrd operon in S. Typhi, including gene sizes, size of intergenic regions, and position of
the putative mrd operon promoter upstream of ybeB (187, 255). Genes drawn to scale.
Operon layout as shown is identical in both Typhi and Typhimurium serovars, except for
rlpA gene; length in S. Typhimurium is 1146 bp.
contain between 97% and 99% identity at the DNA level (163). BLAST sequence
analysis of the whole operon (ybeB-rlpA) showed that the sequence identity
between S. Typhi and S. Typhimurium is 99% (4931/4993 bp), at the DNA level.
3.2.2 Putative promoters of the mrd operon
The RegulonDB database contains comprehensive information on operon
structure, and positional information on promoters, transcription factor binding
sites and other sequences involved in gene regulation, in E. coli (212, 255, 256).
The information based upon both bioinformatic and experimental data, and can be
accessed through the online Ecocyc database (187, 255). Information from this
database suggests that the mrd operon comprises the 5 genes in E. coli: ybeB,
ybeA, pbpA, rodA and rlpA, the promoter being located upstream of ybeB.
There is little experimental evidence to demonstrate whether or not the putative
promoter upstream of ybeB forms the true and sole promoter of the mrd operon,
however, with predicted promoter sequences identified here, and upstream of both
rodA and rlpA (142-144, 186). in silico online bacterial promoter prediction tools,
the BDGP Fruitfly and Softberry BPROM programmes, were therefore used to
identify putative promoter sequences within the region of the mrd operon in S.
Typhi (257-259). in silico promoter prediction methods are based upon
experimentally derived consensus sequences for bacterial promoters. These
include the conserved -35 and -10 sigma factor binding site hexamer sequences
located upstream of the transcriptional start sites (TTGACA and TATAAT
respectively) (260). They have inherent limitations, in that they can often result in
the identification of false positives. Data from this work was therefore considered
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with some caution (255). The Fruitfly programme predicts the presence of
promoter sequences and transcriptional start sites within a region of DNA, whilst
BPROM detects the presence of potential sigma factor 70 (σ70)-specific -10 and -
35 sequences within sections of DNA, σ70 being the housekeeping sigma factor
(255). For Fruitfly analyses the putative mrd operon including intergenic regions
and upstream and downstream genes was analysed as a whole. BPROM
promoter predictions were done by analysing individual 300 bp sections of
genome immediately upstream of each putative mrd operon gene, along with
genes immediately upstream and downstream of the proposed operon. This was
done as advised, to improve accuracy (259). Using both the BPROM and Fruitfly
programmes enabled the identification of several promoter-like sequences within
this region of the S. Typhi genome. The results from these analyses were
compiled and annotated, as shown (Table 3.1 and 3.2). Identified putative
promoter regions are located as shown (Figure 3.2).
Transcriptional start sites are generally located between 20 and 40 nucleotides
upstream of translational start sites (255). On this basis, and given the proximity
between transcriptional and translational start sites as well as upstream sigma
factor binding sites, a 300 bp cut-off point for putative promoter sequences was
considered sufficient; any putative sequences identified further than 300 bp from
the start of the proximal gene of an operon were discounted, being considered
unlikely to constitute an actual promoter.
Putative promoters upstream of ybeB
Of major interest were any promoter-like sequences located upstream of ybeB,
due to the findings of previous studies. Both in silico analyses and β-galactosidase
reporter assays have identified a potential promoter for the mrd operon in the
intergenic region upstream of ybeB in E. coli; the putative position of this promoter
determined in silico, is as shown (Figure 3.3) (142, 143). The transcriptional start
site was thought to be located 36 bp upstream from the start of ybeB, whilst the
predicted -10 and -35 sequences were 48 bp and 75 bp upstream from the start of
ybeB (142, 187) (Figure 3.3). Until now, the location of the mrd operon promoter
has not been analysed in bacterial species other than E. coli.
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Both BPROM and Fruitfly analyses of this region highlighted promoter-like
sequences ~170-250 bp upstream of ybeB, although the identified promoter
sequences did not overlap. The position of the predicted promoter in E. coli
therefore differs considerably from the predicted promoters from BPROM and
Fruitfly analyses of the S. Typhi genome sequence.
Nucleotide BLAST analysis of sequence conservation of the ybeB gene and
upstream regions between E. coli and S. Typhi demonstrated that the ybeB gene
sequences themselves are fairly well conserved between these two organisms
(88% sequence identity). However, this is not the case with sequences upstream
of ybeB; no significant sequence similarity was detected in the region of between
19 bp and 108 bp upstream of the start of ybeB in the Salmonella genome,
although for sequences 0-19 bp and 109-200 bp upstream of ybeB, the sequence
similarity was 100% and 77% respectively between E. coli and Salmonella. The
lack of sequence similarity for the 89 bp stretch of sequence may be relevant,
since within this region is located the proposed promoter of the mrd operon in E.
coli. In E. coli this region lacking homology is 23 bp long and contains the putative
transcriptional start site of ybeB. This may explain why in silico analyses of the
Typhi genome sequences failed to recognise possible promoters in a similar
position to the proposed E. coli promoter.
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BDGP Fruitfly analysis of putative mrd operon and flanking genes
Promoter
location
Putative promoter sequence Score
PcobC 5’ ATGTTTTGCGCATTTAACCTCATGAGGAATACCATGCGATTGTGGCTGGT 3’
(start = -33 bp from cobC)
0.91
PybeB 5’ AGGCTTTTTTCACCTTGCAGAGCTTTGCAGAAATTGTTTTACAAAAATGG 3’
(start = -253 bp from ybeB)
0.91
PybeA None identified within 300 bp of ybeA start
PpbpA None identified within 300 bp of pbpA start
ProdA 5’ AGGTCTTTGGCCTGAAGGCCAACGAAACGTACAATGCGCATAAAATCGCC 3’
(start = -259 bp from rodA)
0.97
PrlpA 5’ TCGCGTGATGGCTGGCGGATTAATGTTAATATTATTCGTTTATGTCTTCG 3’
(start = -215 bp from rlpA)
0.94
PrlpA 5’ GGGATTGTGATGTCGATCCACACCCACAGAAAAATGTTGTCGAAAAGCGT 3’
(start = -64 bp from rlpA)
0.98
PdacA 5’ TATGCTTTTGCTATAGTAGGGCTCTTTTTTAATTTCATCACGGACGTCGT 3’
(start = -60 bp from dacA)
0.90
Table 3.1: BDGP Fruitfly promoter sequence searches: Results of BDGP Fruitfly
analysis of mrd operon for putative promoter sequences within 300 bp of the start (5’ end)
of each gene. Putative transcriptional start sites indicated by underlined text. Probability
score associated with each promoter sequence as shown.
Softberry BPROM analysis of promoter sequences upstream of mrd operon genes
Promoter
location
Putative promoter sequence Position relative to
translational start of gene
Score
PcobC -10 box:    CGCTAAAAT-35 box:    TACCCA
187
208
77
4
PybeB -10 box:    TGATAATCT-35 box:    TTTCTG
176
197
51
28
PybeA -10 box:    CTGTATGAT-35 box:    TTCAGG
217
242
67
17
PpbpA None identified
ProdA -10 box:    ACGTACAAT-35 box:    TGGCCT
233
252
59
19
PrlpA -10 box:    TGTTAATAT-35 box:    GTGATG
192
211
72
19
PdacA -10 box:    TGCTATAGT-35 box:    ATGCCT
52
72
64
26
Table 3.2: Softberry BPROM promoter sequence searches: Results of Softberry
BPROM analysis of mrd operon for putative promoter sequences within 300 bp of the start
(5’ end) of each gene. Putative -35 and -10 boxes indicated, along with distance from start
of each gene. Scores associated with each promoter sequence as shown.
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Figure 3.2: Location of putative promoter sequences within mrd operon region in S.
Typhi: Compiled information from Fruitfly and BPROM analyses of putative promoter
sequences to show locations of putative promoter sequences within 300 bp region
upstream of cobC, ybeB, ybeA, pbpA, rodA, rlpA and dacA genes.
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Figure 3.3: Predicted promoter sequences upstream of ybeB in E. coli: A – Predicted
-35 and -10 box sequences upstream of ybeB start, taken from Asoh et al. “Nucleotide
sequence of the pbpA gene and characteristics of the deduced amino acid sequence of
penicillin-binding protein 2 of Escherichia coli K12” (142); ‘ORF-1’ indicates predicted start
of ybeB gene. B – Putative position of mrd operon promoter and transcriptional start site
upstream of ybeB in E. coli, taken from Ecocyc/RegulonDB database (187, 255).
Promoter-like sequences identified elsewhere within the putative mrd
operon
The majority of putative promoters identified in this work, using either Fruitfly or
BPROM, were located at some distance from the downstream genes, often being
around 200 bp upstream of the translational start of a gene, whilst no putative
promoters were identified upstream of pbpA. However, a few potentially significant
sequences were also identified.
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Putative promoter sequences were identified ~60 bp upstream from the start of
dacA with both BPROM and Fruitfly. The identified sequences overlapped such
that the putative -10 box was located 32 bp (5’ end) upstream of the putative
transcriptional start site. Promoter-like sequences were also identified ~60 bp
upstream of rlpA in Fruitfly but not BPROM analyses. Also, although further
upstream (~200 bp) from the gene start codons, overlapping promoter-like
sequences were identified with both Fruitfly and BPROM, upstream of rodA and
rlpA; in both cases, the putative -10 boxes were located a short distance upstream
of predicted transcriptional start sites (14 bp and 16 bp respectively) (Tables 3.1 &
3.2, Figure 3.2).
The remaining promoter sequences identified in this work are less likely to form
true promoters.  For example, a promoter for cobC was identified in which the
proposed transcriptional start site was located downstream of the start of the gene.
Furthermore, promoter sequences identified upstream of ybeA and rodA were
located a considerable distance from the start of these genes. From these results,
the most likely candidates for actual promoter sequences seem to be those
located close to the rlpA and dacA genes, and potentially the overlapping
sequences located upstream of rodA.
Whilst in silico assays highlighted several putative promoter sequences,
experimental analysis was necessary to validate these findings and demonstrate
actual promoter activity within this region of the Salmonella genome.
3.3 Luciferase promoter reporter assays with pMK1lux to identify promoter
activity within the mrd operon
3.3.1 Construction of mrd operon transcriptional reporter plasmids using
luminescence reporter plasmid, pMK1lux
pMK1lux is high copy number transcriptional luminescence reporter plasmid. It
contains the promoterless Photorhabdus luminescens luxCDABE operon, cloned
downstream of the multiple cloning site (MCS) (240-242). The lux operon is
required for luminescence in various bacterial species. The luxAB genes encode a
91
luciferase enzyme, which catalyses the oxidation of reduced riboflavin phosphate
and a long-chain fatty aldehyde, resulting in the production of blue-green light. The
LuxCDE proteins form the enzymatic complex required for the synthesis of the
fatty aldehyde substrate (242, 261). Thus promoter activity can be detected by
cloning the promoter regions from target genes into the MCS of pMK1lux. The
relative luminescence of cultures expressing pMK1lux constructs gives an
indication of lux gene expression, and therefore of promoter activity. In the
promoter-less pMK1lux parent vector, the lux genes are not expressed.
To test experimentally for promoter activity within and upstream of the putative
mrd operon, as detected in in silico analyses, ~500 bp regions immediately
upstream of each putative mrd gene (as well as genes upstream and downstream
of this region) were cloned into pMK1lux, to create pMK1lux-PcobC, pMK1lux-
PybeB, pMK1lux-PybeA*, pMK1lux-PpbpA, pMK1lux-ProdA, and pMK1lux-PrlpA
(Figure 3.4). Promoter regions were cloned excluding the native Shine-Delgarno
(SD) sequences, such that the pMK1lux promoter inserts were at an equivalent
distance from the pMK1lux-encoded SD sequence, as they would be to that of the
parent gene. Successful construction of each plasmid was verified by sequencing.
A pMK1lux-PdacA construct was also engineered, although sequencing data
demonstrated that the cloned sequence was incorrect, and so this plasmid was not
used.
Figure 3.4: Construction of mrd operon transcriptional reporter plasmids using
pMK1lux: Schematic diagram showing positions of promoter regions cloned into pMK1lux
for each mrd operon gene, along with upstream and downstream genes, to create
luciferase transcriptional reporter plasmids. ~500 bp regions upstream of each gene were
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cloned into pMK1lux. Diagram drawn to scale. The pMK1lux-PybeA* construct consisted
of a ~500 bp region upstream of ybeA cloned into pMK1lux; the putative ybeB promoter
was therefore included in construct. pMK1lux-PybeA contains a ~300 bp region upstream
of ybeA, excluding putative ybeB promoter.
3.3.2 Luciferase promoter reporter assays
In order to assay for promoter activity upstream of each mrd operon gene,
luminescence was detected from S. Typhi BRD948 cultures expressing the
pMK1lux reporter constructs, whereby luminescence is proportional to expression
levels of the lux genes, and hence activity from the promoter cloned into pMK1lux.
Luminescence reporter assays were carried out as described.
Transcriptional luminescence reporter assays with the pMK1lux constructs showed
high levels of relative luminescence in BRD948 cultures expressing both pMK1lux-
PybeB, and pMK1lux-PybeA* compared to the promoterless control, whereas
negligible luminescence was emitted from cultures expressing the pMK1lux–
PpbpA or pMK1lux–ProdA constructs (Figure 3.5 A), indicating little or no lux gene
expression. The pMK1lux-PybeA* construct was created so that the 500 bp cloned
insert contained the whole of the ybeB gene, as well as 205 bp upstream of ybeB;
a region containing both the putative ybeB promoter -10 and -35 box sequences,
as identified by BPROM analyses, and the site of the putative E. coli ybeB
promoter (Figure 3.4). As such, it was possible that the luminescence detected in
cultures expressing pMK1lux-PybeA* resulted from the activity of the putative
ybeB promoter, rather than activity of another downstream ybeA promoter. To test
this, an alternative luciferase reporter plasmid was constructed, whereby a 289 bp
region upstream of ybeA, containing just the ybeB gene, was cloned into pMK1lux,
to generate pMK1lux-PybeA (Figure 3.4). Subsequent luciferase transcriptional
reporter assays with this construct demonstrated that there was no significant
promoter activity upstream of ybeA within ybeB (Figure 3.5 B). It was therefore
concluded that the promoter activity detected in pMK1lux-PybeA* cultures resulted
from the activity of the promoter upstream of ybeB.
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Figure 3.5: Luciferase transcriptional reporter assays for promoter activity
upstream of mrd operon genes: A - Transcriptional luciferase reporter assays of
BRD948 wild-type (WT) cells expressing ~500 bp mrd promoter fusions in the pMK1lux
luminescence reporter plasmid. Activity of each promoter fusion measured as relative
luminescence units (luminescence per culture optical density at 600 nm). B -
Transcriptional luciferase reporter assays of BRD948 wild-type (WT) cells expressing mrd
promoter fusions; pMK1lux (negative control), pMK1lux-PybeB (positive control) and
pMK1lux-PybeA construct. The latter contained a 289 bp region upstream of ybeA cloned
into pMK1lux. Cells were grown in LB medium at 37oC with shaking.  Growth rates of the
strains were equivalent. Values show the means from 3 independent assays.  Error bars =
standard deviation.
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Together this data suggests that the putative promoter sequences located in the
intergenic region upstream of ybeB form a true promoter for at least the first 4
genes of the mrd operon, and hence the ybeB, ybeA, pbpA, and rodA genes are
all cotranscribed. Furthermore, the mrd operon promoter was shown to be located
within 205 bp (upstream) of the start codon of ybeB (TTG). As such, the -35 and -
10 box promoter sequences detected using the BPROM programme could
potentially form part of this promoter. Alternatively, sequences further downstream
in an equivalent position to the putative mrd operon promoter in E. coli could form
the true mrd operon promoter in E. coli. The lack of detectable promoter activity
with strains expressing pMK1lux-ProdA is in contrast to previous studies, which
suggested that a promoter for rodA may be located within pbpA (143, 144).
Significant luminescence was also emitted from cultures expressing pMK1lux–
PrlpA, with relative luminescence generally reaching levels of at least 50% of that
of the ybeB promoter (Figure 3.5 A). This result supports in silico searches of both
this work and a previous study, which identified potential promoter sequences
upstream of rlpA (186). This suggests that rlpA is transcribed independently of
upstream genes, from its own promoter. However, given the reduced strength of
this promoter, it should be considered that rlpA expression may be partially
controlled by the mrd operon promoter.
The cobC gene lies upstream of ybeB. The size of the intergenic region between
cobC and ybeB, along with the presence of the ybeB promoter, make it likely that
this gene is not a part of the mrd operon. Some significant luminescence was
measured from pMK1lux–PcobC cultures, supporting this hypothesis. Promoter
activity upstream of dacA could not be assessed due to problems constructing a
pMK1lux–PdacA reporter plasmid.
3.4 Reverse transcriptase PCR (RT-PCR) to identify co-transcribed genes
Further work was required to determine whether or not rlpA is co-transcribed along
with the preceding genes, or expressed solely under the control of the putative
promoter within rodA. To test this, RT-PCR was carried out to detect the presence
of specific transcripts of mRNA from S. Typhi BRD948. RT-PCR primers were
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designed to flank the short intergenic regions between the mrd operon genes, as
shown (Figure 3.6 A), the resulting PCR products being approximately 500 bp in
length. Purified DNase-treated BRD948 RNA was used as template for each RT-
PCR reaction. Since each PCR product traversed the junction between two genes,
the successful generation of PCR product should be dependent on the two primer
binding sites being present within a single transcript, i.e. where two adjacent
genes are co-transcribed.
RT-PCR reactions were performed as described, with an initial reverse
transcription step followed by 45 cycles of cDNA polymerisation. Primer pairs for
each reaction were designed for all putative mrd operon genes, including
upstream and downstream genes, in order to help verify the full set of co-
transcribed genes within the operon. The experiment was carried out at least 3
times, alongside negative-control reactions with RNase-treated RNA, to screen for
DNA contamination.
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Figure 3.6 RT-PCR screen to identify co-transcribed genes: A - Schematic diagram
showing primer design and subsequent positions of RT-PCR products. Primer pairs wer
designed to be complementary to the 3’ end of one gene and the 5’ end of the adjacent
downstream gene, such that PCR products flanked gene junctions, as shown. RT-PCR
products were all approximately 500 bp in length. Diagram drawn to scale. B - 1%
agarose gel showing PCR products from RT-PCR reactions to screen for co-transcribed
genes. PCR products span the intergenic regions between genes of the mrd operon.
Lanes to the left of the molecular weight marker contain PCR products from reactions with
DNase-treated BRD948 wild-type RNA. Lanes to the right of the molecular weight marker
contain PCR products from reactions with DNase- and RNase-treated BRD948 wild-type
RNA as a negative control. Agarose gel shown is representative of 3 independent repeats
with different RNA preparations.
The products of the RT-PCR reactions were run on 1% agarose gels, then
visualised under UV light. A representative agarose gel is shown (Figure 3.6 B).
Contrary to expectations, PCR products were detected for each adjacent mrd
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operon gene, including the upstream cobC gene, and downstream dacA and ybeD
genes. This would suggest that all 7 genes at least are co-transcribed, although
this result does not agree with the findings of previous studies (187, 211). In
addition, in silico analyses of the Salmonella genome and experimental luciferase
reporter assays have demonstrated both the well conserved nature of the ybeB-
rlpA mrd operon as a unit, as well as the presence of a strong promoter for the
mrd operon genes upstream of ybeB, making it unlikely that both the upstream
cobC and ybeB genes are co-transcribed.
A possible explanation for the findings of these assays is that various transcripts
from this region of the genome may overlap in sequence. For instance, if the
transcriptional start site of ybeB were upstream of a transcriptional termination
signal of cobC, the resulting mRNA constructs would overlap, meaning that cDNA
products would be generated bridging the cobC-ybeB junction in RT-PCR assays.
3.4.1 Transcriptional termination sequences within the mrd operon
Prokaryotic transcriptional termination sequences are recognised by their typical
structure, consisting of a palindromic sequence which results in the formation of a
hairpin loop in the DNA. This is generally followed by a uracil-rich region of DNA.
The TranstermHP algorithm was designed to enable the in silico prediction of
transcriptional terminator sequences within DNA (262, 263). This online tool was
used to search for such sequences within the S. Typhi Ty2 genome, within 1 kb
(downstream) of each putative mrd operon gene, as well as the flanking cobC and
dacA genes (264). Previous studies had noted that transcriptional terminator
sequences were lacking between the pbpA and rodA genes (142). The present in
silico assays using TranstermHP identified transcriptional termination sequences
downstream of both cobC and dacA, but not downstream of any of the
intermediate genes in the S. Typhi genome (264). Both these termination
sequences were located in the intergenic regions. The lack of obvious
transcriptional termination signals elsewhere within this region of the genome
would suggest that all 6 genes from ybeB to dacA are co-transcribed.
98
The proposed transcription termination sequences for cobC lay 171 bp
downstream from the 3’ end of cobC, 10 bp downstream of the putative -10 box of
the ybeB promoter. As such mRNA transcripts from both genes may overlap
slightly. This may also be the case for additional genes in the mrd operon,
explaining why RT-PCR cDNA products were detected for all but the cobC-cobD
junction. The cobC and cobD genes lie on opposite strands of the DNA; hence
mRNA transcripts from these genes would not be complementary, preventing the
generation of a cDNA product in RT-PCR assays. The results of the RT-PCR
assay are therefore inconclusive and may be misleading in terms of identifying co-
transcribed genes.
3.5 Discussion
Published research has produced conflicting theories concerning the structure of
the mrd operon, as well as the position(s) of putative promoter(s). Little
experimental data has been produced to support in silico analyses, and the
majority, if not all work to date, has been conducted solely in E. coli (142, 143, 186,
187, 205). For this reason, both in silico and experimental analyses in this portion
of work sought to characterise the structure of the mrd operon in Salmonella,
focussing predominantly on the characterisation of both the position of the major
promoter, and the cohort of co-transcribed genes.
Whilst the physical proximity of the pbpA, rodA and rlpA genes to each other may
suggest that these genes are co-transcribed, more than one study has identified
potential promoter sequences upstream of both rodA and rlpA, although the lack of
transcriptional terminator sequences between pbpA and rodA led Asoh et al. to
suggest that these genes at least are co-transcribed (142, 143, 186). ybeB and
ybeA are also predicted to form part of the operon due to the presence of a
predicted promoter upstream of ybeB, and rodA expression was shown to be
strongly stimulated by the promoter upstream of pbpA (142, 143). Stoker et al. and
others also suggested that the downstream dacA gene may be contiguous with the
upstream genes, partly due to its functional relationship, being important for cell
shape (155, 204, 205, 207). PBP5 is the most highly expressed of all the penicillin-
binding proteins (265). Although this does not necessarily correlate to transcription
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levels, it is unlikely that dacA transcription levels would be as high or higher than
those of pbpA if it were part of the same operon, particularly being at the 3’ end.
Regulation of dacA expression is also distinct from pbpA expression (266). It
therefore appears to be generally accepted that the mrd operon consists of just 5
genes: ybeB, ybeA, pbpA, rodA and rlpA in Gram-negative bacteria (143, 187).
The present work has identified that this putative 5-gene operon structure is
indeed well conserved among Salmonella serovars, E. coli and more distantly
related Gram-negative bacteria. However, a significant exception to this level of
conservation was identified in an 89 bp stretch of DNA upstream of ybeB in S.
Typhi, a region corresponding to the site of the putative ybeB promoter in E. coli
(Figure 3.3). In contrast to the surrounding regions of DNA, no significant
sequence similarity was identified between the E. coli and Salmonella genomes, in
this stretch.  This may be relevant in terms of the regulation of mrd operon
expression.
In silico analyses of a ~7 kb region of the Salmonella Typhi (Ty2 strain) genome,
containing the putative mrd operon identified promoter-like sequences for ybeB
much further upstream of this site (~170-250 bp from ybeB) in Salmonella.
Luciferase transcriptional reporter assays were utilised to verify these findings,
assaying for promoter activity; 500 bp sections of DNA just upstream of each mrd
operon gene were cloned into the luminescence reporter plasmid pMK1lux,
introduced to the wild-type S. Typhi BRD948 strain, and examined for
luminescence, indicative of promoter activity. Thus assays for promoter activity
were carried out in a native background, to reflect natural conditions as much as
possible. Significant promoter activity was detected in regions upstream of ybeB,
rlpA and cobC, the strongest promoter being that located within ~200 bp upstream
of ybeB.
Several conclusions may be drawn from these findings. Firstly, it is clear that a
strong promoter exists upstream of ybeB. Assuming that the predicted promoter
upstream of ybeB in E. coli forms a true promoter, the absence of an equivalent
promoter in the Salmonella genome may indicate that expression of ybeB (and
potentially downstream genes) is controlled by alternative promoter sequences
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further upstream, as predicted by the BPROM and Fruitfly programmes. If this is
the case, the differences in promoter sequences may result in dissimilar regulation
of the expression of mrd operon genes between the two species. Alternatively, the
true promoter of the mrd operon (or at least ybeB) is located within the conserved
sequences further upstream in both Salmonella and E. coli. If this is the case,
promoter-like sequences identified by BPROM and Fruitfly may form the true
promoter in both organisms. Another possible conclusion is that the BPROM and
Fruitfly programmes failed to identify the true promoter sequences upstream of
ybeB within S. Typhi, which may be located in an equivalent position to the
proposed promoter of E. coli.
The absence of detectable promoter activity upstream of ybeA, pbpA and rodA,
along with a lack of putative transcriptional terminator sequences between ybeB
and rodA, suggested that these genes are co-transcribed, being expressed under
the control of the ybeB promoter. Furthermore, putative promoter sequences
identified for these genes were located at some distance upstream of both ybeA
and rodA, whilst no such sequences were found for pbpA, further supporting this
hypothesis.
in silico analyses identified several putative promoters at positions upstream of the
rlpA and dacA genes, and promoter activity was detected upstream of rlpA in
luciferase reporter assays. The promoter activity identified upstream of rlpA is
surprising since rodA is closely linked to rlpA, and the putative promoter
sequences were located within the rodA gene. However, a previous study also
recognised possible promoter sequences upstream of rlpA, although it was
suggested that rlpA may yet be co-transcribed along with upstream genes (186).
Promoter activity detected upstream of rlpA, however, may indicate that rlpA is not
co-transcribed along with upstream genes, although the strength of this promoter
was significantly lower than the ybeB promoter and no transcriptional terminator
sequences were found downstream of rodA. It is possible that rlpA is expressed
under the control of both its own promoter, and the upstream ybeB promoter,
permitting a tighter level of control over RlpA levels.
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The presence of promoter-like sequences upstream of dacA suggests that this
gene is expressed independently of the mrd operon genes, although these
findings could not be verified experimentally. The position of dacA within this
operon was, however, made unclear by the absence of detected transcriptional
terminator sequences between rlpA and dacA. dacA is thought to be unlikely to
form part of the mrd operon due to its distance from rlpA, as well as the high levels
of expression of the dacA-encoded PBP5 protein (210). As such, the identification
of promoter sequences upstream of dacA was not surprising. Furthermore, in
previous studies ΔrlpA mutants did not possess the morphological defects typical
of ΔdacA mutants, as may be expected if these genes were co-transcribed, as an
rlpA mutation could have polar effects on downstream genes of the same operon
(163, 179, 207, 265, 266). Further experimental analyses are therefore needed,
though results tend to suggest that dacA and rlpA are not co-transcribed.
RT-PCR assays were also designed to identify co-transcribed genes within this
region. Primer pairs were designed to flank the junctions between adjacent genes,
so that the successful amplification of specific cDNA product from an mRNA
template would only occur if the genes were co-transcribed. However, contrary to
other findings, the results of this assay suggested that at least 7 genes, from cobC
to ybeD were all co-transcribed in S. Typhi. It was subsequently recognised that in
some cases mRNA transcripts from divergently expressed genes may have
overlapped, leading to false positive results in RT-PCR assays. As such, data from
RT-PCR assays was disregarded, it likely being misleading.
Taken together, these results suggest that a strong promoter controlling
expression of the mrd operon is located upstream of ybeB in Salmonella, although
it remains to be shown whether or not the promoter is located in the same position
as the putative E. coli mrd operon promoter. It is highly likely that at least ybeB,
ybeA, pbpA and rodA are co-transcribed, due to a lack of likely promoter
sequences or transcriptional terminator sequences within this region; putative
promoter sequences identified for ybeA and rodA were located at a considerable
distance from these genes, whilst no such sequences were found for pbpA. This
finding was supported by luciferase reporter assays demonstrating an absence of
detectable promoter activity upstream of ybeA, pbpA or rodA, although previous
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work suggested that rodA possessed its own promoter (143). Likewise, the
presence of the strong ybeB promoter, along with the identified transcription
termination sequences for cobC, and the physical distance between cobC and
ybeB, suggest that cobC is not part of the operon.
These analyses add further evidence to support the hypothesis that the mrd
operon consists of 5 co-transcribed genes, whose expression is regulated by a
strong promoter located upstream of ybeB. Although further work is needed to fully
characterise the positions of rlpA and dacA, subsequent work in the present study
has taken the tentative assumption that rlpA, but not dacA, forms part of the
operon.
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Chapter 4. Generation of and phenotypic analyses of specific
knockouts of mrd operon genes
4.1 Generation of specific knockouts of mrd operon genes in Salmonella and
complementation of knockout strains
4.1.1 Generation of specific non-polar mutants in mrd operon genes
Specific mutants of each of the mrd operon genes were successfully created in S.
Typhi BRD948 using the Datsenko and Wanner method, as described (238). The
ΔrlpA mutant was created previously (163). Briefly, kanamycin resistant knockout
cassettes flanked by short FRT repeats and regions of homology to the target
gene, were introduced into the BRD948 genome by homologous recombination,
specifically replacing all but short sequences at the 5’ and 3’ ends of each of the
wild-type mrd operon genes (Figure 2.4). In an additional step, the kanamycin
resistance genes were removed to leave a single FRT site flanked by the short
sequences remaining from the wild-type genes. Scar sequences were each 82bp,
excluding the wild-type gene flanking sequences. This enabled the generation of
specific non-polar mutants of each individual gene.
The successful generation of specific mutants was initially verified by PCR using
primers specific to sequences just upstream and downstream of each target gene,
as indicated by an alteration in PCR product size, from the removal of the wild-
type gene (Figure 4.1). As such, PCR amplification of the regions covering each
gene knockout resulted in a product of around 250 bp in size (Figure 4.1). In
addition regions of the genome from around 100 bp upstream to 100 bp
downstream of the target gene start and stop codons were amplified by PCR.
These PCR products were then sequenced to confirm the correct construction of
each mutant. Unlike S. Typhimurium mutants, mutants generated in S. Typhi
BRD948 were not transduced back into a wild-type background due to the lack of
a Typhi-specific phage.
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Figure 4.1: Construction of precise knockouts of mrd operon genes in S. Typhi:
Agarose gel of PCR products from PCR check reactions of mrd knockout genes in
BRD948. Complete knockouts were constructed in each mrd operon gene in BRD948,
with removal of the kanamycin cassette, as demonstrated by a reduction in PCR product
size, compared to the wild-type genes. Wild-type (WT) PCR fragment sizes: ybeB = 372
bp, ybeA = 522 bp, pbpA = 2035 bp, rodA = 1233 bp, rlpA = 1161 bp (ΔrlpA constructed in
previous work (163)). Molecular size markers as indicated.
In addition to the S. Typhi mrd mutants, mutants of the ybeB, and pbpA genes
were made in S. Typhimurium SL1344, with rodA and rlpA mutants having been
generated in previous work (163). These mutations were transduced back into the
wild-type SL1344 parent in order to reduce the risk of accumulating secondary
mutations through the transformation process. Attempts were made to remove the
kanamycin cassette in these mutants, but proved unsuccessful.
4.1.2 Evidence for non-polarity of mutations
It was important that the specific mutants generated in this work were non-polar, in
order to ensure that any observed phenotypes were a direct result of the specific
mutations, rather than a consequence of polar effects on the expression of
downstream genes. Mutations of the mrd operon genes in this study were
generated using the pKD13 plasmid as a template for production of the kanamycin
cassette. Insertion of pKD13-specific knockout cassettes into bacterial genomes
may cause polar effects on downstream protein expression, due to the lack of
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translational signals within the scar sequence, such as ribosome binding site
sequences (238).
However, should the mrd mutants have polar effects on downstream gene
expression, one would expect the ΔybeB and ΔybeA mutants to display
morphological defects, due to effects on downstream pbpA or rodA expression, as
has been observed previously (188). This was observed in S. Typhi ΔybeB and
ΔybeA mutants before removal of the kanamycin resistance gene; cells were
spheroid, appearing identical in morphology to the ΔpbpA and ΔrodA mutants.
However, upon removal of the kanamycin resistance gene, ΔybeB and ΔybeA
cells reverted to a rod-shaped morphology (Figure 4.3). Thus it is likely that the
mrd mutants generated in S. Typhi in this study are non-polar.
4.1.3 Morphology of mrd operon mutants
Morphological defects in each individual mutant were analysed by both phase
contrast microscopy and scanning electron microscopy (SEM) (Figure 4.3 A and
4.7). In agreement with previous studies in various rod-shaped bacteria, ΔpbpA
and ΔrodA mutants of S. Typhi displayed severe morphological defects (128, 130,
131, 163). Cells were spheroid, displaying significant heterogeneity of size and
often appearing much larger than wild-type cells (Figure 4.3 and 4.4). There were
no discernable differences in morphology between ΔpbpA and ΔrodA mutants.
Division defects were also evident in these mutants, in both phase contrast and
SEM images of dividing cells, as illustrated below (Figure 4.2). In round cells,
septation and cell wall invagination originated at one side of the cell, before
progressing around the whole cell.  These asymmetric division patterns have been
observed in round spheroid mutants in several studies, and appear to result from
the formation of incomplete cell division FtsZ rings (127, 131, 182, 267, 268).
Figure 4.2: Asymmetrical division patterns of round-cell mutants: Schematic diagram
to illustrate the progressive asymmetric division patterns in round-cell mrd mutants , as
observed by phase contrast microscopy. Cell wall invagination begins and occurs
predominantly at one side of the cell, eventually moving around the whole cell to bring
about division.
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In contrast, ΔybeB and ΔybeA cells retained a rod-shaped morphology, much as
wild-type. However, the lateral cell walls of some ΔybeB cells, and ΔybeA cells to
a greater extent, appeared to be on average slightly shorter than wild-type cells,
although the cell diameter was unaffected (Figure 4.3 A and 4.7). Previous studies
demonstrated that ΔrlpA mutants also retained the wild-type morphology (163).
4.1.4 Complementation of mrd mutant strains
BRD948 ΔpbpA and ΔrodA knockout strains were complemented with plasmid-
encoded N-terminal YFP-fusion proteins of the respective genes from E. coli,
which are expressed under the control of the lac promoter, and hence are
isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible. These vectors were a kind
gift of Lawrence Rothfield (University of Connecticut, US) (135, 269). Previous
work has demonstrated the ability of these vectors to complement ΔpbpA and
ΔrodA mutants in E. coli, restoring rod-shape to such cells (135). Likewise,
introducing the YFP-fusion proteins of PBP2 and RodA to Salmonella Typhi round-
cell mutants successfully restored the wild-type morphology to ΔpbpA and ΔrodA
mutants respectively (Figure 4.3).
The RodA-YFP fusion vector was introduced to both BRD948 ΔpbpA and ΔrodA
mutants, as well as the wild-type parent. However expression of RodA-YFP in the
ΔpbpA mutant did not restore rod-shape in these cells, demonstrating that both
PBP2 and RodA have individual and essential functions in maintaining cell shape.
The morphological defects observed in the ΔpbpA mutants are not simply due to
polar effects on rodA expression (Figure 4.4).
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Figure 4.3: Phase contrast microscopy images of wild-type, mrd mutant and
complemented mutants of S. Typhi: Phase contrast images of live S. Typhi BRD948
cultures; wild-type (WT) and mrd mutant strains (panel A), wild-type cells expressing mrd
YFP-fusion proteins (panel B), and complemented mrd mutant strains (panel C). Phase
contrast and epifluorescent microscopy images shown for YFP-fusion protein-expressing
strains. ΔrlpA strain and pJBT-rlpA complementation plasmid constructed in previous work
(163). Cells cultured in LB broth with aromatic amino acids and 20 mM MgCl2, at 37°C and
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200 rpm, harvested for microscopy at mid-log phase. Cells were grown without
IPTG/arabinose supplementation (to induce plasmid expression). pLE-ybeB, pLE-ybeA,
pVP6, and pVP3 encode YFP fusion proteins of YbeB, YbeA, PBP2, and RodA
respectively. Scale bars indicate 5 µm.
Figure 4.4: Overexpression of RodA in ΔpbpA cells: Phase contrast microscopy
images of live S. Typhi BRD948 ΔpbpA cells and ΔpbpA cells expressing the RodA-YFP
fusion protein (pVP3). Cells cultured in LB broth with aromatic amino acids and 20 mM
MgCl2, ± 0.5 mM IPTG, at 37°C and 200 rpm. Cells harvested for microscopy at mid-log
phase. All images are to the same scale.
YFP-fusion proteins of the YbeB and YbeA proteins were constructed in this study
using the Rothfield vectors. A parent MreB-YFP-expressing plasmid, pLE7 was
digested with XbaI and HindIII enzymes to excise the mreB gene. The complete
ybeB and ybeA genes (minus the stop codons) were then PCR-amplified from S.
Typhi BRD948 genomic DNA, with specific primers to introduce XbaI and HindIII
restriction sites into the resulting DNA fragments, flanking the ybe genes. These
fragments were digested and ligated into the digested pLE7 vector. Accurate
cloning was checked by DNA sequencing. The resulting plasmids were finally
introduced to the BRD948 wild-type and ybe mutant strains. Attempts to construct
an RlpA-YFP fusion proved unsuccessful. However, BRD948 ΔrlpA mutants from
previous work were complemented with a plasmid-encoded S. Typhi RlpA fused to
the Strep-tag® short epitope tag, also constructed in a previous study (163). This
fusion protein is likely to be functional, given that immunofluorescence microscopy
demonstrated its ability to localise specifically to both the cell septum and the
lateral cell wall in a helical fashion, as observed in previous studies (163, 179).
Successful complementation of both the Δybe and ΔrlpA mutants was difficult to
establish, given the lack of obvious morphological defects in these strains (Figure
4.3).
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Although the YFP-fusion proteins were able to reverse the cell shape defects in
BRD948 ΔpbpA and ΔrodA, these fusion proteins may not be ideal since they
encode E. coli proteins, which although clearly effective, have small differences in
the amino acid sequences which may subtly affect protein activity between the two
bacteria. The identity between the Salmonella Typhi and E. coli PBP2 and RodA
sequences is 96% and 98% respectively, at the amino acid level. Furthermore, the
pLE7 derivatives have a fairly high copy number, which may be problematic when
attempting to restore protein levels that resemble the wild-type. Overexpression of
cell-shape determinants has been shown previously to cause cell-shape defects
similar to those seen in mutant cells (158, 164). Attempts were therefore made to
clone the S. Typhi mrd operon genes into the low copy pNDM220 expression
vector under the control of an inducible promoter (270), although to date this has
proved unsuccessful.
4.1.5 Overexpression of mrd operon proteins
In both induced and un-induced cultures of YFP-fusion protein-expressing cells,
the strength of the YFP signal varied considerably between cells. Hence, in a
culture of ΔpbpA pVP6 or ΔrodA pVP3 cells, rod-shape was not restored in all
cells. Concurrently, in those cells which remained spheroid there was usually very
little, if any fluorescence, demonstrating that PBP2 or RodA expression in these
cells was very low, or that the cells had lost the pVP plasmid (Figure 4.4 and 4.5).
It is evident from both phase contrast and epifluorescence microscopy analyses
that low levels of PBP2-YFP and RodA-YFP expression were, however, sufficient
to restore a wild-type morphology in ΔpbpA and ΔrodA cells since rod-shaped
morphology was restored even with a low fluorescent signal.
In the absence of IPTG, expression of low-levels of the appropriate plasmid-
encoded YFP-fusion restored the rod morphology in BRD948 ΔpbpA and ΔrodA
mutants (Figure 4.3). However, overexpression of the PBP2-YFP and RodA-YFP
proteins through the prolonged growth of pVP6- and pVP3-expressing cells in the
presence of at least 0.5 mM IPTG caused some morphological defects. PBP2- and
RodA-overexpressing cells sometimes became larger or rounded, with an
increased diameter, and a slightly distorted rod-shape (Figure 4.5). Similar
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morphological changes caused by the overexpression of MreB, PBP2 and RodZ,
have been observed previously, as well as the observed filamentation of cells from
the overexpression of MreB (158, 164, 330). Similar defects were not observed
with the overexpression of the YbeB-YFP, YbeA-YFP, and RlpA-Strep proteins
(Figure 4.5) (163).
These observations were verified in further experiments to investigate how IPTG
levels affected YFP fusion protein expression. BRD948 pVP6 and ΔpbpA pVP6
strains were cultured in varying concentrations of IPTG. Phase contrast
microscopy and epifluorescence microscopy of these cultures demonstrated that
increasing levels of IPTG clearly resulted in a much stronger YFP signal from the
increased expression of PBP2-YFP. In addition, cells expressing relatively high
levels of PBP2-YFP (particularly evident with growth in higher IPTG concentrations)
often appeared bloated with an increased cell diameter. As within any population
of cells, significant heterogeneity between individual cells was observed in terms
of levels of PBP2-YFP expression (Figure 4.6).
Were the morphological defects in PBP2/RodA-overexpressing cells seen only in
ΔpbpA and ΔrodA mutant strains, it could be argued that overexpression caused
the YFP-fusion proteins to accumulate in inclusion bodies, preventing them from
functioning properly. Such cells would be expected to revert back to a round-
shape purely through a lack of functional PBP2/RodA, rather than through
overexpression of these proteins causing direct morphological defects. However,
the morphological defects were also seen in some wild-type cells overexpressing
PBP2-YFP and RodA-YFP, providing evidence that overexpression of these cell
shape proteins directly causes morphological defects. However, the possibility
cannot be excluded that the YFP fusion protein itself somewhat perturbs
PBP2/RodA function, causing morphological defects (Figure 4.6).
111
Figure 4.5: Overexpression of mrd operon YFP-fusion proteins: Phase contrast
microscopy images of live S. Typhi BRD948 cultures; wild-type (WT) and mrd mutant
strains (panel A), wild-type cells expressing mrd YFP-fusion proteins (panel B), and
complemented mrd mutant strains (panel C). Phase contrast and epifluorescent
microscopy images shown for YFP-fusion protein-expressing strains. Cells harvested for
microscopy after 5 hours’ growth (mid-log phase) in LB broth with aromatic amino acids,
20 mM MgCl2, at 37°C and 200 rpm. Scale bars indicate 5 µm.
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Figure 4.6: Overexpression of PBP2-YFP: Phase contrast microscopy images of live S.
Typhi BRD948 wild-type (WT), ΔpbpA and WT/ΔpbpA cells expressing the PBP2-YFP
fusion protein (pVP6). Phase contrast and epifluorescent microscopy images shown for
YFP-fusion protein-expressing strains. Cells harvested for microscopy after 5 hours’
growth (mid-log phase) in LB broth with aromatic amino acids and 20 mM MgCl2, at 37°C
and 200 rpm. Cultures supplemented with varying concentrations of IPTG to induce
variable levels of plasmid expression and investigate pbpA overexpression. Scale bars
indicate 5 µm.
4.1.6 Localisation of the mrd operon gene products by epifluorescence
microscopy
The complementation of mrd gene mutants with YFP-fusions of the mrd operon
proteins made it possible to investigate the subcellular localisation of each protein
in S. Typhi cells by epifluorescence microscopy.
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In cells where expression levels of PBP2-YFP and RodA-YFP were large enough
to detect a fairly strong fluorescence signal, the PBP2 and RodA proteins were
observed to localise at distinct foci along the lateral cell wall of S Typhi BRD948
(Figure 4.4 and 4.5). By altering the focus to look at different depths through the
cell, these foci could be observed to form banding patterns, reminiscent of helices,
as noted in previous immunofluorescence microscopy work (163). This is in line
with other studies in E. coli and C. crescentus, which have demonstrated that both
PBP2 and RodA localise in helices along the long axis of the cell (135, 136, 160).
In contrast, both the YbeB and YbeA proteins seemed to be evenly dispersed
throughout the cell cytoplasm (Figure 4.4 and 4.5). Analyses of the protein
sequence of both proteins have shown that the sequences lack both export signal
sequences and putative transmembrane spans, suggesting that these proteins are
indeed cytoplasmic (271, 272). In induced cultures overexpressing pLE-ybeB and
pLE-ybeA cells, YbeB and YbeA sometimes appeared to localise in polar foci as
well as throughout the cytoplasm. However, it is likely that this is a result of excess
protein being gathered into inclusion bodies, particularly as in phase contrast
microscopy images dark spots can be seen in these cells, which co-localise with
the foci (Figure 4.5).
Likewise, it is likely that inclusion bodies formed with the overexpression of RodA,
since RodA-YFP seemed to accumulate in large (usually) polar patches, which
could also be seen in phase contrast images, particularly in IPTG-induced cells
(Figure 4.5). The formation of inclusion bodies may have been caused by excess
protein making the cells sick, the YFP fusion altering protein function, or
expression of an E. coli protein in S. Typhi. It could be argued that the
morphological defects seen with PBP2 and RodA overexpression are caused
purely by the formation of large inclusion bodies, although such defects were also
noticeable in PBP2-YFP-expressing cells, where inclusion bodies were not seen.
4.2 Scanning electron microscopy (SEM) of mrd operon mutants
Scanning electron microscopy (SEM) of each of the mrd operon mutants in S.
Typhi was carried out to help further analyse the observed morphological defects
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and investigate whether additional surface defects were evident in any mutant.
Given that pbpA and rodA at least are involved in cell wall synthesis, mutations in
these genes may be likely to affect cell surface structure and properties in a
manner that could be detected by SEM. SEM images showed clearly both the
morphological and asymmetric division defects evident in round-cell ΔpbpA and
ΔrodA mutants (Figure 4.7 A). However, analysis of cells at a higher magnification
did not reveal any obvious surface abnormalities in these mutants or in ΔybeB or
ΔybeA cells (Figure 4.7 B).
By comparison, the surfaces of S. Typhi ΔrlpA cells appeared to be distinctly
rough when compared to wild-type cells, with small irregular appendages
extending from the surface (Figure 4.7 B). The surface pattern was comparable to
cells treated with the antibiotic polymyxin B. A study by Lounatmaa et al.
demonstrated that wild-type Salmonella Typhimurium treated with 30 µg/ml
polymyxin developed dense ‘rodlike projections’ on the cell surface, resulting from
excess folds of outer membrane extending out from the cell (273). Lounatmaa et al.
suggested that polymyxin brought about these effects by integrating into the outer
membrane, causing an increase in the outer membrane surface area which,
combined with tight binding of the OM to the peptidoglycan, may have
subsequently forced the formation of outer membrane appendages. RlpA is an
outer membrane protein which may be involved in peptidoglycan binding (201).
Further SEM analysis of WT and ΔrlpA cells was therefore carried out to
investigate if the effects seen were significant, and similar to those seen with
polymyxin treatment. In addition wild-type and ΔrlpA BRD948 cells were treated
with 30 µg/ml polymyxin B to assess the effects of this drug on surface
morphology. However, further SEM analysis of such cells proved inconclusive,
since a fairly rough surface texture was seen in both wild-type and ΔrlpA cells, and
the ΔrlpA mutant cells did not appear to have any distinguishing surface features.
With polymyxin treatment cells appeared rougher, with the evident development of
irregular appendages (Figure 4.8). Given the possible relationship between
polymyxin B and RlpA function, it may be worth further investigation to determine
whether or not the surface features observed initially were artefacts.
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Figure 4.7: Scanning electron microscopy (SEM) images of wild-type (WT) and mrd
mutant S. Typhi BRD948: Medium (A) and high (B) magnification SEM images of wild-
type and mutant BRD948 cells. Cells harvested for microscopy at mid-log phase, after
growth in LB broth with aromatic amino acids and 20 mM MgCl2, at 37°C and 200 rpm.
Scale bars indicate 5 µm (A) and 1 µm (B).
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Figure 4.8: Scanning electron microscopy (SEM) images of wild-type (WT) and
ΔrlpA S. Typhi BRD948 ± polymyxin B: Cells harvested for microscopy at mid-log
phase, after growth in LB broth with aromatic amino acids and 20 mM MgCl2. Strains
grown ± 30 µg/ml polymyxin B at 37°C and 200 rpm. Scale bars indicate 2 µm.
4.3 General phenotypic analyses of mrd mutants
Once specific knockouts of the mrd genes were constructed in S. Typhi BRD948,
phenotypic analyses were carried out in order to establish what effects each mrd
gene mutation had upon the general health and physiology of the BRD948 cells,
with the hope of providing more information about gene function.
4.3.1 Divalent cation dependent growth of mrd mutants
Upon initial generation of the mrd operon mutants in S. Typhi BRD948, it became
evident that the round-cell ΔpbpA and ΔrodA mutants did not grow well on LB agar
or in LB broth, even with the supplementation of the growth medium with aromatic
amino acids and tyrosine. This is in contrast to the equivalent ΔpbpA and ΔrodA
mutants of S. Typhimurium generated in this study and in a previous study, which
displayed almost normal growth in LB medium at 37°C (163).
A study in 2005 by Formstone and Errington (229) demonstrated that ΔmreB
mutants of B. subtilis were dependent upon high levels of magnesium and sucrose,
their being major factors required for cell growth; growth in 2.5 mM MgCl2 was
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sufficient to restore a wild-type growth rate, whilst growth in 25 mM MgCl2 almost
completely restored the wild-type morphology. This was aided by concurrent
sucrose addition and reversed upon removal of the magnesium and sucrose,
something which caused cells to gradually expand and lyse. CaCl2 addition had a
similar effect, although it did not prove as effective as MgCl2 (229). Much earlier
studies have demonstrated similar dependencies of cell shape mutants upon
magnesium in B. subtilis (274-276). It was suggested that magnesium and sucrose
may act as osmoprotectants, helping prevent cell lysis in round cells, although
sucrose appeared only to have a minor benefit. Alternatively, magnesium may
instead act to stiffen the cell envelope, although the precise mechanism of
magnesium action remains unknown (229). These studies were all carried out in B.
subtilis, a Gram-positive organism. Thus it is recognised that similar effects may
not be seen in organisms such as Salmonella.
However, in light of these studies, BRD948 round-cell mutants were initially
cultured in medium containing 20 mM MgCl2. When this was found to be effective
in restoring growth, the addition of magnesium was titrated to determine the
concentration of MgCl2 required for optimum growth of S. Typhi ΔpbpA and ΔrodA
mutants. The BRD948 ΔpbpA strain was sub-cultured into LB medium
supplemented with MgCl2 at various concentrations of between 0 mM and 30 mM.
After 4 hours’ growth at 37°C and 200 rpm, bacterial growth was assessed by
measuring the optical density at 600 nm (OD600). The results of this assay
demonstrate that addition of magnesium to the growth medium significantly
improved growth of the ΔpbpA mutant, although not to the level of the wild-type.
Magnesium addition did not significantly affect growth of the wild-type (Figure 4.9
A). 20 mM was shown to be an optimum level for growth in this assay, as higher
concentrations of MgCl2 did not significantly improve growth. As a result, 20 mM
MgCl2 was routinely added to BRD948 ΔpbpA and ΔrodA cultures and wild-type
controls, to assist growth of the ΔpbpA and ΔrodA mutant strains. Growth of the
ΔrodA mutant in the presence of 20 mM MgCl2 was equivalent to that of BRD948
ΔpbpA.
Phase contrast microscopy analysis of both round-cell mutants demonstrated that
unlike B. subtilis ΔmreB mutants, rod-shaped morphology was not restored in S.
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Typhi or S. Typhimurium ΔpbpA or ΔrodA mutants with the addition of magnesium
(Figure 4.10). This may reflect differences between bacterial species, or
differences in function between the MreB, PBP2, and RodA proteins. However,
microscopic analysis also showed that in BRD948 ΔpbpA and ΔrodA cultures
grown in LB medium lacking, or containing low levels of additional magnesium,
considerable numbers of both giant spheroid cells and lysed cells were apparent,
as well as significant cell debris. With higher levels of magnesium, the vast
majority of cells appeared to grow as small spheres, without significant numbers of
lysed cells or evident cell debris (Figure 4.10). An increased magnesium
concentration therefore appears to be associated with more stable healthy growth
of round-cell mrd mutants, and perhaps with better regulation of cell diameter.
Furthermore, wild-type BRD948 cell morphology appeared to change slightly with
increasing magnesium concentrations; cells became slightly shorter in length,
particularly when grown in media containing 20 mM or 50 mM MgCl2, compared to
cells grown without additional magnesium (Figure 4.10).
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Figure 4.9: Divalent cation growth dependence of S. Typhi ΔpbpA and ΔrodA
mutants: A - Growth of S. Typhi BRD948 wild-type (WT) and ΔpbpA in the presence of
increasing concentrations of MgCl2. Extent of growth measured as optical density (OD600)
after 4 hours’ growth in LB medium supplemented with aro/tyr mix, cultured at 37°C, and
200 rpm. B – Growth S. Typhi BRD948 WT ΔpbpA and ΔrodA mutants grown in the
presence of 20 mM MgCl2, MnCl2, or CaCl2, or in the absence of divalent cationsupplementation. Growth (OD600 values) of each strain was measured as a percentage
of the OD600 of wild-type strain grown in absence of additional divalent cations, after 4-5
hours’ culture. Cells grown in LB medium supplemented with aro/tyr mix, at 37°C and 200
rpm. Both results show averages of 3 independent experiments. Error bars indicate
standard deviation. Asterisks show significant differences, as determined using the
Students t-test where P values of ≤0.05 were considered statistically significant.
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The dependence of round-cell mrd mutants on other divalent cations was tested,
to determine if round-cell mutants specifically required magnesium. Wild-type S.
Typhi BRD948, and ΔpbpA and ΔrodA mutants were therefore grown in LB media
supplemented with MgCl2, MnCl2, or CaCl2, each at 20 mM. Culture optical
densities (OD600) were measured at mid-log phase, after 4-5 hours’ growth.
The results of three independent assays were plotted as shown (Figure 4.9 B); OD
values of each culture (wild-type and ΔpbpA/ΔrodA) were plotted as a percentage
of that of the wild-type without the addition of any divalent cation to the growth
medium. In this assay the addition of either MgCl2 or CaCl2 to the growth medium
dramatically improved growth of both BRD948 ΔpbpA and ΔrodA mutants, with no
significant differences between the effects exerted by either cation (Figure 4.9 B).
Microscopic analysis of BRD948 strains grown in the presence of MgCl2, and
CaCl2 reflect this, with no significant differences in the appearance of cells grown
with either divalent cation (Figure 4.10). This suggests that the effect on growth in
S. Typhi is not specific to magnesium, contrary to results seen in B. subtilis, where
calcium did not exert as strong an effect on cell growth as magnesium (229). By
comparison, addition of manganese to the medium drastically reduced growth of
both wild-type and round-cell mutants, in a manner that may indicate that
manganese is naturally toxic to Salmonella Typhi, since the effect on growth of the
wild-type and mutants was similar.
Further work is needed to establish the mechanisms by which calcium and
magnesium bring about the recovery of growth in Salmonella round-cell mutants.
In addition to these assays, the successful preparation of electrocompetent ΔpbpA
or ΔrodA cells of either Typhi or Typhimurium was found to be dependent upon the
addition of 20 mM MgCl2 to ice-cold dH2O for each wash step. In the absence of
additional magnesium, cells formed large clumps, and cell pellets became
particularly viscous, possibly indicative of significant cell lysis.
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4.3.2 Comparisons of growth measurements of S. Typhi wild-type and round-
cell mutants
It was considered that the variable size, shapes and therefore also volumes of the
round-cell mutants, compared to wild-type, may affect growth measurements such
as optical density measurements of light scattering through a culture, or wet
weight measurements. To determine how various measures of growth could be
compared, and the best measure for enabling comparisons to be made between
growth of wild-type and mutant cells, assays were carried out to compare the
optical density (OD600), haemocytometer count and wet weight measurements
between wild-type and round-cell mrd mutants of S. Typhi BRD948.
Haemocytometer counts, wet weight measurements, and optical density
(OD600) measurements of wild-type and round-cell mrd mutants of BRD948
Experiments were conducted to investigate the relationships between cell number,
OD600 values and wet weight, in BRD948 WT and ΔrodA cells. Total cell counts
were carried out as described. Briefly around 3-4 mg cells from overnight agar
plate cultures were transferred to a clean microcentrifuge tube using a sterile
tip/loop, and carefully weighed. The cells were then fixed in 1 ml 4%
paraformaldehyde (PFA), before being resuspended in 1 ml sterile dH2O and
diluted 1:10. Small volumes of each suspension were loaded onto clean
haemocytometer slides, and cell counts were performed as described. Cell
number was then calculated as a product of cell weight (wet weight). The data
from these total cell counts show a clear increase in individual cell weight of round-
cell ΔrodA cells compared to the wild-type, there being almost double the number
of wild-type cells per mg of bacteria (wet weight) than ΔrodA cells (Figure 4.11 A).
This is as expected for ΔrodA cells which often appear to have a volume at least
twice that of the wild-type parent.
In addition, optical density (OD600) measurements of various cell resuspensions
were taken at a range of dilutions, to enable comparisons between cell number,
wet weight and OD600 values. The results of these comparisons were combined
and plotted as shown (Figure 4.11 B,C, and D); cell number was calculated based
on the average cell number per mg wet weight, as established in the preceding
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assay (figure 4.11 A). Surprisingly, the shape defects and increased volume of
ΔrodA cells appeared not to affect OD600 values, which were comparable to cell
number for both wild-type and ΔrodA cells (based upon average values of cell
numbers per mg bacteria) (Figure 4.11 C). Conversely, OD600 values were not
comparable to bacterial weight, since the OD600 values of BRD948 ΔrodA cell
suspensions were significantly lower than those of the wild-type cell suspensions,
at an equivalent initial wet weight (Figure 4.11 B). Thus, measuring culture optical
densities appears to constitute a more accurate means of measuring cell growth
(increase in cell number) between wild-type and round-cell mutant cells. The
relationship between wet weight and cell number, based on average numbers of
cells per mg, is also illustrated (Figure 4.11 D).
Figure 4.11: Comparison between haemocytometer counts, wet weight
measurements and optical density (OD600) measurements of S. Typhi wild-type and
ΔrodA cells: A – Haemocytometer total cell counts of number of bacterial cells per mg
bacteria (wet weight) for S. Typhi BRD948 wild-type (WT) and ΔrodA. Assay conducted in
triplicate on 3 separate occasions. Graph shows average values and standard deviation
(Error bars). Students t-test conducted to determine statistical significance. B – Optical
density (OD600) of S. Typhi BRD948 wild-type (WT) and ΔrodA 1 ml cell suspensions
compared to wet weight (mg) before resuspension, with line of best fit as shown. C –
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OD600 values compared with average cell number per ml of culture (based on average
cell number per mg wet weight measurements (A) and measurements of OD600 values
per mg wet weight, resuspended in 1 ml dH2O (B)). Line of best fit as shown. D – Averagecell number with increasing wet weight (mg) (based on average cell number per mg cells
(A)).
4.3.3 Growth of S. Typhi wild-type and mrd mutants in rich medium at 37°C
Several studies of round-cell mutants have noted that in some bacteria including E.
coli, round-cell mutants show a temperature sensitive phenotype; at fast growth
rates (in nutrient-rich conditions at 37°C), round-cell mutants formed non-dividing
giant cells, whereas the same cells propagated stably forming small spheres in
slow growth conditions (i.e. growth in minimal media at 30°C) (130, 214, 277, 278).
Growth was therefore analysed in S. Typhi mutants to see if the same was true.
Growth of each mrd mutant strain in nutrient rich LB broth was analysed by
measuring the optical density values (OD600) of flask cultures grown at 37°C and
200 rpm, hourly, over an 8 hour period (Figure 4.12).
Contrary to previous studies (130), unpublished work on a Salmonella
Typhimurium ΔrodA mutant demonstrated that growth of this mutant at 37°C in
rich medium was not significantly different from wild-type (163). Work on S. Typhi
mrd operon mutants in the present study reflect this result, in that growth of both
ΔpbpA and ΔrodA mutants of S. Typhi resembled that of the wild-type at 37°C in
nutrient-rich medium (Figure 4.12 B). S. Typhi ΔybeB and ΔybeA mutants also
grew almost as wild-type in LB medium at 37°C, with only a very slight reduction in
the growth of BRD948 ΔybeA (Figure 4.12 A). Previous work showed that the
growth of BRD948 ΔrlpA was equivalent to the wild-type, in LB medium at 37°C
(163).
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Figure 4.12: Growth of S. Typhi wild-type (WT) and mrd operon mutants in rich
medium at 37°C: Growth curves of BRD948 wild-type (WT), ΔybeB and ΔybeA strains
(A), and WT, ΔpbpA and ΔrodA strains (B); cells were cultured in flasks containing LB
broth supplemented with aro/tyr mix and 20 mM MgCl2. Optical density (OD600) valueswere measured hourly for 8 hours, with culture at 37°C, with shaking (200 rpm). Growth
curves were generated from the average OD600 values of 3 independent experiments.
Error bars indicate standard deviation values.
4.3.4 Growth of S. Typhi wild-type and mrd mutants in rich medium at 30°C
Potential temperature sensitivity in S. Typhi mrd operon mutants was considered
by analysing growth of these mutants at 30°C. Growth of the mrd mutant strains
was analysed over 9-10 hours by measuring the optical density values (OD600) of
flask cultures grown in LB broth at 30°C and 200 rpm. As was previously seen in a
Typhimurium ΔrodA mutant, growth was severely affected in S. Typhi round-cell
mutants (Figure 4.13 B) (163). BRD948 ΔpbpA and ΔrodA cells grew considerably
more slowly than the wild-type, reaching OD600 values of less than 1 after 10
hours, compared to values of up to 3 for the wild-type. These results are contrary
to a previous study in E. coli, where growth of round-cell mutants was stable at
30°C but not 37°C (130). Both ΔybeB and ΔybeA strains grew as wild-type at 30°C
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(Figure 4.13 A). Likewise, previous work demonstrated that S. Typhi ΔrlpA
mutants grow as wild-type at 30°C in LB broth (163).
This data is in agreement with the extensive cell lysis observed when round-cell
mutants were subjected to ice-cold temperatures during the generation of
electrocompetent cells. Thus Salmonella ΔpbpA and ΔrodA mutants display
significant sensitivity to cold temperatures.
Figure 4.13: Growth of S. Typhi wild-type (WT) and mrd operon mutants in rich
medium at 30°C: Growth curves of BRD948 wild-type (WT), ΔybeB and ΔybeA strains
(A), and WT, ΔpbpA and ΔrodA strains (B); cells were cultured in flasks containing LB
broth supplemented with aro/tyr mix and 20 mM MgCl2. Optical density (OD600) valueswere measured hourly over 10 hours, with culture at 30°C, with shaking (200 rpm).
Growth curves were generated from the average OD600 values of 3 independent
experiments. Values for 10 hours’ growth only indicate average values of 2 independent
experiments. Error bars indicate standard deviation values.
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Figure 4.14: Growth of S. Typhi ΔpbpA and ΔrodA mutants at 30°C: Phase contrast
microscopy images of BRD948 ΔpbpA and ΔrodA mutants after 3, 6 and 9 hours’ growth
in LB medium supplemented with aro/tyr and 20 mM MgCl2, at 30°C with shaking (200rpm). Arrows indicate lysed cells. Scale bar ~5 µm. All images are to the same scale.
Previous studies have highlighted division defects in round-cell mutants grown at
higher temperatures (37°C), whereas at lower temperatures (30°C) cells formed
small stably-dividing spheres (130). The morphology of S. Typhi ΔpbpA and ΔrodA
mutants was therefore analysed with growth at 30°C. BRD948 ΔpbpA and ΔrodA
cells appeared to grow and divide much the same at 30°C as in 37°C, cells being
roughly the same size and morphology. However, with extended growth at 30°C,
more cell debris and cell lysis became apparent in ΔpbpA and ΔrodA cultures,
than at 37°C (Figure 4.14).
4.3.5 Mecillinam and A22 sensitivity of mrd mutants
Mecillinam sensitivity assays
Mecillinam is a beta-lactam antibiotic which specifically binds and inhibits PBP2
(279, 280). Mecillinam-treatment of wild-type Salmonella causes the formation of
large spheroid cells, similar to ΔpbpA and ΔrodA mutant cells. Furthermore, both
ΔpbpA and ΔrodA mutant strains are known to be mecillinam-resistant,
demonstrating the functional relationship between these genes (281-283). S. Typhi
mrd mutants were treated with mecillinam to determine whether ΔybeB, ΔybeA, or
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ΔrlpA knockouts possessed any inherent mecillinam-resistance, which could be
indicative of a functional linkage with pbpA and rodA.
The mecillinam sensitivity of both BRD948 mrd mutant and wild-type (WT) strains
was examined by measuring antibiotic resistance in disc diffusion assays, as well
as measuring growth of these strains in the presence of varying concentrations of
mecillinam. Disc diffusion assays were conducted as described; mecillinam
sensitivity was measured in terms of the size of zones of clearance around discs
inoculated with 1 mg/ml or 10 mg/ml mecillinam.
As expected, BRD948 ΔpbpA and ΔrodA mutants were highly resistant to
mecillinam treatment in these assays. Surprisingly, both ΔybeB and ΔybeA strains
also exhibited significant resistance to mecillinam, although to a lesser extent than
the round-cell mutant strains (Figure 4.15). BRD948 ΔrlpA, however, remained
mecillinam-sensitive, suggesting that the activities of PBP2 and RodA may be
directly connected with or dependent upon ybeB and ybeA, but not rlpA.
Figure 4.15: Sensitivity of S. Typhi mrd mutant strains to mecillinam: Graph indicates
average diameter (minus disc size) of zones of clearance in WT and mrd mutant strain
bacterial lawns, around mecillinam-containing filter paper discs. Discs were placed on LB
agar containing the relevant strain, and inoculated with 5 µl sterile dH2O, 1 mg/mlmecillinam or 10 mg/ml mecillinam. Zones of clearance were measured after growth
overnight at 37°C. No zones of clearance were observed for any strain around discs
inoculated with dH2O (negative control). Assays were carried out in duplicate on 3
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separate occasions. Error bars indicate standard deviation. Asterisks indicate statistically
significant differences, as determined using the Students t-test, where P values ≤0.05
were considered significant.
A mecillinam growth assay was carried out in order to further analyse the effects of
mecillinam on the mrd mutants which displayed some level of mecillinam-
resistance, and to determine the concentration of mecillinam required to inhibit
growth of each strain. BRD948 wild-type, ΔybeB, ΔybeA, ΔpbpA and ΔrodA cells
were sub-cultured in LB broth containing mecillinam at between 0 µg/ml (negative
control) and 50 µg/ml. Mecillinam sensitivity growth assays were subsequently
carried out as described. The average values from 3 independent growth
experiments were illustrated as growth curves (Figure 4.16). The assay was not
conducted with BRD948 ΔrlpA cells as disc diffusion assays had indicated that this
strain maintained a similar level of sensitivity to mecillinam as wild-type BRD948
cells.
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Figure 4.16: S. Typhi mecillinam sensitivity growth assays: Growth curves of S. Typhi
wild-type (WT) and mrd mutants grown in LB media, in the presence of 0, 0.01, 0.1, 1, 10
or 50 µg/ml mecillinam. Cells were cultured overnight at 37°C, with shaking, in a Tecan
Infinite 200® spectrophotometer. Growth (OD600) was measured every 15-20 minutes
over 15 hours. Graphs show average OD600 values from 3 independent experiments.
Error bars indicate standard deviation.
These growth assays demonstrated the extent of mecillinam resistance of the
ΔpbpA and ΔrodA mutants; even at concentrations of up to 10 µg/ml bacterial
growth was not significantly diminished. Growth of the round-cell mutants was
slightly inhibited at 50 µg/ml mecillinam, although this may be a result of inherent
toxicity from high levels of the drug, rather than specific effects on cell wall
synthesis (Figure 4.16). Contrary to the results of disc diffusion assays, sensitivity
of both the ΔybeB and ΔybeA mutants to mecillinam was equivalent to, if not
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higher than the wild-type in this assay. In all three strains growth was almost
completely inhibited with concentrations of mecillinam as low as 0.1 µg/ml. This is
in stark contrast to the mecillinam-resistant ΔpbpA and ΔrodA strains. Surprisingly,
and for unknown reasons, at low levels of mecillinam (0.01 µg/ml) growth rates
seemed to be higher in WT, ΔybeB, and ΔybeA cells than equivalent growth rates
in the absence of mecillinam.
A22 sensitivity assays
A22 is a drug which specifically binds MreB, blocking the binding of ATP and
therefore inhibiting the polymerisation of MreB. in vivo, A22 disrupts filament
formation, causing the disassembly and loss of the characteristic MreB helices,
with an eventual loss of rod shape in various Gram-negative species, including
Salmonella (281, 284, 285, 498). In E. coli A22 was shown to disrupt cell shape
but not cause cell lysis, even at high concentrations, although given that disruption
of cell shape determinants appears to be associated with the formation of giant
cells and eventual cell lysis, A22 may indirectly bring about cell lysis (281). A22
also possesses inherent toxicity independent to its action upon MreB, having
displayed MreB-independent growth inhibitory effects at high concentrations in a
number of bacterial species and in an E. coli ΔmreB mutant (162, 286). Thus it
may target other cellular functions besides MreB.
An early study on the A22 molecule found that mecillinam-resistant ΔpbpA and
ΔrodA E. coli cells showed a reduced sensitivity to A22 (281). Very few if any
studies have since investigated the sensitivity of ΔpbpA or ΔrodA mutant cells to
A22, with a view to further investigating the functional relationships and
interdependencies between cell shape determinants.
For this reason A22-sensitivity assays were performed for all 5 mrd mutant strains
of S. Typhi; disc diffusion assays were carried out, whereby sterile filter paper
discs, mounted on agar containing the relevant bacterial strains, were inoculated
with either 1 mg/ml or 10 mg/ml A22. The resulting zones of clearance within the
bacterial lawns were measured as an indication of A22 resistance.
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Disc diffusion assays demonstrated that A22 had a minor detrimental effect on the
growth of BRD948 wild-type and mrd mutant cells. Small zones of complete
clearance of ~1-2 mm in diameter were observed around discs containing 10
mg/ml A22, for each strain. Larger zones of partial clearance in growth were also
observed in these assays, as measured and recorded (Figure 4.17). This data
reflected previous observations, in that no partial clearance of growth was
observed around discs containing 1 mg/ml or 10 mg/ml A22 in ΔpbpA and ΔrodA
bacterial lawns, whereas significant clearance of growth was seen in the other
BRD948 strains (281). Unlike observations from mecillinam-sensitivity assays, the
ΔybeB and ΔybeA mutants did not display any resistance to A22.
Figure 4.17: Sensitivity of S. Typhi mrd mutant strains to A22: Graph indicates
average diameter (minus disc size) of zones of clearance in bacterial lawns containing WT
and mrd mutant strains, around A22-containing filter paper discs. Discs were placed on
LB agar containing the relevant strain and inoculated with 5 µl sterile dH2O, 1 mg/ml A22or 10 mg/ml A22. Zones of clearance were measured after growth overnight at 37°C.
Observed zones of clearance showed only partial clearance. No zones of clearance were
observed for any strain around discs inoculated with dH2O (negative control). Assays were
carried out in duplicate on 3 separate occasions. Error bars indicate standard deviation.
Asterisks indicate statistically significant differences, as determined using the Students t-
test, where P values ≤0.05 were considered significant.
It is likely that the small zones of complete clearance observed with each strain
were the result of the inherent toxicity of A22, as demonstrated to be separate
from its activity on MreB. However, partial zones of clearance were not observed
in round-cell mutants. If this partial growth inhibition was also due to MreB-
independent toxicity of A22, the round-cell mutants would be expected to show
equivalent or even increased sensitivity to A22 due to the inherent weaknesses
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possibly associated with these mutants. The partial growth inhibition may therefore
be a result of specific activity of A22 on MreB, with the consequences of
generating spherical cells with a liability to lyse.
4.3.6 Sensitivity of ΔybeB and ΔybeA mutants to a ribosome-targeting
antibiotic
Both YbeB and YbeA are thought to be involved in ribosome binding, assembly,
and possibly stability (189, 194). A number of major therapeutic antibiotics inhibit
processes such as translation by targeting ribosomes (287). In order to investigate
possible roles of the YbeBA proteins in ribosome stability and functionality, an
assay was carried out to investigate the sensitivity of ΔybeB and ΔybeA mutants to
ribosome-targeting antibiotics. For this assay the ribosome-targeting bactericidal
aminoglycoside, streptomycin, was used. Streptomycin has been shown to bind
specifically to the ‘decoding centre’ of the small 30S ribosomal subunit in E. coli, a
region required for the correct reading of tRNA. The binding of streptomycin to this
region brings about conformational changes in protein structure, resulting in the
low-fidelity mis-reading of tRNA codons, and ultimately protein synthesis inhibition
and cell death (288-290). A ribosomal protein S12 (rpsL) forms a crucial part of the
ribosomal decoding centre. Furthermore, the majority of mutations causing
streptomycin resistance were found to map to two highly conserved loops of this
protein, the ‘PNSA’ and ‘PGVRY’ loops, which are physically located close by to
the decoding centre and are involved in tRNA species recognition (290).
The sequences of the S. Typhi and E. coli S12 proteins were initially compared
with those of both S. Typhi and E. coli YbeB and YbeA proteins to search for
structural and possibly functional conservation between the proteins. Sequence
analysis using the online Basic Local Alignment Search Tool (BLAST) ‘blastp’
algorithm revealed a small region close to the N-terminal of the YbeB protein with
homology to S12. The 18 residue length of YbeB possessed 26% sequence
identity, and 48% related ‘positives’, to a 23 residue region of S12. Further
analysis showed that this region of YbeB slightly overlapped with the conserved
‘PGVRY’ loop region of S12 (Figure 4.18 A). Contained within this overlap were
several amino acid residues which have been implicated in streptomycin
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resistance (291). No significant sequence similarity to S12 was detected for YbeA
in blastp searches.
Antibiotic disc diffusion assays were carried out with both wild-type and mrd
mutant BRD948 strains to analyse the sensitivity of each strain to streptomycin.
This assay was aimed in particular at testing the significance of sequence analysis
data, determining whether YbeB and S12 may have some functional relationship.
The results of this assay appear to show a slight decrease in streptomycin
sensitivity in both ΔybeB and ΔybeA mutant strains compared to the wild-type,
although student t-test analyses demonstrated that these differences in sensitivity
were not statistically significant, with P values of 0.16-0.17 (at 10 mg/ml
streptomycin), and 0.32-0.35 (at 100 mg/ml streptomycin) (Figure 4.18 B).
However, this assay also showed that both ΔpbpA and ΔrodA mutants were
significantly more sensitive than wild-type cells to killing by streptomycin at least at
100 mg/ml (Figure 4.18 B).
Further investigations could be worthwhile to determine whether the region of
homology between YbeB and S12 is significant, and whether this N-terminal
region is important to the function of YbeB. In terms of streptomycin resistance,
although the differences were not statistically significant, it may be worth repeating
this or a similar assay to better screen for streptomycin resistance in ΔybeB and
ΔybeA mutants. However, any inherent streptomycin resistance in these mutants
is clearly not substantial. It also remains to be explained why the ΔpbpA and
ΔrodA show increased sensitivity to streptomycin, and whether this relates to the
function of PBP2 and RodA.
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Figure 4.18: YbeB protein sequence analysis and sensitivity of S. Typhi mrd
mutants to streptomycin: A – BLAST sequence comparisons between the S12 and
YbeB proteins of S. Typhi and E. coli. S. Typhi protein sequences are shown, with
highlighted sections showing conserved PGVR loop region of S12 and regions of
homology between YbeB and S12. Amino acid residues previously shown to be involved
in streptomycin resistance are highlighted in red (291). B – Streptomycin disc diffusion
assays with wild-type and mrd mutant BRD948 strains. Streptomycin sensitivity measured
in terms of average diameters of zones of clearance in bacterial lawns around antibiotic
discs inoculated with 10 mg/ml or 100 mg/ml streptomycin, after growth overnight at 37°C.
No zones of clearance were observed around discs inoculated with dH2O (negativecontrol). Assays were carried out in duplicate on 3 separate occasions. Error bars indicate
standard deviation. Asterisks indicate statistically significant differences, as determined
using the Students t-test, where P values ≤0.05 were considered significant.
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4.3.7 Surface properties of mrd mutants and sensitivity to external stress
Mutations in cell shape-determinant genes clearly have significant effects on the
structure of the bacterial cell envelope. The increased sensitivity of round-cell
mutants to external stresses, as well their propensity to lyse, is indicative of a
compromised cell wall structure and barrier function (125, 211, 214).
Peptidoglycan integrity may also be significantly affected; a 50% decrease in
peptidoglycan synthesis rate has been observed in round-cell mutants or
mecillinam-treated cells (127, 292). The inactivation of cell shape determinant
proteins leads to the constitutive activation of the septal cell wall synthetic
machinery, and hence the synthesis of solely septal peptidoglycan synthesis.
Unlike side-wall peptidoglycan, peptidoglycan at the cell poles is metabolically
inert, potentially indicating differences between septal and side-wall peptidoglycan,
although to date no chemical differences in septal and side-wall peptidoglycan
have been characterised (122, 127, 201). Other cell envelope-associated defects
have been observed in round-cell mutants besides those linked to peptidoglycan
structure. For instance, Bendezú and de Boer found that both Δmre and
ΔpbpA/ΔrodA mutants in E. coli were unable to adjust the rate of phospholipid
synthesis, despite altered cell wall synthesis and a decreased surface to volume
ratio. This resulted in the production of excess cytoplasmic membrane, which
folded inwards, forming extensive membrane involutions and vesicles (130).
A number of experiments were conducted to analyse the cell surface properties of
mrd mutant cells, and investigate the effectiveness of the cell wall as a barrier to
external stresses, particularly in the round-cell mutant strains.
Lipopolysaccharide (LPS) profiles of mrdmutants
The outer leaflet of the outer membrane of Gram-negative bacteria such as
Salmonella is composed predominantly of the glycolipid, lipopolysaccharide (LPS),
or ‘endotoxin’. This molecule is well characterised in terms of structure, and
comprises 3 main sections: lipid A, a core oligosaccharide, and the outermost O-
antigen made up of chains of polysaccharide (Figure 4.19) (293-295).
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Lipid A forms the innermost hydrophobic component of LPS, acting to anchor LPS
into the membrane (Figure 4.17). Lipid A is the only element of LPS known to be
essential for growth and its structure remains fairly well conserved between
bacterial species (294, 296, 297). It is also well characterised as the toxic element
of LPS, contributing greatly to the activation of inflammatory responses and
causing endotoxic shock in systemic Gram-negative infections (294, 298). The
core oligosaccharide comprises two regions: the inner and outer cores (294, 299).
The inner core, like Lipid A, is important for outer membrane integrity, and is well
conserved between bacterial species (294, 299). Despite consisting of a
conserved hexose backbone, the outer core is more variable due to various side-
branch alterations. This results in variability between individual bacterial species.
Two distinct core structures have been identified amongst S. enterica serovars
(294, 299). ‘Smooth-LPS’ describes LPS which contains O-antigen linked to the
core oligosaccharide region, as expressed by many Gram-negative bacteria
including Salmonella and E. coli. Conversely, strains and mutants expressing LPS
lacking this outer region are described as ‘rough’. The outer O-antigen
polysaccharide consists of repeating sugar units, which can vary considerably in
structure and chain length between strains of the same bacteria (293-295). The O-
antigen plays an important role in determining the serological specificity of the
bacteria, as this region is exposed to the environment and host immunity (294).
The outer membrane as a whole, and in particular the core and O-antigen regions
of LPS, have a major role in functioning as a physical barrier against
environmental stress. LPS acts as a permeability barrier, preventing the diffusion
of large molecules across the bacterial envelope, and due to its highly hydrophilic
nature, effectively protecting against the diffusion of small hydrophobic molecules
into the cell. This makes Gram-negative bacteria particularly resistant to
hydrophobic antibiotics (301-303). Bacterial lipopolysaccharide is also recognised
as a virulence factor, due to the properties of the O-chain polysaccharides which
may enable bacteria to evade the host immune responses (294).
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Figure 4.19: Structure of bacterial lipopolysaccharide (LPS): A - Generalised
molecular structure of LPS, taken from “LPS, TLR4 and infectious disease diversity” (298).
B - Schematic representation of smooth LPS and the bacterial cell wall structure, taken
from “Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host
immune system” (300)
The outer membrane is linked covalently to the peptidoglycan layer by at least one
highly expressed outer membrane lipoprotein: Braun’s Lipoprotein (Lpp).
Additional outer membrane proteins are known to associate non-covalently with
peptidoglycan, including peptidoglycan-associated lipoprotein (Pal) and RlpA (293,
304, 305). Furthermore, Pal and Lpp, along with outer membrane protein A (OmpA)
are often co-purified with LPS (305).
The biosynthesis of all three LPS components and the linking of the lipid A and
core regions occurs at the inner leaflet of the cytoplasmic membrane. Several
factors are involved further in transporting the components across the inner
membrane and through the periplasm to the cell surface (293). The latter process
is mediated by the Lpt pathway, involving 7 Lpt proteins which together are
thought to form a wall-spanning protein complex for the transportation of LPS
(293). Interestingly, one of the Lpt proteins, LptE is regulated by sigma factor E
(σE), a major regulator of the envelope stress response, which increases the
expression of cell wall biosynthesis factors in response to envelope stress (293,
306, 307).
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The importance of LPS to Salmonella physiology, its role in protection against
environmental stress, its physical linkage with (and possible dependence upon)
the peptidoglycan cell wall in particular, and also the observed regulatory
pathways which appear to stimulate LPS production upon detection of envelope
stress, together make it an important factor to be studied in the mrd mutants. The
ΔpbpA, ΔrodA and ΔrlpA mutants in particular may have significant downstream
effects on LPS expression and structure due to the putative effects of these
mutations on the bacterial cell wall. In order to investigate LPS structure in the S.
Typhi mrd operon mutants, LPS was isolated from cell lysates of each strain and
analysed by SDS-PAGE separation on 12% acrylamide gels, as described. Gels
were silver stained to visualise the LPS. LPS was also prepared in parallel from a
S. Typhimurium rough LPS mutant, SL5338, as a negative control (237). Purified
wild-type S. Typhimurium SL1344 LPS, prepared in previous work, was also run
alongside the other samples.
No alterations in LPS structure, particularly in terms of O-antigen chain structure
were seen in LPS samples from ΔybeB, ΔybeA or ΔrlpA mutants of S. Typhi, with
laddering patterns appearing as wild-type in these strains, as observed by SDS-
PAGE analysis (Figure 4.20). However, the laddering pattern of the O-antigen
appeared somewhat different in round-cell mrd mutant strains. Although these
mutants clearly expressed O-antigen, which appeared as wild-type at lower
molecular weights, the laddering patterns at higher molecular weights (~55-170
kDa) were clearly affected, LPS bands appearing almost completely smeared on
SDS-PAGE gels. However, a faint laddering pattern could just be seen flanking the
smears in both strains (Figure 4.20). The presence of this smearing is not an
artefact, given that it appeared in both ΔpbpA and ΔrodA strains, as well as in
repeat experiments with fresh LPS preparations. However, it remains unknown
whether the observed pattern is indicative of altered LPS structure/chain length in
these strains, or whether another property of the round-cell mutants affected the
preparation of LPS, leading to the observed patterns when separated by SDS-
PAGE. It is also possible that LPS was overproduced in the round-cell mutants,
leading to such a pattern.
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Figure 4.20: LPS structure in S. Typhi wild-type and mrd mutants: SDS-PAGE
separation of LPS fractions isolated from BRD948 wild-type (WT) and mrd mutant cells,
and the SL5338 rough LPS mutant strain. Purified LPS from WT S. Typhimurium SL1344
(from previous work) was run alongside other samples. Laddering patterns were indicative
of O-antigen side chains of different lengths, and hence were missing from the rough
SL5338 mutant. Consecutive ‘rungs’ are equivalent to an increase in chain length of one
repeating O-chain unit (294). Cultures were grown to mid-log phase in LB medium at 37°C
before harvesting and isolating LPS as described. The concentration of LPS in each
preparation was standardised according to original culture optical density values.
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Sensitivity of mrd mutants to hydrophobic antibiotics
The outer membrane and particularly expression of LPS in the outer leaflet in
Gram-negative bacteria is known to afford significant protection against
hydrophobic antibiotics such as rifampicin and erythromycin (302, 308, 309).
Rifampicin is a large hydrophobic antibiotic, which specifically inhibits DNA-
dependent RNA polymerase, thereby blocking transcription (301, 309).
Comparisons between rifampicin potency against E. coli and the Gram-positive
bacteria, Staphylococcus aureus, demonstrated that E. coli was intrinsically much
more resistant to rifampicin; minimimum inhibitory concentrations (MICs) of
rifampicin were 8 µg/ml for E. coli, compared to just 0.002 µg/ml for S. aureus
(309). The authors attributed this to the outer membrane of E. coli cells forming a
protective barrier against the drug (309). Erythromycin is another hydrophobic
antibiotic which halts protein synthesis by binding to the 50S ribosomal subunit
and bringing about the dissociation of peptidyl-tRNA complexes from the ribosome
(310, 311).
Permeabilisation of Gram-negative outer membranes has proven effective at
increasing sensitivity to hydrophobic antibiotics including rifampicin and
erythromycin (118, 308). Mutations which alter outer membrane or LPS structure
can also lead to an increase in the permeability of the outer membrane (301). In
order to further screen for possible perturbations to the outer membrane and LPS
in BRD948 mrd mutant strains, their sensitivity to the hydrophobic antibiotics
rifampicin and erythromycin was tested. This was done by means of antibiotic disc
diffusion assays, as described.
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Figure 4.21: Sensitivity of S. Typhi mrd mutants to hydrophobic antibiotics: Disc
diffusion assays with wild-type and mrd mutant BRD948 strains to screen for sensitivity to
rifampicin (A) and erythromycin (B). Sensitivity measured in terms of average diameters of
zones of clearance in bacterial lawns, around antibiotic discs inoculated with 1 mg/ml or
10 mg/ml rifampicin or erythromycin. Zones of clearance were measured after growth
overnight at 37°C. No zones of clearance were observed for any strain around discs
inoculated with dH2O (negative control). Assays were carried out in duplicate on 3
separate occasions. Error bars indicate standard deviation. Students t-test were
performed to test for statistical significance, where P values ≤0.05 were considered
significant.
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These assays showed a slight but statistically insignificant increase in sensitivity to
rifampicin in the BRD948 ΔpbpA and ΔrodA strains compared to the wild-type,
whereas no observable change in sensitivity to erythromycin was observed for
these mutants. Likewise, no differences in sensitivity for the ΔybeB, ΔybeA, or
ΔrlpA mutants were discernable for either antibiotic (Figure 4.21). However, in
erythromycin sensitivity assays faint outer zones of partial clearance of ~0.5 cm in
diameter, were visible on two occasions around 10 mg/ml discs for ΔpbpA and
ΔrodA strains, besides the more distinct inner zones from which the data was
presented. These partial zones of clearance were absent from any other strain.
These latter features may be indicative of a small increase in sensitivity of round-
cell mutants to hydrophobic antibiotics, which may represent an effect on outer
membrane permeability in these strains. However, there is insufficient evidence to
make any firm conclusions. Conversely, the results suggest that the outer
membrane barrier function of ΔpbpA and ΔrodA mutants remains generally intact.
In agreement with this, mecillinam-treated E. coli cells did not show increased
sensitivity to hydrophobic antibiotic treatment in a previous study (118).
Growth of mrd mutants on Congo red agar
Many enterobacteria, including Salmonella, produce an extracellular biofilm matrix,
consisting of extracellular polysaccharides including colanic acid and cellulose,
and curli and fimbriae. The biofilm is thought to help protect cells from external
environmental stresses as well as from the host immunity (312, 313, 323, 326).
Production of colanic acid, through expression of 19 cps/wca genes, is induced by
the global regulatory RcsCB two-component system, which acts in response to
environmental stimuli including envelope stress, osmotic stress and low
temperature (96, 314-319). The Rcs phosphorelay controls the expression of
around 150 genes, many of which have a function related to the bacterial cell
surface (314, 320). A study in 2001 isolated mecillinam-resistant S. Typhimurium
mutants which were also mucoid from overexpression of the colanic acid capsule
(315). The majority of these mucoid strains contained mutations within the mucM
gene, which acts through the Rcs phosphorelay to help regulate colanic acid.
mucM mutations led to the de-repression of RcsB/RcsC and the subsequent
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activation of RcsB-regulated genes, including ftsZ (321, 322). mucM mutant cells
were often shorter in length than the wild-type parents, most likely due to
overexpression of the ftsZ and ftsA genes. It was proposed that the mucM
mutation and the resulting activation of the RcsBC-mediated phosphorelay led to
the activation of both wca and fts genes. This consequently led to an increase in
colanic acid biosynthesis, and mecillinam resistance, since increased FtsZ levels
have been shown to suppress lethality in round-cell mutants and are required for
mecillinam resistance in E. coli (315, 323, 324). A more recent study also noted
that the majority of isolated mecillinam-resistant colonies were mucoid (325).
In a screen to identify genes whose overexpression led to changes in biofilm
expression or appearance in E. coli, Tenorio et al. isolated several genes involved
in cell wall synthesis or cell shape determination, including mreB and ftsZ, but not
pbpA and rodA. MreB overexpression resulted in non-motile cells with an unusual
biofilm architecture, whilst ftsZ overexpression resulted in the production of
filamentous biofilm. Changes in biofilm structure or appearance were also
associated with a concurrent reduction in motility in many of the isolated mutants
(323).
It was important to assess capsular polysaccharide production in mrd mutant
strains, particularly given the observed relationships between the expression of
cell shape genes and biofilm formation, as well as the links between membrane
stress and biofilm production. To test for overexpression of the extracellular
polysaccharide cellulose in mrd mutant strains, each strain was spread onto LB
agar containing the ‘Congo red’ dye at 100 µg/ml and incubated for ~24 hours at
37°C. Congo red binds cellulose with strong affinity. The growth of bacteria
expressing high levels of a cellulose capsule on medium containing Congo red
leads to extensive Congo red binding and the formation of so called ‘red, dry and
rough’ or ‘rdar’ colonies (312, 326, 499). mrd mutants and wild-type strains were
grown on LB agar containing Congo red to screen for the rdar phenotype.
When grown on LB agar containing Congo red (100 µg/ml), BRD948 ΔpbpA and
ΔrodA mutant colonies had a significantly darker red appearance, compared to the
wild-type and other mrd mutant strains, indicating that cellulose production was
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somewhat increased in these mutants (Figure 4.22). An increased mucoid nature
from excess cellulose or colanic acid production could also explain the tendency of
these strains to form large clumps of cells in liquid culture.
Figure 4.22: Growth of S. Typhi wild-type and mrd mutant strains on Congo red
agar: BRD948 wild-type and mrd operon mutants were streaked onto LB agar with aro/tyr
mix and ±20 mM MgCl2, also containing 100 µg/ml Congo red dye to screen for excesscellulose production, as indicated by the development of darker red colonies; the rdar
phenotype.
Oxidative stress sensitivity of mrd operon mutants
Bacteria possess many mechanisms to both detect and respond to various
environmental stresses, including oxidative stress (98). In order to survive
intracellularly, Salmonella must be also able to resist high levels of oxidative stress
from the oxidative burst of macrophages (44, 327, 328). Perturbations to the cell
surface of Salmonella may be linked to increased sensitivity to oxidative stress,
having a significant impact on virulence; for instance, the inactivation of rpoE, the
alternative sigma factor controlling responses to envelope stress, causes
increased sensitivity to oxidative stress (329).
In order to investigate the effects of mrd operon mutations on sensitivity to
oxidative stress, growth of both wild-type and mrd mutant strains in the presence
of hydrogen peroxide was assessed. Strains were cultured in LB broth containing
10% sterile water or hydrogen peroxide (H2O2) at a range of 10-fold dilutions from
a neat solution of H2O2 (30% w/w). Growth assays were then conducted as
described and plotted as growth curves.
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Figure 4.23: Sensitivity of S. Typhi mrd mutants to hydrogen peroxide: Growth
curves showing growth of S. Typhi wild-type (WT) and mrd mutants in LB media, in the
presence of hydrogen peroxide (H2O2), added at between 10-2 and 10-5 dilutions from astock solution (30% w/w). Cells were cultured overnight at 37°C, with shaking in a Tecan
Infinite 200® spectrophotometer. Growth (OD600) was measured every 15-20 minutes
over 16 hours. Graphs show average OD600 values from 3 independent experiments.
Error bars indicate standard deviation.
Growth assays demonstrated no significant change in sensitivity to hydrogen
peroxide for any of the mrd operon mutants compared to the wild-type (Figure
4.23). All were alike, growing equally well in LB broth containing H2O2 at a 10-5
dilution as in LB broth containing water. Growth of all strains was completely
inhibited in LB containing H2O2 at 10-4, however. That the inactivation pbpA or
rodA, as well as the other mrd operon genes, does not increase the sensitivity of
these cells to oxidative stress, suggests that the cell wall structure and barrier
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function may not be as compromised as was originally thought. Alternatively,
oxidative stress response pathways may be upregulated in round-cell mutants to
compromise for any defects in the barrier function of the cell wall, such that the
oxidative stress sensitivity in these strains is equivalent to the wild-type cells.
4.4 Discussion
4.4.1 Construction and complementation of mrd operon mutants in S. Typhi
After examining the structure of the mrd operon in Salmonella using both in silico
and experimental analyses, continuing work sought to investigate the functions of
the individual mrd operon proteins further. To do this, precise knockout mutations
were constructed using the method of Datsenko and Wanner, in the 5 putative mrd
operon genes of Salmonella Typhi BRD948; namely, ybeB, ybeA, pbpA, rodA and
rlpA. The latter mutant was constructed in previous work (163, 238). Complete
gene knockouts were created for each gene, in which only a short scar sequence
remained from the original insertion cassette along with short residual sequences
from ends of the target gene.
The successful generation of each gene mutant was verified by PCR and DNA
sequencing. Additionally the non-polarity of each mutant was demonstrated by
several means. Firstly, both S. Typhi ΔybeB and ΔybeA mutants recovered a rod-
shaped morphology after the removal of the knockout cassette, despite
possessing severe morphological defects beforehand, suggesting that the
cassette-containing mutations, but not the complete knockouts, brought about
polar defects on the expression of downstream genes. Furthermore, complete
ΔpbpA knockout mutants were complemented with a plasmid-encoded PBP2-YFP
fusion protein, which was able to restore a rod-shape to these mutants, thus
demonstrating that there were no significant polar effects on ΔrodA expression in
these cells.
ΔybeB, ΔybeA, ΔpbpA and ΔrodA mutant strains of BRD948 were each
complemented with YFP-fusion protein-expressing plasmids of the respective wild-
type protein from E. coli. The PBP2-YFP and RodA-YFP plasmids were a kind gift
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of L. Rothfield (University of Connecticut, US) (135, 269). The introduction of
PBP2-YFP and RodA-YFP to ΔpbpA and ΔrodA mutants, respectively,
successfully restored the wild-type morphology to these cells. Complementation of
each mutant strain with a YFP-fusion protein also enabled localisation studies to
be performed, showing, as previously, that PBP2 and RodA localise helically along
the lateral cell wall (135, 136, 160, 163). However, significant overexpression of
RodA-YFP, but not PBP2-YFP, tended to cause its accumulation into large polar
inclusion bodies. This may be to do with the YFP fusion affecting protein structure.
RodA is a highly hydrophobic membrane protein, containing at least 8 trans-
membrane spans, which may be affected to a greater extent than PBP2 (which
possesses only one or two trans-membrane spans) by the YFP fusion (154, 271).
Lower levels of PBP2 or RodA overexpression also occasionally brought about
morphological defects to wild-type cells, in which the formation of inclusion bodies
was not evident. It is possible that the YFP-fusion protein may have contributed to
this defect, by significantly affecting the function of PBP2 and RodA. As such,
overexpression of the YFP fusion proteins in wild-type cells may lead to an overall
decrease in the proportion of fully-functional PBP2 or RodA molecules in the
membrane, causing associated morphological defects. However, these YFP fusion
proteins are known to be functional, given that they are able to complement ΔpbpA
and ΔrodA mutations. The overproduction of MreB, RodZ, Mbl (B. subtilis), PBP2,
and PBP5, at least, have been shown to cause morphological defects similar to
those seen with the inactivation of the respective genes (158, 164, 209, 330). Thus
it is more likely that the overproduction of PBP2 and RodA themselves led to
defects in cell wall synthesis, with the observed morphological defects.
It is well accepted that the inactivation of either ΔpbpA or ΔrodA in bacteria such
as E. coli and Salmonella results in severe and identical morphological defects. In
Gram-positive organisms such as B. subtilis, the pbpA and rodA genes are located
within separate loci on the genome. Hence in this organism morphology defects
from the inactivation of pbpA are clearly not due to polar effects on rodA
expression. Asoh et al., however, generated non-polar Tn5 transposon insertion
mutants in pbpA and rodA, in E. coli, demonstrating that both genes were required
for cell shape determination (144). Similarly the expression of PBP-YFP, but not
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RodA-YFP in S. Typhi ΔpbpA was able to restore rod-shape, verifying that the cell
shape defects in ΔpbpA mutants are not merely due to defective rodA expression.
YbeB-YFP and YbeA-YFP-expressing plasmids were generated in this work, from
the same plasmid parent as the other YFP fusion vectors. The successful
complementation of ΔybeB and ΔybeA was more difficult to ascertain, however,
since few differences in phenotypes have been seen between these cells and the
wild-type cells, both in the course of this study and in previous studies (188, 189).
Both YbeB-YFP and YbeA-YFP appeared to have a cytoplasmic localisation, in
line with protein sequence analyses, which did not detect the presence of possible
transmembrane helices in either YbeB or YbeA structures (253, 271). However, it
is unknown whether these protein fusions retain their functionality.
4.4.2 Microscopic analysis of cell shape and surface features of mrd operon
mutants in S. Typhi
The morphology and surface appearance of each mrd operon mutant was
examined by both phase contrast and scanning electron microscopy. These
observations reinforced those of previous studies; stark morphological defects
were associated with ΔpbpA and ΔrodA mutants, which formed large spherical
cells, which were often heterogeneous in size (127, 130, 157). As described
previously, round-cell mutants were also shown to divide in an asymmetrical
manner, with the formation of heart-shaped cells prior to cell division. It is thought
that the increased diameter of these cells leads to the formation of an incomplete
FtsZ division ring, such that constriction begins at one side of the cell and
develops until cell division is permitted (127). Overexpression of the essential cell
division proteins FtsA, FtsQ, and particularly FtsZ is known to help suppress
lethality in round-cell mutants of Salmonella and E. coli. It was originally thought
that high levels of these division proteins were needed to compensate for the
increased diameter in the spherical cells, enabling cells to divide (130, 331, 332).
A more recent model, however, suggests that excess production of the inner
membrane in round-cell mutants causes FtsZ to mis-localise, preventing it from
regulating cell division (130, 332). However, despite the putative increase in the
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levels of the FtsZ, FtsA and FtsQ proteins, levels are clearly not sufficient to permit
efficient symmetrical cell division.
The YbeB and YbeA proteins clearly do not play a direct role in cell shape
determination, as microscopy in this study demonstrated that ΔybeB and ΔybeA
mutants of S. Typhi retain wild-type morphology. However, in numerous assays
average cell length appeared to be reduced in ΔybeA cells compared to the wild-
type cells, although the cell diameters were not affected.
Bacterial cell size is determined to a large extent by environmental factors, and
primarily by the availability of nutrients (333). Nutrient-rich conditions (fresh growth
medium, for example) cause an increase in growth rate (decreased mass doubling
time) and an increase in cell size, whereas nutrient starvation (for example during
stationary phase) results in a decrease in both growth rate and cell size (334,
335). Cell length in rod-shaped bacteria is also fundamentally determined by the
rate of cell division. This in itself is coordinated by the FtsZ protein, which directs
the formation of the FtsZ division ring and the recruitment of downstream division
proteins. However, many of the signals which direct the rate of FtsZ ring formation,
and hence cell division, remain to be characterised. These factors must form the
link between environmental signals and the FtsZ protein (335, 336).
In round-cell mutants lethality is suppressed by the overexpression of cell division
proteins, including FtsZ, as well as an increase in the concentration of the
alarmone ppGpp (guanosine tetraphosphate and guanosine pentaphosphate), and
a low growth rate (130, 331, 332). Although originally thought to simply prevent
rRNA and tRNA synthesis with amino acid starvation, ppGpp is now known to
function as a major global regulator of growth rate in response to various forms of
nutritional starvation (337). In addition to regulating growth rate, ppGpp also
regulates level of ftsQAZ transcription; ftsQAZ transcription varies with growth rate
and cell cycle stage, and increased ppGpp levels led to an increase in FtsZ protein
levels (338).
Overproduction of ppGpp in both wild-type and mrd operon mutants was
previously shown to be associated with a decrease in cell size, from an increase in
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cell division rate. Increased ppGpp levels also bring about mecillinam resistance
(130, 331). Thus overproduction of ppGpp in round-cell mrd mutants may cause
an increase in FtsZ levels, leading to a restoration of cell division. Given the
observed decrease in cell size of ΔybeA (and possibly ΔybeB) mutants, it is
possible that growth rate is also affected; an increase in ppGpp and FtsZ levels
may cause the observed decrease in cell size of these mutants. Growth rate is
associated with levels of ribosomal RNA and protein synthesis and growth rate
regulation is mainly determined by regulating the levels of rRNA/tRNA and
ribosomal protein synthesis (337). Since YbeB and YbeA are both involved in
ribosome assembly and stability, it is possible that a mutation in either gene
affects protein synthesis and with it growth rate, leading to a decrease in growth
rate and cell size, as seen in wild-type cells with the reduction of nutrient
availability.
Interestingly, the addition of magnesium or calcium to growth medium, to suppress
lethality of the pbpA and rodA mutations in S. Typhi, decreased the prevalence of
giant spherical cells, and also appeared to cause a slight reduction in cell length in
wild-type cells. It was previously suggested that magnesium decreases lethality in
round-cell mutants by stiffening the cell envelope, or acting as an osmoprotectant
to reduce cell lysis (229). Calcium has been shown to induce ppGpp production in
certain plant chloroplasts, whilst magnesium levels regulate the metabolism of
ppGpp; activity of the ppGpp synthetic Rel enzymes is dependent upon
magnesium, although high magnesium concentrations inhibit ppGpp synthesis
(339-341). Magnesium is also involved in the binding of ppGpp to RNA
polymerase in the regulation of transcription (373). However, manganese is
required for the degradation of ppGpp (341). It would be interesting to assess
whether the short-cell phenotype of magnesium-treated S. Typhi cells is linked to
ppGpp and ftsZ expression, and therefore whether magnesium and calcium play a
role in suppressing the lethality of round-cell mutants by increasing ppGpp
synthesis and therefore increasing ftsZ transcription. Furthermore, magnesium
ions were shown to induce the oligomerisation of FtsZ protein monomers in vitro,
suggesting that magnesium may also assist with FtsZ ring formation, something
which may be of significant importance in round-cell mutants (342). These
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hypotheses, however, do not explain why the vulnerability of ΔpbpA and ΔrodA
mutants to cold shock was reduced with the addition of magnesium.
ΔrlpA mutants retained their rod morphology, as previous work has shown (163,
201). However, initial SEM analyses highlighted potentially interesting surface
features in these cells, which previous studies have not identified. The observed
rough surface of ΔrlpA cells was reminiscent of surface appendages seen with
polymyxin B treatment of wild-type S. Typhimurium (273). Although repeated SEM
analyses of ΔrlpA and wild-type cells were inconclusive, the observations may still
warrant future work. Polymyxin B is thought to act by incorporating into the outer
membrane and therefore increasing its surface area. This, along with the tight
binding of the outer membrane to the peptidoglycan, may have forced the excess
sections of outer membrane outwards, forming the observed projections. RlpA is a
peptidoglycan-binding outer membrane lipoprotein, which may be involved in
linking the outer membrane to the peptidoglycan layer, along with other major
outer membrane lipoproteins (201). As such ΔrlpA mutants may be expected to
display visible surface defects such as those seen initially by SEM. If
peptidoglycan-outer membrane associations were affected in this mutant, outer
membrane projections could be observed, resulting from the disconnection in
places of the outer membrane and the peptidoglycan layer. A number of major
outer membrane lipoproteins are involved in linking the peptidoglycan layer to the
outer membrane, including Pal and Lpp, indicating some possible redundancy of
function (201). The variability in observed cell surface appearance of ΔrlpA cells in
this study could potentially result from variability in Pal/Lpp expression between
individual cells or cultures, such that increased levels of Pal/Lpp mask any cell
surface defects caused by the ΔrlpA mutation.
4.4.3 Conclusions from general phenotypic analyses of round-cell mrd
operon mutants of S. Typhi
In addition to those phenotypes already discussed, a number of other phenotypic
screens were utilised to functionally analyse the mrd operon mutants. The
sensitivity of the mrd mutants to a number of external stresses and antibiotics was
assayed; furthermore, a number of cell surface features in these mutants were
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assessed, given the role that PBP2 and RodA play in cell wall synthesis. Several
previous studies have investigated cell wall synthesis in ΔpbpA and ΔrodA
mutants and the sensitivity of these and similar mutants to environmental stress,
suggesting that the cell wall integrity is somewhat compromised in round-cell
mutants (127, 211, 214, 343).
The results of several phenotypic assays in this study highlighted some interesting
features in ΔpbpA and ΔrodA mutants of S. Typhi. Although growth at 37°C in rich
medium was not significantly affected, these mutants had an increased sensitivity
to cold shock, and a slightly increased sensitivity to hydrophobic antibiotics. In
addition, cells were prone to lysis. These results may be indicative of a significant
weakening of the cell wall barrier function or structural integrity in round-cell
mutants. Possible alterations to the surface structure were also highlighted with
significant differences in the LPS profiles of ΔpbpA and ΔrodA mutants compared
to the wild-type, as well as a noticeable increase in cellulose capsule production in
these strains. However, it is possible that the alterations to LPS profiles resulted
from the effects of pbpA/rodA mutations on LPS preparations, or levels of LPS
expression rather than effects on LPS structure. Work by Matsuzawa et al. found
that surprisingly, ΔrodA mutants were more resistant to UV irradiation than wild-
type cells, reflecting results of several other studies (343). Similarly, despite
ΔpbpA and ΔrodA mutations seemingly bringing about cell wall defects, these cells
appeared no more sensitive to oxidative stress, from exposure to hydrogen
peroxide, than wild-type cells.
Thus, it would appear that the cell wall barrier function and structure in ΔpbpA and
ΔrodA mutants may not be as severely compromised as expected, although some
changes in the overall cell envelope structure may be apparent. It is possible that
Salmonella respond to the defects brought about by the inactivation of cell shape
determinants by altering the expression of stress response pathways, and other
cell surface-associated features, to compensate for a possible increase in
sensitivity to external stress. A number of stress response pathways exist in
Salmonella, which are activated in response to the detection of cell envelope
stress. These pathways are regulated by a number of global regulators including
CpxA/CpxR, RcsB, and RpoE (118, 344, 345). Further experimental analyses will
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help establish whether these factors are involved in responding to the defects
associated with pbpA/rodA inactivation, to maintain viability and resistance to
environmental stresses. The possible upregulation of biofilm synthesis in round-
cell mutants supports the hypothesis that envelope stress pathways may be
involved (118).
As expected both ΔpbpA and ΔrodA mutants of S. Typhi were resistant to both
mecillinam and the MreB-targetting molecule A22. The latter feature has been
noted previously but not widely studied (281). MreB is thought to direct lateral cell
wall synthesis through positioning the cell wall synthetic enzymes, including PBP2
and RodA, in the lateral cell wall (131). In addition, MreB localisation was shown to
be dependent on RodA (131, 126). There are clear functional links between MreB,
PBP2 and RodA, and in preventing MreB polymerisation and function A22 inhibits
lateral cell wall synthesis (149). It is therefore not surprising that ΔrodA mutants at
least are resistant to A22; if RodA is required for the correct localisation of MreB,
MreB would already be mislocalised in ΔrodA mutants - the addition of A22 would
not bring about any further effects. In terms of PBP2, although not essential for
MreB localisation, lateral cell wall synthesis is already stalled in ΔpbpA mutants
and so the addition of A22 would be ineffective at inhibiting lateral cell wall
synthesis. These observations further reinforce the functional links between MreB,
PBP2 and RodA, and their involvement in lateral cell wall synthesis.
In the course of these assays, no significant phenotypic differences were observed
between the ΔpbpA and ΔrodA mutants of S. Typhi, suggesting they are closely
linked in function. The activity of pbpA is known to be dependent on RodA (130,
146).
4.4.4 Conclusions from general phenotypic analyses of the ΔybeB, ΔybeA,
and ΔrlpA mutants of S. Typhi
The functions of the three remaining mrd operon genes, ybeB, ybeA, and rlpA, in
Salmonella remain less well characterised. It is also unknown whether they are in
any way functionally linked to pbpA or rodA. Phenotypic analyses of mutants of
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these genes sought to better characterise the roles of these proteins, and the
reason for their placement within the mrd operon.
Experimental analysis of both the ybe mutants did not reveal any significant
phenotypic traits; growth of these mutants at both 37°C and 30°C, and sensitivity
to oxidative stress, A22, hydrophobic antibiotics did not differ significantly from the
wild-type. In addition, LPS structure and extracellular cellulose synthesis were not
affected in ΔybeB or ΔybeA mutants. Although additional work was carried out to
assess virulence factor functionality in these strains, from these initial assays it
was difficult to glean much useful information on the function of ybeB or ybeA.
However, several interesting features of these mutants were noted; firstly in terms
of their slightly short-cell appearance, as already discussed. Also, antibiotic disc
diffusion assays revealed increased resistance to mecillinam in both ΔybeB and
ΔybeA strains. This would suggest a possible functional link between the ybeB
and ybeA genes, and pbpA and rodA. Conversely though, the ΔybeB and ΔybeA
mutants did not display any increased resistance to mecillinam in liquid growth
assays.
The conflicting results seen with ΔybeB and ΔybeA cells in disc diffusion and
growth rate assays may indicate differences in behaviour of these cells on solid
and liquid medium. A study by Costa and Antón described round-cell mutants
whose viability was somewhat dependent on growth medium; Δmre and ΔrodA
mutations were isolated which were lethal with growth on solid but not in liquid
media (157). However, were the present results to reflect these results, one would
expect the mecillinam resistance of ΔybeB and ΔybeA cells to be observed in
liquid culture, rather than in disc diffusion assays. Alternatively, some polar effects
of the ΔybeB or ΔybeA mutations on pbpA or rodA expression may be apparent in
these mutants when grown on solid media, leading to significant mecillinam
resistance. However, if this was the case it would be expected for the results of
both assays to display similar resistance phenotypes, and no obvious polar effects
on pbpA or rodA expression were otherwise noted in these mutants.
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Analysis of the YbeB protein revealed a short sequence containing homology to
the conserved ‘PGVRY’ loop region of the S12 ribosomal protein (290). The
PGVRY loop of S12 is important for the recognition of specific tRNAs, enabling
correct coding during protein synthesis. Furthermore mutations are often isolated
within this loop, which confer streptomycin resistance (290). S12 itself is
associated with the 30S ribosomal subunit. YbeB, however, is a 50S subunit
ribosome-associated protein which may be involved in ribosome stability, but has
no known role in the regulation of translation (189, 192, 193). Also, the sequences
within the YbeB protein which direct the interaction with the 50S subunit have not
been analysed (189). Streptomycin resistance assays resulted in only a negligible
increase in resistance to streptomycin in ΔybeB and ΔybeA mutants. As such
YbeB (and YbeA) appears not to be directly functionally connected to S12. Further
work would be needed to establish whether the observed overlap in homology
between YbeB and S12 is significant, or indicative of sequences within YbeB that
are important for the function of YbeB, which may be analogous to the role of
corresponding sequences within S12. It also remains to be assessed which
portions of YbeB are involved in ribosome binding.
It is well established that YbeA functions to methylate a pseudouridine residue
within stem-loop 69 of the 23S ribosomal subunit rRNA. This occurs in the final
stages of ribosome assembly and may provide a signal to enable translation to
begin (194-196). Similarly to the ΔybeB mutants, streptomycin sensitivity assays
showed that YbeA is not directly involved in translation functions which would
normally by inhibited by streptomycin. YbeA is required prior to translation, so if
mutations in ybeA were to affect translation, some resistance to translation-
inhibiting antibiotics may be expected in ΔybeA cells. As such, this mutation may
not have a large inhibitory effect on protein synthesis.
Aside from the observed mecillinam resistance of ΔybeB and ΔybeA mutants,
phenotypic analyses did not provide evidence of a functional link between these
genes and pbpA or rodA. YFP-fusion proteins of YbeB and YbeA enabled the
localisation of these proteins to be assessed. However, both YbeB and YbeA were
spread diffusely through the cytoplasm. If YbeB or YbeA were linked with PBP2
and RodA they may be expected to co-localise with these proteins and the lateral
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cell wall peptidoglycan synthetic complex. Studies in B. subtilis have shown that
ribosomes were specifically localised around the cell periphery or at the cell poles
(230, 231). It is possible that elements of the bacterial cytoskeleton may be
involved in directing their localisation. However, no such localisation pattern was
observed for the YbeB and YbeA ribosome-associated proteins in this study.
Assuming the YFP-fusion constructs of these proteins are functional, it may be
that these proteins exist freely in solution, as well as within ribosome complexes,
in which case it is not possible to determine whether ribosome-associated YbeB
and YbeA exhibit specific localisation patterns, which may be directed or linked to
the bacterial cytoskeleton and associated proteins. It is also possible that the YFP
protein fusion interfered with ribosome binding in both proteins, therefore masking
any specific localisation patterns of these proteins.
The successful isolation of ΔybeB and ΔybeA mutants lacking obvious phenotypes
demonstrates that these genes are not essential for viability in Salmonella.
However, the observed mecillinam resistance in disc diffusion assays, along with
the short-cell phenotypes, warrant further investigation to determine whether they
relate specifically to the function of ybeB and ybeA.
RlpA is a peptidoglycan-binding outer membrane lipoprotein, which has been
shown to localise both at the cell septum, and also at distinct foci along the lateral
cell wall (163, 179, 201). Previous studies were unable to isolate a distinct
phenotype associated with the ΔrlpA mutation, however, suggesting that its role is
not important, or that significant functional redundancy exists (201). Likewise,
microscopic analysis and general phenotypic analyses of the S. Typhi ΔrlpA
mutant in the present study did not reveal any distinct features, besides those
isolated by SEM. It might be expected that the cell morphology and structure of the
outer surface of S. Typhi cells would be affected with the inactivation of rlpA;
phase contrast microscopy and LPS profiles, though not comprehensive, did not
highlight any changes, however. It may be that the simultaneous inactivation of
other major peptidoglycan-associating outer membrane lipoproteins is required to
reveal a phenotype for the ΔrlpA mutation. Further analysis of virulence
determinant functionality in this mutant was also subsequently carried out.
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If significant, the surface features noted in SEM analyses of ΔrlpA cells may
highlight a role for RlpA in maintaining attachment of the outer membrane to the
peptidoglycan cell wall. Given its localisation pattern, RlpA may be an important
member of both the septal and lateral cell wall synthetic complexes at different
stages of cell growth; it may be required, for instance, to maintain outer
membrane-peptidoglycan associations in areas where active cell wall synthesis is
occurring, or to establish those associations in newly incorporated peptidoglycan
strands. It is recognised that a great deal more work will be needed to test these
hypotheses.
159
Chapter 5. Phenotypic analyses of mrd operon gene knockout
mutants to assess virulence factor functionality
5.1 Introduction and overview of major virulence determinants of Salmonella
Although many studies have investigated the roles of cell shape determinant
proteins, few to date have considered the potential relationships between virulence
and cell shape determination in rod-shaped bacterial pathogens. However, several
studies have noted detrimental effects of cell shape determinant inactivation upon
flhDC expression and motility (118, 166). A role for MreB in pili localisation has
also been assessed (221, 222). This is significant, given that many crucial
virulence determinants form cell surface or wall-spanning organelles, which may
depend upon the cell wall structure for function.
Both S. Typhi and S. Typhimurium, along with the majority of Salmonella serovars,
share a number of virulence determinants which are important for pathogenesis.
Foremost among these are the two type 3 secretion systems (T3SS), which are
both essential for virulence. The SPI-1 T3SS is required in the early stages of
infection, where effector proteins injected into host epithelial or macrophage cells
induce phagocytosis of the bacterium. Once Salmonella is internalised, the SPI-2
T3SS is required for intracellular survival and ultimately for systemic spread of
Salmonella (4, 11).
Other significant surface-associated virulence determinants of Salmonella include
flagella-mediated motility, which is known to assist in invasion potentially by
physically bringing cells into closer proximity with host cells, as well as directing
chemotaxis mechanisms (51, 53). S. Typhi and some Paratyphi serovars
exclusively express an extracellular polysaccharide capsule, the Vi antigen. The
capsule is anti-opsonic, assisting in the evasion and modification of host immune
responses. The Vi capsule is thought to help particularly in systemic spread of S.
Typhi (11, 70, 72, 114).
In the present study, a range of assays were used to assess the functionality of
these major virulence determinants in each of the mrd operon mutants. As well as
160
providing useful information about the effects of mrd mutations on virulence, it was
hoped that these analyses would provide further insights into the functions of the
mrd operon genes.
5.2 Motility of S. Typhi mrd operon mutants
5.2.1 Microscopic analysis of mrd mutants
Initial observations of live S. Typhi BRD948 mrd mutant cells revealed that whilst
the rod-shaped ΔybeB, ΔybeA, and ΔrlpA mutants appeared motile under the
microscope, the vast majority of ΔpbpA or ΔrodA cells appeared completely non-
motile. Amongst a large population of cells, only very few individual cells
occasionally appeared motile.
5.2.2 Motility assays with mrd mutant cells
To assess the potential motility phenotype associated with round-cell mrd mutants,
motility assays were performed, as described. After several hours of culture at
37°C, the extent of spread of wild-type and mrd mutant cultures through semi-solid
agar was measured to give an indication of the motility functionality of each strain.
A non-motile S. Typhimurium ΔflhDC strain was routinely used as a negative
control in motility assays. Previous motility assays with BRD948 ΔrlpA
demonstrated that there were no significant effects on motility in this mutant (163).
In line with previous observations in a S. Typhimurium ΔrodA mutant, both ΔpbpA
and ΔrodA mutants in S. Typhi were completely non-motile in motility assays
(Figure 5.1 C and D) (163). Motility assays were also carried out in BRD948
complemented strains in the presence or absence of 0.5 mM IPTG, to determine
whether motility could be restored in ΔpbpA and ΔrodA strains expressing PBP2-
YFP and RodA-YFP and to check that the observed motility defects were a direct
result of the inactivation of pbpA and rodA. In the absence of IPTG, added to
induce overexpression of the YFP-fusion proteins, around 50-70% motility was
restored in BRD948 ΔpbpA and ΔrodA mutants expressing the relevant YFP-
fusion complementation plasmids, pVP6 and pVP3 respectively (Figure 5.1 C and
D). However, the addition of 0.5 mM IPTG to the motility agar was accompanied
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by a complete loss of motility in the same cells. Overexpression of PBP2-YFP in
wild-type BRD948 (with the addition of IPTG) also produced a slight but significant
reduction in motility compared to the wild-type, although the equivalent
measurement for RodA-YFP (pVP3) was not significantly different from the wild-
type.
It is plausible that overexpression of PBP2-YFP and RodA-YFP caused
detrimental effects to the cells; it has previously been seen that when
overexpressed, RodA-YFP at least aggregates into inclusion bodies. Were this to
occur, BRD948 ΔpbpA pVP6 and ΔrodA pVP3 cells grown in the presence of
IPTG could revert to a spherical shape, with the concurrent loss of motility, as was
seen. Alternatively, given that the overexpression of cell shape determinant
proteins also causes morphological defects, it is possible that the motility defects
are a result of overexpression of the functional proteins rather than a loss of
functional PBP2/RodA.
In motility assays with BRD948 ΔybeB and ybeA mutant strains, as well as those
expressing the YbeB-YFP and YbeA-YFP fusion plasmids, generally no significant
differences in motility were observed; only the ΔybeB mutant displayed a small
decrease in motility, being around 80% compared to the wild-type (Figure 5.1 A
and B).
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Figure 5.1: Motility assays of S. Typhi mrd operon mutants and complemented
strains: Motility assay results for BRD948 ΔybeB (A), ΔybeA (B), ΔpbpA (C), and ΔrodA
(D) mutants and YFP-fusion protein complemented strains. Cells were inoculated into
semi-solid motility agar (with aro/tyr mix and 20 mM MgCl2) and cultured at 37°C for at
least 6 hours. Motility was measured in terms of extent (diameter) of culture spread
through motility agar, as a percentage of that of wild-type cells. Results show averages
from 3 independent assays. SL1344 ΔflhD, routinely used as a negative control, was
completely non-motile in all assays. Error bars indicate standard deviations. Asterisks
indicate statistically significant differences, where P values were ≤0.05 as determined by
Students t-tests.
5.2.3 Motility assays with mecillinam-treated cells
Motility assays with round-cell mrd mutants demonstrated that these cells were
completely non-motile. However, it remained to be seen whether or not the motility
defects were the direct result of cell-wall and morphological defects in these
mutants, with the resulting round cells becoming incapable of assembling or
supporting structures such as flagella. If this were the case, the formation of round
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cells would be associated with an immediate loss of motility, with a breakdown of
flagella structures.
To investigate further the relationship between cell shape and motility, motility
assays were carried out in semi-solid motility agar containing mecillinam at
concentrations of 0, 0.001, 0.005, 0.01, 0.02, or 0.05 µg/ml. Motility assays were
coupled with microscopic analysis to assess the concentrations of mecillinam
required to both cause the formation of round cells and to inactivate motility
function. These assays were carried out in parallel for each rod-shaped mrd
mutant strain as well as the wild-type, to examine possible differences between
the mutants. The results of motility assays in the presence of mecillinam are
shown below (Figure 5.2 A). The motility of each strain was measured relative to
the motility of that same strain in the absence of mecillinam.
Figure 5.2: Motility of S. Typhi wild-type and mrd mutant strains in the presence of
mecillinam: A - Motility assay results for BRD948 wild-type (WT), ΔybeB, ΔybeA, and
ΔrlpA mutants in the presence of 0, 0.001, 0.005, 0.01, 0.02, or 0.05 µg/ml PBP2-
inhibiting mecillinam. Cells were inoculated into semi-solid motility agar (with aro/tyr mix
and 20 mM MgCl2) containing mecillinam at a range of concentrations, and cultured at
37°C for ~6 hours. Motility was measured in terms of extent (diameter) of culture spread
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through motility agar, as a percentage of that of the same strain grown in the absence of
mecillinam. Results show averages from 3 independent assays. Error bars indicate
standard deviations. Asterisks indicate statistically significant differences, where P values
were ≤0.05 as determined by Students t-tests. Coloured asterisks demonstrate where the
motility of a strain was significantly different to the motility of that strain in the absence of
mecillinam. B – Schematic diagram representing the morphology of wild-type cells after 6-
8 hours’ growth in the presence of various concentrations of mecillinam, as observed by
phase contrast microscopy of mecillinam motility assay cells.
Mecillinam motility assays demonstrated that increased mecillinam concentrations
were accompanied by a concomitant decrease in motility in both wild-type and mrd
mutant cells. However, even at concentrations of 0.05 µg/ml, 50-60% motility
remained in all strains (Figure 5.2 A). In general no significant differences in
motility between ΔybeB, ΔybeA, ΔrlpA, and wild-type strains were observed in this
assay. Phase contrast microscopy analysis of these cultures demonstrated that
mecillinam treatment was also associated with a loss of rod-shape, as represented
(Figure 5.2 B). At low mecillinam concentrations, wild-type BRD948 retained a rod-
shape. With increasing amounts of mecillinam, cells gradually became shorter,
with a widened cell diameter, such that at 0.02 µg/ml the majority of cells were
almost completely round. However, even at this concentration, both the cell size
and diameter remained fairly regular between individual cells, although cells were
slightly wider than the wild-type cells grown in the absence of mecillinam. At 0.05
µg/ml mecillinam cells were completely round and significant heterogeneity of size
and diameter between individual cells was evident.
Despite the complete round morphology of all cells grown in 0.05 µg/ml mecillinam,
these cells clearly retain some ability to swim. The motility observed was not
simply ‘residual’ motility left from a number of cells in the culture which somehow
remained rod-shaped, since no rod-shaped cells were observed by microscopy in
cultures containing 0.05 µg/ml mecillinam. Furthermore many clearly motile
spherical cells were seen by microscopy in these cultures. Thus, the motility defect
seen in ΔpbpA and ΔrodA mutants is not a direct consequence of a loss of rod-
shape; there in fact appears to be some delay between the loss of rod-shape and
the complete loss of motility.
The isolation of completely spherical yet motile cells demonstrates that these cells,
and significantly the cell walls, are able to support functional flagella, although it
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may be that the number of flagella expressed by such cells is decreased.
Alternatively, the slight reduction in motility may be caused by the loss of motility in
some, but not all cells.
5.2.4 Luciferase promoter reporter assays to investigate flagella gene
expression
Motility assays in this work showed that the round-cell mrd mutants were all non-
motile, although the ybeB and ybeA mutants retained their motility. This supports
the results of previous work (118, 163, 166). Transcriptional reporter assays were
therefore carried out to further investigate the nature of the motility defect, by
assessing flagella gene expression.
The promoter region of the flagella fliF gene was cloned into the pMK1lux reporter
plasmid. fliF is a Class 2 flagella gene, in terms of the hierarchical regulation
involved in the expression of the flagella structural genes. FliF is the first flagellar
structural protein to be incorporated into the cell wall during flagella assembly,
where it forms the MS basal body ring (346, 347). Thus fliF is expressed very early
on in flagella assembly; the assembly of all subsequent basal body apparatus
proteins and also expression of the downstream class 3 genes, is dependent upon
the expression and assembly of the FliF MS ring (56, 62). It is for this reason that
FliF was chosen as an ideal candidate to study flagella gene expression.
Luciferase transcriptional reporter assays were carried out in both wild-type and
mrd mutant strains of BRD948 expressing the pMK1lux-fliF reporter plasmid,
whereby relative luminescence of cultures expressing the reporter plasmid gave
an indication of fliF expression. Strains were cultured in nutrient rich LB medium to
stimulate flagella expression. As expected for the rod-shaped ΔybeB, ΔybeA, and
ΔrlpA S. Typhi mutants, fliF expression remained at the level of the wild-type.
However, transcription of fliF in both the ΔpbpA and ΔrodA mutants appeared to
be almost completely downregulated (Figure 5.3 A-E).
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Figure 5.3: Motility gene expression in wild-type and mrd operon mutants of S.
Typhi: A-E – Transcriptional luciferase reporter assays of BRD948 wild-type (WT) and
mrd operon mutant cultures expressing a promoter fusion of the fliF gene, cloned into the
pMK1lux luminescence reporter plasmid. Promoter activity was measured in terms of
relative luminescence units (luminescence per culture optical density at 600 nm). Results
are indicative of fliF transcription levels in WT and mrd mutant cells. F – Transcriptional
luciferase reporter assays of BRD948 wild-type (WT), ΔpbpA and ΔrodA strains
expressing pRG38; a promoter fusion of PflhDC cloned upstream of lux genes (108).
Promoter activity was measured in terms of relative luminescence units (luminescence per
culture optical density at 600 nm). Results are indicative of flhDC transcription levels in
WT and mrd mutant cells. Cells were grown in LB medium at 37oC with shaking. Growth
rates of strains were equivalent. Values show means of 3 independent assays.  Error bars
= standard deviation.
To further analyse flagella gene expression in these mutants, an flhDC luciferase
transcriptional reporter plasmid, pRG38, was introduced into wild-type, ΔpbpA and
ΔrodA BRD948 strains. The flhDC genes encode the major global transcriptional
regulatory proteins which control flagella gene expression as well as the
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expression of a number of other genes (56, 348-350). The pRG38 vector was a
kind gift from Brian Ahmer (Ohio State University, US) (243). Luciferase reporter
assays with this plasmid demonstrated that flhDC expression was significantly
downregulated in the BRD948 ΔrodA strain and almost completely downregulated
in ΔpbpA mutants (Figure 5.3 F). The difference in flhDC expression between the
two round cell mutants may be significant, given that in all other assays conducted
the phenotypes of these mutants have been indistinguishable.
5.2.5 Immunofluorescence microscopy of flagella expression in mrd mutant
strains
Mid-log phase BRD948 wild-type and mrd mutant cultures were fixed and labelled
with Salmonella agglutinating serum specific for Typhi-flagellin, followed by an
anti-rabbit fluorophore-conjugated secondary antibody. Cells were then mounted
onto slides and viewed by epifluorescence microscopy. Specific binding of the
primary agglutinating serum to flagellin proteins permitted the visualisation of
individual flagella expressed at the surface of cells.
The resulting images clearly show that long flagella filaments are expressed at the
surface of both wild-type cells and rod-shaped mrd mutant cells. However, such
filaments were not visible in ΔpbpA and ΔrodA cells. Fluorescent foci or very short
flagellin tails were very occasionally observed at the surface, or around the cell
wall in both mutants, possibly resulting from heterogeneous flagella protein
expression between individual cells (Figure 5.4).
It is likely that during the preparation of the samples for immunofluorescence
microscopy, some flagella filaments would have been physically sheared off the
cells. This possibility is supported by the observation that wild-type cells contained
within large clumps appeared to possess more flagella than individual cells, and
explains why many cells of rod-shaped BRD948 strains appear to have no flagella.
Alternatively, the anti-flagellin serum may have caused the agglutination and
clumping of highly motile cells expressing large numbers of flagella filaments.
Consequently, the cells which were seen not to form clumps may generally be
those which are less motile. Hence, it is not possible to use this method to assess
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levels of flagella expression between strains, although it effectively demonstrates
whether flagella are expressed at all, as well as whether flagella generally appear
relatively normal in terms of length, as demonstrated for ΔpbpA and ΔrodA
mutants.
In conclusion, the results of various phenotypic assays have demonstrated that
whilst BRD948 ΔybeB, ΔybeA and ΔrlpA mutants remained completely motile,
motility was not only defective in S. Typhi round-cell mrd mutants, but completely
downregulated from the level of transcription of the flagella master regulator
operon, flhDC (163). Despite this, analyses of motility in mecillinam-treated cells
suggested that round-cells with defective PBP2 remained physically able to
support functional flagella.
Figure 5.4: Flagella expression in wild-type and mrd operon mutants of S. Typhi:
Epifluorescence microscopy of S. Typhi wild-type (WT) and mutant cells fixed and labelled
with flagellin-agglutinating serum and a fluorophore conjugated secondary antibody, to
enable visualisation of cell surface flagella by immunofluorescence microscopy. Cells
further stained with DAPI DNA stain (blue) and Nile Red membrane stain (red). All images
are to the same scale.
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5.3 SPI-1 type 3 secretion system (T3SS) functionality in S. Typhi mrd
operon mutants
5.3.1 Western blots and immunofluorescence microscopy with anti-SipD
antibody
Expression and functionality of the SPI-1 T3SS was analysed in each of the mrd
operon mutants in S. Typhi. Data from a previous study on an S. Typhimurium
ΔrodA mutant strain had shown that the SPI-1 T3SS proteins were not expressed
in this strain, whilst SPI-1 expression was active in both S. Typhimurium and
BRD948 ΔrlpA mutant strains (163). For the purpose of testing SPI-1 functionality,
strains were routinely cultured in nutrient-rich LB broth medium, which has been
shown to stimulate SPI-1 gene expression (90).
SPI-1 T3SS protein expression and functionality were tested by means of western
blots, immunofluorescence microscopy and luciferase reporter assays.  Total cell
protein and secreted protein fractions were isolated from mid to late exponential
phase cultures of BRD948 wild-type and mrd mutant strains, as previously
described. Protein samples were then subjected to SDS-PAGE, blotted onto a
nitrocellulose membrane and labelled with antibodies specific to the SPI-1
secreted effector protein SipD. Along with SipB and SipC, this protein forms part of
the SPI-1 needle translocon (351).
Western blot analyses demonstrated that the SPI-1 effector proteins were
expressed both intracellularly and in the secreted protein fractions of wild-type
ΔybeB, ΔybeA and ΔrlpA BRD948 cultures (163). However, similarly to the S.
Typhimurium ΔrodA strain, SipD bands were absent from both total cell protein
and secreted protein fractions of the BRD948 round-cell mutant strains (Figure 5.5
A) (163), suggesting that SPI-1 protein expression may be downregulated in
ΔpbpA and ΔrodA mutants.
Immunofluorescence microscopy images supported these results. Mid-log phase
cells of BRD948 mrd mutants were fixed and labelled with anti-SipD primary
antibody, followed by a fluorophore-conjugated secondary antibody. The nature of
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the SipD protein as a translocon protein means that it resides at the tip of the
T3SS needle and can therefore be detected at the cell surface by
immunofluorescence microscopy, whereby fluorescent foci indicate the location of
SPI-1 needles. Whilst clear fluorescent foci were present in several copies along
the lateral cell walls of wild-type, ΔybeB, ΔybeA, and ΔrlpA cells, such foci were
completely absent from the surfaces of ΔpbpA, and ΔrodA mutant cells (Figure 5.5
B).
Figure 5.5: SPI-1 functionality in wild-type and mrd operon mutants of S. Typhi: A –
Western blots showing expression of the SPI-1 SipD effector protein in total protein and
secreted protein fractions of BRD948 wild-type and mrd mutant cultures, along with S.
Typhimurium (SL1344) Δspi-1, as a negative control. Western blots were repeated a
number of times, using antibodies to other effectors including SipA and SipC. B -
Immunofluorescence microscopy images of S. Typhi BRD948 wild-type (WT) and mrd
mutant cells overlaid onto phase contrast images; samples labelled with anti-SipD
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antibody and fluorophore-conjugated secondary antibody. All images are to the same
scale.
5.3.2 Luciferase promoter reporter assays to investigate SPI-1 gene
expression
HilD is the major SPI-1-encoded transcriptional regulator of the SPI-1 T3SS genes.
Together with HilC it activates expression of HilA, which goes on to directly
activate SPI-1 T3SS genes (352, 353). Expression of the SPI-1 genes is therefore
dependent upon hilD expression (88). Western blot analyses showed that SPI-1
effector proteins were not expressed in round-cell mrd mutants. This, along with
observed transcriptional repression of motility genes, hinted at the possibility that
SPI-1 transcription may also be repressed in round-cell mutants. To test this,
expression of hilD was investigated in the BRD948 wild-type and mrd operon
mutant strains. The hilD promoter was cloned into the luciferase reporter plasmid
pMK1lux and introduced into BRD948 wild-type and mutant strains. The relative
luminescence of strains expressing pMK1lux-hilD was subsequently measured
over 16 hours of growth in LB broth, as a measure of hilD expression. As was
seen with expression of flagella gene regulators, hilD transcription was almost
completely downregulated in the round-cell mrd operon mutants compared to the
wild-type. In contrast, hilD expression remained largely unaffected in the ΔybeB,
ΔybeA and ΔrlpA mutants, with only a slight depression of expression in ΔybeA
and ΔrlpA cells at 6-10 hours’ growth (Figure 5.6).
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Figure 5.6: SPI-1 regulator gene expression in wild-type and mrd operon mutants of
S. Typhi: A-E – Transcriptional luciferase reporter assays of BRD948 wild-type (WT) and
mrd operon mutant cultures expressing a promoter fusion of the hilD gene, cloned into the
pMK1lux luminescence reporter plasmid. Promoter activity was measured in terms of
relative luminescence units (luminescence per culture optical density, at 600 nm). Results
indicative of hilD transcription levels in WT and mrd mutant cells. Cells were grown in LB
medium at 37oC with shaking. Growth rates of strains were equivalent. Values show
means of 3 independent assays.  Error bars = standard deviation.
5.4 Total cell protein and secreted protein profiles of S. Typhi mrd mutant
strains in SPI-1 growth conditions
Global protein expression in the BRD948 wild-type and mrd operon mutants was
assessed by separating both total cell protein and secreted protein preparations
from each strain by SDS-PAGE. Proteins were separated on 12% gels and then
stained using Coomassie® Brilliant Blue (Figure 5.7).
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#Protein identity based upon identification by peptide mass fingerprinting
* Putative protein identity based upon protein size and published information on abundant
Salmonella SPI-1 secreted effectors/flagella proteins (354, 355)
**Protein molecular weights estimated based upon calculations from amino acid sequence (253,
356)
†Effector encoded outside of SPI-1 region of genome (357)
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Figure 5.7: Global protein expression in wild-type and mrd operon mutants of S.
Typhi: A - Total and secreted protein profiles of BRD948 wild-type and mrd mutants
grown in flagella/SPI-1-inducing conditions (LB nutrient rich conditions). SL1344 Δspi1
secreted protein profile included as negative control. Protein molecular weight (MW)
marker sizes as indicated. Arrows indicate differentially expressed proteins between wild-
type and round-cell mrd mutant strains. B - Putative identities of differentially expressed
proteins based on molecular weight or peptide mass fingerprinting identification, as
indicated by arrows in A.
The total cell protein profiles of BRD948 wild-type and mrd mutant strains
appeared largely identical. The one exception seen in both ΔpbpA and ΔrodA
lanes was the absence of a protein of approximately 50 kDa in molecular weight
(arrow A) (Figure 5.7 A). Excision of this band from the lanes of both the wild-type
and other rod-shaped mrd mutants, followed by peptide mass fingerprinting protein
sequencing (done by Pinnacle, Newcastle University) revealed that the protein
was the Typhi flagellin protein, FliC. Flagellin is one of the most abundantly
expressed secreted proteins in Salmonella (358). The absence of FliC from total
cell protein fractions of round-cell mrd mutants was echoed in secreted protein
profiles where the strong bands, which are likely to be flagellin (arrow B), were
missing from these strains (Figure 5.7 A).
Whilst the secreted protein profiles of ΔybeB, ΔybeA and ΔrlpA mutant strains
appeared very similar to the wild-type, stark differences were seen in the profiles
of round-cell ΔpbpA and ΔrodA mutants. Perhaps most notably was the presence
of a large number of proteins in secreted protein fractions of ΔpbpA and ΔrodA
cells, compared to wild-type cells. This is indicative of significant cell lysis in round-
cell mutants, as observed previously (Chapter 4.3) (130), with the subsequent
release into the culture supernatant of ordinarily non-secreted cytoplasmic proteins.
Several major secreted proteins, as indicated by the secreted protein profiles of
the other strains, were also missing from the round-cell mutants (labelled arrows B
to H). Whilst the most highly expressed of these proteins (arrow B) is likely to be
the FliC protein, several other proteins are likely to encompass major SPI-1
effector proteins, since western blot analysis has shown that SPI-1 effectors,
including SipA, SipC, and SipD, are not expressed by round-cell mrd mutant
strains. SPI-1 effector proteins are normally highly expressed (358). Comparisons
with both wild-type and Δspi1 secreted protein profiles, along with published
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information on the major SPI-1 secreted effector proteins of Salmonella, enabled
attempts to be made at identifying these proteins (Figure 5.7 B) (253, 354-357).
Surprisingly, the higher molecular weight SPI-1 effectors (>55 kDa), including the
most abundantly expressed SPI-1 effector, SipA, were not clearly distinguishable
in any profile (354). However, lower molecular weight effectors, SipC and SipD are
likely candidates for bands indicated by arrows C and E respectively, since they
were absent from both Δspi1 and round-cell mutant lanes. Other putative effectors
which were absent from the ΔpbpA and ΔrodA mutants may include SopD and
SopE (arrows D and F). These proteins appeared in the Δspi1 profile, although
SopD and SopE are both encoded outside of SPI-1, so it is possible that they were
secreted independently of SPI-1 in the Δspi1 mutant, if indeed these proteins were
SopD and SopE. Protein identification by peptide mass fingerprinting is required to
unequivocally identify the proteins of interest. In addition, further two-dimensional
SDS-PAGE assays would be needed for the comprehensive analysis of the
proteomes of the mrd mutant strains.
5.5 SPI-2 type 3 secretion system (T3SS) functionality in S. Typhi mrd
operon mutants
5.5.1 Preparation of strains for analysis of SPI-2 functionality
In order to test the functionality of the SPI-2 T3SS in BRD948 mrd mutants, strains
were cultured in M5.8 minimal medium, which has been shown to induce
expression of the SPI-2 genes, somewhat resembling conditions inside the
macrophage Salmonella-containing vacuole (SCV). SPI-2 gene expression is
thought to be induced by a number of factors, including an acidic pH and possibly
a low magnesium concentration (90, 359). As such, cultures grown in SPI-2-
inducing conditions were not supplemented with additional magnesium.
BRD948 wild-type and mrd mutant strains, as well as a SL1344 ΔssaV SPI-2 non-
secreting strain (360) (as negative control) were transformed with the pWSK-
sseJ2HA expression plasmid. This was kindly given by David Holden (Imperial
College London, UK) and encodes the SPI-2 effector protein SseJ conjugated to a
double haemagluttinin epitope tag. SseJ-2HA is expressed under the control of its
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own promoter (244). Strains expressing pWSK-sseJ2HA were cultured overnight
in SPI-2-inducing conditions. From these cultures secreted protein fractions were
prepared for analysis by SDS-PAGE and western blotting. Western blots were
labelled with antibody specific for the haemagluttinin tag of the SseJ-2HA protein
to assess expression of the SseJ effector protein.
5.5.2 Western blotting and immunofluorescence microscopy with SPI-2
effector protein and translocon antibodies
The western blot of secreted protein fractions from BRD948 wild-type and mrd
mutant strains showed that SseJ was expressed and secreted in all mrd mutants,
including the round-cell ΔpbpA and ΔrodA mutants (Figure 5.8 A). In wild-type
cells, SPI-2 effectors are only secreted upon assembly of the needle complex;
therefore the secretion of SseJ suggests that the SPI-2 T3SS may be functional
(24). However, it has previously been demonstrated that round-cell mutants are
liable to cell lysis. It could therefore be argued that the presence of SseJ-2HA
within the culture supernatant was the result of lysis of ΔpbpA and ΔrodA cells
rather than active secretion through the SPI-2 T3SS needle, particularly as SPI-2
effector protein expression is not dependent upon needle assembly (361). To test
this, parent BRD948 wild-type and mrd mutant strains were cultured in SPI-2-
inducing conditions. Cells were fixed and labelled with a polyclonal antibody
specific for SseB, a SPI-2-encoded secreted effector protein, which forms part of
the translocon component of the SPI-2 needle (228, 360). After labelling with a
secondary fluorophore-conjugated antibody, cells were visualised by
epifluorescence microscopy to look for the presence of cell surface SPI-2 T3SS
needles.
Fluorescent foci, indicative of SPI-2 needles, were visible on the surface of all
BRD948 strains, including ΔpbpA and ΔrodA cells, but were absent from negative
control SL1344 ΔssaV cells (Figure 5.8 B). The visualisation of cell surface SPI-2
needles provides evidence that unlike SPI-1, the SPI-2 T3SS remains actively
expressed and functional in all mrd mutants. Immunofluorescence microscopy of
α-SseB-labelled cells also demonstrated that SPI-2 T3SSs exhibit a polar
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localisation, in contrast to SPI-1 T3SS which appeared to localise all around the
lateral cell wall (Figure 5.5 B and 5.8 B).
Figure 5.8: SPI-2 functionality in wild-type and mrd operon mutants of S. Typhi: A -
Western blot of secreted protein fractions of BRD948 wild-type (WT) and mrd mutant
strains expressing plasmid-encoded double haemagluttinin-tagged SseJ (pWSK-sseJ2HA)
SPI-2 effector protein. SL1344 ΔssaV expressing pWSK-sseJ2HA used as negative
control. ΔssaV mutants are attenuated and do not secrete SPI-2 effectors (27). SseJ-2HA
expressed under the control of its natural promoter. B - Immunofluorescence microscopy
images of S. Typhi BRD948 wild-type (WT) and mrd mutants, and SL1344 ΔssaV cells
overlaid onto phase contrast images; samples labelled with anti-SseB antibody and
fluorophore-conjugated secondary antibody. All images are to the same scale. All cultures
grown in SPI-2 inducing M5.8 media at 37°C, and 200 rpm, for 16 hours.
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5.5.3 Total cell protein and secreted protein profiles of S. Typhi mrd mutant
strains in SPI-2-inducing growth conditions
Global protein expression in BRD948 wild-type and mrd operon mutant strains
was assessed in SPI-2-inducing conditions by separating both total cell protein
and secreted protein preparations from each strain by SDS-PAGE. Proteins were
separated by electrophoresis on 12% gels and then stained using Coomassie®
Brilliant Blue dye.
Total protein profiles for both wild-type and mrd mutant strains grown in SPI-1 and
SPI-2 conditions did not appear vastly different (Figure 5.7 and Figure 5.9).
Likewise there were no apparent differences in total cell protein profiles between
the wild-type and mutants grown in SPI-2-inducing conditions.
Whilst flagellin and SPI-1 effector proteins were highly expressed in SPI-1
secreted protein profiles, the equivalent protein bands were not clearly visible in
SPI-2 secreted protein profiles. This was particularly noticeable with differences in
flagellin expression. This demonstrates the differences in secreted protein
expression in different growth conditions. Flagella and SPI-1 systems are
generally differentially expressed to the SPI-2 T3SS (4, 90). Many global
regulators responsible for SPI-1, SPI-2 and flagella gene expression are known to
stimulate expression of one, whilst repressing expression of the other. This
enables Salmonella to respond to the gut environment and express invasion-
associated SPI-1 and flagella systems, and conversely to suppress invasion-
associated genes in the relatively nutrient-starved intracellular niche whilst
activating SPI-2 to aid with intracellular survival (90, 96, 98).
Unlike observations in SPI-1 inducing conditions, comparisons between the
secreted protein profiles of wild-type and mrd mutant strains grown in SPI-2-
inducing conditions did not reveal significant changes in protein expression
between strains (Figure 5.9). Minor differences were apparent, possibly due to
experimental error, with differences in the total amounts of protein loaded onto the
gel (despite standardising protein preparations by OD600) rather than due to
alterations in the expression of individual proteins. Surprisingly, the round-cell
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ΔpbpA and ΔrodA mutant secreted protein profiles also appeared similar to the
wild-type strain. Furthermore, significant cell lysis was apparent from ΔpbpA and
ΔrodA mutants grown in SPI-1-inducing conditions, but not in SPI-2 secreted
protein profiles.
Figure 5.9: Global protein expression in wild-type and mrd operon mutants of S.
Typhi in SPI-2-inducing conditions: Total and secreted protein profiles of BRD948 wild-
type and mrd mutants grown in SPI-2-inducing M5.8 minimal medium. Protein molecular
weight (MW) marker and sizes as indicated. All cultures grown in SPI-2 inducing M5.8
media (+ aro/tyr mix) at 37°C and 200 rpm, for 16 hours.
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5.6 Vi antigen capsule expression in S. Typhi mrd operon mutants
5.6.1 Serum agglutination assays and immunofluorescence microscopy
assays
Expression of the extracellular Vi antigen capsule was analysed in both wild-type
and mrd mutant BRD948 strains by means of serum agglutination assays. Briefly,
several microlitres of mid-log phase cultures were mixed with equal volumes of
PBS and Vi antigen-typing agglutinating antisera on a clean microscope slide.
After incubation for around 5 minutes at room temperature, slides were observed
for signs of cell agglutination, which is indicative of Vi capsule expression. Slide
agglutination assays were performed in parallel with wild-type and mutant BRD948
cells, as well as S. Typhimurium SL1344 cultures as a negative control. Extensive
agglutination was observed in wild-type, ΔybeB, ΔybeA, ΔpbpA and ΔrodA
BRD948 strains, but not in the SL1344 control, indicating that the Vi capsule is
actively expressed in all BRD948 strains (Figure 5.10 A). Previous data has shown
that Vi capsule expression is active in BRD948 ΔrlpA cells (163). Although this
technique provides qualitative rather than quantitative data, ΔpbpA and ΔrodA
cells appeared to agglutinate more quickly than other mutants or the wild-type,
also forming larger clumps of cells. This may suggest that the Vi capsule is
overexpressed in round-cell mutants, although further investigation is needed to
verify this.
Alongside slide agglutination assays, immunofluorescence microscopy assays
were done to visualise Vi capsule expression in each strain and examine whether
the excess clumping of ΔpbpA and ΔrodA cells was due to visible Vi capsule
overexpression. BRD948 wild-type/mrd mutant and SL1344 cultures were
harvested after 5 hours’ growth, fixed in 4% PFA and labelled with Vi-typing serum,
followed by a fluorophore-conjugated secondary antibody. Samples were then
visualised by epifluorescence microscopy. The resulting images of wild-type and
mrd mutant cells clearly show Vi capsule expression around the periphery of both
wild-type and mutant cells, but absent from SL1344 cells (Figure 5.10 B).
Particularly bright fluorescent signals could be seen around the periphery of some,
but not all ΔpbpA and ΔrodA cells, although overall there appeared not to be any
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obvious Vi capsule overexpression in these cells compared to the wild-type
(Figure 5.10 B).
Figure 5.10: Vi antigen expression in wild-type and mrd mutant strains of S. Typhi:
A - Slide agglutination assays with BRD948 wild-type (WT), mrd mutant strains and S.
Typhimurium (SL1344) as negative control; Vi capsule-agglutinating antisera incubated
with small culture volumes for 5-10 minutes and photographed. Images show signs of
agglutination (cell clumping) for all BRD948 strains, but not for SL1344 (negative control),
where cells remained evenly suspended. B - Epifluorescence microscopy of S. Typhi wild-
type (WT) and mrd mutant cells fixed and labelled with Vi-agglutinating serum and a
fluorophore conjugated secondary antibody to enable visualisation of the cell surface Vi
capsule by immunofluorescence microscopy. Vi capsule shown by bright green signal
around cell peripheries. Cells labelled with DAPI DNA stain (blue) and Nile Red
membrane stain (red). All images are to the same scale.
5.7 Assessment of virulence of round-cell mrd operon mutants in vivo
Assays to investigate virulence factor functionality of each of the mrd operon
mutants in vitro have demonstrated that in the round-cell ΔpbpA and ΔrodA S.
Typhi mutants, SPI-1 and motility were completely inactive, whilst the SPI-2 T3SS
remained actively expressed on the surface of these cells. These results do not
necessarily correlate to actual virulence in vivo, where the situation is much more
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complex. It was therefore important to test whether ΔpbpA and ΔrodA mutants
remained virulent in vivo, given that SPI-2 remained active. The virulence of S.
Typhimurium ΔpbpA and ΔrodA mutants was therefore investigated in the mouse
model. These assays were kindly carried out by Andrew Grant (University of
Cambridge, UK), as previously described (Chapter 2.2.28). Previous work has
shown that the SPI-1, motility and SPI-2 phenotypes are identical in S. Typhi and
S. Typhimurium round-cell mutants (unpublished data from this lab) (163). As such,
S. Typhimurium strains were used in these assays, since S. Typhi is human-
specific. S. Typhimurium infections of mice form a useful model for typhoid fever
(12, 250).
Since SPI-1 is essential in the early stages of Salmonella infection for penetration
of the gut epithelia, and is known to be repressed in these mutants, wild-type cells
and ΔpbpA and ΔrodA mutants of S. Typhimurium were inoculated intravenously
rather than orally, to bypass SPI-1 and test for SPI-2-mediated virulence (4).
Growth of each strain in vivo was measured by recovering bacteria from the livers
and spleens of infected mice. Viable counts (CFU counts) were performed to
determine the bacterial load in each organ at 6 hours, 24 hours, 72 hours, 6 days,
14 days and 28 days post-infection. The results show the average counts (log10
CFU/organ) from 4 mice (Figure 5.11).
Figure 5.11 Virulence of S. Typhimurium ΔpbpA and ΔrodA in vivo: Mice were
inoculated intravenously with 104 SL1344 wild-type (WT)/ΔpbpA/ΔrodA cells. Viable
counts were performed 6 hours, 24 hours, 72 hours, 6 days, 14 days and 28 days post-
infection to determine bacterial load for each strain in the liver and spleen. Mice infected
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with wild-type SL1344 were euthanised at day 3. Results show average bacterial
liver/spleen loads from 4 mice. Standard deviation indicated by error bars.
Viable counts showing average liver and spleen bacterial loads demonstrated that
the ΔpbpA and ΔrodA mutants of S. Typhimurium were highly attenuated in vivo.
After an initial kill, wild-type bacterial loads dramatically increased over 3 days.
Similarly ΔpbpA and ΔrodA cells experienced an initial kill, followed by a slow
recovery in cell numbers over 6 days, and a subsequent steady decline in bacterial
load in both the liver and spleen (Figure 5.11). However, the mice were not able to
kill the ΔpbpA and ΔrodA strains over the 28 days, suggesting that although
significantly attenuated compared to the wild-type, these mutants were not
completely avirulent. Intracellular survival and systemic spread is dependent upon
SPI-2, and the SPI-1-dependent stages of infection were bypassed with
intravenous injection of the bacteria. The observed attenuation therefore would be
at the level of SPI-2 or related genes. The apparent attenuation of ΔpbpA and
ΔrodA cells is therefore surprising, given that SPI-2 expression is active in round-
cell mrd mutants. Interestingly, similar in vivo virulence assays with an S.
Typhimurium ΔmreCD mutant showed very different results (368). In contrast to
ΔpbpA and ΔrodA mutants, ΔmreCD bacterial loads gradually increased over 9
days, after an initial kill, until they reached lethal levels. This is the first instance
where phenotypic differences have been observed between Δmre and Δmrd
operon round-cell mutants. The reason for the increased attenuation in the ΔpbpA
and ΔrodA mutants is unknown.
S. Typhimurium ΔpbpA and ΔrodA cells recovered from the livers and spleens of
infected mice at 6, 14 and 28 days post-infection, were examined by microscopy,
which showed no distinguishable differences between these and the pre-infection
S. Typhimurium ΔpbpA and ΔrodA strains.
5.8 Discussion
Whilst investigating the factors which contribute to cell wall synthesis and cell
shape determination, very few studies have considered the effects of these
proteins on the assembly and functioning of large cell wall-spanning organelles,
particularly those involved in virulence (215, 222). It is not known to what extent
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the ability of flagella, pili and T3SSs to assemble and function is dependent upon
cell shape determinant proteins and the integrity of the peptidoglycan cell wall.
Many cell wall-spanning multi-protein complexes physically associate with the
peptidoglycan layer in a manner which may be important for their assembly and
stability (49, 63). Also, the bacterial cytoskeletal proteins are thought to specifically
position synthetic complexes within the cell wall; it is therefore possible that they
are involved in positioning other integral cell wall complexes, including virulence
organelles, which are known to be specifically localised within Salmonella cells
(222). Flagella are spread diffusely across the whole cell surface, as are SPI-1
type three secretion needles, whilst SPI-2 T3S needles have a polar localisation
(Figure 5.4, 5.5, and 5.8) (54, 224, 226-228).
One of the major aims of this study was to investigate the ability of mrd operon
mutants, and particularly ΔpbpA and ΔrodA mutants, to express and assemble
functional virulence organelles including flagella and T3SS protein complexes.
5.8.1 Motility of mrd operon mutants of S. Typhi
A number of screens were utilised to assess both motility and flagella gene
expression in each of the mrd operon mutants. Initial observations suggested that
the round-cell ΔpbpA and ΔrodA mutants were non-motile, whilst the ΔybeB and
ΔybeA mutants appeared motile under the microscope. ΔrlpA mutants of S. Typhi
were known to remain motile from previous work (163). These observations were
supported by both motility assays and immunofluorescence microscopy which
showed that round-cell S. Typhi mrd operon mutants were completely non-motile,
with the vast majority of cells lacking visible flagella. Total protein and secreted
protein profiles of wild-type and mrd mutant strains grown in nutrient-rich
conditions also demonstrated that flagellin expression was lost in ΔpbpA and
ΔrodA strains (362). By comparison flagella expression and motility was largely
unaffected in the other mrd operon mutants.
Complementation of ΔpbpA and ΔrodA mutants with the PBP2-YFP and RodA-
YFP-expressing plasmids, pVP6 and pVP3 respectively, was sufficient to restore
between 50% and 80% motility to these mutants, verifying that the observed
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motility phenotypes are directly due to the inactivation of pbpA or rodA in these
strains. Motility (and rod-shape) was restored in complemented cells grown
without the addition of IPTG to induce overexpression of the YFP-fusion proteins,
suggesting that low level background expression of these proteins was enough to
cause both shape and motility to recover.
The heterogeneity of YFP-fusion protein expression, with morphological defects
resulting from the loss of, or the overexpression of either PBP2-YFP or RodA-YFP,
was observed previously in ΔpbpA and ΔrodA cells (Figure 4.3 and 4.5). Likewise,
the lack of full motility recovery may be due to heterogeneous YFP-fusion protein
expression between individual cells, whereby varying PBP2-YFP or RodA-YFP
levels between cells affect morphology and consequently motility expression.
Thus, motility defects seen in this work were shown to be associated with a loss of
cell shape. However, it remained to be shown whether or not the loss of motility
was a direct result of the inactivation of pbpA or rodA, whereby the cell wall
defects associated with a loss of function of lateral cell wall synthesis resulted in
the direct dysfunction and perhaps disassembly of the flagella. If this were the
case, one would expect the loss of rod shape to be quickly followed by a drop in
motility function.
To test this, the motility of both wild-type and rod-shaped mrd mutant strains in the
presence of varying concentrations of mecillinam was assessed. Mecillinam
specifically binds PBP2, inhibiting its function and resulting in the formation of
spherical cells, which appear identical to ΔpbpA mutants (145, 155, 363). These
assays showed that exposure of all strains to increasing mecillinam concentrations
was coupled with a reduction in motility. However, microscopic analysis
demonstrated that at concentrations of mecillinam sufficient to render cells
completely spherical, significant amounts of motility (~60%) were still retained.
There was evidently a delay between the formation of spherical cells and the loss
of motility, which may result from the active repression of motility in these cells,
rather than an immediate loss in functionality from the formation of round cells.
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The nature of the observed repression of motility was analysed in transcriptional
reporter assays to assess flagella gene expression in the mrd operon mutants. As
expected, flagella gene expression was as wild-type in ΔybeB, ΔybeA and ΔrlpA
mutants. However, expression of both the class II fliF gene, and the flhDC master
flagellar gene regulator was almost completely repressed in both ΔpbpA and
ΔrodA mutants of S. Typhi. Since flagella gene expression and motility are
dependent upon the expression of the flhDC operon, these results demonstrate
that the motility phenotype of the round-cell mrd mutants resulted at least in part
from the complete downregulation of flagella gene expression, at the level of flhDC
(364). This is in agreement with a previous study, in which it was found that flhDC
expression was decreased in E. coli cells treated with mecillinam (118).
Although mecillinam-treated spherical cells of S. Typhi were isolated which
remained motile, further work is necessary to determine both whether motility can
be recovered in round-cell mutants of S. Typhi and also why the flagella genes are
completely repressed in these mutants.
5.8.2 SPI-1 and SPI-2 type 3 secretion system (T3SS) expression and
functionality in mrd operon mutants of S. Typhi
It was evident from western blot data that the expression of both SPI-1 and SPI-2
effector proteins were unaffected in ΔybeB, ΔybeA and ΔrlpA (the latter mutant
having been assessed in previous work (163)). In addition, SPI-2 effector protein
expression was unaffected in ΔpbpA and ΔrodA mutants.
Expression of the SPI-1 and SPI-2 secreted effector proteins themselves was not
sufficient to prove that the T3SS needle complexes were correctly assembled and
functional in either wild-type or mutant cells. Unlike flagella assembly, which is
sequentially regulated so that the flagellin proteins are only expressed upon
completion of the basal body and hook assembly, SPI-1 gene expression appears
to be not so tightly regulated, since the hilA master regulator directly regulates
expression of both the SPI-1 T3SS apparatus proteins and the effector proteins,
as well as indirectly activating the latter through InvF (62, 84, 86, 365, 366).
Expression of SPI-2 effectors may also not be indicative of correct SPI-2 needle
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assembly (361). However, various regulatory mechanisms of SPI-1 effector protein
expression are thought to exist which enable Salmonella to alter the substrate
specificity of secretion upon completion of needle assembly and contact with a
host cell (84). The visualisation of cell surface-associated translocon subunits
through immunofluorescence microscopy afforded better evidence that the T3SS
needles were correctly assembled in the cell wall, suggesting that SPI-1 or SPI-2
T3SSs were functional in a particular strain. The translocon component comprises
the tip of the T3SS needle, which is required to interact with and form a pore in the
host cell membrane, permitting the translocation of other effectors into the host cell
(228, 367). In SPI-1 the translocon consists of SPI-1-encoded SipB, SipC, and
SipD, effector proteins which are also secreted (351). The SPI-2 translocon
consists of the SPI-2-encoded SseB, SseC, and SseD proteins (228).
As such, the presence of both SPI-1 and SPI-2 needles at the cell surface of rod-
shaped mrd operon mutants and wild-type S. Typhi cells suggested that both SPI-
1 and SPI-2 were able to assemble and function in these strains. However, only
the SPI-2 T3SS appeared to be expressed and functional in round-cell mrd operon
mutants. SPI-1 effector proteins were not expressed intracellularly, or observed in
secreted protein fractions of S. Typhi ΔpbpA and ΔrodA cells, as has been seen
previously in a S. Typhimurium ΔrodA strain (163).
Investigation of SPI-1 gene expression in round-cell mutants of S. Typhi showed
that, similarly to the motility defect, expression of hilD, the master regulator of the
SPI-1 genes, was almost completely downregulated in both ΔpbpA and ΔrodA
mutants; this suggests that the primary reason for SPI-1 non-functionality in these
cells was the downregulation of SPI-1 expression, since hilD is required for SPI-1
gene expression (87-89).
5.8.3 Explanations for the observed virulence phenotypes
The interesting aspect of these results was that despite the downregulation of SPI-
1 and motility, the SPI-2 T3SS remained actively expressed and functional in S.
Typhi ΔpbpA and ΔrodA cells cultured in SPI-2 conditions. Whilst further work is
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needed to establish why SPI-1 and motility expression is repressed yet SPI-2
remains active, there may be several explanations for these observations.
It may be that localisation of these virulence organelles affects functionality; SPI-1
and flagella are spread around the lateral cell wall, whilst SPI-2 needles are
localised at cell poles. PBP2 and RodA are involved primarily in lateral cell wall
synthesis, whilst polar peptidoglycan synthesis is controlled by a separate septal
protein complex (126, 131). Furthermore, polar peptidoglycan is known to be inert
once synthesis is completed (127). As such, it may be that in round cell mutants
such as ΔpbpA and ΔrodA, cell wall structure and integrity at the cell poles
remains intact. If cell wall integrity is important for the assembly and physical
support of structures such as T3SS, it may follow that SPI-2 expression is
unaffected in round-cell mutants because the cell wall at the poles remains able to
support the SPI-2 T3SS whilst damage to the lateral cell wall may make it unable
to support SPI-1/flagella assembly and functionality. Also, if, as previously
suggested, the cell shape determinants are involved in directing the localisation of
T3SSs and flagella, the SPI-1 and flagella defects may be caused by the
disruption of cytoskeletal elements themselves, which regulate organelle
localisation. SPI-2, with its polar localisation, may be organised by alternative
factors, meaning it is not disrupted in round-cell mutants.
However, these data together demonstrate that the SPI-1 and motility defects of
round-cell mrd operon mutants are at least primarily the result of SPI-1/motility
downregulation at the level of transcription, although downstream features of
round-cell mutants which affect SPI-1/flagella assembly and functionality may also
play a part in bringing about the observed defects. It may be that an unknown
regulatory factor detects lateral cell wall changes in the round-cell mutants and
acts to downregulate SPI-1 and motility genes, whilst the same, or an alternative
regulator, by a similar mechanism detects that the polar cell walls remain intact
and therefore does not downregulate the SPI-2 genes.
The SPI-1 T3SS and flagella of Salmonella both comprise invasion-associated
systems required for the invasion of host cells. As such, they are often co-
regulated by some of the same global regulators in response to similar
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environmental conditions, although the mechanisms controlling flagella and SPI-1
expression are not identical or completely understood (50, 362, 369-371).
Furthermore, flhDC has been shown to positively regulate hilA (92). Invasion-
associated genes appear to be activated in nutrient rich, aerobic conditions (362).
Signals which activate the SPI-2 T3SS, however, are very different; being required
for intracellular survival, SPI-2 is activated in response to low osmolarity, acidic pH
and possibly low magnesium, all conditions indicative of an intracellular
environment (4, 90, 318, 359). As such, the observed downregulation of both the
SPI-1 and motility genes, but not SPI-2, in round-cell mutants may be the result of
regulation from a common global transcriptional regulator; when activated in
response to cell wall defects from the pbpA/rodA mutations, it may subsequently
act to suppress invasion-associated genes, but activate stress-response genes,
including those required for intracellular survival such as SPI-2 genes. Several
global stress response regulators influence the expression of both SPI-1 and SPI-
2 virulence genes, including the PhoP/PhoQ , RcsCDB and OmpR/EnvZ two-
component systems (96, 98, 318).
In support of this, the Vi antigen capsule was also actively expressed in S. Typhi
wild-type and mrd operon mutant strains, potentially being upregulated in the
ΔpbpA and ΔrodA cells. Given that cellulose production was also increased in
these latter mutants, it is plausible that biosynthesis of other extracellular
polysaccharides such as colanic acid is also upregulated (Figure 4.20). Both
colanic acid biosynthesis and Vi capsule synthesis, as well as the SPI-2 genes,
are known to be upregulated by the RcsC and RcsB global regulators, part of the
Rcs phosphorelay system which responds to envelope stress (50, 118).
5.8.4 Virulence of round-cell mrd operon mutants of S. Typhimurium in vivo
In the assessment of virulence determinant functionality in the mrd mutants, it was
important to assess the actual virulence of these mutants in vivo. This was
particularly important in round-cell mutants, where in vitro assays had
demonstrated that virulence was significantly affected. ΔpbpA and ΔrodA strains of
S. Typhimurium were inoculated into mice intravenously to determine whether
these mutants remained able to both survive intracellularly and spread
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systemically, features of infection which are dependent upon SPI-2. However,
whilst data from in vitro assays suggested that SPI-2 remained active and
functional in ΔpbpA and ΔrodA mutants, in vivo assays showed that these mutants
were significantly attenuated. This result is in contrast to similar in vivo assays with
S. Typhimurium ΔmreCD mutants; these mutants were slightly attenuated but still
lethal to the mice, the infection lasting 10 days compared with 4 for the wild-type
strain (368). This latter aspect is surprising since until now no significant
differences in phenotype have been observed between round-cell mrd or mre
mutants (130).
These results suggest that despite the active expression of SPI-2 in round-cell mrd
mutants, the inactivation of pbpA or rodA results in more pronounced defects than
those seen in ΔmreCD mutants. It is possible that the attenuation in these strains
results from more serious perturbations to the cell wall structure which may leave
these cells more vulnerable to external stress and host cell defences. However,
these mutants did not show decreased resistance to oxidative stress in vitro, a
feature which is particularly important for intra-macrophage survival. Therefore the
increased attenuation of these strains may not be caused by increased sensitivity
to killing by the macrophage oxidative burst. Also, the increased cellulose
expression in these mutants may help to counteract any cell wall defects, helping
protect the cells from external stress. It is possible that the increased surface
expression of extracellular polysaccharides such as cellulose or colanic acid may
make these mutants more vulnerable to targeting by the host immunity. However,
capsular polysaccharides are reportedly poorly immunogenic and colanic acid
overexpression may not occur intracellularly (372, 500).
Although SPI-1 and SPI-2 were once thought to act in isolation of each other,
recent studies are establishing significant cross-over between the two systems.
Several SPI-1-encoded effector proteins persist post-internalisation, and are
important for SPI-2 function. It is possible therefore that the downregulation of SPI-
1 genes, including those important during the later stages of infection, affects SPI-
2 functionality and intracellular survival (4, 20, 48). However, if this were the case,
the same attenuation phenotype would be seen in ΔmreCD mutant, in which SPI-1
was also downregulated (368).
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It is possible that other factors affect SPI-2 expression in the ΔpbpA and ΔrodA
mutants in vivo, which are not recognised in vitro. The structure of the cell wall and
envelope may also be affected in as yet unrecognised ways in ΔpbpA and ΔrodA
mutants, leading to increased killing in vivo. Whatever the reasons for the
attenuation of the ΔpbpA and ΔrodA mutants, these results demonstrate
differences in the downstream effects of mrd round-cell mutations compared to
ΔmreCD mutants, which may suggest that the former genes play a more crucial
role in cell wall synthesis and maintenance of the cell wall integrity.
5.8.5 Conclusions
Together these results suggest that virulence is severely affected in round-cell mrd
operon mutants of S. Typhi, but not in ΔybeB, ΔybeA or ΔrlpA cells. The effects on
virulence in the ΔpbpA and ΔrodA mutants are surprising, highlighting possible
global regulatory pathways which may be activated in these mutants. Further work
is needed to establish the identity of these pathways. Also the results of these
assays did not definitively identify whether or not ΔpbpA and ΔrodA mutants could
support functional flagella and SPI-1 T3SSs if hilD and flhDC expression were
recovered in these cells. To answer this question would help in understanding
more fully the mechanisms behind the motility and SPI-1 defects of round-cell
mutants.
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Chapter 6. Transcriptional profiling of mrd mutants
Transcriptional profiling was done to enable further analysis of the global effects of
the ΔpbpA and ΔrodA mutations on the physiology of Salmonella, thus providing a
more comprehensive picture of the role these cell shape determinant proteins play
in the biology and pathogenicity of Salmonella. It was also hoped that microarrays
would enable the identification of candidate global regulators involved in the
control of the observed phenotypes in round-cell mrd operon mutants, such as
flagella and SPI-1 gene regulation.
6.1 Microarrays to analyse transcriptional profile of wild-type and ΔrodA S.
Typhimurium
Microarrays were performed to examine the global differences in gene expression
between the wild-type and ΔrodA strains of S. Typhimurium SL1344. S.
Typhimurium strains were used rather than S. Typhi strains, due to the lack of
availability of Typhi-specific arrays at the time. The SL1344 ΔrodA strain used in
this assay was generated in previous work (163). This was chosen above the
ΔpbpA strain. As both strains retain the kanamycin resistant knockout cassette, it
is likely that both mutations would have polar effects on downstream gene
expression. Since rodA is downstream of the pbpA gene, the polar effects from
this mutation are likely to be less pronounced than those from the ΔpbpA mutant,
enabling results of transcriptional profiling to be more confidently attributed to the
specific effects of the ΔrodA knockout. However, the results of this assay were
treated with some caution; although distinct phenotypes associated with the rlpA
mutation have yet to be recognised, it is possible that differences in gene
expression profiles resulted from indirect effects on rlpA expression rather than the
inactivation of rodA.
NimbleGen 4x72000 multiplex arrays were used as described, enabling the
analysis of gene expression in 4504 S. Typhimurium genes. Data from the arrays
was analysed using the ArrayStar® software and assessed for statistical
significance using two-tailed Student’s t-test. P values from gene expression data
of ≤0.05 were considered statistically significant; thus, the expression data for
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1608 genes was significant. Microarray results were examined to investigate the
significant effects of the ΔrodA mutation on global gene expression and to identify
genes with the greatest significant fold-change in expression in ΔrodA cells
compared to the wild-type. The 100 most upregulated and downregulated genes in
the ΔrodA mutant, compared to the wild-type, were hence plotted (Figure 6.1).
Major alterations in gene expression in a number of distinct features and pathways
in Salmonella will be discussed.
6.1.1 Analysis of major changes in gene expression between wild-type and
ΔrodA strains; transcriptional downregulation
The microarray data highlighted numerous large changes in gene expression in
the ΔrodA mutant, including 435 genes which were significantly downregulated at
least 2-fold in ΔrodA cells compared to the wild-type. Analysis of just the 100 most
downregulated genes revealed a clear pattern in terms of the effects of the ΔrodA
mutation on the expression of several key classes of genes. The most common
functional classes of genes which were affected are now outlined.
Flagella/chemotaxis
Amongst the 100 most highly downregulated genes in the ΔrodA mutant were 43
whose function related to motility or chemotaxis (Figure 6.1). Expression of these
genes was downregulated at least 15-fold compared to gene expression in the
wild-type. Flagella and chemotaxis genes were amongst the most common highly
downregulated genes in the whole transcriptional profile, the majority of
flagella/chemotaxis-related genes represented in this array being downregulated
at least 10-fold (46/66 genes).
The range of flagella and chemotaxis genes represented amongst the most
downregulated genes included structural proteins of the flagella basal body, rod
and hook sections, as well as the flagellin and flagellar motor proteins and major
chemotaxis regulators (Table 6.1). Knowing the hierarchical control of flagella
gene expression and its coupling to flagella assembly, it was evident that the
expression of both class 2 and class 3 flagella genes was highly downregulated in
this mutant. Furthermore, the major transcriptional regulators of class 2 and class
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3 genes were significantly downregulated, as well as the flagellar gene master
regulator proteins, encoded by flhD and flhC, although the latter were
downregulated to a much lesser extent. The downregulation of flhDC would,
however, have led to the downregulation of all downstream flagella genes due to
the hierarchical flagellar gene regulation (56).
Gene name Protein function Fold change in gene expression in
SL1344 ΔrodA compared to WT
Hook and basal body structural proteins
fliF (stm1969) IM-spanning MS ring -10.17
fliM (stm1976) Cytoplasmic C ring -22.56
fliN (stm1977) Cytoplasmic C ring -18.16
flgB (stm1174) Rod protein -21.33
flgI (stm1181) Periplasmic P ring -22.79
flgH (stm1180) L ring -19.89
fliJ (stm1973) Rod-capping protein -31.18
flgE (stm1177) Hook protein -16.04
Flagella filament proteins
fljB (stm2771) Flagellin filament protein -72.18
fliC (stm1959) Flagellin filament protein -27.93
Flagella motor proteins
motA (stm1923) Flagellar motor protein -28.87
motB (sttm1922) Flagellar motor protein -46.54
Flagella transcriptional regulators
flhD (stm1925) Class 1 gene. Master regulator of
flagellar genes
-6.48
flhC (stm1924.S) Class 1 gene. Master regulator of
flagellar genes
-2.74
fliA (stm1956) Sigma factor 28 (σ28) – positive
transcriptional regulator of class 3 genes
-41.02
flgM (stm1172) Anti-σ28 repressor of class 3 genes -28.71
fliZ (stm1955) Activator of class 2 genes through
altering FlhD2C2 promoter binding
-45.69
Chemotaxis proteins
cheA (stm1921) Sensor kinase of the CheA/CheB/CheY
two-component system to regulate
chemotaxis
-49.71
cheB (stm1917) Part of two-component system to regulate
chemotaxis
-61.57
cheY (stm1916) Part of two-component system to regulate
chemotaxis
-40.33
cheW (stm1920) Part of two-component system to regulate
chemotaxis; couples CheA to response
regulators
-24.04
Table 6.1: Microarray expression data of major motility and chemotaxis genes in S.
Typhimurium ΔrodA: Fold-change in gene expression as compared to wild-type. Unless
otherwise stated, P values ≤0.05. Information on gene function taken from KEGG
database (253).
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SPI-1
The second most common class of genes found amongst the highly
downregulated genes in the ΔrodA mutant were SPI-1-encoded genes. 38 out of
the 43 SPI-1 genes represented were downregulated between 5-fold and 128-fold
in this mutant. The two most highly downregulated genes in this array were also
the SPI-1 genes stm2883 (sipD) and stm2871 (prgK) (Figure 6.1, Table 6.2). The
SipD protein is a secreted effector protein which forms part of the translocon unit
at the tip of the SPI-1 needle, needed to form pores in the host cell membrane.
PrgK is a T3SS needle structural protein which together with PrgH forms a
peptidoglycan-associated inner membrane-spanning ring (49, 374). SPI-1 genes
whose expression was severely downregulated in the ΔrodA mutant included
those encoding T3SS apparatus proteins, secreted effector proteins and
chaperones. Expression of non-SPI-1 encoded secreted effector proteins, such as
SopB and SopE2 was also affected, these effectors being downregulated 112.7-
fold and 39.5-fold respectively in the ΔrodA mutant.
Genes encoding the major transcriptional activators of SPI-1 gene expression, hilA,
hilC, hilD and invF, were downregulated 75.0-fold, 24.6-fold, 42.8-fold and 68.9-
fold respectively, in the ΔrodA mutant. Interestingly, expression of the Hil master
regulators of SPI-1 appeared to be more radically affected than expression of the
flhDC flagellar gene regulators. Expression of SPI-1-encoded genes is known to
be dependent upon expression of the upstream Hil transcriptional regulators,
particularly HilD. Hence, in a similar manner to flagella gene expression, the
repression of hilA, hilC and hilD gene expression would bring about the
downregulation of SPI-1 gene expression in the ΔrodA mutant (87, 88).
The flagella and SPI-1 microarray expression data was supported by the
observations of phenotypic tests, demonstrating that the SPI-1 and motility
functionality defects in round-cell mrd operon mutants of Salmonella were caused
by the almost complete downregulation of SPI-1 and flagella genes, brought about
by the repression of expression of the upstream transcriptional regulators.
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Gene name Protein function Fold change in gene expression in
SL1344 ΔrodA compared to WT
SPI-1 T3SS structural proteins
prgI (stm2873) Major extracellular T3SS needle rod
component
-82.00
invG (stm2898) Outer membrane T3SS needle apparatus
protein
-49.82
prgK (stm2871) Inner membrane T3SS needle apparatus
lipoprotein
-120.83
SPI-1 T3SS secreted effectors
sipA (stm2882) SPI-1-encoded T3SS effector; alters host
actin polymerisation
-55.62
sipC (stm2884) SPI-1-encoded T3SS effector; translocon
component, alters host actin
polymerisation
-33.01
sipD SPI-1-encoded T3SS effector; translocon
component, alters host actin
polymerisation
-128.27
sopB (stm1091) Non-SPI-1 secreted effector; actin
filament rearrangement
-112.69
sopE2 (stm1855) Non-SPI-1 secreted effector; actin
filament rearrangement
-39.49
SPI-1 T3SS chaperone proteins
sicA (stm2886) SPI-1 chaperone required for effector
secretion
-27.59
invB (stm2895) SPI-1 chaperone required for effector
secretion
-92.86
SPI-1 transcriptional regulators
hilA (stm2876) Master regulator of SPI-1 gene
expression
-75.06
hilC (stm2867) Activator of HilA to regulate SPI-1 genes -24.59
hilD (stm2875) Activator of HilA to regulate SPI-1 genes -42.85
hilE (stm4509.S) Repressor of SPI-1 gene expression -1.29 (P value = 0.18)
Table 6.2: Microarray expression data of major SPI-1 genes in S. Typhimurium
ΔrodA: Fold-change in gene expression as compared to wild-type. Unless otherwise
stated, P values ≤0.05. Information on gene function taken from KEGG database (253).
SPI-4 and SPI-5
A number of genes from additional horizontally acquired pathogenicity islands,
SPI-4 and SPI-5, were represented among the most highly downregulated genes
in the SL1344 ΔrodA mutant (Figure 6.1). These included the SPI-5-encoded
T3SS effector protein, SopB, which is secreted by SPI-1. The other significantly-
downregulated SPI-5 gene, pipC (stm1090) is possibly encoded within the same
operon as sopB (stm1091) (Table 6.3). PipC is thought to be a chaperone to SopB,
aiding its secretion (375). stm1089, a small gene adjacent to pipC, was also
significantly downregulated (4.56-fold) in the ΔrodA mutant. This gene encodes an
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inner membrane protein of unknown function. Expression of the remaining 7 genes
of the SPI-5 region of the chromosome, however, was not significantly affected in
the ΔrodA mutant.
5 of the 8 SPI-4 genes found within this array were downregulated over 19-fold in
SL1344 ΔrodA compared to the wild-type. Another SPI-4 encoded gene was
downregulated 6.31-fold, expression of another gene was unaffected, and the
remaining gene was upregulated just over 2-fold in the round-cell mutant (Table
6.3). The SPI-4 pathogenicity island encodes a type 1 secretion system (T1SS)
along with an extremely large cognate T1SS-secreted adhesin, SiiE. This island is
thought to assist in virulence by helping Salmonella to adhere to host gut epithelial
cells and promoting the inflammatory response (376). The SPI-4 T1SS apparatus
proteins, encoded by stm4259 (siiC), stm4260 (siiD) and stm4262 (siiF), were
downregulated 33.0-, 42.2- and 6.3-fold in the ΔrodA microarray. The SiiE adhesin
(stm4261) was downregulated 33.7-fold. The only upregulated SPI-4 gene was
yjcC (stm4264), encoding a putative diguanylate cyclase EAL domain protein.
Previous studies have shown that SPI-4 genes are co-regulated with the SPI-1
invasion genes and that their expression is regulated by HilA. Hence it is not
surprising to find these genes downregulated in the ΔrodA mutant (376, 377). It
was suggested that SPI-4-mediated adhesion to host cells may be linked to the
subsequent functioning of SPI-1 (376).
Gene name Fold change in gene expression in
SL1344 ΔrodA compared to WT
P value
(<0.05 = significant)
SPI-4 genes
stm4257 (siiA) -19.04 0.009
stm4258 (siiB) -23.21 0.011
stm4259 (siiC) -32.98 0.011
stm4260 (siiD) -42.19 0.010
stm4261 (siiE) -33.72 0.009
stm4262 (siiF) -6.32 0.007
stm4263 (yjcB) +1.14 0.352
stm4264 (yjcC) +2.03 0.020
SPI-5 genes
stm1096 (copR) +1.13 0.135
stm1095 (copS) -1.02 0.710
stm1094 (pipD) -1.10 0.159
stm1093 +1.87 0.108
stm1092 (orfX) +1.45 0.120
stm1091 (sopB) -112.69 0.007
stm1090 (pipC) -72.43 0.009
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stm1089 -4.56 0.011
stm1088 (pipB) -2.44 0.082
stm1087 (pipA) +1.50 0.085
Table 6.3: Microarray expression data of SPI-4 and SPI-5 genes in S. Typhimurium
ΔrodA: Fold-change in gene expression as compared to wild-type. P values as stated.
Nitrogen and amino acid metabolism
Interestingly, a significant number of the major downregulated genes were those
with functions related to nitrogen metabolism. Transcription of these 8 genes was
reduced between 16- and 25-fold in the ΔrodA mutant compared to wild-type. The
8 genes were clustered within one of three operons; the nar, nap or nrf operons
(Figure 6.1).
Two of the isolated operons, nar and nap, encode two of the three individual
nitrate reductase systems, as identified in E. coli. Nitrate reductase complexes are
required for anaerobic growth, enabling bacteria to utilise nitrate as a terminal
electron acceptor, and these are upregulated in anoxic conditions (378, 379).
stm1762 and stm1763 encode the NarJ and NarH proteins respectively. These
proteins form part of a membrane-bound heterotrimeric nitrate reductase complex,
along with NarI (378, 380). Microarray data showed that stm1762 and stm1763
were downregulated 19.0-fold and 16.3-fold respectively in ΔrodA. The seven nap
operon genes (napA-H) encode a periplasmic nitrate reductase complex, of which
4 (napA-napD) are essential in E. coli. The stm2255 (napC), stm2256 (napB) and
stm2258 (napG) genes were downregulated 22.1-, 18.3- and 16.2-fold in the
ΔrodA mutant, respectively. Similarly, the nrfA and nrfB genes encode a formate-
dependent periplasmic nitrite reductase (378). The nrf operon is required for the
reduction of nitrite to ammonia (381). The Salmonella homologues of nrfA
(stm4277), nrfB (stm4278.S) and nrfC (stm4279), were downregulated in the
ΔrodA mutant 23.1-, 25.6- and 19.7-fold, respectively.
A further 7 major downregulated genes were identified with related functions in the
metabolism of lysine or arginine. These were included in three clusters of genes:
stm2558 (cadB) and stm2559 (cadA), stm4465-4467, and stm0700 and stm0701.
cadA encodes a lysine decarboxylase enzymes, whilst the upstream cadB gene
encodes a lysine/cadaverine transporter. Expression of these genes is induced by
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the presence of lysine combined with an extracellular reduction in pH (pH ≤5.8)
(382, 383). The cad genes are involved in the acid tolerance response (ATR),
which enables Salmonella to adapt to and survive in a highly acidic environment
(pH ≤3.0) (383).
The stm4465-4467 genes comprise the arcABC operon. The arcA (stm4467), arcB
(stm4465) and arcC (stm4466) genes encode three enzymes involved in the
arginine fermentation pathway. The arcABC–encoded proteins are upregulated
with growth in anaerobic conditions, permitting arginine to be used as an energy
source in the absence of oxygen (379). The results of this array showed that
expression of arcA, arcB and arcC was reduced in the ΔrodA mutant 73.3-fold,
19.0-fold and 40.2-fold, respectively.
Finally, stm0700 (potE) and stm0701 (speF) encode a putrescine/ornithine
transporter protein and an ornithine decarboxylase, respectively. Similarly to
arcABC, these genes appear to be involved in the adaptation of Salmonella to
growth in anoxic conditions. potE and speF were previously shown to be activated
by ArcA in S. Typhimurium, the response regulator of the ArcA/ArcB two-
component system, an important global transcriptional regulator which responds to
changes in oxygen levels and assists with adaptation to anaerobic growth (379,
384). In anaerobic conditions ArcA positively regulates genes involved in
anaerobic respiration, as well as flagella genes, and suppresses aerobic
respiration (384, 385). Confusingly, this arcA (stm4598) is a completely different
gene from the stm4467/arcA gene (384). The present microarrays showed that
potE and speF were downregulated 27.9-fold and 31.3-fold respectively, in ΔrodA
cells.
These data show that several major factors involved in the utilisation of alternative
carbon sources for anaerobic respiration were strongly repressed in the ΔrodA
mutant, compared to the wild-type. The reason for the repression of anaerobic
respiration genes in this mutant is unknown. FNR is a global regulator involved in
detecting and responding to varying oxygen levels. Along with other regulators
including the ArcA/ArcB two component system, or in isolation, FNR regulates
gene expression to enable Salmonella to adapt to anaerobic growth (379, 385,
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386). It was also shown to stimulate expression of both flagella and SPI-1 genes
(386). Surprisingly, expression of both fnr (stm1660.S) and arcA (stm4598) in the
ΔrodA mutant were not particularly affected, being only slightly increased by ~1.2-
fold compared to their expression in the wild-type. However, two other
transcriptional regulators, NarP and NarL, are also known to be important for
controlling the use of nitrate/nitrite in anaerobic respiration (387). Expression of
narP and narL was reduced 3.8-fold and 15.4-fold respectively in the ΔrodA
mutant, although expression of their cognate sensor kinases was not significantly
affected for either protein. The extent to which these regulators affected
expression of nitrate utilisation genes is unclear, since NarL is known to repress
both nrf and nap operons, whilst NarP activates these operons (387). It may be
that other upstream transcriptional regulators are involved in the suppression of
anaerobic respiration-related genes in ΔrodA cells.
Type I Fimbrial protein
The microarray data highlighted the stm0543 gene as being highly downregulated
in the ΔrodA mutant. This gene encodes FimA, a Type I fimbrial major subunit
protein (21). Type I fimbriae enable Salmonella to adhere to a number of different
cell types, and are thought to assist with virulence (389-391). The immediately
downstream fimI gene was also significantly downregulated in this array, although
expression levels for the remaining fim operon genes were not significantly altered
(Table 6.4). The fim operon is required for Type I fimbriae expression (391-393).
Theoretically regulators which control the expression of SPI-1 and flagella genes
in the ΔrodA mutant may also be responsible for the suppression of expression of
Type I fimbriae.
fim operon genes Fold change in gene expression in
SL1344 ΔrodA compared to WT
P value
(<0.05 = significant)
stm0543 (fimA) -33.47 0.011
stm0544 (fimI) -7.22 0.014
stm0545 (fimC) -2.18 0.106
stm0546 (fimD) -1.56 0.120
stm0547 (fimH) -1.20 0.399
stm0548 (fimF) -1.10 0.315
Table 6.4: Microarray expression data of fim operon genes in S. Typhimurium
ΔrodA: Fold-change in gene expression as compared to wild-type. P values as stated.
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stm1328
Of the 100 most highly downregulated genes, the remaining gene not belonging to
any of the aforementioned functional classes was stm1328, whose expression was
reduced 40.1-fold in the ΔrodA mutant, compared to wild-type. stm1328 (lpxR)
encodes a putative outer membrane calcium-dependent 3’-O-deacylase enzyme,
which covalently alters the structure of the Lipid A component of LPS, possibly
functioning to assist in the evasion of host immunity (394). The downregulation of
this Lipid-A modifying enzyme may bring about alterations in LPS structure in the
rodA mutant, although it has previously been noted that LpxR-mediated lipid A
deacylation is not commonly seen in standard culture conditions (394, 395).
6.1.2 Analysis of major changes in gene expression between wild-type and
ΔrodA strains; transcriptional upregulation
Comparisons of gene expression between wild-type and ΔrodA cells showed that
464 genes were significantly upregulated at least 2-fold in SL1344 ΔrodA. As with
downregulated genes, the 100 most upregulated genes were analysed.
Expression of these genes was increased between 4-fold and 239-fold in SL1344
ΔrodA, although the majority of genes were not upregulated more than 50-fold
(Figure 6.1). Several particularly prevalent functional classes emerged among the
major upregulated genes, as discussed.
Transport proteins
23 genes were identified amongst the major upregulated genes of the ΔrodA
mutant with functions related to the transport of substrates into or out of the cell,
as summarised (Figure 6.1, Table 6.5). The majority of these genes encoded inner
membrane transport proteins or components of transport protein complexes. An
additional 4 SPI-1 genes, encoding an iron transporter, were also represented in
this group (Table 6.8). These changes could illustrate both a significant alteration
in the cohort of inner membrane proteins expressed in the round-cell mutant,
and/or an increased requirement for the import of specific nutrients from the
culture medium.
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Transport-related
genes
Protein function Fold change in gene expression in
SL1344 ΔrodA compared to WT
stm2787 Putative tricarboxylic transport inner
membrane protein
+30.53
ydhC (stm1428) Inner membrane transport protein;
member of major facilitator superfamily
(MFS)
+24.67
yqaE (stm2796) Putative transport protein +21.03
cysU stm2443 ABC superfamily inner membrane protein;
sulphate/thiosulphate transporter;
permease subunit
+19.56
fhuA (stm0191) Outer membrane ferrichrome transporter
protein
+14.96
stm2786 Putative tricarboxylic transport inner
membrane protein
+14.80
nanT (stm3338) MFS family sialic acid transporter +11.69
nixA (stm2783) Putative high-affinity nickel transporter +11.55
cysW (stm2442) ABC superfamily inner membrane protein;
sulphate/thiosulphate transporter;
permease subunit
+10.05
stm1494 ABC superfamily osmoprotectant
transporter; permease subunit
+9.52
cysP (stm2444) ABC superfamily inner membrane protein;
sulphate/thiosulphate transporter;
substrate-binding subunit
+8.97
sapB (stm1693) ABC superfamily peptide transporter;
permease protein
+7.78
sapC (stm1694) ABC superfamily peptide transporter;
permease protein
+7.14
chaA (stm1771) Calcium/sodium:H+ antiporter +6.71
tehA (stm1609) Potassium-tellurite ethidium and proflavin
transporter
+5.80
narU (stm1576) Inner membrane MFS transporter; nitrate
extrusion transporter
+5.80
stm1492 ABC superfamily osmoprotectant
transporter; permease subunit
+5.61
stm1491 Proline/glycine betaine transport;
osmoprotectant transporter; ATP-binding
subunit
+5.24
yjeH (stm4328) APC super family inner membrane
protein; basic amino acid/polyamine
antiporter
+5.08
potF (stm0877) Putrescine ABC transporter; periplasmic
substrate-binding protein
+5.01
stm1493 ABC superfamily osmoprotectant
transporter; periplasmic substrate-binding
subunit
+4.87
exbB (stm3159) Inner membrane iron-siderophore
complex transporter protein
+4.72
Table 6.5: Microarray expression data of major upregulated transporter genes in S.
Typhimurium ΔrodA: Fold-change in gene expression as compared to wild-type. Unless
otherwise stated, P values ≤0.05. Information on gene function taken from KEGG
database (253).
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Stress response factors
Perhaps not surprisingly, the second most prevalent functional class of genes
among highly upregulated genes were those related to responses to various types
of environmental stress in Salmonella (Table 6.6, Figure 6.1). These included
several heat shock or hyperosmotic shock related proteins, an oxidative stress
regulatory protein, DNA repair enzymes, mis-folded protein repair proteins, a
putative catalase, and a protease for the degradation of damaged proteins. The
concert of stress-related genes identified here demonstrates something of the
state of the round-cell mutants; it suggests that as expected, inactivation of cell
shape determinants results in a compromised the cell wall structure and barrier
function, leaving the mutants more susceptible to a range of environmental
stresses, including heat, osmotic and oxidative stress.
Interestingly, the periplasmic protein CpxP encoded by stm4060, along with a
similar periplasmic protein (stm1308) were upregulated 14.5-fold and 34.3-fold
respectively in the ΔrodA mutant. This is unexpected given that CpxP is a
repressor of the Cpx envelope stress response (253). The Cpx pathway is one of
at least three envelope stress-detecting pathways, encompassing the CpxA/CpxR
two-component system. In response to envelope stress and misfolded envelope
proteins the CpxR response regulator activates the expression of genes involved
in protein folding and protein degradation at the cell envelope (396). CpxP acts
through CpxA to suppress the Cpx pathway (396). Little is known about
stm1308/spy, although it was shown to be regulated directly by PhoP (397).
BLAST alignment of the CpxP and Spy amino acid sequences showed that the
two proteins have 29% identity with 50% positives in terms of related amino acid
residues. The CpxA gene (stm4058), but not CpxR (stm4059), was also
upregulated 2.25-fold in the ΔrodA mutant.
Another significant gene represented here was htrA, which was upregulated over
7-fold in the ΔrodA mutant. htrA encodes a serine endoprotease which is positively
regulated by both RpoE (σE) and CpxA/CpxR. htrA is essential for both growth at
high temperatures and virulence in Salmonella; ΔhtrA mutants are unable to resist
the oxidative burst and therefore cannot survive inside macrophages. HtrA
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functions to remove mis-folded or damaged proteins by sequestering or degrading
them (398).
Stress response-
related genes
Protein function Fold change in gene expression
in SL1344 ΔrodA compared to
WT
Heat shock genes
(stm1251) Similar to E. coli small heat shock protein.
Putative molecular chaperone, similar to
IbpA.
+15.38
ibpB (stm3808) Chaperone protein IbpB: IbpA and IbpB
protect aggregated proteins from
denaturation and degradation
+15.27
ibpA
(stm3809.S)
Chaperone protein IbpA +11.57
htrA (stm0209) Serine endoprotease Do: Degrades
damaged proteins at high temperatures.
Required for virulence.
+7.74
dnaJ (stm0013) Hsp40: Molecular chaperone, prevents
aggregation of denatured proteins in
response to heat and hyperosmotic stress
+6.59
htpG
(stm0487.S)
Hsp90: Molecular chaperone +6.15
dnaK (stm0012) Hsp70: Molecular chaperone, helps fold
nascent polypeptide chains and re-fold
mis-folded proteins
+4.96
Envelope stress-related genes
spy (stm1308) Function unknown, although similar to
CpxP
+34.33
cpxP (stm4060) Repressor of Cpx envelope stress pathway
via CpxA
+14.51
DNA repair genes
recN (stm2684) DNA recombination and repair protein +7.61
mutM (stm3726) Formamidopyrimidine-DNA glycosylase;
base excision repair of DNA damaged by
oxidative stress or mutagens – recognises
and removes damaged bases
+4.77
Other putative stress-related genes
stm0581 Putative regulatory protein involved in
resistance to oxidative stress
+19.51
osmB (stm1705) Osmotically inducible lipoprotein B
precursor
+8.11
stm2789 Hypothetical protein, induced by carbon
starvation, σS-dependent.
+6.88
stm1731 Putative catalase +5.25
Table 6.6: Microarray expression data of major upregulated genes related to stress
responses in S. Typhimurium ΔrodA: Fold-change in gene expression as compared to
wild-type. Unless otherwise stated, P values ≤0.05. Information on gene function taken
from KEGG database (253).
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Colanic acid biosynthesis
A large number of genes involved in colanic acid biosynthesis were significantly
upregulated in the ΔrodA mutant. 16 genes related to synthesis of the colanic acid
capsule were upregulated at least 2-fold whilst 11 were amongst the most
upregulated genes in the ΔrodA strain, along with another biofilm-related gene
(stm1564) (Table 6.7, Figure 6.1). This result was supported by phenotypic assays
which showed that both ΔpbpA and ΔrodA mutants of S. Typhi expressed
increased amounts of the cellulose polysaccharide capsule. Previous work has
also identified mutants in cell shape determinant genes with increased mucoidy,
from an increase in colanic acid biosynthesis (323). Treatment with beta-lactam
antibiotics has also been shown to induce expression of colanic acid biosynthesis
genes in E. coli (399). Furthermore, downregulation of the SPI-1 and flagella
genes often appears to be associated with an increase in colanic acid capsule
expression, regulated by a number of global regulators including the Rcs
phosphorelay (RcsCDB), MqsR and the second messenger molecule cyclic
diguanylate (c-di-GMP) (318, 400-402).
Colanic acid capsules are integral to mature biofilms, when, as a result of specific
environmental conditions, bacteria are induced to form a multicellular state. In
these conditions motility is not required, hence motility and colanic acid capsule
related genes are inversely regulated (372, 403). The wca/cps gene cluster is
responsible for colanic acid biosynthesis in E. coli and Salmonella (399, 404, 405).
The products of these genes catalyse the biosynthesis, assembly, translocation
and modifications of the colanic acid capsule, and they are essential for capsule
expression (399, 405). Many of these genes were highly upregulated in the ΔrodA
mutant (Table 6.7).
Little is known about the biofilm-related yddX gene, although it was induced in E.
coli during stationary phase growth and its expression was regulated by RpoS (σS)
(406).
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Gene Protein function Fold change in gene expression in
SL1344 ΔrodA compared to WT
Colanic acid biosynthesis gene cluster
gmd (stm2109) GDP-D-mannose dehydratase, contained
within colanic acid biosynthesis cluster
+22.15
wcaD (stm2112) Putative colanic acid polymerase,
essential for colanic acid biosynthesis
+12.34
wcaE (stm2111) Glycosyl transferase +12.28
wcaA (stm2115) Glycosyl transferase +11.76
wcaG (stm2108) GDP-fucose synthetase +11.25
wcaF (stm2110) Putative colanic acid biosynthesis
acetyltransferase
+10.67
cpsG (stm2104) Phosphomannomutase +8.64
wcaM (stm2099) Essential for biofilm formation, may be
involved in colanic acid biosynthesis
+7.36
wcaB (stm2114) Putative colanic acid biosynthesis
acetyltransferase
+7.07
wcaL (stm2100) Putative glycosyl transferase +6.01
wcaK (stm2101) Putative pyruvyl transferase +5.57
Biofilm-related genes
yddX (stm1564) Biofilm-dependent modulation protein +9.30
Table 6.7: Microarray expression data of major upregulated colanic acid
biosynthesis genes in S. Typhimurium ΔrodA: Fold-change in gene expression as
compared to wild-type. Unless otherwise stated, P values ≤0.05. Information on gene
function taken from KEGG database (253).
SPI-1 sit operon
In stark contrast to all other SPI-1 genes represented in the microarray, four SPI-1-
encoded genes were upregulated between 5.4-fold and 21.5-fold in SL1344 ΔrodA
(Table 6.8). These genes, stm2861-stm2864, are contained within a distinct
operon of SPI-1, and together encode an iron/manganese uptake ABC transporter
which is common to SPI-1 in all S. enterica serovars. The GC content of this sit
operon is higher than the rest of SPI-1 and more reminiscent of the rest of the
Salmonella genome, suggesting that it may have a different origin from the
remainder of SPI-1 (407-409). Also unlike other SPI-1 genes, expression of the sit
genes is induced after uptake into epithelial cells and they are not required for
invasion. Furthermore the sit-encoded iron transporter is known to assist in
virulence in vivo (408, 410, 411). Expression of the sitABCD genes is repressed by
the Fur and MntR transcriptional regulators in response to increasing iron and
manganese levels (411).
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Gene Protein function Fold change in gene expression in
SL1344 ΔrodA compared to WT
sitA (stm2861) Iron transporter; periplasmic binding
protein
+21.51
sitB (stm2862) Iron transporter; putative ATP-binding
protein
+13.13
sitC (stm2863) Iron transporter; putative integral
membrane permease
+20.72
sitD (stm2864) Iron transporter; putative integral
membrane permease
+5.35
Table 6.8: Microarray expression data of upregulated SPI-1 genes in S.
Typhimurium ΔrodA: Fold-change in gene expression as compared to wild-type. Unless
otherwise stated, P values ≤0.05. Information on gene function taken from KEGG
database (253).
The dissimilarity of both the functions and regulation of the sit operon genes
compared to other SPI-1 genes, may explain why these genes are not
downregulated along with the majority of SPI-1-encoded genes in the ΔrodA
mutant. The reason for the increased expression of these genes in the ΔrodA
mutant is unknown. Expression of the upstream Fur and MntR regulators was not
significantly changed in this mutant, compared to the wild-type.
Outer membrane proteins
4 genes whose expression was increased over 4-fold in the ΔrodA mutant
encoded integral outer membrane proteins or outer membrane lipoproteins, which
did not function as transport proteins (Figure 6.1).
By far the most upregulated gene in this mutant was stm3031, encoding an outer
membrane OmpX-like protein; stm3031 was upregulated just over 239-fold in
SL1344 ΔrodA. Recent studies have implicated stm3031 in resistance to the
cephalosporin antibiotic, ceftriaxone. Ceftriaxone-resistant strains expressed
increased levels of this protein, whilst Δstm3031 mutants had reduced ceftriaxone-
resistance (412, 413). Further evidence suggested that stm3031 may be involved
in regulating levels of both the multidrug resistance efflux pump protein, AcrD, and
the outer membrane porin OmpD; thus overexpression of stm3031 may lead to the
increased export of ceftriaxone, along with a decreased permeability to the influx
of drugs (412). However, the precise role of OmpX-like protein in Salmonella is not
known. In Yersinia pestis OmpX-like protein, or Ail, is an outer membrane adhesin,
required for successful Type III secretion (414, 415).
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Outer membrane expression of stm3031 is associated with that of a putative inner
membrane transporter encoded by yjeH, which may help to export OmpX-like
protein (412, 416). Expression of stm3031 may also be regulated by the
transcriptional regulator BaeR (413). In the present arrays, yjeH (stm4328)
expression was increased ~5.1-fold in ΔrodA cells, although baeR expression was
not significantly altered, being reduced ~1.7-fold. Notably, expression of stm3030,
the gene immediately downstream of stm3031 encoding a hypothetical protein,
was increased 93.0-fold in these arrays.
Like other beta-lactam antibiotics, ceftriaxone inhibits the penicillin-binding
proteins, perturbing peptidoglycan synthesis (413, 417). It is possible that the
overexpression of OmpX-like protein in the ΔrodA mutant is induced in order to
protect cells from further cell wall damage, from the action of environmental
stresses, drugs, antimicrobial molecules, or host immunity factors, for example.
Aside from OmpX-like protein, 3 putative outer membrane lipoproteins, encoded
by stm1254, stm0080 and stm1561 were significantly upregulated in the arrays,
15.5-fold, 6.1-fold and 4.8-fold respectively (Figure 6.1). These significant changes
in gene expression in the ΔrodA, particularly demonstrated by the vast increase in
stm3031 expression, suggest that the outer membrane structure and composition
is considerably affected in round-cell mutants. However, expression of the genes
encoding two major outer membrane porin proteins, OmpA and OmpC, was not
much changed in the ΔrodA mutant, although other porin genes ompF and ompW
were downregulated 3.1-fold and 2.3-fold respectively.
SPI-2
Although the vast majority of SPI-2-encoded genes were not represented amidst
the highly upregulated classes of genes in the ΔrodA mutant, the ssrA gene
(stm1392), encoding the major regulator of the SPI-2 genes was upregulated ~5.8-
fold (Figure 6.1). ssrA forms the histidine kinase component of the SsrA/SsrB two-
component system, which is essential for the expression of SPI-2-encoded genes
(99). ssrB, encoding the transcriptional activator, was not significantly upregulated
in SL1344 ΔrodA, however.
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Of the 49 SPI-2 encoded genes within the microarray, 2 genes were
downregulated just over 2-fold in SL1344 ΔrodA, the expression of 5 genes was
changed less than 1.5-fold, 4 genes were upregulated 1.5-2-fold and 5 genes were
upregulated over 2-fold in SL1344 ΔrodA compared to the wild-type. Expression
data for the remaining SPI-2 genes was not statistically significant. From these
data it is difficult to gauge whether the expression of SPI-2 genes as a whole was
significantly changed in the ΔrodA mutant compared to wild-type, although the
microarray data echoes the results of phenotypic assays, showing that SPI-2 is
clearly not repressed in this mutant. However, microarrays were conducted using
RNA from cells grown in nutrient rich SPI-1-inducing medium. Hence it is hard to
evaluate the effects on SPI-2 expression in the ΔrodA mutant, since SPI-2 is
expressed at a low level in these conditions.
SPI-3 and SPI-6
Microarray data showed that of the 11 SPI-3 genes, 3 were significantly
upregulated in SL1344 ΔrodA (Figure 6.1) (384). These included the co-
transcribed stm3763 (mgtB) and stm3764 (mgtC) genes, which encode a
magnesium transporter and a magnesium transport protein respectively. This
operon is activated by PhoP/PhoQ in response to low magnesium levels, and is
essential for intracellular growth in the macrophage (418, 419). mgtB and mgtC
were upregulated 3.2-fold and 4.4-fold in the arrays. Furthermore, the slsA gene
(stm3761) was upregulated 6.8-fold in the ΔrodA mutant. This gene encodes a
putative inner membrane protein, which may be involved in virulence, as it is
required for gut colonisation in chickens and calves (384, 420). Both the mgtCB
operon and slsA are regulated by ArcA/ArcB. In anaerobic conditions, ArcA
strongly repressed mgtCB expression, although it is thought to activate slsA (384).
The SPI-6 pathogenicity island is a region of between ~35-50kb, depending on
specific serovars. In S. Typhi and Typhimurium SPI-6 encodes both a type 6
secretion system (T6SS) and the saf fimbrial operon, although the presence of
pseudogenes within this region suggests that the T6SS may be non-functional in
Typhi. In S. Typhi SPI-6 possesses an additional tcf fimbrial operon (421).
Transcription of both the SPI-6 T6SS genes and the saf fimbrial operon was not
significantly altered in the ΔrodA mutant from the present microarrays, although
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two other SPI-6 genes were upregulated 2.9-fold (stm0306) and 8.7-fold (stm0307)
in this mutant (Figure 6.1). stm0306 encodes PagN, a PhoP-activated outer
membrane invasin, which is optimally expressed in SPI-2-inducing conditions and
upregulated in vivo during mouse infections (422-425). PagN is able to mediate
invasion of mammalian cells in vitro and assists with virulence in vivo (423, 425).
The upstream stm0307 encodes a VirG-like protein, which is also thought to be
involved in invasion or virulence (422). The Shigella VirG is an outer membrane
protein which is involved in the recruitment of host cell F-actin, enabling the
bacteria to move through the host cell cytoplasm, although the function of stm0307
is unknown (426).
Cell envelope-associated proteins
Although a number of integral membrane and periplasmic proteins have already
been described whose expression was considerably increased in the ΔrodA
mutant, it remains noteworthy that a large number of upregulated genes in the
array were cell envelope associated. Of the 100 most highly upregulated genes, at
least 45 are thought to encode inner membrane, outer membrane or periplasmic
proteins (Figure 6.1). These included the transporter subunit proteins, outer
membrane lipoproteins, adhesins, periplasmic stress-related proteins and other
uncharacterised proteins, as well as others. This is highly significant and suggests
that mutations which affect cell wall synthesis and cell shape bring about stark
differences in the cell wall structure as a whole.
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6.1.3 Expression of global transcriptional regulators in SL1344 wild-type and
ΔrodA
Microarray data concerning the expression levels of various major global
transcriptional regulators were analysed in SL1344 ΔrodA as compared to the
wild-type. This was done to provide a better overall picture of the patterns of gene
expression in the ΔrodA mutant and to potentially identify any major regulators
responsible for the observed virulence gene repression in round-cell mutants of
Salmonella. In particular, the expression of global regulators involved in controlling
responses to external environmental stress, was considered. The fold-changes in
gene expression levels in ΔrodA for each gene are illustrated (Figure 6.2).
As previously discussed, the major transcriptional regulators of both SPI-1 and
flagella genes were highly downregulated in the ΔrodA mutant. Furthermore the
expression of the sensor kinase component of the SPI-2 major regulator, ssrA,
was increased 5.8-fold. A number of global transcriptional regulators also showed
considerable changes in gene expression in the microarrays. Global regulators
whose expression was altered at least 2-fold compared to the wild-type included
cpxA, rpoE and rpoS, which were upregulated 2.3-fold, 3.0-fold and 2.2-fold
respectively, and slyA, lrhA and cspA, which were downregulated 2.5-fold, 7.0-fold
and 4.1-fold respectively in the ΔrodA mutant (Figure 6.2). Although the
expression data for a number of global regulators was not statistically significant,
the expression of a number of other genes, though statistically significant, was
altered less than 2-fold compared to the wild-type. These genes included arcA,
barA, ompR, fnr, csrA, baeR and baeS (Figure 6.2).
The significant increases in both rpoE and rpoS transcription are perhaps not
surprising. These two genes encode alternative sigma factors which control gene
expression in response to external stresses, including high osmolarity, low pH and
oxidative stress. As such they are needed in Salmonella for both stationary phase
growth and also for intracellular survival. Furthermore, rpoE acts in response to
the sensing of envelope stress (98, 307, 345, 427, 428). Perturbations in the cell
wall structure from the inactivation of rodA are likely to be detected as envelope
stress, leading to the activation of cell envelope stress-sensing mechanisms,
213
including rpoE, and hence the activation of envelope-stress/stationary phase
associated genes. This is supported by the observation that cpxA was also
upregulated in these arrays. This gene encodes the sensor kinase component of
the CpxA/CpxR two-component system, which also responds to cell envelope
stress, upregulating genes involved in periplasmic protein repair (307, 428, 429).
Likewise, the increased sensitivity of this mutant to environmental stress could
lead to the upregulation of general stress response pathways, regulated, for
example, by rpoS. However, slyA, another stationary phase regulator whose
regulon includes cell-envelope associated proteins and virulence factors, was
found to be significantly downregulated in this array. SlyA is a major activator of
the SPI-2 genes through SsrA/SsrB (38, 44).
Also contrary to expectations was the finding that lrhA, a repressor of flhDC
transcription, was significantly downregulated in the ΔrodA mutant (437). However,
it is recognised that the regulation of flhDC expression is complex and multifaceted.
As such the downregulation of lrhA may not significantly affect flhDC expression. It
also remains unknown whether the reduced expression of cspA is important,
although CspA, the major cold-shock protein, activates H-NS, which goes on to
downregulate SPI-2 expression. Hence it is possible that the downregulation of
CspA indirectly affected the maintenance of SPI-2 expression in ΔrodA cells.
Interestingly, two other related cold shock proteins CspC and CspE, were
upregulated by 2.1-fold and 2.3-fold respectively in these arrays. This may be
important, as both proteins have been shown to be involved in regulating the
stress response; overexpression of these proteins led to increased levels of both
rpoS mRNA and RpoS protein (427).
A number of other global regulators would be expected to play major roles in
regulating the SPI-1 and flagella expression phenotypes in ΔrodA mutants,
including the PhoP/PhoQ and OmpR/EnvZ two-component systems which both
regulate virulence gene expression, and the Rcs phosphorelay sensor kinase and
response regulator proteins RcsC and RcsB (99, 119, 397, 435). However no
meaningful expression data was generated for these genes, since the microarray
results were not statistically significant (Figure 6.2). Expression data for other
important members of the Rcs phosphorelay, the cell-envelope stress-sensing
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RcsF protein and the intermediate protein in signal transduction, RcsD, was also
non-significant. Further work will therefore be needed to assess whether these
global regulators play a major role in regulating virulence genes in round-cell
mutants.
6.1.4 Other significant changes in gene expression between SL1344 wild-
type and ΔrodA
Several additional notable changes in gene expression were observed between
the wild-type and ΔrodA strains, which will be briefly discussed.
Cell division genes
A large number of cell division-associated genes exist, encoding the major
components of the septal cytokinetic ring machinery and the septal peptidoglycan
synthesis complex. At least ten of these proteins play an essential role in cell
division (175). Various studies have observed that the major cell division proteins
FtsZ, FtsA and FtsQ (encoded by the ftsQAZ operon) are upregulated in round-cell
mutants, and that upregulation of these proteins is essential to prevent cell lysis
and restore viability to round-cell mutants (130, 131).
9 genes associated with cell division were upregulated at least 2-fold in the ΔrodA
mutant (stm0119-stm0127), including the major cell division transpeptidase PBP3
(FtsI) and the cognate FtsW protein, as well as FtsL, another essential cell division
protein (175). FtsQ was also upregulated 2.3-fold and FtsA expression was
increased 1.9-fold in the ΔrodA mutant. However microarray data for ftsZ was not
statistically significant. Overall, and in support of previous studies, proteins
comprising the cell division machinery seem to be upregulated in this mutant.
mrd operon genes
As would be expected, the rodA gene was downregulated (8.3-fold) in the ΔrodA
mutant, since the gene was completely inactivated in this strain and replaced by a
kanamycin-resistance cassette. The rlpA gene, which lies immediately
downstream of rodA, was also downregulated 10.3-fold in this mutant, suggesting
that the ΔrodA mutation has a polar effect on downstream co-transcribed genes.
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Alternatively, the effect on rlpA expression could result from the removal of the
putative rlpA promoter with the removal of the rodA gene.
The expression of dacA was decreased only by 1.7-fold in the ΔrodA mutant,
although this data was not statistically significant. The lack of a significant change
in gene expression may indicate that dacA does not form part of the mrd operon,
and hence its expression was not significantly perturbed in the ΔrodA mutant.
Expression of the pbpA, and the other upstream mrd operon genes was also not
significantly affected in these arrays.
6.2 Discussion
6.2.1 Usability and verification of microarray data
Microarrays provide a highly useful tool for the comprehensive analysis of gene
expression between wild-type and mutant strains. However, this technique has a
number of inherent limitations and further in vivo experimental analyses are
therefore required to fully validate microarray data. The microarray data presented
here was well supported by previous phenotypic tests, which showed that the
observed defects in SPI-1 and motility in round-cell mutants were at least in part a
result of downregulation of the major flagella/SPI-1 regulators. Furthermore, the
experimental observations of excess capsular polysaccharide production in the
round-cell mutants may provide additional evidence to verify the overexpression of
the colanic acid biosynthesis genes seen from the ΔrodA microarrays. Data from
previous studies may also help to validate the current microarray data in terms of
the expression of global stress regulators. Similarly to the data shown here,
mecillinam-treated E. coli cells were shown to upregulate several major stress
regulators, including rpoE, cpxAR and the Rcs phosphorelay (118). Ideally, given
time the gene expression data generated in these arrays would best be verified
with additional transcriptional reporter assays or quantitative real-time PCR
(qPCR). Nevertheless, the phenotypic data provide strong evidence to support and
verify the observations from microarray data, showing that it affords a reliable
representation of the S. Typhimurium ΔrodA transcriptional profile.
217
It is important to note that although microarrays enabled a large-scale global
analysis of gene expression, this data only represents one level of expression, not
taking into account post-transcriptional and post-translational regulatory
mechanisms which influence protein expression and function. As such the
microarrays may not provide an accurate or complete representation of the
physiological state of the ΔrodA mutant. However, the present microarrays have
provided a wealth of information regarding global gene transcription in the ΔrodA
mutant as compared to the wild-type.
Arrays were conducted using purified mRNA from mid-log phase cultures. Cultures
were standardised according to culture optical densities (OD600). RNA
concentrations were further standardised so that equal quantities of wild-type and
mutant cDNA were hybridised to the arrays. This was done to enable comparisons
to be made between the wild-type and ΔrodA mutant. As such, the results of these
microarrays were used to compare gene expression between individual cells. It is
recognised that some changes in gene expression may be the indirect result of
cells compromising for the increase in both cell volume and quantity of cell
membrane per cell in the ΔrodA mutant by increasing gene expression. However,
if this were the case, one may expect that a large proportion of genes in the round-
cell mutant would be upregulated.
6.2.2 Major gene expression changes in SL1344 ΔrodA mutant
DNA microarrays were carried out to characterise the major changes in gene
expression in the round-cell S. Typhimurium ΔrodA mutant as compared to the
wild-type, and hence to help gain a better understanding of the function of this
gene. Several major changes in gene expression were evident in the mutant, the
most pronounced of which being those seen in flagella and SPI-1 gene expression.
In agreement with previous phenotypic assays, the vast majority of
flagella/chemotaxis and SPI-1-encoded genes were highly downregulated in this
mutant. Furthermore, expression of the major transcriptional regulators of these
genes was also highly suppressed. The only exception was a SPI-1 encoded iron
transporter, which was upregulated in the round-cell mutant. The DNA sequence
of this operon is known to differ significantly from that of the rest of SPI-1 (407). In
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addition, this operon is differentially regulated from the rest of SPI-1, and assists in
intracellular survival rather than invasion (352, 410, 411). In reflection of
phenotypic assays, a significant number of genes involved in colanic acid
biosynthesis were also upregulated in the ΔrodA mutant.
A number of genes involved in responding to a variety of environmental stresses
were upregulated in the ΔrodA cells. This may result from the upregulation of the
global regulatory alternative sigma factors RpoE and RpoS, which are required in
stationary phase particularly to regulate genes involved in stress resistance (98,
253, 345). As would be expected from a mutation which affects cell wall structure,
pathways involved in reacting to cell envelope-associated stress also appeared to
be upregulated in the ΔrodA mutant, including rpoE and cpxA. Furthermore,
significant alterations were observed in the expression of several cell envelope-
associated proteins, including a number of outer membrane proteins and integral
membrane nutrient transporters. These features point towards significant changes
in the general makeup and structure of the cell envelope and constituent proteins
in round-cell mutants. Changes in the cell envelope as a whole have been noted in
round-cell mutants. For example both round cell mrd and mre operon mutants
have been seen to produce excess inner membrane from an inability to adjust the
rate of phospholipid synthesis in response to an altered cell wall (130).
Round-cell mutants are known to have a decreased surface:volume ratio
compared to wild-type cells, being considerably larger in diameter and volume
than wild-type cells. This must be considered when analysing alterations in the
expression of genes encoding membrane proteins. The upregulation of gene
expression for a large number of membrane proteins may be a result of mutant
cells responding to an increased overall quantity of cell envelope by concurrently
overproducing important membrane proteins. As such the actual concentration of
the majority of membrane proteins may not be much altered in ΔrodA cells.
Alternatively the increased cell volume may lead to a decreased intracellular
concentration of, among other things, essential nutrients. This may require ΔrodA
cells to upregulate the expression of nutrient uptake transport proteins to enable
cells to maintain the required intracellular concentration of essential nutrients.
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A surprising feature of the ΔrodA mutant was a significant decrease in the
expression of several genes associated with anaerobic respiration. This was
echoed by the significant downregulation of two genes involved in the regulation of
nitrate-associated anaerobic respiration, narP and narL, although these genes
have opposing effects on the expression of nitrate reductase systems. Also, gene
expression was not significantly altered in other important anaerobic respiration
regulators, arcA, arcB, fnr, and fur (387, 430).
Genes important for intracellular survival appeared to be upregulated in the ΔrodA
mutant, including the SPI-2 master regulator sensor kinase, ssrA. It is therefore
surprising that anaerobic respiration genes should be downregulated in this mutant.
Studies have shown that the ability of Salmonella to respire anaerobically is
essential for intracellular survival; S. Typhi mutants that could not respire
anaerobically were also less able to invade and replicate inside epithelial cells
(431-433). This may suggest that anaerobic respiration genes would be
upregulated or co-regulated along with other genes important for intracellular
survival in ΔrodA cells. However, one study suggested that the Salmonella-
containing vacuole (SCV) of the macrophage may not be completely anaerobic, as
FNR and ArcA were not upregulated intracellularly (430). Also, FNR was shown to
upregulate flagella and SPI-1 genes in anaerobic conditions, as well as the
anaerobic respiration genes (386). Therefore anaerobic respiration genes may be
co-regulated with invasion genes in the ΔrodA mutant, and as such the
downregulation of both anaerobic respiration and invasion genes may result from
the regulation of a common upstream factor.
6.2.3 Implications of major changes in gene expression and insights into the
physiological state of the ΔrodA mutant
Taken together, these observations suggest that invasion-associated genes (e.g.
flagella, SPI-1 and type I fimbriae) are almost completely repressed in round-cell
mutants, whilst genes required in the later stages of infection for intracellular
survival and resistance to external stresses, are activated. The latter class of
genes are upregulated in conditions where cells are exposed to heightened levels
of environmental stress, including a low pH, low magnesium, oxidative stress and
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nutrient starvation, all of which are indicative of the intracellular environment (39,
96, 98, 434). Since such stress response pathways may be upregulated in the
rodA mutant, it may follow that the observed virulence gene expression in this
mutant is an indirect result of the upregulation of stress response pathways. These
results provide further evidence that the mutation of cell shape determinant genes
may affect the structure of the peptidoglycan cell wall, leaving cells more exposed
to environmental stress, or alternatively that such mutants respond defensively to
changes in the wall structure by upregulating stress response pathways regardless
of any actual perturbation of barrier function. In support of these results, round cell
mutants are known to show increased sensitivity to several stresses, and the
presence of antibiotics (211, 214, 229).
These data provided important insights into the physiological state of the ΔrodA
mutants. Potentially significant clues into the structure and expression of the mrd
operon were also provided in this array, suggesting that dacA does not form part
of the mrd operon, since its expression was not affected in the ΔrodA mutant.
6.2.4 Global transcriptional regulator expression in the ΔrodA mutant
Microarrays were conducted with the additional aim of identifying putative
transcriptional regulator(s) which may be to a large extent responsible for the
observed gene expression profile of the ΔrodA mutant. The expression of several
major global transcription regulators was analysed, including those which regulate
both essential housekeeping genes and virulence genes in response to
environmental factors or stress. Several major transcription factors conversely
regulate expression of both invasion-associated (e.g. SPI-1) and intracellular
survival-associated (e.g. SPI-2) virulence genes in Salmonella, in a manner
reminiscent of the observed phenotype in the ΔrodA mutant. Among these are the
rcsC and rcsB genes, and phoP, and phoQ, which act to suppress flagella and
invasion gene expression, whilst upregulating SPI-2. The Rcs phosphorelay genes
also form a major activator of colanic acid biosynthesis (96, 98, 318, 435, 436).
Another likely candidate could be the lrhA gene, which directly regulates flagella
expression by binding to the flhDC promoter and inhibiting its expression, and
represses type I fimbriae expression, although this gene also represses rpoS
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expression and is repressed by the Rcs phosphorelay (437, 438). lrhA was
significantly downregulated in the arrays, and hence it is unlikely to form a major
regulator of the observed phenotypes. However, the more likely candidates, the
rcs and phoP/phoQ genes were not significantly altered in expression between the
wild-type and ΔrodA mutants. As such, the microarray data did not highlight any
obvious candidates responsible for regulating the expression of SPI-1 and flagella
genes in round cell mrd operon mutants. Further work will be needed to identify
this/these regulator(s). It also remains to be seen to what extent other envelope
stress response pathways, regulated by RpoE, CpxA/CpxR, and BaeS/BaeR, may
influence the observed phenotypes in round-cell mutants (216, 428).
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Chapter 7. Restoration of SPI-1 and flagella functionality through
expression of major SPI-1/motility regulators in trans, in ΔpbpA
and ΔrodA strains
7.1 Recovery of motility and SPI-1 functionality in complemented mrd
mutants
Microscopic analysis of BRD948 S. Typhi ΔpbpA and ΔrodA mutants expressing
plasmid-encoded YFP fusion proteins of the respective proteins demonstrated that
these plasmids were able to restore rod-shape to the round-cell mutants (Figure
4.3). Subsequent assays for recovery of motility showed that around 50-70%
motility was restored in both S. Typhi ΔpbpA pVP6 and S. Typhi ΔrodA pVP3
complemented strains, compared to the wild-type (Figure 5.1). Secreted protein
profiles of these strains grown up to mid-log phase also clearly showed recovered
flagellin expression (Figure 7.1 B).
The functionality of the SPI-1 T3SS was also assayed by western blot analysis of
SPI-1 effector protein expression in the complemented strains. Secreted protein
preparations from mid-log phase cultures of both wild-type, mutant and
complemented strains were subjected to SDS-PAGE, blotted onto nitrocellulose
and labelled with antibodies specific to the SPI-1-secreted effector protein, SopE.
Although the resultant SopE band appeared faint, it was clearly present in both S.
Typhi ΔpbpA pVP6 and S. Typhi ΔrodA pVP3 complemented strains. However,
SPI-1 effector protein bands were not observed when the complemented strains
were grown in the presence of 0.5 mM IPTG (Figure 7.1 A). This is reminiscent of
motility assays, where the overexpression of pbpA and rodA in complemented
strains caused a complete loss of motility (Figure 5.1). This is also seen in
secreted protein profiles of these strains; the flagellin bands were significantly
reduced with the addition of IPTG to complemented strains, as indicated (Figure
7.1 B).
Overexpression of the PBP2-YFP and RodA-YFP fusion proteins may have led to
an accumulation of these proteins in inclusion bodies, resulting in a subsequent
loss of morphology and with it a loss of motility and SPI-1 secretion in ΔpbpA and
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ΔrodA strains. Alternatively, overexpression of these proteins may also lead to cell
shape defects, as seen previously, along with an associated shut-down of SPI-1
and motility functionality (Figure 4.6) (158, 164, 330).
Figure 7.1: Recovery of motility and SPI-1 effector protein expression in
complemented ΔpbpA and ΔrodA strains: A – Western blots showing expression of the
SPI-1 SopE effector protein in secreted protein fractions of BRD948 wild-type, ΔpbpA and
ΔrodA, and complemented mutant strains. Background protein bands likely due to
antibody cross-reactivity to intracellular proteins; round-cell mutants are known to be
prone to cell lysis (Figure 5.7) (130). B - Secreted protein profiles of BRD948 wild-type,
ΔpbpA and ΔrodA, and complemented mutant strains. Arrow indicates flagellin band.
Cultures grown in LB broth, harvested at mid-log phase. Protein molecular weight (MW)
marker sizes as indicated.
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The detection of SPI-1 effector proteins in secreted protein fractions may result
from cell lysis with the release of non-secreted proteins into culture supernatant,
and not active secretion through the SPI-1 T3S needle, particularly as round-cell
mutants are prone to lysis (130). However, the clear functionality of motility in
these complemented strains makes it probable that the SPI-1 T3SS is also
functional. These data together demonstrate that the SPI-1 and motility defects
observed with the inactivation of cell shape determinants such as pbpA and rodA
are the direct results of the inactivation of these genes. This was important to
establish, as it is plausible that the observed phenotypes may have resulted from
the accumulation of secondary mutations through several passages of growth and
the processes involved in the generation of specific S. Typhi mrd operon mutants.
Data from several phenotypic assays, as well as microarray analyses,
demonstrated that both motility-related genes and genes encoding the SPI-1 T3SS
were almost completely downregulated in round-cell mrd mutants of both S. Typhi
and S. Typhimurium (Figure 5.3 and 5.6, Table 6.1 and 6.2). However, motility
assays in the presence of mecillinam suggested that there was a significant delay
between the loss of rod-shape and the shut-down of motility (Figure 5.2).
Furthermore, in microscopic analysis of both ΔpbpA and ΔrodA mutants, within a
population of cells a few motile round cells were occasionally noticed, likely due to
natural heterogeneity within a population.
These observations, as well as the data showing that SPI-2 T3SS functionality
remained intact in round-cell mutants, suggest that the motility and SPI-1 defects
may be caused purely from the shutdown of gene expression and not from any
additional incapacity to assemble the complex multi-protein structures in the cell
wall of ΔpbpA and ΔrodA mutants. In order to test this hypothesis, it was
necessary to attempt to restore expression of both SPI-1 and motility genes in
these mutants, and assay for a parallel recovery of SPI-1 and motility functionality.
Expression of the major SPI-1 and flagella gene transcriptional regulators was
restored in each of the round-cell mutants by inducing their expression in trans,
from heterologous promoters. These strains were subsequently assayed for
motility and SPI-1 functionality.
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7.2 Expression flhDC under the control of a tetracycline-inducible promoter
in mrd mutant strains
7.2.1 Introduction of TPA14 tetracycline-inducible flhDC vector into S.
Typhimurium ΔpbpA and ΔrodA mutants
Expression of all flagella and chemotaxis genes is tightly controlled by the
upstream master regulator FlhD4C2, encoded by the flhD and flhC genes. Motility
is therefore dependent upon expression of the flhDC operon (56, 62, 108).
In order to attempt to restore motility in round-cell mrd mutants, S. Typhimurium
ΔpbpA, ΔrodA and wild-type cells were transduced with a P22 phage lysate stock
containing ‘TPA14’, a chromosomally-encoded vector where the native promoter
of the flhDC operon is replaced by a tetracycline-inducible PtetA promoter with the
insertion of a T-POP transposon (236). Hence, in cells harbouring TPA14 flhDC
expression (and hence downstream motility) is no longer subject to the native
regulatory mechanisms which may suppress flhDC with the inactivation of pbpA
and rodA, but instead dependent upon addition of tetracycline to growth medium
(236). The TPA14 phage stock was a kind gift of Philip Aldridge (Newcastle, UK).
TPA14 was transduced into S. Typhimurium SL1344 wild-type, ΔpbpA and ΔrodA
strains and tetracycline-resistant transductants were subsequently screened for
recovered motility. This work was done in S. Typhimurium wild-type and mutant
strains rather than BRD948 strains, due to the inherent inability to transduce S.
Typhi with Typhimurium-derived P22 phage lysates (439).
7.2.2 Motility of S. Typhimurium WT, ΔpbpA and ΔrodA expressing TPA14
To test for recovery of motility in ΔpbpA and ΔrodA mutants expressing TPA14,
tetracycline resistant TPA14 transductants and relevant negative controls were
inoculated onto semi-solid motility agar, with or without the addition of 50 µg/ml
tetracycline, and cultured for at least 6 hours at 37°C. The extent of culture spread
was then measured as an indication of motility functionality in these strains. The
motility of each strain was measured as a percentage of that of the wild-type
harbouring TPA14 (Figure 7.2).
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These motility assays demonstrated a clear and significant recovery of motility in
ΔpbpA TPA14 and ΔrodA TPA14 cells, where flhDC was expressed under the
control of the PtetA promoter, compared to mutant strains lacking TPA14, in which
flhDC was expressed from its natural promoter (Figure 7.2 A). In the absence of
tetracycline ΔpbpA TPA14 and ΔrodA TPA14 cells recovered ~30-50% of the
motility of wild-type SL1344 TPA14 cells. This suggests some low-level
background expression of flhDC was evident, which was sufficient to restore
significant amounts of motility to the ΔpbpA and ΔrodA mutants. However, in the
presence of tetracycline, though some motility was restored to the round-cell
mutants motility levels were highly variable in both ΔpbpA and ΔrodA strains
expressing TPA14, making the results overall not statistically significant. Cell
growth in motility agar appeared to be affected by the presence of tetracycline,
being slightly diminished in both wild-type and mutant strains. As such, the
variability in motility may be a result of either growth perturbation or variability in
levels of flhDC expression.
Microscopic analysis of both wild-type and round-cell mutant cells of SL1344
confirmed that no overall differences in morphology were seen between wild-type,
ΔpbpA and ΔrodA cells, and their TPA14-harbouring counterparts (Figure 7.2 B).
Therefore, the recovery of motility in round-cell mutants was due specifically to a
restoration of flhDC expression, with the downstream re-activation of flagella gene
expression, rather than any secondary effects causing cells to regain a rod-shaped
morphology. In addition, ΔpbpA TPA14 and ΔrodA TPA14 cells were clearly motile
under the microscope, demonstrating that the observed spread of these strains in
motility agar was due to active motility, and not just increased growth rates.
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Figure 7.2: Motility assays of S. Typhimurium mrd operon mutants and TPA14
complemented strains: A - Motility assay results for SL1344 wild-type, ΔpbpA and
ΔrodA strains expressing flhDC under the control of the native, or tetracycline-inducible
PtetA promoter (cells expressing TPA14). Cells were cultured in semi-solid motility agar at37°C for ~6 hours. Motility was measured in terms of extent (diameter) of culture spread
through motility agar, as a percentage of that of relevant wild-type strain. Results show
averages from 3 independent assays. Error bars indicate standard deviations. Asterisks
indicate statistically significant differences, where P values were ≤0.05 as determined by
Students t-tests. B – Phase contrast microscopy images of the above strains. Scale bar
~5 µm; all images are to the same scale.
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These results demonstrate that the motility defects seen in round-cell mutants, in
S. Typhimurium are to a large extent due to the downregulation of flagellar genes,
brought about from the repression of flhDC expression. Thus, motility defects do
not result from an inability to assemble functional flagella in round-cell mutants.
However, since motility was restored only up to ~50% in these cells through the
recovery of flhDC expression (in the absence of tetracycline), it is possible that
other regulators act on flagella gene expression further downstream of flhDC to
diminish flagella gene expression. Also, it is possible that perturbations to the cell
wall structure affect the assembly of flagella in these cells, reducing motility still
further.
7.3 Expression of hilD from an arabinose-inducible pBAD vector in mrd
mutant strains
7.3.1 Transformation of S. Typhi and S. Typhimurium ΔpbpA and ΔrodA
mutants with pBAD-hilD
The expression of all SPI-1-encoded genes is essentially regulated by 3 SPI-1-
encoded genes: hilA, hilD, and hilC. hilA is considered the master regulator of SPI-
1, forming the point at which upstream regulatory inputs converge. However, hilA
expression is dependent upon hilC and hilD and the vast majority of factors which
regulate SPI-1 expression do so at the level of hilD, post-transcriptionally
regulating its expression (86-89, 91). Furthermore, hilD expression was shown to
be almost completely repressed in round-cell mrd mutants of S. Typhi (Figure 5.6).
HilD may be the most crucial factor responsible for downregulating SPI-1 gene
expression in these mutants; therefore in attempting to restore SPI-1 expression in
the round-cell mutants it was necessary to attempt to restore hilD expression first
and foremost.
The hilD gene, lacking its natural promoter, was cloned into the pBR322-derived
expression vector pBAD24, such that it was expressed under the control of the
arabinose-inducible araBAD operon PBAD promoter (245). This vector was
constructed and kindly provided by David Bulmer (Newcastle, UK). The pBAD-hilD
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plasmid was introduced into wild-type, ΔpbpA and ΔrodA strains of both S. Typhi
(BRD948) and S. Typhimurium by transformation.
7.3.2 SPI-1 functionality in S. Typhi and S. Typhimurium ΔpbpA and ΔrodA
mutants expressing pBAD-hilD
Recovery of SPI-1 expression and functionality was initially tested in S. Typhi
strains expressing hilD from the pBAD-hilD plasmid. Strains were cultured in LB
medium supplemented with 1 mM arabinose to induce hilD expression, 1 mM
glucose to repress expression of hilD from pBAD-hilD, as a negative control, or
without supplementation. In the absence of arabinose, pBAD-hilD-containing cells
may still express low levels of background hilD from the PBAD promoter, potentially
resulting in more native HilD proteins levels (440). pBAD24 is a relatively high
copy-number expression vector and so supplementing cultures of pBAD-hilD-
expressing strains with arabinose may lead to HilD overproduction. Secreted
protein fractions were prepared from mid-log phase cultures and analysed by
SDS-PAGE and western blotting.
Western blots of S. Typhi secreted protein fractions were labelled with antibody
specific to the SipA effector protein (Figure 7.3 A). It was quickly evident from
western blots that distinct SipA protein bands were present in both the wild-type S.
Typhi and the wild-type S. Typhi pBAD-hilD strain. The addition of arabinose
should induce PBAD-regulated hilD expression whilst glucose addition should
suppress hilD expression. As such, one would expect the effector protein
expression, and hence SPI-1 expression as a whole, to be significantly increased
in the presence of arabinose in pBAD-hilD expressing cells. Contrary to
expectations, however, no observable alteration in the SipA band intensity was
observed with growth in arabinose or glucose. A minor increase in SipA
expression was observed for S. Typhi wild-type pBAD-hilD cells grown without the
addition of glucose or arabinose, compared to wild-type, although this difference
was only very slight. In fact, the SipA bands appeared more intense in both wild-
type strains grown in the presence of glucose (Figure 7.3 A).
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Furthermore, SipA was not detected in secreted protein fractions of ΔpbpA pBAD-
hilD or ΔrodA pBAD-hilD strains, cultured in the presence of 1 mM arabinose, or in
the absence of either arabinose or glucose. This suggests that restoring hilD
expression does not lead to the recovery of SPI-1 expression and functionality in
round-cell S. Typhi mutants – the propensity of round-cell mutants to lyse meaning
that effector proteins would likely be observed in secreted protein fractions,
regardless of active secretion. Surprisingly, faint SipA bands were observed in
secreted protein fractions of S. Typhi ΔpbpA and ΔrodA strains, but not ΔpbpA
pBAD-hilD and ΔrodA pBAD-hilD strains, grown in the presence of glucose.
The pBAD-hilD expression vector was also introduced to wild-type and mutant
strains of S. Typhimurium SL1344. Wild-type, ΔpbpA and ΔrodA strains of SL1344
expressing pBAD-hilD were cultured in LB medium without the addition of glucose
or arabinose, in order to attempt to keep HilD protein levels more closely
resembling wild-type levels (440). Cells were harvested at mid-log phase, fixed
and labelled with both anti-SipD antibody and a fluorophore-conjugated secondary
antibody, and analysed by immunofluorescence microscopy. Meanwhile, secreted
protein fractions were prepared from culture supernatants, subjected to SDS-
PAGE and western blotting, and also labelled with antibody specific to the SipD
effector protein.
In contrast to the results seen in S. Typhi cells expressing pBAD-hilD, SPI-1
secreted effector protein levels were significantly increased in S. Typhimurium
wild-type cells overexpressing hilD, as shown by western blotting. In addition, SipD
bands were clearly visible in both S. Typhimurium ΔpbpA pBAD-hilD and ΔrodA
pBAD-hilD secreted protein fractions (Figure 7.3 B). Immunofluorescence
microscopy analysis echoed these results, as SPI-1 needles were observed
around the surfaces of many ΔpbpA pBAD-hilD and ΔrodA pBAD-hilD cells,
suggestive of SPI-1 functionality, but were absent from the parent ΔpbpA and
ΔrodA mutants. A significant increase in the number of cell-surface SPI-1
fluorescent foci was also observed in wild-type pBAD-hilD cells, showing that the
overexpression of hilD led to an increase in SPI-1 T3SS expression (Figure 7.3 C).
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These data demonstrate that in S. Typhimurium ΔpbpA and ΔrodA mutants, low
levels of hilD expression from the pBAD-hilD vector, or rather the recovery of hilD
expression, was necessary and sufficient to restore SPI-1 functionality. Also, SipD
levels in ΔpbpA pBAD-hilD and ΔrodA pBAD-hilD cells were recovered
approximately to that of the wild-type (Figure 7.3 B). This suggests that as
expected, in S. Typhimurium at least, upstream regulators suppress expression of
the SPI-1 genes in round-cell mrd mutants by regulating expression of the hilD
SPI-1 regulator.
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Figure 7.3: SPI-1 effector protein expression in ΔpbpA and ΔrodA mutants
expressing pBAD-hilD: A – Western blots showing expression of the SPI-1 SipA effector
protein in secreted protein fractions of BRD948 wild-type, ΔpbpA and ΔrodA strains ±
pBAD-hilD. B – Western blot showing expression of the SPI-1 SipD effector protein in
secreted protein fractions of SL1344 wild-type, ΔpbpA and ΔrodA strains ± pBAD-hilD.
Background protein bands likely due to antibody cross-reactivity to intracellular proteins or
aggregated Sip proteins. Protein molecular weight (MW) marker sizes as indicated. C -
Immunofluorescence microscopy images of SL1344 wild-type (WT), ΔpbpA and ΔrodA
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strains ± pBAD-hilD, overlaid onto phase contrast images; samples labelled with anti-SipD
antibody and fluorophore-conjugated secondary antibody. All images are to the same
scale. SL1344 Δspi-1 included as negative control.  All cultures grown in LB broth at 37°C
and 200 rpm, and harvested at mid-log phase. Where indicated, cultures were
supplemented with 1 mM arabinose or glucose after 3 hours’ growth.
7.4 Discussion
7.4.1 Introduction
Comprehensive analyses of major virulence determinant functionality in round-cell
mrd mutants of Salmonella Typhi and Typhimurium have shown that the SPI-1
T3SS and flagella-mediated motility are non-functional in both ΔpbpA and ΔrodA
mutants, whilst the SPI-2 T3SS remains active. These phenotypes were shown to
be a direct consequence of the mutations in the pbpA or rodA genes. The SPI-1
and motility defects are thought to be at least in part due to the repression of
expression of the major transcriptional regulators of the SPI-1 and flagella genes.
In order to further characterise the mechanisms behind the SPI-1 T3SS and
motility defects, it was necessary to determine whether expression of both SPI-1
and flagella genes could be de-repressed in the round-cell mutants through
recovered expression of the flagella and SPI-1 master regulators, and ultimately to
determine whether this was sufficient to subsequently restore the functionality of
these systems. For this reason the major transcriptional regulators of the SPI-1
and flagella genes, hilD and flhDC respectively, were expressed under the control
of inducible heterologous promoters in round-cell mrd operon mutants of
Salmonella in an attempt to restore flagella or SPI-1 gene expression (56, 62, 88).
The resultant strains were assayed for functionality of SPI-1 or motility.
7.4.2 Recovery of SPI-1 and flagella gene expression with expression of SPI-
1/flagella gene master regulators in trans
The recovery of hilD or flhDC expression in trans under the control of inducible
heterologous promoters, was shown to restore SPI-1 functionality or motility
respectively, in round-cell mrd mutants of S. Typhimurium. No significant
differences in the expression levels of SPI-1 effector proteins, or actual numbers of
SPI-1 needles were seen between ΔpbpA pBAD-hilD and ΔrodA pBAD-hilD
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strains, and the wild-type. However, further work would be needed to accurately
quantify levels of SPI-1 protein expression between wild-type and round-cell
mutant strains expressing pBAD-hilD, to determine whether SPI-1 expression is
reduced in the ΔpbpA and ΔrodA mutants.
However, although some motility was restored to round-cell mutants harbouring
TPA14, motility remained significantly reduced in the ΔpbpA TPA14 and ΔrodA
TPA14 strains, being on average less than 50% of that of the wild-type TPA14
strain. There may be a number of reasons for the observed reduction in the
motility of round-cell mutants. It may indicate that other factors are involved in
regulating flagella gene expression in round-cell mrd mutants, which act
downstream of flhDC, at the level of the class II or class III gene promoters for
example, to fine-tune flagella gene expression.
The FlgM and FliA proteins, encoding anti-σ28 and σ28 respectively, are important
for the regulation of class III gene expression. FliA is naturally repressed by FlgM.
With the removal of FlgM-mediated repression, on completion of basal body and
hook assembly, FliA is enabled to activate expression of the class III genes, as
well as class I and II genes (56, 62, 441). The ratio of FlgM to FliA molecules is
also thought to be important in determining flagella number (441). fliA expression
is dependent upon FlhD and FlhC, and a number of global regulators which induce
fliA expression appear to act through FlhD4C2 (442, 443). However, a recent study
in E. coli found that the transcriptional repressor NsrR specifically binds to the fliA
promoter, inhibiting its expression, and ultimately reducing motility (444).
The finding that at least one transcriptional regulator can inhibit fliA expression,
and with it motility, independently of flhDC, suggests that it is plausible that NsrR
or a similar transcriptional repressor may also be involved in repressing motility at
a level downstream of flhDC in round-cell mrd mutants, by decreasing the number
of flagella per cell. FliA or FlgM form likely candidates as targets for such gene
regulation, as they constitute the major regulators of genes involved in the later
stages of flagella assembly which, importantly, act downstream of flhDC.
Microarray data, however, showed that nsrR expression was not significantly
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affected in the SL1344 rodA mutant, compared to the wild-type, being increased
1.23-fold compared to the wild-type (P value = 0.08).
Alternatively, defects in the cell wall structure of round-cell mutants may have
restricted the successful assembly of the flagella apparatus, causing a reduction in
the number of functional flagella expressed per cell. This explanation is unlikely
when considering single cells, as flagella gene expression is tightly coupled to
flagella assembly. A stalling in the assembly of the flagella apparatus results in the
repression of downstream class III gene expression, and a complete loss of
motility (56, 62). At a population level, however, variability between round-cell
mutants may be such that motility is recovered in some, but not all ΔpbpA and
ΔrodA cells. In some cells, the extent of defects to the cell wall structure may be
sufficient to stall flagella assembly, preventing motility.
Although motility was reduced in ΔpbpA TPA14 and ΔrodA TPA14 strains, these
results together demonstrate that round-cell mutants are able to assemble
functional SPI-1 T3SS and flagella multi-protein complexes, the cell walls of these
mutants remaining sufficiently robust to support such organelles. The inactivation
of SPI-1 and motility systems appears to be caused, to a large extent, simply by
the downregulation of hilD and flhDC gene expression.
Global responses to envelope-associated stress, caused by cell wall structural
defects with the inactivation of pbpA or rodA, may lead to the inactivation of SPI-1
and flagella gene expression, although the major upstream regulators involved in
mediating the ΔpbpA and ΔrodA motility/SPI-1 phenotypes remain to be identified.
Future work will seek to isolate these regulators, and to further delineate the
pathways involved in regulating SPI-1 and flagella genes in response to the
inactivation of pbpA or rodA. This work will help better understanding into the
global effects that the inactivation of cell shape determinants have on the
physiology of Salmonella.
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7.4.3 Recovery of SPI-1 expression in S. Typhimurium, but not S. Typhi
ΔpbpA and ΔrodA mutants
Introduction of pBAD-hilD to ΔpbpA and ΔrodA mutants restored SPI-1
functionality in S. Typhimurium but not S. Typhi mutants. Furthermore, the addition
of arabinose to S. Typhi cultures appeared to significantly inhibit growth of these
strains. Increased sensitivity of S. Typhi to arabinose, from an inability to take up
or utilise arabinose may be responsible for the growth defects in these strains.
This may also have prevented arabinose from inducing expression of hilD from the
PBAD promoter in S. Typhi strains. However, background levels of uninduced hilD
expression from the pBAD-hilD vector were also not apparent in these strains (in
the absence of arabinose-mediated growth effects); effector protein expression
was increased in uninduced S. Typhimurium cultures expressing pBAD-hilD
(compared to the parent strain), but not in the equivalent S. Typhi strain. This may
indicate that the S. Typhi strain was inherently unable to express pBAD-hilD.
Alternatively, differences between the Typhi and Typhimurium serovars may be
such that low levels of hilD expression were insufficient to restore SPI-1
expression in S. Typhi round-cell mutants. If this is the case, it may highlight
differences in the regulation of SPI-1 between S. Typhi and S. Typhimurium
mutants.
Interestingly a small amount of SPI-1 expression was recovered in S. Typhi ΔpbpA
and ΔrodA mutants lacking pBAD-hilD when grown in the presence of glucose.
Further work is needed to establish how glucose was able to slightly alleviate
suppression of SPI-1 gene expression.
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Chapter 8. Global transposon mutagenesis screen to identify
negative regulators of the motility phenotype in round-cell
mutants and analysis of mrd mutant phenotype regulation
8.1 Introduction
Data from both phenotypic screens and complementation assays of the
Salmonella ΔpbpA and ΔrodA mutants demonstrated that the expression of two
major virulence factors, the SPI-1 T3SS and flagella-mediated motility, was almost
completely downregulated in these mutants, at the level of the master regulator
genes hilD and flhDC. However, the SPI-2 T3SS remained actively expressed in
these mutants. Complementation of the expression of these genes in trans under
the control of heterologous inducible promoters was sufficient to bring about a
considerable recovery of SPI-1 expression and functionality, or motility, in both
ΔpbpA and ΔrodA mutants. It is hypothesised that in round-cell mutants such as
ΔpbpA and ΔrodA, the detection of envelope or other stress resulting from the
inactivation of these genes results in the activation of transcription factors which
repress the expression of both the SPI-1 and motility genes, but not SPI-2. It is
likely that such regulators control the global stress response pathways. In order to
better understand the regulatory pathways involved, which act upstream of hilD
and flhDC, as well as to further characterise the effects that the inactivation of
pbpA or rodA have on the cell wall and the general physiology of the cell, a screen
was developed to enable the identification of upstream regulators which control
flhDC, and possibly SPI-1, expression. Microarray data had not highlighted any
specific candidate regulators with significantly altered expression in the ΔrodA
mutant; therefore an alternative comprehensive screening strategy was required to
identify putative regulators.
8.2 Global Tn10d(Tc) transposon screen in S. Typhimurium ΔrodA pMK1lux-
fliF strain to identify luminescent revertants
8.2.1 Rationale for using a global transposon mutagenesis screen to identify
major regulators of flhDC/fliF in ΔrodA mutants
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A transposon mutagenesis screen was developed to enable the identification of
putative regulators which are important for flagella gene regulation in ΔpbpA and
ΔrodA mutants. Such a screen was considered ideal, since it permitted an
unbiased and comprehensive coverage of the Salmonella genome. A global assay
was needed whereby individual transposon-insertion mutants in the Salmonella
ΔpbpA/ΔrodA genomes could be quickly screened for recovery of motility gene
expression. The subsequent identification of the transposon insertion site would
then identify genes whose functions were important for the repression of motility in
round-cell mutants.
8.2.2 The Tn10d(Tc) mini transposon and generation of the Tn10d(Tc)-
harbouring P22 phage library
Tn10d(Tc) is a 2640 bp transposition-defective derivative of the tetracycline-
resistant Tn10 transposon. It retains the tetA and tetR genes for tetracycline
resistance, but lacks the transposase gene as well as the majority of the IS10
inverted repeat sequences. Transposition of Tn10d(Tc) randomly into a host cell
genome is therefore dependent upon the exogenous expression of the
transposase protein from a plasmid (251, 252) (Figure 8.1). For use in the present
screen, a phage lysate of a parent Salmonella strain (provided by Philip Aldridge,
Newcastle, UK), which contained both Tn10d(Tc) and a plasmid-encoded
transposase, was transduced into a wild-type SL1344 strain to enable the
generation of individual transductant mutants with randomly inserted Tn10d(Tc)
elements. These mutants were pooled to create a mutant library containing around
12000 individual mutants, allowing for good coverage of the Salmonella genome.
A P22 phage lysate was then generated from the mutant library. This work was
done prior to the present study (Hannah Spencer, Newcastle, UK). The P22 phage
lysate of this Tn10d(Tc) mutant library was used for the present screen.
Figure 8.1: Structure of the mini transposon Tn10d(Tc): Schematic diagram illustrating
the general structure of the Tn10d(Tc) Tn10-derived mini-transposon, including the tetA
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and tetR genes. Image taken from “Transposition without Transposase: a Spontaneous
Mutation in Bacteria” (252).
8.2.3 Use of pMK1lux-fliF-expressing strains for the detection of luminescent
revertant Tn10d(Tc) mutants in global mutagenesis screen
Luciferase transcriptional reporter assays screening for fliF expression in mrd
operon mutants of S. Typhi had shown that luminescence emitted from ΔpbpA and
ΔrodA cultures was very low, indicating that fliF expression was highly
downregulated compared to wild-type strains. The same assays were carried out
in wild-type, ΔpbpA and ΔrodA strains of S. Typhimurium SL1344, producing
almost identical results (Figure 8.2 A). Furthermore, the difference in
luminescence emitted between the wild-type and round-cell mutant cells was
clearly visible by eye from plate cultures of these strains, such that if exposed to
light-sensitive film for as little as 20 seconds, the light emitted even from single
colonies could be detected. The strong luminescence from the wild-type resulted
in a large dark patch on light-sensitive film, whereas the signal from round-cell
mutants was considerably weaker (Figure 8.2 B).
Figure 8.2: Expression of fliF in wild-type, ΔpbpA and ΔrodA strains of S.
Typhimurium: A – Transcriptional luciferase reporter assays of SL1344 wild-type (WT),
ΔpbpA and ΔrodA cultures expressing the luciferase promoter reporter plasmid pMK1lux-
fliF. Promoter activity was measured in terms of relative luminescence units
(luminescence per culture optical density at 600nm). Results indicative of fliF transcription
levels in WT and mrd mutant cells. Cells were grown in LB medium at 37oC with shaking.
Growth rates of strains were equivalent. Values show means of 3 independent assays.
Error bars = standard deviation. B – Image of light-sensitive film after exposure to plate
cultures of SL1344 wild-type, ΔrodA and ΔmreC strains expressing pMK1lux-fliF, for ~20
seconds in the dark.
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8.2.4 Global Tn10d(Tc) mutagenesis screen to recover luminescent
revertants of S. Typhimurium ΔrodA with recovery of fliF expression
The strong luminescent signal emitted from the fliF promoter-luciferase plasmid in
wild-type but not round-cell mutant strains enabled the development of a reporter
system for the transposon mutagenesis screen; S. Typhimurium ΔrodA cells
expressing the transcriptional reporter plasmid pMK1lux-fliF were transduced with
the Tn10d(Tc) mutant phage library. After recovery and growth of the SL1344
ΔrodA pMK1lux-fliF Tn10d(Tc) mutant colonies, each of which harboured the
Tn10d(Tc) transposon  inserted somewhere into the genome, colonies were
screened for recovery of luminescence, and hence fliF expression. Such revertant
colonies were visualised by exposure to light-sensitive film, as previously
described (Figure 2.5). Around 7200 transductant colonies have been screened in
this way to date. Out of these, 21 luminescent revertants were isolated (0.29%).
Arbitrary PCR, followed by DNA sequencing, was then used to identify the
insertion sites of the Tn10d(Tc) transposon in all 21 revertants (Figure 2.3). The
morphology of each luminescent revertant was also checked by microscopy. In all
screens, wild-type and ΔrodA strains expressing pMK1lux-fliF were used as
positive and negative controls, respectively.
S. Typhimurium strains were used in this screen rather than S. Typhi, due to the
inability to transduce S. Typhi with P22, and the lack of an alternative Typhi-
specific phage stock, although to date the phenotypes of ΔpbpA and ΔrodA
mutants have been largely identical in both serovars (439). Also, the pMK1lux-fliF
luminescence reporter plasmid was used rather than pRG38 (flhDC), as flhDC is
thought to be a global regulator, controlling the expression of genes besides those
involved in motility and chemotaxis (350). Measuring the expression of fliF
therefore enabled a higher level of specificity, as the screen assayed for the
recovery of motility specifically. However, since fliF is regulated by flhDC, a
recovery of fliF expression would almost certainly be due to the upstream recovery
of flhDC (56, 62). Finally the ΔrodA mutant was chosen over the ΔpbpA mutant for
use in this screen, as it is likely that this mutant would have fewer polar effects on
downstream gene expression than the ΔpbpA mutant, resulting from the
kanamycin-resistance knockout cassette.
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8.3 Identification of putative regulators of fliF expression and verification of
revertant phenotypes
8.3.1 Re-screening of revertant colonies for luminescence and transduction
of lesions into parent strains
In all, 21 luminescent ΔrodA pMK1lux-fliF Tn10d(Tc) mutant colonies have been
recovered to date through the transposon mutagenesis screen. Each revertant
retained its round-morphology, indicating that the recovery of luminescence was
not from contamination, or a reversion in cell shape, but due to the specific
recovery of fliF expression. The 21 revertants were each individually re-screened
by exposing fresh re-patched plate cultures of each mutant to light-sensitive film.
This was done to verify the luminescent phenotype. As such, 2 non-luminescent
clones were rejected. The identity of the genetic lesions within each revertant is
shown below (Table 8.1). The positions of each genetic lesion were mapped using
the Vector NTI 10® software (Invitrogen™, California, US) (Figure 8.3).
Revertant
clone
Identity/location of
Tn10d(Tc) genetic
lesion
Gene function Gene expression in
SL1344 ΔrodA
compared to WT*
Revertant
morphology
(rod/round)
4a 5’ end of rcsC
(stm2271)
Sensor kinase
component of Rcs
phosphorelay envelope
stress response
pathway; regulates
flagella, colanic acid,
and virulence gene
expression.
-1.19 (ns) Round
9a 5’ end of rcsC Round
9b 5’ end of rcsC Round
10a Middle of pagN
(stm0306)
PhoP-activated gene;
outer membrane
adhesin/invasin
+2.87 Round
15a Middle of rcsC Round
18a 5’ end of phsA
(stm2065)
Thiosulphate reductase -11.00 Round
37a 3’ end of rcsC See above Round
40a Intergenic, upstream
of lrhA (stm2330)
Transcriptional
repressor of motility
and chemotaxis genes
-7.03 Round
2a (b) rcsC – As 15a See above Round
5a (b) rcsC – As 15a See above Round
6a (b) 5’ end of dcm
(stm1992)
DNA cytosine
methylase
-1.04 (ns) Round
9a (b) 5’ end of rcsC See above Round
13a (b) Middle of rcsC See above Round
18a (b) rcsC – As 4a See above Round
22a (b) ? Round
22b (b) ? Round
32a (b) rcsC (un-mapped) See above Round
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42a (b) rcsC (un-mapped) See above Round
45a (b) rcsC (un-mapped) See above Round
*Data from microarray analysis of gene expression of SL1344 ΔrodA compared to wild-type. ‘ns’ –
non-significant, where P values were >0.05
Table 8.1: Identity of Tn10d(Tc) genetic lesions within the genome of luminescent
revertants of S. Typhimurium ΔrodA: Position of genetic lesions identified by arbitrary
PCR and sequencing, as described. Information on gene function taken from Kegg gene
database (253).
Figure 8.3: Mapped positions of S. Typhimurium ΔrodA pMK1lux-fliF Tn10d(Tc)
luminescent revertants: Tn10d(Tc) insertion positions for each positive revertant were
sequenced and mapped using Vector NTI 10® software, to illustrate their position within
the genome. Insertion sites are indicated by black arrows, along with revertant names.
Gene maps drawn to scale (2640 bp Tn10d(Tc) elements not drawn to scale).
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In addition to re-screening each revertant for recovery of luminescence, to ensure
the initial observations were not artefacts, the motility of each ΔrodA pMK1lux-fliF
Tn10d(Tc) revertant strain was examined microscopically and in motility assays.
These initial assays demonstrated that both the prc::Tn10d(Tc) and
lrhA::Tn10d(Tc) mutants were non-motile or showed negligible motility. Since the
screen aimed to identify major regulators of motility genes in round-cell mutants,
ultimately it sought to identify revertants in which motility was also recovered. As
such these two mutants were not further analysed.
P22 phage lysates were subsequently generated from each revertant strain. Both
wild-type and ΔrodA parent strains of SL1344 were then transduced with each
lysate and grown overnight on LB agar containing tetracycline to select for
transductants in which the Tn10d(Tc) lesion was transferred back into the parent
strain. The transduction of the genetic lesions back into the parent strains
constituted a further step to ensure the recovered revertants were not false
positives, through the accumulation of secondary mutations which may have
altered fliF expression.
8.3.2 Insertional hot spots of Tn10d(Tc)
The Tn10 transposon, and hence the Tn10d(Tc) derivative, preferentially targets
particular DNA sequences, creating ‘hot spots’; regions in the genome into which
the transposon frequently inserts. The preferred consensus sequence helping
determine the point of insertion of Tn10d(Tc) is a 6 base pair sequence:
GCTNAGC, contained within a 9 bp symmetrical sequence which is cleaved and
duplicated upon transposon insertion. This sequence is thought to be recognised
by the transposase enzyme (445-447).
The tendency of Tn10d(Tc) to transpose into ‘hot spot’ regions, rather than
randomly into the genome could affect the ability to achieve comprehensive
genome-wide coverage within a global transposon mutagenesis screen. It was
also considered that the repeated isolation of revertants with mutations at the
same sites could be caused by the presence of strong hot spot sequences, rather
than the identification of likely regulator candidates.
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For this reason 12 randomly selected non-luminescent colonies of the SL1344
ΔrodA pMK1lux-fliF Tn10d(Tc) transductants were isolated, re-screened for
luminescence, and sequenced to determine the insertion site of Tn10d(Tc). This
was done to determine whether any specific mutants were isolated at a particularly
high frequency, and to judge whether the frequent isolation of rcsC mutants was
due to a high rate of transposition into this gene, rather than specifically because
of recovery of luminescence. The 12 randomly picked transductants were
sequenced and mapped, as shown (Figure 8.4). All were shown to lack any
recovery of luminescence.
Figure 8.4: Mapped positions of randomly-selected S. Typhimurium ΔrodA
pMK1lux-fliF Tn10d(Tc) non-luminescent mutants (negative controls): Tn10d(Tc)
insertion positions for each randomly picked non-luminescent mutant were sequenced
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and mapped using Vector NTI 10® software, to illustrate position within the genome.
Insertion sites are indicated by black arrows. Individual gene maps drawn to scale (2640
bp Tn10d(Tc) elements not drawn to scale).
From this assay 3 non-luminescent transductants were identified with Tn10d(Tc)
insertions located at an intergenic position between the transcriptional regulator
lrhA (stm2330) and the yfbQ (stm2331) gene. These insertions were located at an
almost identical position to the Tn10d(Tc) insertion in the 40a revertant strain
(Table 8.1) and another isolated revertant (which was later rejected, due to a lack
of recovered luminescence), as well as several luminescent revertants isolated in
a parallel ΔmreCD transposon screen (unpublished work from this lab) (Figure 8.3
and 8.4). Thus it would appear that this region in particular constitutes a strong hot
spot for the insertion of Tn10d(Tc). However, lrhA initially presented itself as a
potential candidate for the regulation of flagella, since it encodes a transcriptional
repressor of flhDC, and also due to its frequent isolation (437). However, the
position of the insertion is likely to increase lrhA expression, which would be
expected to decrease motility, as was observed previously in a similar transposon
mutant (448). Subsequent motility assays and repeated luminescence screens
with lrhA::Tn10d(Tc) mutants showed that these revertants were not in fact motile,
or luminescent. An additional non-luminescent clone was isolated in which
Tn10d(Tc) was inserted close to the Tn10d(Tc) insertion point in the positive
revertant 6a (b), within the dcm gene (Figure 8.3 and 8.4). As such, both lrhA, and
dcm were disregarded as potential regulator candidates.
The apparent frequency of Tn10d(Tc) insertion into hot spots clearly demonstrated
that care must be taken when conducting this screen; it was essential to verify
results, ensuring that luminescent revertants were not artefacts, but the result of
the insertion of Tn10d(Tc) directly affecting the expression of fliF and downstream
motility functionality. In these false positive strains, it may be that secondary
mutations led to a significant increase in fliF expression and luminescence. During
the screen to identify non-luminescent transductants, neither rcsC or pagN were
isolated. In contrast, just over 60% of the positive luminescent revertants
harboured Tn10d(Tc) insertions within rcsC. This combined with further verification
which indicated that flagella gene expression and motility were significantly
recovered in both rcsC::Tn10d(Tc) and pagN::Tn10d(Tc) mutants of ΔrodA,
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provided evidence to suggest that these two genes may form true candidates for
regulators.
8.3.3 Identification of rcsC and pagN as putative flagella gene regulators in S.
Typhimurium ΔrodA
After excluding those revertants identified in the screen which appeared to be
artefacts, two genes remained as possible candidates for involvement in the
regulation of motility genes in round-cell mutants: rcsC and pagN. rcsC forms the
sensor kinase component of the Rcs phosphorelay; a two component system
which is one of the major global regulators of the stress response (118, 119). This
system responds to certain stresses, including envelope stress, activating the
expression of colanic acid biosynthesis, SPI-2 and Vi capsule biosynthesis genes,
whilst downregulating transcription of flagellar and SPI-1 genes (50, 96, 118, 320).
Furthermore, the Rcs phosphorelay activates the expression of the ftsA and ftsZ
division genes in E. coli at least (119, 322). This points towards rcsC being a
highly likely candidate for involvement in flagella gene regulation in round-cell
mutants, particularly as it is known to respond specifically to peptidoglycan-
associated stress, such as may be seen in pbpA and rodA mutants (118). The
isolation of 13 luminescent revertants with genetic lesions at various positions
within rcsC added further weight to the possibility that this gene may play a major
regulatory role in the ΔrodA mutant. However, Tn10d(Tc) insertions were strangely
isolated only in the rcsC and not within other important members of the Rcs
phosphorelay, including the response regulator RcsB, the intermediate RcsD
protein, or the outer membrane RcsF protein, which is thought to detect envelope
stress and activate RcsC (119). Also, transcriptional data from microarrays in the
present study did not provide meaningful information on the expression of rcsC or
the other major Rcs phosphorelay genes in the ΔrodA mutant.
pagN (stm0306) may also be of some interest, potentially playing a role in motility
regulation. Although a pagN::Tn10d(Tc) revertant was isolated just once in this
assay, a parallel screen with round-cell ΔmreCD mutants has also isolated a
pagN::Tn10d(Tc) luminescent revertant (unpublished work of this lab). Less is
known about PagN, although it was recently characterised as an integral outer
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membrane adhesin protein, which is encoded within the SPI-6 pathogenicity island
of both Salmonella Typhi and Typhimurium (423, 449). PagN, a paralog of SapA,
assists in adhesion to and invasion of mammalian cells, and hence may be
important for virulence (397, 423, 425). Studies also demonstrated that pagN is
maximally expressed in SPI-2-inducing conditions, being upregulated by the
PhoP/PhoQ virulence gene master regulator as well as the virulence gene
activator SlyA (38, 98, 422, 423, 450). Interestingly, the overexpression of PagN
was shown to compensate for a lack of SPI-1. A possible explanation for this is
that it is needed intracellularly to exit cells in situations where SPI-1 is not
expressed (423). However, a role for PagN in the regulation of gene expression
has not been identified. Microarray data from this study showed that pagN was
upregulated ~2.9-fold in the S. Typhimurium ΔrodA mutant.
The positions of the Tn10d(Tc) insertions were all within the coding sequence of
the rcsC and pagN genes, suggesting that gene function would be completely
inactivated in these mutants. Furthermore, among the rcsC revertant mutants
isolated, the position of the Tn10d(Tc) insertion varied between transductants, with
insertions being isolated at the 5’ end, the 3’ end and in the middle of the rcsC
coding sequence (Figure 8.3). This suggests that the motility reversion is not
specific to the inactivation of a particular segment of the gene; rather that an
insertion of Tn10d(Tc) in any part of rcsC is sufficient to disrupt its function,
particularly in terms of motility regulation.
8.3.4 Motility of S. Typhimurium wild-type, ΔrodA, rcsC::Tn10d(Tc) and
pagN::Tn10d(Tc) strains
Motility functionality in S. Typhimurium ΔrodA rscC::Tn10d(Tc) and
pagN::Tn10d(Tc) transduced strains was assessed by culturing these cells in
semi-solid motility agar containing 20 mM MgCl2 and measuring the extent of
culture spread in comparison to that of the wild-type and the wild-type
rscC::Tn10d(Tc) and pagN::Tn10d(Tc) transduced strains. In addition, revertant
strains were observed by phase contrast microscopy for signs of motility. Two
individual rscC::Tn10d(Tc) strains were tested for recovery of motility, both strains
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harbouring rcsC insertions at different positions within the 5’ end of the rcsC gene
(‘4a’ and ‘9a’) (Figure 8.3).
Motility assays demonstrated that motility functionality in rscC::Tn10d(Tc) and
pagN::Tn10d(Tc) strains, where the lesions were transduced into wild-type
SL1344, was not significantly changed from the wild-type strain in which rcsC and
pagN were functional. However, when compared to the SL1344 ΔrodA mutant
strain, the ΔrodA rscC::Tn10d(Tc) (9a) and ΔrodA pagN::Tn10d(Tc) strains
showed a significant increase in motility, up to around 50% of that of the wild-type.
This was not the case for the ΔrodA rscC::Tn10d(Tc) (4a) strain, however, in
which motility was not significantly greater than the parent ΔrodA strain (Figure 8.5
A). Interestingly, this parent strain appeared slightly motile, with motility assays
demonstrating just under 20% of the motility of the wild-type. However, it is known
that within a population of ΔrodA or ΔpbpA cells, a small proportion of cells remain
motile. Thus the low level of motility in this strain, and perhaps the ‘4a’ strain, may
be due to this small proportion of motile cells. By microscopy, the vast majority of
the ΔrodA parent cells appeared non-motile, and though the extent of spread
throught motility agar was up to 20% of that of the wild-type, it was noted that the
density of cells within this margin of spread was very low and faint compared to
the wild-type.
The motility of the revertant ΔrodA strains remained significantly less than both the
wild-type, and the wild-type rscC::Tn10d(Tc) and pagN::Tn10d(Tc) strains. This,
along with the identification of two possible factors which influence motility in
round-cell mutant strains, suggests that the control of flagella gene expression in
round-cell mutants is more complex and multi-factorial, as would be expected
given the number of global regulators known to influence flagella expression (110).
However, the significant recovery of fliF expression, along with motility functionality,
in ΔrodA ΔrcsC and ΔrodA ΔpagN double mutants, suggests that these two genes
are indeed involved in regulating flagella gene expression in round-cell mutants. It
may be that in the ΔrodA rcsC::Tn10d(Tc) (4a) strain, other factors were active to
a greater extent in regulating flagella expression, possibly working to counteract
the loss of rcsC.
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The majority of ΔrodA rcsC::Tn10d(Tc) revertants, as well as the transduced
ΔrodA rcsC::Tn10d(Tc) (9a) and the ΔrodA pagN::Tn10d(Tc) (10a) strains
appeared highly motile by microscopy. In addition, from phase contrast
microscopy images it was noted that cells of the revertant strains generally
appeared significantly smaller in diameter than the parent ΔrodA strains,
particularly with rcsC::Tn10d(Tc) (9a) and pagN::Tn10d(Tc) (10a) cells. This was
also true of a large proportion of revertant strains, seen in both this screen, and in
a similar screen with a SL1344 ΔmreCD mutant (unpublished work of this lab).
Since the same phenotype was not as obvious in rcsC::Tn10d(Tc) 4a, it may be
that motility is influenced by cell size and diameter, or that factors involved in
regulating the size of these mutants, also act on motility genes (Figure 8.5 B).
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Figure 8.5: Motility assays and phase contrast microscopy of S. Typhimurium wild-
type, ΔrodA, rcsC::Tn10d(Tc) and pagN::Tn10d(Tc) strains: A - Motility assay results
for SL1344 wild-type, ΔrodA, and rcsC::Tn10d(Tc) and pagN::Tn10d(Tc) revertant strains
(Tn10d(Tc) lesions transduced back into parent wild-type and ΔrodA strains). Cells were
cultured in semi-solid motility agar containing 20 mM MgCl2, at 37°C for ~6 hours. Motility
was measured in terms of extent (diameter) of culture spread through motility agar, as a
percentage of that of relevant wild-type strain. Results show averages from 3 independent
assays. Error bars indicate standard deviation. Asterisks indicate statistically significant
differences, where P values were ≤0.05 as determined by Students t-tests. B – Phase
contrast microscopy images of the above strains. All images are to the same scale.
251
8.4 SPI-1 T3SS functionality in S. Typhimurium ΔrodA rcsC::Tn10d(Tc) and
ΔrodA pagN::Tn10d(Tc) double mutants
In addition to examining the morphology and motility phenotypes of the ΔrodA
rcsC::Tn10d(Tc) and ΔrodA pagN::Tn10d(Tc) revertant strains, it was important to
analyse the expression of the SPI-1 T3SS in these strains, to determine whether
the inactivation of rcsC or pagN was sufficient to restore SPI-1 expression, and
thus whether these genes formed likely candidates for global regulators of the
overall virulence phenotypes in round-cell mrd operon mutants.
Wild-type, ΔrodA, rcsC::Tn10d(Tc) and pagN::Tn10d(Tc) strains were grown to
mid-log phase, harvested, fixed and labelled with anti-SipD antibody for
visualisation by immunofluorescence microscopy. Secreted protein fractions were
also prepared from culture supernatants and subjected to SDS-PAGE and western
blotting with anti-SipD antibody.
Western blotting from secreted protein samples of S. Typhimurium wild-type,
ΔrodA, rcsC::Tn10d(Tc), and pagN::Tn10d(Tc) cultures showed that there was
considerable restoration of SipD expression  in both the ΔrodA rcsC::Tn10d(Tc)
(9a) and ΔrodA pagN::Tn10d(Tc) (10a) strains, as a reasonably strong SipD band
was evident in these lanes. SipD was not expressed in the ΔrodA parent, or in the
ΔrodA rcsC::Tn10d(Tc) (4a) strain (Figure 8.6 A). This result echoed motility
assays, which showed that motility was recovered in the 9a and 10a revertants,
but not in 4a. However, SipD protein expression levels in the ΔrodA 9a and 10a
revertant strains were clearly not as high as those in the wild-type, or equivalent
rcsC::Tn10d(Tc) and pagN::Tn10d(Tc) strains with a wild-type rodA gene, the
intensity of the SipD band being much greater in the latter strains.
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Figure 8.6: SPI-1 effector protein expression in S. Typhimurium wild-type, ΔrodA,
rcsC::Tn10d(Tc) and pagN::Tn10d(Tc) strains: A – Western blot showing expression of
the SPI-1 SipD effector protein in secreted protein fractions of SL1344 wild-type, ΔrodA,
rcsC::Tn10d(Tc) and pagN::Tn10d(Tc), and Δspi-1 (negative control). Background protein
bands likely due to antibody cross-reactivity to intracellular proteins or SipD translocon
complexes. Protein molecular weight (MW) marker sizes as indicated. B -
Immunofluorescence microscopy images of SL1344 wild-type, ΔrodA, rcsC::Tn10d(Tc)
and pagN::Tn10d(Tc) cells, overlaid onto phase contrast images; samples labelled with
anti-SipD antibody and fluorophore-conjugated secondary antibody. All images are to the
same scale. All cultures grown in LB broth at 37°C and 200 rpm, and harvested at mid-log
phase.
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However, immunofluorescence microscopy analysis of SPI-1 functionality
suggested that though SipD may be expressed in the ΔrodA rcsC::Tn10d(Tc) and
pagN::Tn10d(Tc) revertant strains, the SPI-1 T3SS needle may not be functional
in these cells; fluorescent foci indicative of SPI-1 T3S needles were clearly visible
around the surface of all strains with a wild-type rodA gene, but not in any of the
ΔrodA strains, including ΔrodA rcsC::Tn10d(Tc) (9a) and ΔrodA pagN::Tn10d(Tc)
(10a) (Figure 8.6 B). Only occasionally were fluorescent foci observed at the
surface of these cells. Interestingly, the average size of ΔrodA ΔrcsC/ΔpagN
double mutant cells in these cultures did not appear significantly different from the
parent ΔrodA strain.
In conclusion, the global transposon mutagenesis screen was clearly effective,
enabling the identification of two possible regulators of flagella gene expression in
the round-cell mrd operon mutants of Salmonella. Inactivation of either pagN or
rcsC through the insertion of the mini transposon Tn10d(Tc) was shown to bring
about significant recovery of fliF expression, actual motility and SPI-1 T3SS
protein expression, although the SPI-1 T3SS may not be functional in these strains.
The mechanisms behind the recovery of motility and SPI-1 expression in ΔrodA
rcsC::Tn10d(Tc) and ΔrodA pagN::Tn10d(Tc) strains remain unclear. Whether or
not, and how, the morphology and size of revertant cells is linked to the recovery
of flhDC and motility, also remains to be elucidated.
8.5 Growth of S. Typhimurium ΔrodA Tn10d(Tc) motility revertants on Congo
red agar
Another potentially interesting aspect of the revertant cells, and particularly those
with rcsC mutations, was the level of extracellular polysaccharide expression in
these strains, giving an indication of biofilm production (cellulose and colanic acid
both form integral parts of mature biofilms (323, 471)). Growth of a number of the
un-transduced revertant Tn10d(Tc) mutants (those expressing pMK1lux-fliF) on
Congo red agar demonstrated that cellulose production in these strains was
similar to that in the S. Typhimurium ΔrodA strain. Cellulose capsule expression
appeared significantly greater than the wild-type in both the ΔrodA and ΔrodA
Tn10d(Tc) revertant strains, as indicated by the more intense red colony
254
appearance (rdar phenotype) (Figure 8.7) (326). Given that the Rcs phosphorelay
is a major activator of colanic acid biosynthesis, one may expect colanic acid
production to be reduced in rcsC::Tn10d(Tc) strains particularly, although Congo
red-binding gives an indication of cellulose, and not colanic acid production (119,
320). This result also reiterates the hypothesis that the regulation of extracellular
polysaccharide biosynthesis and virulence phenotypes of round-cell mutants may
be complex and multifactorial.
Figure 8.7: Growth of S. Typhimurium wild-type, ΔrodA and Tn10d(Tc) positive
motility revertant strains on Congo red agar: SL1344 wild-type, ΔrodA and Tn10d(Tc)
positive motility revertant strains were streaked onto LB agar containing 100 µg/ml Congo
red dye to screen for excess cellulose production, as indicated by the development of red
colonies; the rdar phenotype.
8.6 Generation and phenotypic analyses of specific ΔpbpA/ΔrodA
ΔrcsC/ΔpagN double mutants in S. Typhimurium and S. Typhi
8.6.1 Generation of specific ΔpbpA/ΔrodA ΔrcsC/ΔpagN double mutants in S.
Typhimurium and S. Typhi
In order to further investigate the role that rcsC and pagN may play in the
regulation of virulence genes in round-cell mrd operon mutants of Salmonella,
specific knockout mutants of the pagN and rcsC genes were constructed in wild-
type, ΔpbpA and ΔrodA strains of both S. Typhi and S. Typhimurium, using the
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Datsenko and Wanner method (238). In this instance the pKD3 template plasmid
was used to generate chloramphenicol-resistance cassettes for specific insertion
into each target gene. This enabled the construction of non-polar mutants of the
rcsC and pagN genes. The successful generation of chloramphenical-resistant
ΔrcsC and ΔpagN mutants was checked by both PCR and DNA sequencing.
Using this method ΔrcsC mutants were created in wild-type, ΔpbpA and ΔrodA
strains of both S. Typhi and S. Typhimurium. ΔpagN mutants were successfully
created in wild-type, ΔpbpA and ΔrodA strains of S. Typhimurium, and in the wild-
type and ΔrodA strains of S. Typhi. Chloramphenical resistance cassettes were
not removed from the ΔrcsC or ΔpagN mutant strains, although due to the inherent
stop codons and ribosome binding sites of the pKD3-encoded knockout cassette,
mutants generated with these cassettes should be non-polar on the expression of
downstream genes (238).
This creation of such mutants was necessary in order to verify that the observed
phenotypes of the ΔrodA rcsC::Tn10d(Tc) and pagN::Tn10d(Tc) strains could be
replicated, demonstrating that they were due specifically to the inactivation of rcsC
or pagN and not due to polar or other effects brought about by the transposon
insertion. It was also important to test whether the inactivation of rcsC or pagN
was sufficient to restore at least some motility or SPI-1 gene expression in round-
cell mutants of S. Typhi, as well as S. Typhimurium.
8.6.2 Phenotypic analysis of ΔrcsC and ΔpagN mutants in S. Typhimurium
and S. Typhi
Motility assays
Motility of the wild-type, round-cell mrd mutant, ΔrcsC, ΔpagN and double mutant
strains, of both S. Typhi and S. Typhimurium, was assayed by measuring the
extent of spread of each culture after growth in semi-solid motility agar containing
20 mM MgCl2 at 37°C for at least 6 hours. The motility of each strain was
measured as a percentage of that of the wild-type.
These assays demonstrated that around 30% motility was restored in both ΔpbpA
ΔrcsC and ΔpbpA ΔpagN double mutants of S. Typhimurium, as well as the ΔrodA
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ΔrcsC strain, but not in ΔrodA ΔpagN cells. However, a difference in motility of
statistical significance between these strains and the ΔpbpA or ΔrodA parent was
only true for the ΔpbpA ΔrcsC cells, suggesting that the deletion of rcsC in ΔpbpA
may restore some motility, if only low levels. This recovery of motility was much
less evident than that seen in ΔrodA rcsC::Tn10d(Tc) (9a) and ΔrodA
pagN::Tn10d(Tc) (10a) strains, where motility was recovered to around 50% of the
wild-type motility levels (Figure 8.8 A and Figure 8.5A). In S. Typhimurium ΔrcsC
and ΔpagN, motility was very slightly reduced compared to wild-type cells,
although this was only statistically significant in the ΔpagN mutant (Figure 8.8 A).
Motility assays with the equivalent S. Typhi strains demonstrated that double
mutants of both ΔpbpA and ΔrodA strains remained completely non-motile (Figure
8.8 B). Also, motility was slightly, but significantly reduced in both BRD948 ΔrcsC
and BRD948 ΔpagN strains compared to the wild-type (Figure 8.8 B).
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Figure 8.8: Motility assays with S. Typhimurium and S. Typhi wild-type,
ΔpbpA/ΔrodA and ΔrcsC/ΔpagN mutants: A - Motility assay results for SL1344 wild-
type, ΔpbpA/ΔrodA and ΔrcsC/ΔpagN, single and double mutants. B - Motility assay
results for BRD948 wild-type, ΔpbpA/ΔrodA and ΔrcsC/ΔpagN, single and double mutants.
Cells were cultured in semi-solid motility agar containing 20 mM MgCl2, at 37°C for ~6hours. Motility was measured in terms of extent (diameter) of culture spread through
motility agar, as a percentage of that of relevant wild-type strain. Results show averages
from 3 independent assays. Error bars indicate standard deviations. Asterisks indicate
statistically significant differences, where P values were ≤0.05 as determined by Students
t-tests.
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SPI-1 T3SS functionality
To measure the expression of SPI-1 effector proteins and determine the
functionality of the SPI-1 T3SS in ΔrcsC and ΔpagN double mutants, SDS-PAGE
separation of mid-log phase secreted protein fractions, with western blotting, was
carried out, along with immunofluorescence microscopy of fixed cells.
Figure 8.9: SPI-1 effector protein expression in S. Typhimurium and S. Typhi wild-
type, ΔpbpA/ΔrodA and ΔrcsC/ΔpagN mutants: A & C - Western blots showing
expression of the SPI-1 SipD (A) and SipA (C) effector proteins in secreted protein
fractions of SL1344 (A) and BRD948 (C) wild-type, ΔpbpA/ΔrodA and ΔrcsC /ΔpagN,
single and double mutants, and Δspi-1 (negative control) strains. Background protein
bands likely due to antibody cross-reactivity to intracellular proteins or SipD translocon
complexes. Protein molecular weight (MW) marker sizes as indicated. B & D -
Immunofluorescence microscopy images of SL1344 (B) and BRD948 (D) wild-type,
ΔpbpA/ΔrodA and ΔrcsC/ΔpagN, single and double mutants, and Δspi-1 (negative control)
strains, overlaid onto phase contrast images; samples labelled with anti-SipD antibody
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and fluorophore-conjugated secondary antibody. All images are to the same scale. All
cultures grown in LB broth at 37°C and 200 rpm, and harvested at mid-log phase.
Both western blots and immunofluorescence microscopy images of round-cell
ΔrcsC/ΔpagN double mutants showed that SPI-1 functionality was not restored in
these strains. Whilst SPI-1 needles were clearly visible at the surface of both wild-
type and ΔrcsC/ΔpagN single mutants, they were not found at the surface of either
ΔpbpA/ΔrodA single mutants or ΔpbpA/ΔrodA ΔrcsC/ΔpagN double mutants, of S.
Typhi or S. Typhimurium (Figure 8.9 B and D). The lack of a visible SipD band in
secreted protein fractions of these strains suggests that these proteins were not
expressed intracellularly, or secreted into the media; round-cell mutants are prone
to lysis and so proteins expressed intracellularly are usually visible in secreted
protein fractions (Figure 8.9 A and C). This contrasts the results seen with
rcsC::Tn10d(Tc) and pagN::Tn10d(Tc) revertants, where SPI-1 effector proteins
were clearly expressed at least intracellularly. A faint band of an equivalent size to
the SipA effector protein band was present in the BRD948 ΔrodA ΔpagN double
mutant in this western blot, although it was also present in the ΔpbpA mutant
control, and as such this data may not be representative. This assay therefore
remains to be repeated.
8.6.3 Conclusions
The present data from precise ΔpbpA/ΔrodA ΔrcsC/ΔpagN knockout strains
suggested that although motility may have been slightly recovered in these mutant
strains, SPI-1 functionality was not significantly altered with the inactivation of the
putative regulators, pagN and rcsC, in round-cell mrd mutants. This differs
considerably with the results of the Tn10d(Tc) transposon mutagenesis screen in
which both SPI-1 functionality and motility were significantly restored in ΔrodA
mutants with the inactivation of rcsC or pagN. It is possible that other factors or
secondary mutations in the Tn10d(Tc) transposon mutant strains played a
significant role alongside rcsC and pagN in producing the observed phenotypes,
by further regulating flhDC or SPI-1 gene expression, or altering other aspects of
the cell physiology (such as cell size), enabling flagella/SPI-1 functionality in these
cells.
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However, the transposon screen results, along with the repeated isolation of
rcsC::Tn10d(Tc) mutants, suggest that rcsC at least plays a significant role in the
down-regulation of both flhDC and the SPI-1 genes in round-cell mrd mutants of S.
Typhimurium, and possibly S. Typhi. Extensive further studies may be needed to
characterise the importance of both rcsC and pagN in the regulation of
flagella/SPI-1. The present data suggested that S. Typhi and S. Typhimurium
respond differently to pbpA and rodA mutations, or that the regulatory pathways
activated by these mutants are different. Further investigation into these observed
differences is therefore also required.
8.7 Investigation of c-di-GMP as a putative regulator of the round-cell mrd
mutant phenotypes
8.7.1 c-di-GMP as a potential regulator of motility and SPI-1 in round-cell
mutants
Although the transposon mutagenesis screen was partially successful in
identifying putative transcriptional regulators responsible for the repression of
flagella and SPI-1 genes in ΔpbpA and ΔrodA mutants, the results importantly
highlight that other factors are also likely to be involved, in the transcriptional
and/or post-transcriptional regulation of motility and SPI-1 in these mutants.
A likely candidate for involvement in the post-transcriptional regulation could be
the second messenger molecule c-di-GMP, a universal global regulator among
bacteria. Bis-(3´-5´)-cyclic dimeric guanosine monophosphate, or c-di-GMP, is a
small cyclic di-nucleotide which is important in the regulation of motility and biofilm
formation, helping to regulate the switch between two lifestyles; determining
whether cells adopt a free-living motile state or a multicellular sessile state within a
biofilm. c-di-GMP acts on numerous proteins to stimulate the production of
extracellular adhesins and polysaccharides, and to repress motility (Figure 8.10)
(95, 451-453). This molecule has also been shown to regulate virulence in various
pathogens (95, 451, 453). In Salmonella, overproduction of c-di-GMP inhibited
invasion; through the activation of the biofilm master transcriptional regulator CsgD,
c-di-GMP was shown to inhibit the secretion of flagellin, and a SPI-1 effector
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protein (95, 453). This occurred downstream of and independently of HilA
regulation (95).
c-di-GMP acts post-transcriptionally to regulate biofilm and motility expression.
The mechanisms by which it acts are complex and not fully understood. It is
thought to directly bind and alter the structure of specific target effector proteins
and RNAs, which are then enabled to act on and regulate the expression or
activity of downstream genes and proteins (451, 454, 455). Four types of c-di-
GMP-binding proteins have been described to date, including PilZ-domain proteins
which act on downstream proteins, structurally un-related c-di-GMP-binding
transcription factors, and proteins containing a c-di-GMP-binding ‘I site’ (451). In E.
coli c-di-GMP regulates motility at least partially by binding the PilZ-domain protein
YcgR. This protein targets the basal body of fully assembled flagella, interrupting
motor function and reducing motility (451, 457).
c-di-GMP-mediated regulation of biofilm formation and motility depends on
intracellular levels of this molecule, and as such high levels of c-di-GMP bring
about biofilm production and an inhibition of motility (403, 451, 453). c-di-GMP
levels are in turn regulated by the combined action of a large number of c-di-GMP-
synthesising (diguanylate cyclases or DGCs) and c-di-GMP-degrading
(phophodiesterases or PDEs) enzymes. DGC or PDE enzymatic activity is
dependent upon two protein domains, the GGDEF and EAL domains, respectively.
A third protein domain, HD-GYP, also possesses phosphodiesterase activity (403,
451-453). Many proteins possess both EAL/HD-GYP and GGDEF domains,
although only one is usually enzymatically active (451, 453). Numerous bacterial
GGDEF and EAL domain proteins have been identified and these proteins are
extremely widespread among all bacteria. GGDEF/EAL domain proteins are also
abundant within individual genomes (452, 453, 457). Salmonella Typhimurium
itself expresses at least 20 c-di-GMP-metabolising enzymes, whilst Typhi
expresses 21 (457-459). c-di-GMP-synthesising enzymes of major importance in
Salmonella include AdrA and stm1987, whilst important c-di-GMP-degrading
proteins include stm1827, YciR and YhjH (403, 95, 451, 452). The regulation of
GGDEF/EAL-domain protein expression and activity is fundamental for regulating
the intracellular levels of c-di-GMP (451, 453), and the overproduction of either
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GGDEF or EAL proteins can significantly alter intracellular c-di-GMP levels (403,
451, 460).
Figure 8.10: Summary of c-di-GMP biosynthesis/degradation, structure and function:
Schematic diagram demonstrating the major aspects of c-di-GMP metabolism, and its
major roles in regulating motility, sessility, virulence and cell cycle progression. Image
taken from “Principles of c-di-GMP signalling in bacteria” (451).
In light of the observation that motility and biofilm formation appear to be
significantly and inversely affected in round-cell mrd mutants, c-di-GMP has
emerged as a potentially important regulator, which perhaps in conjunction with
other regulators such as the Rcs phosphorelay, may play a major role in the
control of motility and biofilm formation in ΔpbpA and ΔrodA mutants. In addition,
whilst no genes involved in c-di-GMP metabolism were isolated in ΔrodA
Tn10d(Tc) mutagenesis screens, such genes were isolated in a similar ΔmreCD
Tn10d(Tc) screen (unpublished data). Whether and how c-di-GMP is involved in
motility regulation in these mutants therefore warrants investigation.
8.7.2 Expression of Salmonella Typhimurium genes encoding GGDEF/EAL
domain proteins in wild-type and ΔrodA mutants
Increased intracellular levels of c-di-GMP have been shown to suppress motility
and activate biofilm formation, leading to the rdar phenotype on Congo red agar
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(403, 451, 459). In order to investigate the role of c-di-GMP in motility regulation in
round-cell mrd mutants, it was therefore important to determine whether the
expression of both EAL and GGDEF domain-containing proteins was affected in
these mutants, in a manner which could ultimately significantly alter c-di-GMP
levels.
Microarray gene expression data from S. Typhimurium wild-type and ΔrodA strains
was examined to assess whether the expression levels of GGDEF and EAL
domain protein genes varied between S. Typhimurium ΔrodA and wild-type strains,
since alterations in gene expression may give an indication of the downstream
effects on c-di-GMP levels. The S. Typhimurium LT2 genome encodes 8 EAL
domain proteins, 5 GGDEF domain proteins and 7 proteins with both EAL and
GGDEF domains, but lacks any HD-GYP domain proteins (253, 458, 461). The
expression of these genes in S. Typhimurium ΔrodA compared to the wild-type, as
shown by microarray data, is illustrated below (Table 8.2).
Expression of many of the Salmonella EAL and GGDEF domain genes was not
significantly affected in the ΔrodA mutant. However, yciR, yjcC, stm1827.S and
yhjH, 4 genes which have been shown to play significant roles in c-di-GMP
metabolism, were altered at least 2-fold in this mutant (403, 459). The former three
were slightly upregulated, whilst yhjH was down-regulated over 40-fold (Table 8.2).
All four of these proteins have been demonstrated to possess c-di-GMP
phosphodiesterase activity, significantly reducing c-di-GMP levels and biofilm
formation in vivo in Salmonella. They are also known to help regulate the
expression of CsgD (403, 459). However, the proteins also may have distinct
functions. For instance, YciR appeared to significantly affect biofilm formation,
whereas YhjH played a more important role in the regulation of motility, having a
lesser effect on biofilm formation (459). Another study also established a
significant role for YhjH in motility regulation, and ΔyhjH mutants exhibited a
motility defect (466). Considering that these proteins have related functions, it is
surprising that they appeared to be inversely regulated in ΔrodA cells compared to
the wild-type. However, the strong suppression of yhjH expression in this mutant
may override the minor increases in the expression of the other three
phosphodiesterases.
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Gene Protein function (253) Expression in ΔrodA compared to WT
EAL domain-containing proteins
stm0343 Hypothetical protein +2.23 (P value = 0.07)
stm0468 (ylaB) Hypothetical protein +1.18 (P value = 0.19)
stm1344 (ydiV) Hypothetical protein +1.29
stm1827.S Phosophodiesterase (459) +2.33
stm2215 (rtn) Hypothetical protein +1.40
stm3611 (yhjH) Phosophodiesterase (459);
flagella/chemotaxis protein
-49.45
stm4264 (yjcC) Phosophodiesterase (459) +2.03
PSLT032 Putative phosophodiesterase -1.08 (P value = 0.70)
GGDEF domain-containing proteins
stm0385 (adrA) Diguanylate cyclase -1.09 (P value = 0.47)
stm1283 (yeaJ) methyl-accepting chemotaxis protein -1.38
stm1987 Inner membrane diguanylate cyclase +1.96 (P value = 0.15)
stm2672 (yfiN) Hypothetical protein +1.38 (P value = 0.16)
stm4551 Hypothetical protein +1.58 (P value = 0.14)
EAL & GGDEF domain-containing proteins (Major enzyme activity indicated, where known)
stm1703 (yciR) RNase II stability modulator,
phosphodiesterase (459)
+3.61
stm2123 (yegE) Diguanylate cyclase (460) +1.97
stm2410 (yfeA) Hypothetical protein -1.25 (P value = 0.34)
stm2503 Diguanylate cyclase +1.61 (P value = 0.16)
stm3375 (yhdA) Regulatory protein CsrD +1.64
stm3388 Signal transduction protein,
diguanylate cyclase (460)
+1.69 (P value = 0.10)
stm3615 (yhjK) Phosphodiesterase -1.16 (P value = 0.54)
Table 8.2: Microarray expression data of EAL and GGDEF domain-containing genes
in S. Typhimurium ΔrodA mutant: Data from NimbleGen 4x72000 multiplex arrays
comparing gene expression of EAL- and GGDEF-domain proteins between SL1344 wild-
type and ΔrodA strains. Fold-change in gene expression in ΔrodA compared to the wild-
type as indicated. All data was statistically significant, as determined using two-tailed
Student’s t-test, with P values of ≤0.05, except where indicated. Information on gene
function taken from the Kegg database and references shown (253, 458, 459, 461).
Interestingly, no c-di-GMP-synthesising GGDEF domain genes were significantly
upregulated in the ΔrodA mutant, as may be expected since an increase in c-di-
GMP production would lead to a similar motility/biofilm phenotype to that observed
in this mutant (although some data was not statistically significant). However, the
notable depression of yhjH transcription in the ΔrodA mutant may cause a
pronounced increase in c-di-GMP levels and consequently increased biofilm
expression, combined with decreased motility. It is plausible that this protein is
therefore significantly involved in the regulation of the biofilom/motility phenotype
in the ΔrodA mutant.
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8.7.3 Analysis of c-di-GMP levels in wild-type and round-cell mutants of S.
Typhi
To determine whether c-di-GMP plays a significant role in the regulation of motility
and biofilm formation in round-cell mrd mutants, it was necessary to determine
whether intracellular levels of c-di-GMP were significantly altered in these mutants.
In 2009 Simm et al. successfully developed a high-performance liquid
chromatography (HPLC)–mass spectrometry-based method to directly quantify c-
di-GMP levels between various species, and a wild-type and biofilm-overproducing
mutant of Salmonella Typhimurium. This method enabled the detection of
picomole or femtomole (pmole/fmole) levels of c-di-GMP within nucleotide extracts
(457). The study produced data representative of actual physiological levels of c-
di-GMP within cells. In the present study a liquid chromatography mass
spectrometry (LC/MS/MS) method was developed to quantify c-di-GMP from cell
lysates of wild-type and ΔrodA cultures of S. Typhi, allowing direct comparisons to
be made between strains. Lysates were prepared as described, and samples were
dried, reconstituted in dibutylamine acetate (DBAA) buffer and subjected to
LC/MS/MS analysis. The LC/MS/MS assays were kindly developed and performed
by Joe Gray (Pinnacle, Newcastle University).
The quantities of starting material for use in LC/MS/MS assays were calculated
based on data from the New England BioLabs® and Epicentre® websites
(http://www.neb.com/nebecomm/tech_reference/general_data/protein_data.asp
and http://www.epibio.com/techapp.asp), which state that individual wild-type
Salmonella cells have a wet weight of 0.95 pg. In this study 1 mg of wild-type
Salmonella cells was therefore taken to be equivalent to around 109 cells.
Analyses from the present study established that a 1 ml cell suspension containing
9.5 mg (wet weight) wild-type cells had an OD600 value of ~2 (Figure 4.11).
Comparisons between cell-number and OD600 values had also shown that at a
given OD600 value, cultures of an equal volume of wild-type and ΔrodA strains
contained approximately equal cell numbers. These data were taken together to
enable conservative estimates to be made concerning the amounts of cell lysates
required for LC/MS/MS analysis. Both wild-type and ΔrodA cells were grown up to
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mid-log phase, standardised to an optical density (OD600) of 2 in HPLC-grade
dH2O, lysed by sonication, then centrifuged and filtered to remove cell debris,
large proteins and DNA from cell lysates. 1 ml lysate was then recovered for
LC/MS/MS analysis, based upon the calculations indicating that 1 ml standardised
lysate was equivalent to 1010 wild-type or ΔrodA cells. These considerations
enabled comparisons to be made between wild-type and ΔrodA cells, based upon
both cell number and cell mass. This was important given the observations that
round-cell mutants are considerably larger than wild-type cells.
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Figure 8.11: Direct LC/MS/MS quantification of cellular c-di-GMP levels in S. Typhi
wild-type and ΔrodA strains: Data from initial LC/MS/MS quantification assay of c-di-
GMP levels in S. Typhi wild-type and ΔrodA strains. A – MS response values resulting
from 0, 50, 100, 500, 1000 and 5000 fmoles pure c-di-GMP standard loaded onto the
column. Resulting average MS response values were used to generate the calibration
curve. B – MS response values were measured in triplicate from wild-type and ΔrodA cell
lysates loaded on column. Average c-di-GMP levels for each sample were derived from
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calibration curve values. Calculations of c-di-GMP concentrations per mg cells (wet weight)
or per 1010 cells were based on previous estimates, as indicated. SEM = standard error of
the mean. SD = standard deviation.
After developing and refining the c-di-GMP LC/MS/MS quantification method, an
initial run was carried out using fresh lysates of BRD948 wild-type and ΔrodA cells,
and an additional wild-type sample spiked with 10 pmoles/ml c-di-GMP. A
calibration curve was prepared from injections of a fresh solution of pure c-di-GMP
standard, at 0, 50, 100, 500, 1000 and 5000 femtomoles; as c-di-GMP levels in
wild-type S. Typhimurium were previously measured at around 0.1-0.5 pmoles per
mg cells (wet weight), this range for a calibration curve was considered suitable
(457) (Figure 8.11 A). The average strength of the c-di-GMP peaks from MS
spectra (average MS response) for both wild-type and ΔrodA lysates were then
compared to the calibration curve to extrapolate c-di-GMP levels per mg cells
(Figure 8.11 B). c-di-GMP levels measured from the spiked wild-type sample were
close to the expected values (9.65 pmole c-di-GMP per ml lysate).
From this initial assay, the measured c-di-GMP levels in BRD948 wild-type and
ΔrodA samples were much lower than expected, with less than 50 fmoles detected
in each loaded sample (Figure 8.11 B). These figures were equivalent to values of
around 0.015 pmoles c-di-GMP per mg wild-type cells (wet weight), which was
around 10-fold lower than expected, from a previous study (457). The recorded c-
di-GMP levels of the unspiked samples were lower than the minimum value of the
calibration curve (50 fmole). This made it difficult to be sure of accurate c-di-GMP
quantification in wild-type and ΔrodA lysates. However, these results provide
information on relative c-di-GMP levels, demonstrating that c-di-GMP levels were
approximately 3 times higher in ΔrodA lysates compared to the wild-type, per ml of
original lysate. Since the samples were standardised by OD600 so that lysates
generated from 1 ml of either wild-type ΔrodA cultures contained an approximately
equal number of cells before lysis, this equates to c-di-GMP levels which were 3
times higher in individual ΔrodA cells, than in wild-type cells (Figure 8.11 B).
It could be argued that the perceived increase in c-di-GMP levels in ΔrodA cells
was simply the result of the increased size and volume in round cell mutants. If the
increase in c-di-GMP levels is proportional to the increase in volume, the overall
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intracellular concentration of c-di-GMP may not differ much between wild-type and
ΔrodA cells. However, when comparing c-di-GMP levels by wet weight, these
figures showed that c-di-GMP levels were just under 2 times higher in ΔrodA than
wild-type cells, per mg of cells (Figure 8.11 B). This data suggests that c-di-GMP
levels were in fact significantly increased in ΔrodA mutant cells, to a greater extent
than can be explained merely by an increase which simply compensates for the
increased cell volume, leading to a fairly constant intracellular c-di-GMP
concentration between wild-type and mutant cells.
As such, the combined data from both the microarray and initial LC/MS/MS results
suggest that c-di-GMP may be involved in the regulation of motility and SPI-1
genes in round-cell mutants; in these cells, c-di-GMP levels appear to be
increased, possibly as a result of the strong repression of expression of the major
c-di-GMP-degrading phosphodiesterase, yhjH. Increased c-di-GMP levels are
known to lead to the suppression of motility and virulence, combined with the
activation of genes which promote a sessile lifestyle (403, 451, 453).
8.8 Discussion
8.8.1 Introduction
The purpose of work in this chapter was to identify putative regulators responsible
for the downregulation of both motility and SPI-1 gene expression through the
suppression of flhDC and hilD in the round-cell ΔpbpA and ΔrodA mutants of S.
Typhi and S. Typhimurium. In addition work sought to determine the extent to
which motility and SPI-1 functionality could be restored to these mutants through
interrupting the regulatory pathways identified to be acting on flhDC and hilD
expression. In doing so it was hoped to gain a better understanding of both the
effects that these mutations have upon the cell wall and the physiological state
inherent in the round-cell mrd mutants.
270
8.8.2 Identification and verification of RcsC and PagN as putative
motility/SPI-1 regulators in round-cell mrd mutants
A global transposon mutagenesis screen using Tn10d(Tc), was developed and
implemented in order to identify putative regulators of fliF expression in the S.
Typhimurium ΔrodA mutant, whose inactivation through Tn10d(Tc)-mediated
mutagenesis would bring about a restoration of fliF expression and motility. In the
course of this work, over 7000 SL1344 ΔrodA Tn10d(Tc) mutants expressing the
luminescence reporter plasmid pMK1lux-fliF plasmid were screened for recovery
of luminescence, indicative of recovered fliF expression. This enabled good but
not complete coverage of the Salmonella genome. The screening of at least
10,000 mutant colonies would be needed to ensure more comprehensive
coverage of the Salmonella genome, or perhaps more, considering the tendency
of Tn10d(Tc) to transpose into ‘hot spots’ within the genome, defined by a
particular consensus sequence (445, 446). Due to time constraints and a
requirement to further investigate positive revertants already isolated, the screen
was not carried on further. However, it is recognised that further putative
regulators may remain to be identified.
Of the 7000 mutants, 21 luminescent revertants were initially isolated in which fliF
expression appeared to be recovered. These were rescreened for both recovered
luminescence, recovery of motility and retention of the spherical morphology. As
such several revertants were disregarded. In addition, two revertants were
rejected, being unlikely to constitute actual positive revertants due to the isolation
of non-luminescent mutants harbouring similar or identical Tn10d(Tc) insertions. It
is likely that these latter revertants were false positives resulting from the high
frequency of Tn10d(Tc) insertions within specific regions of the genome. This work
culminated in the identification of two putative regulators of SPI-1 and motility in
round-cell mutants: rcsC and pagN.
The vast majority of luminescent ΔrodA revertants were found to contain Tn10d(Tc)
insertions within the rcsC gene. In addition, a single revertant was isolated in
which the pagN gene was disrupted by Tn10d(Tc). Motility assays demonstrated
that significant motility was restored in the pagN::Tn10d(Tc) revertants and some
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rcsC::Tn10d(Tc) revertants. Furthermore, western blots demonstrated that SPI-1
protein expression was also recovered in these strains, indicating that these genes
are involved in the regulation of both flagella and SPI-1 expression in round-cell
mutants. However, SPI-1 needles were not visible at the surface of revertant cells,
suggesting that though expressed, SPI-1 functionality may remain inactivated.
Further in vivo analysis in the form of tissue culture invasion assays may be
required to determine whether SPI-1 functionality is restored in these strains.
RcsC
RcsC is well described as the major sensor kinase component of the Rcs
phosphorelay, which in response to various signals and activation by RcsF,
phosphorylates the response regulator RcsB via RcsD. In response to envelope
stress, the Rcs phosphorelay activates a global regulon, including SPI-2 genes,
genes responsible for colanic acid biosynthesis and Vi capsule expression, whilst
suppressing motility and SPI-1 gene expression (50, 96, 118, 119, 320). Knowing
its major role in both motility and SPI-1 regulation, the isolation of numerous
rcsC::Tn10d(Tc) mutants in this screen is not surprising, suggesting that the Rcs
phosphorelay plays a major role in regulating motility and SPI-1 in response to
mutations in pbpA and rodA. However, it is interesting that mutants were not also
isolated within the rcsB, rcsD and rcsF members of the Rcs phosphorelay, or rcsA,
encoding RcsA which in concert with RcsB binds the flhDC promoter and
regulates its expression (119, 318). It was also surprising that motility was only
significantly restored in one of the two rcsC::Tn10d(Tc) mutants tested.
Precise knockout mutants were constructed of the rcsC gene in the wild-type,
ΔpbpA and ΔrodA strains of S. Typhi and S. Typhimurium, although neither
motility nor SPI-1 expression was restored in these double mutant strains, with the
exception of a slight recovery of motility in S. Typhimurium ΔpbpA ΔrcsC cells.
The precise knockouts of both pagN and rcsC were generated to help verify that
the observed phenotypes in ΔrodA rcsC::Tn10d(Tc) and ΔrodA pagN::Tn10d(Tc)
mutants were not artefacts, resulting from the accumulation of secondary
mutations or the effect of Tn10d(Tc) on downstream genes, for instance. There
may be several explanations for the observed differences in rcsC::Tn10d(Tc) and
ΔrcsC strains of ΔpbpA/ΔrodA.
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It is possible that the isolated rcsC::Tn10d(Tc) mutants in these screens for
recovery of fliF expression were simply artefacts, resulting from a high frequency
of Tn10d(Tc) insertions into this gene. However, this is unlikely due to the
repeated isolation of various different rcsC::Tn10d(Tc) mutants, whilst no
rcsC::Tn10d(Tc) mutants were identified in screens for non-luminescent mutants.
Another possible explanation is that the rcsC::Tn10d(Tc) insertions resulted in
polar defects on the expression of downstream genes (a feature which would not
be observed in the precise ΔrcsC knockouts, due to their non-polar nature), and
that these, rather than the inactivation of rcsC, resulted in the recovery of flagella
gene expression. The rcsC gene is located downstream of rcsB in both Salmonella
and E. coli, but transcribed on the opposite strand, and independently expressed
and regulated (462, 463). rcsC is thought to comprise a single transcriptional unit
(187, 463). As such, it is unlikely that the inactivation of rcsC would affect the
transcription of downstream genes such as rcsB.
Another more plausible explanation for the observed phenotypic differences is due
to differences in the nature of the Tn10d(Tc) insertion mutants and the ΔrcsC
complete knockout mutants. The RcsC protein contains a periplasmic N-terminal
domain (298 amino acids) and a complex C-terminal 614 amino acid cytoplasmic
region which contains both kinase and phosphatase activity (463-465). The
majority of rcsC::Tn10d(Tc) mutants isolated in this screen contained Tn10d(Tc)
insertions within the first 1.2 kilobase pairs of the rcsC coding sequence, encoding
the N-terminal sensor region of RcsC, and just upstream of the histidine kinase
and phosphatase regions (272, 463, 464). This clustering could result from the
presence of hot spot regions within the 5’ end of rcsC, or because this section of
the protein is more relevant in the regulation of motility. It is thought that the
Tn10d(Tc) insertions would completely disrupt rcsC, inactivating RcsC function.
However, it may be that a truncated form of RcsC is expressed in rcsC::Tn10d(Tc)
mutants, comprising just the C-terminal region, which may still retain some kinase
and phosphatase activity. If this is the case, this may explain the slight differences
in phenotypes observed between rcsC::Tn10d(Tc) mutants and ΔrcsC knockout
mutants, where the full gene is inactivated. Thus the structure of the mutants may
affect rcsC and hence Rcs phosphorelay activity.
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In a previous study, point mutations within rcsC which increased expression of
RcsC and hence activation of the Rcs phosphorelay as a whole, also increased
colanic acid capsule production, whilst a ΔrcsB null mutant suppressed colanic
acid synthesis and restored motility to these former rcsC mutant alleles (325).
Another fairly recent study also found that the inactivation of rcsB, rcsD, or rcsF
restored motility to non-motile mutants, through the suppression of the Rcs
phosphorelay, although the inactivation of rcsC was not as effective at restoring
motility. The RcsC sensor kinase is known to possess both kinase and
phosphatase activity, and hence is able to activate or deactivate the response
regulator RcsB, through RcsD. As such the authors suggested that the deletion of
rcsC may have left some residual Rcs phosphorelay activity since RcsB could not
be de-phosphorylated in ΔrcsC mutants (463, 466-468).
In a similar manner, differences in rcsC::Tn10d(Tc) and ΔrcsC knockout mutant
phenotypes (and differences between individual rcsC::Tn10d(Tc) mutants) could
result from differences in residual RcsC activity in these mutants. The inability to
de-phosphorylate RcsB in ΔrcsC complete knockouts, from removal of the
phosphatase, may result in the same incomplete reduction in the Rcs
phosphorelay activity, preventing motility from being significantly restored in
ΔpbpA ΔrcsC and ΔrodA ΔrcsC strains. By comparison, the recovery of motility in
ΔrodA rcsC::Tn10d(Tc) may result from some residual phosphatase activity with
the expression of a truncated RcsC.
PagN
The pagN gene is encoded within the SPI-6 pathogenicity island of Salmonella
and is thought to be important for virulence. This outer membrane protein forms an
invasin protein which can mediate invasion of mammalian cells. In addition pagN
expression is activated in SPI-2-inducing conditions by the PhoP/PhoQ master
regulators of virulence (397, 423, 425). Although pagN expression is upregulated
in conditions along with other factors involved in the downregulation of motility and
SPI-1, such as the Rcs phosphorelay, SPI-2 genes and PhoP/PhoQ, a link
between PagN and motility regulation or functionality has not previously been
identified. Also since PagN forms an outer membrane adhesin, it is unlikely to form
a direct regulator of flagella gene expression.
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It is possible that the inactivation of pagN leads to the activation of flagella gene
expression, as seen in pagN::Tn10d(Tc) mutants, by indirect means. Considering
its position in the outer membrane, it is possible that PagN may play a hitherto
unrecognised role in sensing environmental conditions. PagN is known to assist in
invasion; this role may involve more than simply the direct binding of host cells,
and also comprise the consequent downstream signalling which informs the cell of
the extracellular environment, bringing about the upregulation of genes involved in
intracellular survival (423, 425). As such the inactivation of pagN would interrupt
any such signalling pathway and affect the expression of genes involved in
intracellular survival.
As with ΔrcsC complete knockouts, the ΔpagN knockout did not appear to bring
about the recovery of motility in round-cell mutants seen in pagN::Tn10d(Tc) cells,
although the recovery of motility in the latter mutants was not great. This may
again result from differences in the nature of the mutants, whereby the possible
expression of even a truncated version of PagN may cause different effects to the
removal of the whole gene. Due to the position of pagN in the genome the
inactivation of pagN is unlikely to affect the expression of downstream genes and
so the effects on motility in either pagN::Tn10d(Tc) or ΔpagN mutants cannot be
said to be due to polar effects on downstream genes.
The expression of flhDC in trans from an inducible promoter resulted in a recovery
of around 40-60% motility compared to the wild-type, whilst the inactivation of
pagN or rcsC resulted in a similar level of motility functionality in ΔrodA Tn10d(Tc)
mutants. However, recovery of hilD expression in trans was sufficient to restore
the surface expression of SPI-1 T3SS needles, although this was not seen in
ΔrodA rcsC::Tn10d(Tc) or ΔrodA pagN::Tn10d(Tc) mutants. These observations,
along with the isolation of two possible regulators of motility, suggest that the
regulatory pathways involved in repressing motility/SPI-1 in round-cell mutants are
more complex, involving input from a number of unidentified factors. This is highly
likely considering the numerous regulatory pathways already characterised for
their involvement in the regulation of motility and invasion genes in response to
various environmental signals (56, 98, 119, 403, 437, 450). This may also explain
the differences seen between Tn10d(Tc) mutants and complete knockout mutants
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of rcsC and pagN. Motility revertants isolated in the Tn10d(Tc) mutagenesis
screen may harbour secondary mutations or other properties, bringing about slight
differences in motility gene regulation; for instance, in the different mutants other
factors may input into the regulatory pathways to a greater or lesser extent.
8.8.3 Relationship between cell size and recovery of motility in round-cell
ΔrodA revertants
It was noted that many of the revertant ΔrodA Tn10d(Tc) mutant cells, of various
different identities, appeared significantly smaller in size and diameter than the
parent ΔrodA cells. However, in one instance, with repeated culture during the
preparation of cells for immunofluorescence microscopy, the difference in size
appeared less significant. Interestingly, in these cells surface expression of the
SPI-1 needles was not apparent. Smaller spherical cells also sometimes appeared
more motile by microscopy. It is possible that the recovery of flhDC expression
may itself be insufficient for full recovery of motility and that motility in these
revertants was also dependent to some extent on cell size, regulated
independently to the recovery of motility gene expression.
Motility functionality and cell size could be linked in a number of ways. For
instance, motility recovery may be mediated to some extent, or even to a greater
extent, by parallel effects of rcsC/pagN inactivation on cell size, rather than simply
due to the direct de-repression of flhDC expression. It may be that a decreased
cell size increases the stability in cell walls, rendering them more physically able to
support flagella assembly. This may explain why motility was not significantly
affected in the 4a rcsC mutants, even if flhDC expression was recovered.
The Rcs phosphorelay is known to activate ftsZ and ftsA expression (321, 322,
469). Since FtsZ and associated proteins play a major role in coordinating cell size,
alterations in the expression of these proteins may significantly have affected the
size of cells of the revertant strains (335, 336). However, since the Rcs
phosphorelay increases ftsZ expression, an ΔrcsC mutation would be expected to
result in a decrease in ftsZ expression, which would not lead to a reduction in cell
size.
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It is also possible that the reduction in cell size in these mutants may be due to a
selection for secondary mutations which result in a decreased cell size, meaning
that cells in which flagella gene expression was also recovered, were rendered
more able to assemble functional flagella.
flhDC has also been shown to regulate cell division; it activates expression of
cadA, and through the CadA protein acts to decrease rates of cell division during
stationary phase, although this occurs independently of ftsZ. Furthermore, ΔflhD
mutant cells were smaller than wild-type cells (349, 350). However, this is again
contrary to expectations; if flhDC is significantly involved in regulating cell size and
cell division in ΔpbpA and ΔrodA mutants, one would expect the recovery of flhDC
expression to be associated with a decrease in cell division and an increase in cell
size.
In conclusion, the present studies have isolated both pagN and rcsC as possible
regulators of flagella and SPI-1 gene expression, which when inactivated in round-
cell mutants, bring about a partial recovery of motility and SPI-1 protein expression
at least. However, the mechanisms by which motility and SPI-1 expression are
recovered remain to be characterised; it is likely that a number of factors are
involved in the regulation of motility and SPI-1 in response to the inactivation of
pbpA or rodA. It is also possible that other factors are involved in, or essential for,
the recovery of actual motility and SPI-1 functionality downstream of flagella/SPI-1
gene expression. It was recognised that cell size may play a role in determining
the functionality of flagella and SPI-1 in round-cell mutants. This is supported by
the observations that only up to ~60% of the wild-type motility has been seen to be
recovered in round-cell mutants, upon recovery of motility gene expression.
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8.8.4 Identification of c-di-GMP as a putative motility/SPI-1 regulator in
round-cell mrd mutants
Work which identified pagN and rcsC as regulators mostly considered these genes
in terms of their function in the regulation of flhDC transcription. It has also been
shown that the recovery of flhDC and hilD transcription is sufficient to restore
significant motility and SPI-1 functionality to ΔpbpA and ΔrodA cells.
However, as previously discussed, it is likely that more than one factor may be
involved in motility and SPI-1 functionality in round-cell mrd operon mutants. This
regulation may also occur at a number of levels downstream of transcription. For
this reason the secondary messenger c-di-GMP was considered as a possible
additional regulator of motility and SPI-1 in round-cell mutants. c-di-GMP is quickly
being realised as a major global regulator in bacteria, responsible for regulating
transition from a free-living motile lifestyle, to a sessile multicellular lifestyle within
a biofilm. c-di-GMP post-transcriptionally activates biofilm formation and represses
motility and SPI-1 virulence through a number of mechanisms which are not well
understood (95, 403, 453). c-di-GMP levels are regulated through the combined
action of c-di-GMP synthesising and degrading enzymes; GGDEF and EAL
domain-containing proteins respectively. The overexpression of GGDEF-domain
diguanylate cyclases or EAL-domain phosphodiesterases results in the increase or
decrease in intracellular c-di-GMP levels, with a consequent repression or
activation of motility, respectively (403, 452, 453, 459, 460). Salmonella
Typhimurium expresses 20 GGDEF and EAL domain proteins, whilst S. Typhi
expresses 21 (458, 461).
Microarray data showed that a major EAL-domain protein of Salmonella, YhjH,
was downregulated over 40-fold in a ΔrodA mutant compared to the wild-type.
YhjH has been shown to decrease c-di-GMP levels in vivo in Salmonella, and is a
major EAL domain protein affecting the regulation of motility (459). Furthermore,
liquid chromatography with mass spectrometry (LC/MS/MS) analysis to compare
c-di-GMP levels between S. Typhi wild-type and ΔrodA cells showed that c-di-
GMP levels were significantly increased in the ΔrodA mutant. c-di-GMP levels in
individual ΔrodA cells were approximately 3 times higher than levels in the wild-
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type. Also, weight for weight, ΔrodA cells contained twice as much c-di-GMP as
wild-type cells. These results suggest that the increase in c-di-GMP levels in the
ΔrodA mutant is not simply due to the increased volume of the ΔrodA mutant cells,
such that the overall concentration of c-di-GMP is equal. Thus, initial results
suggest that c-di-GMP levels are actively increased in round-cell mrd operon
mutants.
The accurate direct quantification of c-di-GMP levels in both S. Typhi wild-type and
ΔrodA strains was difficult in the present work, as observed c-di-GMP levels fell
below the minimum value of the calibration curve, that of 50 fmoles. In a recent
study, c-di-GMP levels in the wild-type S. Typhimurium strain were detected at
around 0.16-0.17 pmoles per mg cells (wet weight) (457). In contrast, c-di-GMP
levels in the present study were around 10-fold lower in the wild-type, at 0.015
pmoles/mg. This result may highlight inherent problems with the present method,
which led to the observed results.
Several factors may have affected c-di-GMP levels in S. Typhi wild-type cells, or
the detection of c-di-GMP. Whilst differences between the two Salmonella
serovars may result in varying c-di-GMP levels between S. Typhi and S.
Typhimurium, a 10-fold reduction in c-di-GMP levels seems excessive. Simm et al.
found that c-di-GMP levels varied up to 10-fold between S. Typhimurium and
Vibrio cholerae. However c-di-GMP levels in E. coli, which is much more closely
related to S. Typhimurium, were comparable to those in S. Typhimurium (2, 457).
S. Typhi is still more closely related to S. Typhimurium (2). Minor differences
between closely related serovars are unlikely to result in such major differences in
c-di-GMP levels. However, it must be considered whether the attenuating
mutations of the BRD948 Typhi strain could also significantly affect c-di-GMP
levels. In particular, HtrA, which is inactivated in the BRD948 strain, is an envelope
stress response protein, which is regulated by RpoE (232, 398). In addition, there
is some evidence that RpoE, a major envelope stress regulator, may be involved
in the formation of mature biofilms (470, 471). As such it is possible that the
inactivation of htrA in BRD948 has some effect on biofilm formation and c-di-GMP
signalling.
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The specific phase of growth also may impact intracellular c-di-GMP levels, along
with the culture medium and method of culture. In the study by Simm et al. cell
lysates and nucleotide fractions were prepared from plate cultures of cells grown
on LB agar without salt, rather than in liquid culture in LB medium, as was done in
the present study. Elevated c-di-GMP levels are linked to biofilm overexpression,
which is also associated with stationary phase (457, 470, 471). In the present
study cells were cultured to mid-log phase, whereas in the 2004 study S.
Typhimurium cells were cultured to a later growth phase. As such higher c-di-GMP
levels may be expected in the latter cells (457). In another study different culture
preparation methods, corresponding to different growth phases, were also shown
to considerably affect c-di-GMP levels (457, 472). c-di-GMP levels from stationary
phase BRD948 wild-type cells (after 16 hours’ growth) have also been measured
(unpublished results from this lab), being approximately double that of the mid-log
phase cells. As such, growth phase appears to significantly affect c-di-GMP levels.
Sample purity is also an important factor which affects detection levels of c-di-
GMP (457). Here again, differences may be evident between the study of Simm et
al., and the present study; in the former, nucleotide extracts were analysed, whilst
in this study cell lysates were centrifuged and filtered to remove cell debris and
large molecules, using 10 kDa cut-off filters. The level of background noise seen in
the LC/MS/MS spectra was quite high, resulting from the biological matrix mixed in
with the c-di-GMP. This is likely to result from the extraction method. The
biological matrix may have also partially blocked the column, preventing c-di-GMP
loading and detection. It is therefore likely that a lower level of sample purity in this
study considerably affected c-di-GMP detection.
A final possibility is that the c-di-GMP contained within cell lysates was somewhat
degraded in the course of sample preparation. It was observed that reconstituted
pure c-di-GMP degraded in solution at a rate of approximately 1% per day. Other
factors present in cell lysate samples may have further increased the rate of c-di-
GMP degradation, being retained even after filtering. It was intended that
LC/MS/MS analysis would be done with as fresh samples as possible, to retain
close to physiological levels. Although there was a slight delay (2-3 days) in the
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preparation of samples and LC/MS/MS analysis due to unforeseen factors,
calibration curves were generated on the same day as the samples were run.
Taking all these factors into consideration, the difference in c-di-GMP levels
detected in the Simm study and the present study are most likely to be caused
predominantly by differences in sample preparation and sample purity, although
other factors may have affected c-di-GMP levels to a much lesser extent. Sample
purity may need to be improved in future work, through the additional extraction of
nucleotides from lysate preparations.
8.8.5 Motility/SPI-1 regulation in S. Typhi and S. Typhimurium round-cell mrd
mutants
An important observation of this section of work was that whilst some recovery of
motility was observed in ΔpbpA/ΔrodA ΔrcsC/ΔpagN double mutants of S.
Typhimurium, no recovery was seen in the equivalent mutants in S. Typhi cells.
This is likely to be caused by differences between the two serovars, or through the
effects of the strain-specific mutations in the S. Typhi BRD948 strain. It may be
that the same regulatory factors do not play the same, or as extensive roles, in S.
Typhi; alternative or additional factors may be important in regulating motility in
BRD948 ΔpbpA and ΔrodA mutants.
Comparisons between the genomes of S. Typhi and S. Typhimurium have shown
that the two serovars share a large proportion of DNA content. Conserved regions,
which make up around 90% of the genome of both serovars, share on average
97% homology at the DNA level (1-3, 18, 80). In addition, major global
transcriptional regulator and regulatory pathways are conserved in both serovars,
including the major stress response mechanisms and the Rcs phosphorelay (1, 2,
116, 253). In this respect it is expected that the regulatory pathways involved in
SPI-1 and motility gene regulation in S. Typhi and S. Typhimurium round-cell mrd
mutants would be the same. It is possible, however, that important global
regulators exist in one serovar, but not the other (3, 80). S. Typhi is known to
possess at least one major transcriptional regulator involved in virulence gene
regulation, TviA, which is absent from S. Typhimurium. TviA is encoded within the
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Typhi-specific SPI-7 pathogenicity island. It positively regulates expression of the
SPI-7-encoded Vi capsule and negatively regulates motility and SPI-1 expression
through suppression of flhDC and fliZ (116). Moreover, TviA is positively regulated
by the Rcs phosphorelay, and also acts in concert with the response regulator
RcsB to repress motility and SPI-1 gene expression. Unlike the situation in S.
Typhimurium, both TviA and RcsB are required for SPI-1/motility suppression in S.
Typhi. TviA is also able to regulate flhC independently of RcsB, in response to
changes in osmolarity (116).
Thus, it is possible that TviA plays a major role in directing SPI-1 and motility gene
regulation in S. Typhi mutants, leading to the observed phenotypic differences.
The importance of TviA may be such that the inactivation of both the Rcs
phosphorelay and TviA may be necessary to restore flagella and SPI-1 gene
expression in round-cell mutants of S. Typhi; the inactivation of rcsC (or pagN)
alone is clearly not sufficient for the restoration of motility and SPI-1.
The S. Typhi BRD948 vaccine strain harbours mutations in the aroC, aroD, and
htrA genes, the latter of which encodes an important RpoE-regulated protein (232,
398). The inactivation of htrA in the BRD948 strain may also considerably affect
SPI-1 and motility gene expression in round-cell mutants of this strain. htrA
encodes a periplasmic protease which is involved in the envelope stress
responses in Salmonella (216, 232, 398, 473, 474). However, htrA mutations do
not affect invasion or adherence to host cells (233, 475). The BRD948 strain was
used instead of the wild-type S. Typhi Ty2, to permit work and manipulation of S.
Typhi at containment level 2 conditions.
It is possible that the ΔhtrA mutation may have affected the detection of and
responses to envelope stress caused by the inactivation of pbpA or rodA in
BRD948 cells, resulting in alterations to the regulatory pathways involved in
controlling SPI-1 and motility expression, such that flagella and SPI-1 genes were
more strongly repressed in S. Typhi round-cell mutants. ΔhtrA mutants are also
known to be more sensitive to oxidative stress (473, 474). It is therefore also
plausible that the inactivation of htrA rendered BRD948 cells more sensitive to
envelope associated stress, leading to increased activation of alternative stress
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response pathways, with the consequent tightened repression of SPI-1 and
motility genes. The cell envelope in S. Typhi round-cell mutants may also be
weaker than in equivalent S. Typhimurium mutants, leaving it naturally too
compromised to permit the assembly of flagella or T3S needles, even if SPI-
1/flagella gene expression were recovered.
Further work is required to characterise the extent to which htrA and tviA are
involved in virulence gene regulation in round-cell mrd mutants of S. Typhi. The
inactivation of both tviA and rcsC may help determine whether SPI-1 and motility
expression and functionality can be restored in S. Typhi ΔpbpA and ΔrodA
mutants.
8.8.6 Conclusions
The work of the present chapter has provided evidence that the Rcs phosphorelay
plays a major role in the down-regulation of SPI-1 and motility gene expression in
round-cell mrd operon mutants of Salmonella Typhimurium, such that the
inactivation of the sensor kinase RcsC brings about the recovery of gene
expression in ΔpbpA and ΔrodA mutants, and some recovery of functionality. This
work has also identified the outer membrane adhesin PagN for its possible
involvement in the regulation of SPI-1/motility genes in these mutants. Thus, the
SPI-1 and motility defects in ΔpbpA and ΔrodA mutants are complementable,
caused to a large extent by the repression of flhDC and hilD expression.
In addition, these results demonstrate that, in agreement with microarray data,
major envelope stress response pathways are likely upregulated in these mutants,
leading to the observed phenotypes. It is recognised that the regulation of SPI-1
and motility in response to the pbpA and rodA mutations is likely to be more
complex, involving the interplay of a number of both transcriptional and
posttranscriptional regulatory factors. Whilst evidence from this study suggests
that c-di-GMP may also play a major regulatory role in round-cell mutants,
considerable further work is required to further characterise identified regulators, to
isolate other factors which contribute to flagella and SPI-1 regulation, and finally to
establish how the various factors are interlinked.
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In order to further elucidate the regulatory pathways involved in responding to
pbpA or rodA mutations, future work will also need to assess possible regulators
which work upstream of the Rcs phosphorelay (or related regulators), which in
response to defects or certain properties in the cell wall of round-cell mutants, may
activate this regulatory pathway. A possible important candidate would be RcsF,
the outer membrane activator of the Rcs phosphorelay (119).
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Chapter 9. General Discussion
9.1 Introduction
The mrd operon is thought to comprise the 5 contiguous genes: ybeB, ybeA, pbpA,
rodA and rlpA, the putative operon promoter being located in the intergenic region
upstream of ybeB. However, till now little experimental evidence has definitively
shown this (142, 143, 155, 186, 187). pbpA and rodA encode PBP2 and RodA
respectively, two proteins which play an essential role in longitudinal cell wall
synthesis. Whilst PBP2 is known to be the major lateral cell wall transpeptidase in
rod-shaped bacteria, the precise function of RodA is unknown, although it is
required for PBP2 function (126, 130, 145, 155). Despite their location just
upstream of pbpA and rodA, ybeB and ybeA appear to have completely unrelated
roles, being involved in ribosome biosynthesis and stability (194, 189). The outer
membrane lipoprotein RlpA is less well described. Evidence has shown that it
localises to both the cell septum and at distinct foci along the lateral cell wall. It
also is thought to bind peptidoglycan, although its precise role remains unknown
(179, 201). Further experimental analysis is therefore required to elucidate the
structure of the mrd operon and the functions of the mrd operon genes, particularly
with respect to determining whether ybeB, ybeA and rlpA play any roles in cell wall
synthesis and cell shape determination. The placing of these genes within close
proximity and possibly within the same operon of pbpA and rodA, suggest that
these genes are co-regulated and may share some functional relationship with
pbpA and rodA.
In rod-shaped bacteria lateral and septal cell wall synthesis are thought to be
directed by two cell wall-spanning multiprotein complexes, comprising the
penicillin-binding proteins and associated proteins. The localisation patterns of
these complexes, and hence the spatial organisation of peptidoglycan synthesis,
are thought to be coordinated by the bacterial cytoskeleton proteins MreB and
FtsZ, respectively. In this model PBP2 and RodA form an integral part of the
lateral cell wall synthesis ‘elongase’ complex. Evidence suggests that these
proteins are associated with, and spatially coordinated by MreB, MreC and MreD.
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Along with RodZ, these five proteins all form major members of the elongase,
being essential for rod shape maintenance (122, 126, 130, 131, 167).
The inactivation of any of the cell shape determinant proteins causes cells to form
large spheres which are somewhat prone to cell lysis in the absence of either
compensatory mutations, permissive growth conditions, or the addition of
magnesium and sucrose to growth medium (130, 229). In these spherical mutants
longitudinal cell wall synthesis appears to be replaced by constitutive activity of the
septal cell wall synthesis complex (127). Cell wall structure and integrity may also
be affected in these cells, with round-cell mutants showing increased sensitivity to
external stress, as well as lysis (130, 157, 211, 214).
However, relatively few studies have investigated the possible roles of cytoskeletal
proteins in the positioning of other cell wall-spanning multiprotein complexes, or in
fact, on the effect of perturbations to lateral cell wall synthesis on the assembly,
stability and functioning of other such organelles, which may depend on a certain
level of cell wall integrity for their function (221, 222). In particular, the functionality
of cell shape determinants and hence the integrity of the cell wall, may have major
implications for the virulence of pathogens such as Salmonella, in which many of
the major virulence determinants involve cell wall-spanning multi-protein
organelles.
Thus, the major aims of this study encompassed the characterisation of the mrd
operon in Salmonella enterica serovar Typhi. In particular the work aimed to better
describe both the structure of the operon and the roles of the constituent genes in
the biology and pathogenicity of Salmonella. To this end, in silico and experimental
analyses have been implemented to characterise the mrd operon structure, along
with the position of the mrd operon promoter(s). In addition, a large number of
phenotypic screens have been employed to analyse the effects of the inactivation
of each individual mrd operon gene on the general physiology of Salmonella and
the functionality of major virulence factors.
Based on the results of these phenotypic screens, continuing work aimed to
identify the major regulatory factors involved in the control of the observed
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virulence phenotypes in response to pbpA or rodA inactivation. These latter
studies, complemented by global transcriptional analyses, have provided further
important insights into the effects of pbpA and rodA mutations on the physiology of
Salmonella. The studies have also highlighted significant phenotypic differences
between S. Typhi and S. Typhimurium round-cell mutants.
9.2 The structure of the mrd operon and constituent genes
Initial work investigated the structure of the mrd operon in Salmonella Typhi. in
silico analyses to compare operon structure across various Gram-negative species
showed that the proposed operon, as a putative 5 gene transcriptional unit, is well
conserved in both pathogenic and non-pathogenic Gram-negative organisms,
including E. coli, Pseudomonas, Caulobacter, Yersinia and Vibrio species, for
instance. However, it is not conserved in Gram-positive organisms such as B.
subtilis, where homologues of each of the mrd operon genes are dispersed across
the genome (Chapter 3.2.1). in silico analyses of the mrd operon DNA sequence
and flanking areas of the genome in Salmonella were also carried out to identify
putative promoter sequences, as well as putative transcriptional terminator
sequences within the region (Chapter 3.2.2 and 3.4.1).
These analyses were accompanied with luciferase transcriptional reporter assays
to identify experimentally any active promoters within the mrd operon region
(Chapter 3.3). 500 bp regions immediately upstream of each gene were cloned
into the promoter-less luciferase reporter plasmid pMK1lux. The luminescence
emitted from cultures expressing the resulting pMK1lux plasmids was then
measured as an indication of promoter activity. Furthermore, RT-PCR assays
were performed to identify co-transcribed genes of the mrd operon (Chapter 3.4).
Taken together, the data from these assays showed that a strong promoter for the
mrd operon lies upstream of ybeB, within approximately 200 bp of the start of this
gene. The lack of likely promoter sequences, transcriptional terminator sequences,
or detectable promoter activity within the region between ybeB and rodA strongly
suggests that these 4 genes at least are co-transcribed, under the control of the
ybeB promoter. In support of this, both ΔybeB and ΔybeA mutants of S. Typhi and
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S. Typhimurium generated in this study had morphological defects identical to
those of ΔpbpA and ΔrodA mutants. These defects were reverted upon removal of
the knockout cassette from S. Typhi mutants, suggesting that they were caused by
polar effects on pbpA and rodA expression.
A putative promoter was previously mapped upstream of ybeB in E. coli (142).
However, a 23 bp region in the E. coli genome shortly upstream of ybeB, proposed
to contain this promoter, was not conserved between Salmonella and E. coli. In
Salmonella this region was replaced by a ~90 bp stretch of dissimilar DNA
(Chapter 3.2.2). By comparison, other regions of the mrd operon both upstream
and downstream of these individual sections were conserved by around 88% at
the DNA level between E. coli and Salmonella. It is possible that an alternative
mrd operon promoter lies within this 90 bp section in Salmonella. If this is the case
the differences in the promoter sequences between Salmonella and E. coli may be
indicative of slight differences in the regulation of the mrd operon genes between
Salmonella and E. coli, and also potential minor differences in gene function. The
short sequences of DNA specific to E. coli and Salmonella genomes may contain
specific promoter sequences for ybeB. Alternatively, it is possible that the true
promoter for ybeB lies upstream of this region in Salmonella, and potentially also
in E. coli, perhaps corresponding to other promoter-like sequences identified in
this work.
In terms of the position of rlpA within the mrd operon, the close proximity of this
gene to rodA would suggest that it may be co-transcribed along with rodA.
However, significant promoter activity upstream of rlpA (within the rodA gene) was
detected in luciferase transcriptional reporter assays, although the strength of this
promoter was less than that of the ybeB promoter. In addition, several putative
promoter sequences were identified upstream of rlpA in in silico analyses, both in
the present work and in a previous study, although no transcriptional terminator
sequences were identified downstream of rodA (186). For these reasons it is
thought that rlpA also forms part of the mrd operon, although some rlpA
expression may be controlled independently of the upstream genes through a
separate rlpA promoter within rodA. RlpA is thought to play a role in cell division,
having been visualised to have a septal localisation. This protein has also been
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observed to localise along the lateral cell wall in a manner reminiscent of PBP2
and RodA (163, 179, 201). This evidence suggests a possible functional link
between RlpA, PBP2 and RodA. Hypothetically, RlpA may function in both lateral
and polar cell wall synthesis. Such a dual role may be differentially regulated, so
that, for instance, rlpA expression is co-regulated with pbpA and rodA for
involvement in lateral cell wall synthesis from the mrd operon promoter, whilst its
cell division role may be independently regulated, through the control of the
promoter immediately upstream of rlpA.
Microarray analysis of gene expression in the S. Typhimurium ΔrodA mutant
demonstrated that rlpA transcription was downregulated around 10-fold compared
to the wild-type (Chapter 6.1.4). This could be caused both by polar effects on rlpA
expression from the insertion of a knockout cassette into the rodA gene, if indeed
rlpA forms part of the mrd operon, or from the knockout of the rlpA promoter within
rodA in this strain, disrupting rlpA expression..
It therefore remains unclear whether rlpA forms part of the mrd operon, or whether
it may be expressed under the control of two separate promoters. In addition,
despite the larger spacing between the rlpA and dacA genes, no putative
transcriptional terminator sequences were detected between rlpA and dacA.
Problems with cloning meant that the region upstream of dacA was not assayed
for promoter activity. Furthermore, RT-PCR assays to identify co-transcribed
genes proved unsuccessful. It is thought that the likely false-positive results
generated in this assay may have resulted from overlapping mRNA transcripts of
the mrd operon region causing the generation of PCR products which bridged the
junction between adjacent, non-cotranscribed genes. However, putative promoter
sequences were isolated a short distance upstream of dacA, in silico. In addition,
microarray analyses showed that dacA expression was not significantly affected in
the ΔrodA mutant. The retention of the kanamycin-resistance knockout cassette in
both S. Typhi and S. Typhimurium mutants was shown to cause major polar
effects on the expression of downstream operonic genes, as seen in ΔybeB and
ΔybeA mutants. As such the absence of morphological defects in the ΔrlpA
mutants of S. Typhi or S. Typhimurium prior to removal of the knockout cassette,
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such as those associated with ΔdacA strains, suggests that dacA is not co-
transcribed along with the upstream mrd operon genes (163, 207, 266).
Additional experimental analyses are needed to definitively identify whether rlpA
and dacA form part of the mrd operon. Northern blot analysis, for instance, would
form a useful assay to identify co-transcribed genes. Primer extension analyses
would also be valuable in helping to accurately map the mrd operon promoter
position(s) in Salmonella. Unfortunately it was not possible to conduct such assays
within the course of the present study. For the purposes of this study it was
assumed that rlpA, but not dacA, forms part of the mrd operon. As such rlpA was
included in investigations into the functions of mrd operon genes.
9.3 Phenotypic characterisation of mrd operon gene mutants
9.3.1 Growth, morphology and division defects of the mrd operon mutants
Round-cell S. Typhi ΔpbpA and ΔrodA mutants
In order to further characterise the functions of the mrd operon genes, precise
knockout mutants of the ybeB, ybeA, pbpA, rodA and rlpA genes were generated
in S. Typhi (Chapter 4.1). Previous work has shown that the inactivation of pbpA or
rodA in Salmonella or E. coli causes cells to lose their rod-shaped morphology and
grow as spheres (130, 157, 163). Likewise, pbpA and rodA mutants of S. Typhi
displayed identical morphological defects. These mutant cells were also
considerably larger than wild-type cells, and much heterogeneity of size was
evident between individual cells. Furthermore, significant numbers of lysed cells
and cell debris were evident in cultures of round-cell mutants. Several studies
have noted that the addition of magnesium, or calcium to a lesser extent, and
sucrose, aided the growth of round-cell mutants of Bacillus subtilis, as well as
helping to restore rod-shape (229, 274-276). In the present study, the addition of
either 20 mM MgCl2 or CaCl2 was shown to greatly improve growth of both ΔpbpA
and ΔrodA mutants of S. Typhi (Chapter 4.3.1). Although rod-shape was not
restored in these cells, the extent of cell lysis was notably reduced. Furthermore
cells appeared more uniform in size, with a reduction in the number of giant cells.
Unlike previous studies, calcium appeared to have the same effect as magnesium
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(229). Interestingly wild-type cells treated with 20 mM MgCl2 also appeared slightly
smaller in length than those grown without the addition of magnesium.
The round-cell ΔpbpA and ΔrodA mutants also displayed asymmetrical division
defects, as observed previously (Chapter 4.1.3) (127). The general growth of
round-cell mrd operon S. Typhi mutants was assessed in nutrient rich LB medium
at both 37°C and 30°C. Significant growth defects compared to the wild-type were
observed in round-cell mutants with growth at low temperatures (Chapter 4.3.4).
The general morphological defects, cell division defects and divalent cation-
dependency of round-cell mutants have all been described previously, in
organisms including B. subtilis, E. coli, Caulobacter and Salmonella (127, 130, 157,
229, 476). The phenotypes of mutants of all the cell shape determinant genes (i.e.
mreBCD, pbpA, rodA or rodZ) are highly similar or indistinguishable (122, 126,
130). However, the observed temperature sensitivity of round-cell mutants in this
study has not been much described in the literature, although a similar phenotype
was also seen for S. Typhimurium ΔpbpA and ΔrodA mutants, in previous
unpublished work (163). In contrast, several studies have shown that growth of
round-cell mrd and mre mutants is rescued at conditions permitting slow growth
rates (minimal media, and low temperatures, e.g. 30°C). Rather, growth in
conditions permitting fast growth rates (nutrient rich media at temperatures >30°C)
caused the formation of large non-dividing spherical cells which lysed (127, 130,
277, 278).
The reason for the stable growth of Salmonella round-cell mutants at 37°C in LB
medium, (in apparently ‘non-permissive’ conditions), but not at 30°C is unknown.
Furthermore, these mutants were particularly sensitive to low temperatures and
extensive cell lysis was observed with incubation of these cells at 4°C. Two major
cold-shock proteins, CspC and CspE, were also upregulated ~2-fold in S.
Typhimurium ΔrodA microarrays (Chapter 6.1.3). It therefore appears that S. Typhi
(and S. Typhimurium) ΔpbpA and ΔrodA mutants were particularly sensitive to
cold-shock, being more so than previously characterised round-cell mutants in
other bacteria, where lower temperatures assisted rather than hindered growth. It
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is possible that features peculiar to Salmonella may be responsible for this
difference in phenotype.
A number of factors are recognised as being required to rescue growth and
prevent cell lysis in spherical cells, such as ΔpbpA and ΔrodA mutants. These
include slow growth rates, as already mentioned, overexpression of the cell
division proteins FtsZ, FtsA and FtsQ, and an increase in the levels of ppGpp, an
alarmone which regulates growth rates and ftsQAZ transcription (130, 324, 331,
332, 337, 338). A widely held explanation for this is that the increase in the volume
and diameter of round-cell mutants means that intracellular FtsZ levels are
insufficient to form a complete septal ring to bring about division, something which
the above factors help to alleviate (127, 130). The observation of asymmetric
septation, with the formation of in-complete FtsZ rings, may support this model
(127). However, Bendezú and de Boer suggested that the requirement for
increased FtsZ levels is caused by the accumulation of FtsZ and associated
proteins at non-division sites; excess inner membrane involutions and intracellular
vesicle formation may cause FtsZ to be diverted from mid-cell, accumulating
instead at these regions. For this reason, FtsZ levels are insufficient to coordinate
symmetrical cell division (130).
It is likely that FtsZ levels are increased in S. Typhi ΔpbpA and ΔrodA mutants, as
these cells appear to stably propagate. Also, microarray analysis of gene
expression in the S. Typhimurium ΔrodA mutant showed that several genes
involved in cell division were upregulated over 2-fold in this mutant, although ftsZ
expression was not significantly altered (Chapter 6.1.4).
In addition, magnesium and calcium are known to help suppress cell lysis in
round-cell mutants, although by an unknown mechanism (229, 274). Previous
studies have hypothesised that magnesium, calcium and sucrose may act as
osmoprotectants, preventing cell lysis in round-cell mutants in which cell wall
integrity is compromised and so cells are unable to resist osmotic pressure.
Alternatively it was suggested that magnesium somehow acts to physically stiffen
the cell wall, preventing lysis (229, 274). Another possible explanation is that the
addition of magnesium or calcium also affects FtsZ levels or FtsZ ring formation;
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there is evidence that calcium and magnesium may both be involved in the
regulation of ppGpp production or ppGpp activity, and as such they may affect ftsZ
expression (339-341, 373). Furthermore, magnesium is able to induce FtsZ
monomer oligomerisation in vitro. As such, it may also act to stabilise FtsZ ring
formation in round-cell mutants (342). This is supported by the observation that the
addition of magnesium slightly reduced cell length in wild-type cells. FtsZ is a
major regulator of cell length, through its regulation of cell division rates (335, 336).
As such, magnesium may have affected cell size through FtsZ in wild-type S.
Typhi cells. However, magnesium is known to play a large number of roles in
bacterial physiology, so the mechanism(s) by which it restores stability to round-
cell mutants are likely to be complex (229). This hypothesis also does not explain
why magnesium may be required for round-cell mutant viability at low
temperatures, particularly at 4°C where the addition of magnesium was observed
to significantly reduce cell lysis.
Rod-shaped S. Typhi ΔybeB, ΔybeA and ΔrlpA mutants
Until now, the morphology of ΔybeB and ΔybeA mutants has not been properly
characterised. A previous study isolated ΔybeB mutants with morphological
defects similar to ΔpbpA or ΔrodA mutants, although these defects were likely due
to polar effects on pbpA and rodA expression; a feature which was also seen in S.
Typhi ΔybeB and ΔybeA mutants of this study, prior to removal of the kanamycin
resistance cassette (188). Morphological defects in ΔybeA mutants have not been
noted, although minor growth defects in an E. coli ΔybeA mutant were observed,
with growth at 37°C in rich medium (194, 196).
The present study demonstrated that unlike ΔpbpA and ΔrodA mutants, S. Typhi
ΔybeB and ΔybeA mutants retained a rod-shaped morphology, showing that these
genes do not play a direct role in cell shape determination. Also, neither mutant
displayed significant growth or division defects, or temperature sensitivity
phenotypes. However ΔybeA cells in particular appeared to have a slightly
reduced length compared to wild-type cells (Chapter 4.1, 4.2 and 4.3.3).
As previously mentioned, cell size is regulated by the rate of cell division, and
hence by the major cell division protein FtsZ. Overproduction of both FtsZ and
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ppGpp cause a reduction in cell size (130, 331, 335, 336). Upstream of FtsZ, cell
size is coordinated by environmental factors and nutrient availability. As such
nutrient rich conditions cause an increase in cell size and growth rates, whilst
nutrient starvation brings about the reverse (333-335). YbeA (or RlmH) is a
methyltransferase, responsible for the methylation of a specific pseudouridine
residue within the 23S ribosome subunit rRNA. This step occurs in the final stages
of ribosome biosynthesis and may act as a checkpoint, allowing translation to
proceed (194). The interruption of this step may cause downstream effects on
protein synthesis, ultimately leading to a necessary reduction in growth rate,
accompanied by the observed reduction in cell size. Alternatively, it is possible that
the slight reduction in size of ΔybeA mutants is caused by direct overproduction of
FtsZ and/or ppGpp in these cells. This echoes the situation in ΔpbpA and ΔrodA
mutants and may highlight a functional link between ybeA and pbpA/rodA,
whereby mutations in each gene have certain similar effects, stimulating FtsZ
overproduction. Similar growth defects were observed in ΔybeA mutants and
round-cell Δmrd/Δmre mutants in previous work, although in the present study
growth of the ΔybeA mutant was only very slightly reduced (Chapter 4.3.3) (194,
196).
Previous work demonstrated that ΔrlpA mutants of E. coli, S. Typhi and S.
Typhimurium do not display morphological, growth or division defects, suggesting
that this gene is not directly involved or essential in lateral cell wall synthesis
(Chapter 4.1 and 4.3) (163, 179, 201). However, scanning electron microscopy
analysis of S. Typhi ΔrlpA mutants in this study highlighted possible cell surface
abnormalities on these cells, although further analysis is needed to verify these
observations (Chapter 4.2). The rough surface appearance of some ΔrlpA cells
may be suggestive of outer membrane protrusions, similar to those observed with
polymyxin B treatment, an antibiotic which is thought to integrate into the outer
membrane, increasing its surface area and therefore forcing excess membrane to
project out of the cell (273). RlpA is an outer membrane protein involved in
peptidoglycan binding (179, 201). If RlpA plays a significant role in maintaining
peptidoglycan-outer membrane associations, the disruption of this role through the
inactivation of rlpA may be expected to be associated with a loosening of outer
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membrane-peptidoglycan connections, with a consequent extrusion of sections of
the outer membrane, as has been observed.
9.3.2 Virulence factor functionality in mrd operon mutants
The expression and functionality of the major Salmonella virulence factors were
tested in each mrd operon mutant of S. Typhi, by means of a number of
phenotypic assays and microarray analysis (the latter being carried out in S.
Typhimurium ΔrodA) (Chapter 5 and 6).
Examination of virulence factor functionality in the ΔybeB, ΔybeA and ΔrlpA
mutants suggested that these mutants remained pathogenic, as wild-type (the
majority of virulence screens for the ΔrlpA mutant were carried out in a previous
study (163)). The major SPI-1 and SPI-2 type three secretion systems (T3SS),
essential for invasion and intracellular survival respectively, remained actively
expressed. Other important virulence traits, such as motility and Vi capsule
expression, were also functional and actively expressed in these mutants (4).
However virulence was markedly affected in ΔpbpA and ΔrodA mutants of both S.
Typhi and S. Typhimurium (163). The present study showed that major virulence
determinants involved in initial invasion were completely down-regulated in these
mutants in S. Typhi. Phenotypic assays were backed up by transcriptional reporter
assays, showing that motility and SPI-1 genes were almost completely
downregulated in these mutants from the level of the master transcriptional
regulators of these systems, flhDC and hilD, respectively (Chapter 5.2.4 and 5.3.2).
Microarray data also showed that the vast majority of SPI-1 genes and
motility/chemotaxis genes were downregulated at least 5-fold in the S.
Typhimurium ΔrodA mutant. Expression of flhDC and to a greater extent hilD, was
also significantly reduced (Chapter 6.1.1). In contrast, the SPI-2 T3SS and the Vi
capsule, virulence factors required later for intracellular survival and systemic
spread, remained functional and actively expressed in these mutants (the former
being expressed in SPI-2-inducing conditions). Microarray data also suggested
that expression of the majority of SPI-2 genes was not affected in S. Typhimurium
ΔrodA, and the sensor kinase regulator of SPI-2, ssrA, was upregulated in this
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mutant (Chapter 5.5 and 6.1.2). In addition, a SPI-1 encoded iron transporter
which aids intracellular survival but not invasion of Salmonella, was upregulated in
the S. Typhimurium ΔrodA mutant (410).
It was speculated that the differences in SPI-1/motility and SPI-2 functionality in
round-cell mrd operon mutants may relate to the spatial placement of these
organelles within the cell wall. In agreement with previous work,
immunofluorescence microscopy demonstrated that SPI-2 T3SS needles are
expressed only at the cell poles in wild-type Salmonella. Conversely, SPI-1 and
flagella organelles are spread across the whole surface of Salmonella cells
(Chapter 5.2.5, 5.3.1 and 5.5.2) (54, 226-228). In light of the models of two modes
of peptidoglycan synthesis, involving separate lateral and septal cell wall synthetic
complexes, it is plausible that the localisation and functionality of the SPI-1 and
SPI-2 needles may depend upon the functionality of the lateral and septal
peptidoglycan synthase complexes respectively.
For instance, cytoskeletal elements such as MreB may be involved in the
localisation of multiprotein complexes other than the cell wall synthesis machinery,
such as virulence determinants (173, 222). If this is the case, the distribution of
SPI-1 and SPI-2 T3SS needles may result from alternate cytoskeletal factors
specifically directing their localisation. As such, the inactivation of ΔpbpA or ΔrodA,
which may also disrupt MreB helices (126, 131), may have resulted in the mis-
localisation and dysfunction of SPI-1, but not SPI-2 needles.
Alternatively, the disruption of lateral cell wall synthesis in round-cell mutants, and
any associated lateral cell wall-specific structural defects, may lead to the
perturbation of SPI-1, but not SPI-2 needle assembly. Furthermore any wall-
contained signals directing SPI-1 and flagella organelles to localise in the lateral
cell wall specifically, could result in the mis-localisation and mis-assembly of SPI-
1/flagella structures in round-cell mutants, since in these mutants lateral cell wall
synthesis is replaced with constitutive septal peptidoglycan synthesis. If SPI-2
needle assembly is associated specifically with areas of polar peptidoglycan, the
constitutive activation of septal peptidoglycan synthesis may likewise cause SPI-2
assembly to remain unaffected. However, to date no structural or chemical
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differences between septal and lateral cell wall peptidoglycan have been found,
although polar peptidoglycan is known to be metabolically inert (122, 201, 477).
Further experimentation was needed to test the above hypotheses, initially by
determining whether SPI-1 and motility functionality could be restored simply with
the recovery of SPI-1 and flagella gene expression. It was subsequently
demonstrated that the SPI-1 and motility defects in ΔpbpA and ΔrodA mutants
were predominantly caused by downregulation of the SPI-1 and flagella genes;
restoration of flhDC or hilD expression in trans was sufficient to restore significant
motility functionality and surface expression of SPI-1 needles respectively, to both
ΔpbpA and ΔrodA mutants of S. Typhimurium (Chapter 7). In addition, mecillinam-
treated wild-type S. Typhi cells were recovered which retained significant ability to
swim, despite being completely round in morphology (Chapter 5.2.3). These
results importantly demonstrated that the motility and SPI-1 defects were not due
to defects in the assembly of these organelles, either resulting from perturbations
to the integrity of the lateral cell wall, or due to the disruption of cytoskeletal
elements causing the mislocalisation of SPI-1 and flagella structures.
The demonstration that the SPI-1 and motility defects were caused by active
downregulation of the motility and SPI-1 genes opened up further questions as to
the nature and identity of the regulatory signals involved in repressing flhDC and
hilD transcription, which further work sought to investigate.
9.3.3 Virulence of round-cell mrd operon mutants in vivo
In addition to testing virulence factor functionality in vitro, it was ultimately
important to assess the actual virulence of mrd operon mutants in vivo, in the
mouse model, particularly for the ΔpbpA and ΔrodA strains. S. Typhimurium
ΔpbpA and ΔrodA were subsequently shown to be significantly attenuated for
virulence in vivo (Chapter 5.7). This attenuation was independent of SPI-1, as
bacteria were inoculated intravenously in order to bypass SPI-1-dependent stages
of infection. This was done since in vitro data had demonstrated that invasion-
associated virulence genes were downregulated. The observed attenuation of
ΔpbpA and ΔrodA mutants was contrary to expectations, as data suggested that
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the SPI-2 T3SS remained functional in these mutants, and that several genes
involved in intracellular survival were upregulated. Also, in vivo assays with
ΔmreCD mutants conducted previously had shown that these mutants remained
virulent with intravenous inoculation (unpublished data) (368). This is one of the
first indications of phenotypic differences between round-cell mrd and mre operon
mutants (130). The attenuation of ΔpbpA and ΔrodA mutants may be explained by
possible increases in the sensitivity of these cells to growth in the nutrient-starved
in vivo environment, or to host cell defence mechanisms. However, the sensitivity
of these strains to oxidative stress, such as would be experienced in vivo inside
the macrophage, was shown to be equivalent to the wild-type in vitro (Chapter
4.3.9).
Several factors may account for the differences seen between the virulence of
round-cell mutants in vivo and in vitro. The in vitro growth of the mutant strains,
even in SPI-2-inducing conditions, cannot be well compared with the highly
complex in vivo situation. It is also known that bacteria grown in vivo and in vitro in
standard laboratory media, are very different in terms of their physiology and cell
envelope composition in particular (480). As such, it may not come as a surprise
that ΔpbpA and ΔrodA mutants appear to behave differently in vivo. In these
conditions, many other factors will come into play, affecting the surface properties,
and perhaps SPI-2 functionality in ΔpbpA and ΔrodA mutants. It may be that in
these conditions, the general cell envelope integrity is so compromised in these
mutants that it cannot well withstand environmental stress and host immune
mechanisms. Also, though in vitro data showed that SPI-2 needles were actively
expressed at the cell surface in round-cell mutants it is possible that, for whatever
reason, these needle complexes remain non-functional or non-secretory, resulting
in attenuation in vivo.
In the course of the in vivo assays, S. Typhimurium ΔpbpA and ΔrodA mutant
levels in both the livers and spleens of the mice gradually dropped, although the
mice were not able to clear the infection in the 28 days. It is possible that these
mutants were not completely attenuated in vivo, although in vivo assays
conducted for a longer period would be needed to determine this.
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9.4 Regulation of virulence phenotypes in round-cell mutants
As well as demonstrating that invasion-associated virulence determinants were
downregulated in round-cell mrd mutants, the various phenotypic assays and
microarray analysis of the ΔpbpA and ΔrodA mutants also highlighted several
interesting features concerning the physiology of these cells, particularly in terms
of cell surface features. Further work was therefore necessary to identify global
factors responsible for the regulation of both invasion genes and the general
physiology of round-cell mutants.
9.4.1 Microarray analysis of global regulator expression in round-cell
mutants
It was hoped that microarray transcriptional profiling data of S. Typhimurium ΔrodA
cells would highlight potential global regulators involved in the control of virulence
gene expression in round-cell mutants. The microarray expression data of several
major global regulators, including the major stress response regulators, was
therefore analysed (Chapter 6.1.3). Although several global regulators were
significantly altered in this mutant, including genes such as rpoE and cpxA,
involved in regulating envelope stress responses (cpxA also regulates SPI-1
expression (478)), expression of other major transcriptional regulators of motility or
SPI-1 genes, such as the Rcs phosphorelay, OmpR, H-NS and CsrA, were
surprisingly not significantly changed from the wild-type (≥2-fold difference from
wild-type, with P values of ≤0.05) in these arrays (109, 110, 216). lrhA, a major
transcriptional repressor of flhDC, was also downregulated in the ΔrodA mutant.
9.4.2 rcsC and the Rcs phosphorelay as a putative regulator of virulence
gene expression in round-cell mrd operon mutants
In addition to analysing the microarray data, it was crucial to examine
experimentally possible global regulators involved in controlling the virulence
phenotypes of the round-cell mutants. A transposon mutagenesis screen was
implemented to identify double mutants of the S. Typhimurium ΔrodA strain in
which motility was recovered. This screen resulted in the identification of two
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possible factors involved in motility and SPI-1 gene regulation in round-cell
mutants: rcsC and pagN (Chapter 8.2).
Approximately 60% of the motile ΔrodA revertants isolated in the transposon
mutagenesis screen contained mutations within rcsC, encoding the sensor kinase
component of the Rcs phosphorelay two component system (Chapter 8.2) (119).
In S. Typhimurium ΔrodA rscC::Tn10d(Tc) mutants, significant levels of motility
and SPI-1 expression were recovered, although SPI-1 needles were not observed
at the surface of these cells, and the level of motility recovered varied between
individual rscC::Tn10d(Tc) mutants. Also, specific knockout mutants of rcsC were
generated in ΔpbpA and ΔrodA strains of S. Typhimurium, in which motility was
only slightly recovered, and SPI-1 effector protein expression was not observed
(Chapter 8.6). RcsC and the Rcs phosphorelay as a whole presents itself as a
likely candidate for involvement in motility and SPI-1 gene regulation in response
to mutations in pbpA or rodA. The Rcs phosphorelay is well known as a global
envelope stress response pathway in Salmonella; in response to osmotic and
envelope stress the Rcs phosphorelay activates genes involved in survival in
unfavourable conditions, including colanic acid biosynthesis and SPI-2 genes. It
also represses both SPI-1 and flagella expression. As such the Rcs phosphorelay
is also involved in intracellular survival (118, 119, 318, 400).
The repeated isolation of rcsC mutants in the transposon mutagenesis assay
suggests that rcsC indeed plays a major role in regulating SPI-1 and flagella gene
expression in ΔpbpA and ΔrodA mutants. The overexpression of colanic acid
biosynthesis, combined with the SPI-1 and motility repression in round-cell
mutants is in agreement with expectations from overexpression of the Rcs
phosphorelay in these mutants. Furthermore, a study by Laubacher and Ades
showed that expression of the rcs genes was induced specifically from the
inactivation of PBP2 through mecillinam treatment of E. coli cells (118).
Expression data of the rcsB, rcsC, rcsD and rcsF genes, major components of the
Rcs phosphorelay, was however, not statistically significantly in the S.
Typhimurium ΔrodA microarrays of the present work. The nature of this regulatory
system as an envelope stress response pathway which responds to peptidoglycan
stress, also makes it a highly likely candidate for involvement in the detection of
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and responses to defects induced by the inactivation of ΔpbpA or ΔrodA (118,
119). In summary, it is proposed that in response to the inactivation of ΔpbpA and
ΔrodA in Salmonella, cell wall and morphological defects lead to the activation of
the Rcs phosphorelay, which goes on to play a significant role in the
downregulation of SPI-1 and motility genes, resulting in the observed phenotypes.
However, the variable data concerning the extent to which SPI-1 and motility
functionality could be restored in ΔpbpA/ΔrodA ΔrcsC double mutants sheds doubt
on this hypothesis. Also it is interesting that mutations in the other major
components of the Rcs phosphorelay were not isolated in this work. It is likely that
other global transcriptional regulators, as well as post-transcriptional regulatory
mechanisms are also involved in feeding into and the complex regulation and fine-
tuning of SPI-1 and motility expression in ΔpbpA and ΔrodA mutants, leading to
the variation seen. It must also be noted that rcsC functions both as a kinase and
a phosphatase enzyme. As such, the inactivation of rcsC does not completely
inactivate Rcs phosphorelay signalling (463-465). This factor may be another
reason for the observed variability in the recovery of motility and SPI-1 in
ΔpbpA/ΔrodA ΔrcsC double mutants.
9.4.3 pagN as a putative regulator of virulence gene expression in round-cell
mrd operon mutants
The transposon mutagenesis screen also isolated a ΔrodA pagN::Tn10d(Tc)
mutant of S. Typhimurium in which motility was recovered. Unlike rcsC, a pagN
mutant was isolated only once in this assay and once in a parallel ΔmreCD
Tn10d(Tc) mutagenesis screen (unpublished results of this lab). Similarly to ΔrodA
rscC::Tn10d(Tc) mutants, motility and SPI-1 gene expression was recovered in
ΔrodA pagN::Tn10d(Tc) mutants, but not significantly recovered in ΔrodA ΔpagN
knockout mutants (Chapter 8.3, 8.4 and 8.6).
PagN is a SPI-6-encoded outer membrane adhesin protein which assists in
invasion and virulence in Salmonella infections. It is positively regulated by
PhoP/PhoQ, and as such is upregulated in the intracellular stages of Salmonella
infection (38, 397, 422, 423, 425). In support of hypotheses that genes important
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for intracellular survival remain actively expressed in round-cell mutants, pagN
was shown to be upregulated nearly 3-fold in the ΔrodA mutant in microarrays
(Chapter 6.1.2). PagN may also compensate for a lack of SPI-1 in some way,
possibly assisting in the exiting of cells (423). A role for PagN in the regulation of
virulence genes has not previously been recognised, however. The isolation of
PagN in these assays is therefore of considerable interest. In its function as an
outer membrane adhesin and invasin, it is possible that the interaction of PagN
with host cells results in signalling to the bacteria, informing the cell of its position
and therefore inducing invasion. In a similar light, PagN may be involved in
passing information into the cell concerning environmental conditions, or cell wall
factors specifically. However, a great deal of work is required to determine how
PagN may be involved in motility and SPI-1 gene regulation in round-cell mrd
mutants.
The isolation of both rcsC and pagN in this work provides further evidence that the
pathways controlling virulence gene regulation in response to the inactivation of
pbpA and rodA are complex, involving multiple factors.
9.4.4 c-di-GMP as a putative regulator of motility and SPI-1 functionality in
round-cell mrd operon mutants
The complexity of these regulatory pathways was further established with the
investigation of the role of c-di-GMP in motility and SPI-1 regulation in round-cell
mutants (Chapter 8.7). c-di-GMP is a major post-transcriptional regulator of both
biofilm formation and motility, whereby increased levels of this secondary
messenger lead to an increase in biofilm formation and factors associated with a
sessile lifestyle, and a concurrent decrease in motility. The mechanisms by which
c-di-GMP controls motility are not fully understood (95, 403, 453). The expression
of several major EAL domain proteins, responsible for the degradation of c-di-
GMP, was altered in the S. Typhimurium ΔrodA mutant at the level of transcription.
In particular, yhjH, encoding a major c-di-GMP phosphodiesterase in Salmonella,
was downregulated nearly 50-fold in the ΔrodA mutant, according to microarray
data (Chapter 8.7.2). This EAL domain protein has been shown to affect motility to
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a greater extent than biofilm formation, through its influence on c-di-GMP levels
(459, 466).
Furthermore, convincing preliminary data demonstrated that c-di-GMP levels in S.
Typhi ΔrodA cells were significantly increased compared to the wild-type (Chapter
8.7.3). These results demonstrated that c-di-GMP may be involved as another
level of control, in the regulation of SPI-1 and motility expression, as well as
extracellular polysaccharide biofilm synthesis. The involvement of additional
factors such as c-di-GMP may also explain why motility was not fully restored in
round-cell mutants with the recovery of hilD or flhD expression, or through the
inactivation of rcsC alone.
Further work is certainly needed to better establish the role of c-di-GMP, and YhjH
in particular, in round-cell mutants, as well as determining whether any direct links
exist between the c-di-GMP and Rcs (and other) regulatory pathways in these
mutants.
9.5 Surface properties and physiology of the mrd operon mutants, and
activity of the global stress response pathways
9.5.1 The cell envelope and global stress response pathways in Salmonella
In the course of this study, analyses sought firstly to phenotypically characterise
the mrd operon mutants, and then secondly to further describe the regulatory
mechanisms involved in controlling virulence in response to the inactivation of
pbpA and rodA. As a result of these several interesting features have come to light
concerning the physiological state of round-cell ΔpbpA and ΔrodA mutants of
Salmonella, as will now be discussed.
The bacterial cell wall is crucial as a stress-bearing molecule which helps resist
internal turgor pressure, preventing cell lysis (124, 125, 213). The cell envelope as
a whole plays an essential barrier function in Salmonella, forming the first line of
defence against exposure to harmful substances and environmental stress,
including osmotic, oxidative and pH stress, as well as drugs, toxic molecules and
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the host immunity. In addition, the ability of the cell envelope to sense
environmental conditions is extremely important. As such, factors which disrupt
cell wall synthesis and the general structure of the cell wall may have significant
and wide-ranging effects on the sensitivity of Salmonella cells to environmental
stress and host defence mechanisms (216, 428, 479, 480). Likewise, increased
sensitivity to environmental stresses may be indicative of perturbations to the cell
envelope structure (122, 173, 301, 302, 481). Furthermore, the major alternative
sigma factor regulating the envelope stress response, RpoE, upregulates factors
involved in cell envelope biosynthesis, in response to envelope stress (216, 293,
306, 307).
The importance of the cell envelope is such that a number of major regulatory
systems are necessarily in place to detect and respond to perturbations to its
structure and integrity. A number of envelope stress response pathways exist, and
have been well characterised (216, 428). These responses are controlled by
global regulators including the alternative sigma factor RpoE (σE), the phage stock
response regulated by the psp operon genes, and various two-component
systems including CpxAR, BaeSR, and the Rcs phosphorelay (118, 216, 428, 429).
The CpxAR two component system is also able to regulate rpoE expression (428,
429). The environmental factors which contribute to the activation of these
systems in Salmonella include heat/cold shock, oxidative stress, nutrient starvation,
osmotic stress, acid stress, onset of stationary phase, and in vivo growth, as well
as the presence of misfolded periplasmic proteins (428). The Rcs phosphorelay in
particular is also able to respond to LPS- and peptidoglycan-associated stress, as
already described (118).
The envelope stress response pathways are also directly connected with virulence
in Salmonella; RpoE is required for intracellular survival and helps regulate SPI-2
genes, whilst cpxA regulates hilA expression and is required for virulence in vivo.
The Rcs phosphorelay is known to activate SPI-2 expression and repress SPI-1
and motility (118, 216, 318, 428, 429, 482). The action of other major stress
response pathways in Salmonella also affects virulence. For instance, PhoP/PhoQ
and OmpR/EnvZ are both involved in SPI-1 and SPI-2 virulence regulation (98,
397).
304
Previous studies to have analysed round-cell mutants or cells treated with A22 or
mecillinam, in various bacteria, have described several features of these cells
indicative of significant perturbations to the cell wall/envelope structure and
integrity, as would be expected from the inactivation of proteins essential for lateral
cell wall synthesis. These features include morphological defects and a tendency
of these cells to lyse, whilst increased sensitivities to various environmental
stresses including temperature, osmotic stress, oxidative stress, and various drugs,
have also been documented (127, 130, 211, 214). However, despite these
observations, the activity of global stress response pathways have been largely
overlooked, or at least not studied in detail, although one study noted that several
major stress response pathways were upregulated in mecillinam-treated E. coli
cells, including rpoE, cpxAR, fur and the Rcs phosphorelay (118). The
consideration of global stress responses is important as these pathways have
global impacts on the physiology and behaviour of the cell as a whole, and may
provide further clues towards the function of cell shape determinant genes.
9.5.2 Surface properties of the mrd operon mutants and sensitivity to
external stress
A number of phenotypic tests were applied to specifically ascertain what effects
the inactivation of mrd operon genes had on the structure of the cell envelope as a
whole, and the integrity its barrier function (Chapter 4.3.7). This work aimed to
provide insights into both mrd gene function and the resulting downstream
physiological states of each mutant, particularly in terms of identifying putative
global stress response pathways likely to be involved in flagella and SPI-1 gene
expression in the ΔpbpA and ΔrodA mutants.
Few studies to date have assessed the wider effects of ΔpbpA and ΔrodA mutants,
or other mrd operon mutants on components of the cell envelope besides
peptidoglycan structure (127, 130). In 2008 Bendezú and de Boer described
effects of round-cell mrd and mre mutants on the inner membrane, whereby
spherical mutants were unable to regulate rates of phospholipid synthesis. As
such, these cells produced excess cytoplasmic membrane which folded inwards to
form intracellular vesicles (130). These mutants also may have increased
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sensitivity to external stress, possibly through alterations to the cell envelope
barrier function (211, 214). A number of studies have also recognised that round-
cell mutants or mecillinam-treated cells are often mucoid, indicative of excess
colanic acid and biofilm production (315, 323, 325).
This latter feature was observed in ΔpbpA and ΔrodA mutants of both S. Typhi
and S. Typhimurium in the current study, as previously noted. Growth of these
mutants on Congo red agar demonstrated that biofilm or cellulose synthesis was
significantly increased in round-cell mutants compared to the wild-type (Chapter
4.3.7). The tendency of these cells to form large clumps in liquid culture may also
have been caused by excess biofilm formation. Furthermore, microarray analysis
of the S. Typhimurium ΔrodA mutant showed that a number of genes involved
colanic acid biosynthesis were strongly upregulated (Chapter 6.1.2). Colanic acid
and cellulose are extracellular capsular polysaccharides, which form an integral
part of mature biofilms in Enterobacteriaceae (313, 372, 401, 471, 483). This
phenotype may be indicative of the involvement of regulatory pathways controlled
by the Rcs phosphorelay, or c-di-GMP as already discussed (118, 119, 400, 484).
Lipopolysaccharide (LPS) forms the major constituent of the outer leaflet of Gram-
negative outer membrane (294, 295). LPS provides innate defence against
environmental stress and in particular prevents the diffusion of small hydrophobic
molecules, such as antibiotics, into the cell. LPS biosynthesis is also upregulated
with envelope stress (301-303). LPS O-side chain structure remained unaltered in
ΔybeB, ΔybeA, and ΔrlpA mutants of S. Typhi, as demonstrated by SDS-PAGE
analysis (Chapter 4.3.7). ΔpbpA and ΔrodA mutants of S. Typhi also seemed to
express the full length O-side chains. However, LPS profiles of these mutants did
appear slightly different to the wild-type, with significant smearing on LPS gels,
possibly due to overproduction of LPS in these strains. Alternatively, other features
of these mutants may have affected the purity of the LPS extracts, leading to the
observed smearing. Hydrophobic antibiotic testing of each mrd operon mutant was
carried out to further test for possible changes to LPS integrity. However, these
results showed only a very slight increase in sensitivity of the round-cell mutants of
S. Typhi to rifampicin and erythromycin, supporting LPS profiling and suggesting
that LPS structure was not much affected or compromised in round-cell mrd
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operon mutants. Furthermore, microarray analysis of the lpt genes, encoding
proteins involved in transporting LPS components across the cell envelope to the
outer membrane, showed that their expression was not significantly affected in the
ΔrodA mutant of S. Typhimurium (293). Only lptF, encoding an inner membrane
permease component of the LptBFGC LPS export complex, was upregulated
nearly 2.5-fold in this mutant compared to the wild-type (P value = 0.054) (253).
Interestingly, a previous study also noted that mecillinam-treated E. coli cells did
not show increased sensitivity to hydrophobic antibiotics (118).
Other assays hinted at possible effects on the cell envelope structure in mrd
operon mutants, although more work is needed to verify or quantify these findings.
For instance, slide agglutination assays in the S. Typhi mrd operon mutants
highlighted a possible upregulation of Vi capsule expression in round-cell mutants,
as shown by the apparent increased rate and extent of agglutination of these
strains in the presence of Vi-agglutinating antiserum (Chapter 5.6).
Potential differences in the composition of the outer membrane were noted from
microarray data, which showed that the expression of a number of outer
membrane proteins was significantly altered in S. Typhimurium ΔrodA cells
(Chapter 6.1.2). This included an OmpX-like protein, encoded by stm3031, which
was upregulated over 200-fold in the ΔrodA mutant. Microarrays with an ΔmreCD
mutant and an A22-treated wild-type strain showed that stm3031 was also one of
the most highly upregulated genes in each of these strains (unpublished work of
this lab). OmpX-like protein is implicated in resistance to Ceftriaxone, an antibiotic
which targets the penicillin-binding proteins (412, 413, 416, 417). As such, the
overexpression of stm3031 may be indicative of a defence mechanism employed
by Salmonella to protect against further cell wall stress. A large number of genes
encoding cell envelope-associated proteins were upregulated in S. Typhimurium
ΔrodA, as shown by microarray data. The majority of these were genes encoded
components of nutrient transporters, such as the SPI-1-encoded iron transporter
along with several transporters involved in osmoprotectant transport. Likewise,
these data may be indicative of inherent defence mechanisms induced by round-
cell mutants to protect cells against external stress and to maintain viability. It is
also possible that the increased volume of ΔpbpA and ΔrodA mutant cells leads to
307
a requirement for increased nutrient uptake, with the subsequent increase in
transporter gene expression. In addition, the microarray data highlighted
potentially major changes in the protein composition of the inner and outer
membranes of round-cell mrd operon mutants, although further work, such as 2D
PAGE and outer membrane protein profiling is needed to further examine protein
expression in these mutants.
Oxidative stress sensitivity assays were carried out in each mrd operon mutant,
testing the susceptibility of each strain to hydrogen peroxide. These assays
surprisingly showed that despite the potentially major effects of ΔpbpA or ΔrodA
mutations on the cell wall structure, the sensitivity of these strains to oxidative
stress was not significantly heightened.
9.5.3 Evidence for the upregulation of global stress response pathways in
Salmonella mrd operon mutants and their effects on mutant phenotypes
Data from this study suggests that stress response pathways, and envelope stress
response pathways in particular, play a major role in contributing to the
phenotypes associated with round-cell ΔpbpA and ΔrodA mutants, and especially
the virulence phenotypes in these strains.
It was initially predicted that the inactivation of pbpA or rodA would physically
disrupt the localisation or assembly of virulence organelles such as the SPI-1/SPI-
2 T3SSs and flagella, in the bacterial cell wall. However, it has become apparent
that the SPI-1 T3SS and motility defects are caused by the downregulation of the
major transcriptional regulators of these genes. This downregulation is thought to
be mediated by several global stress response pathways. The isolation of motile
ΔrodA rcsC::Tn10d(Tc) mutants suggests that the Rcs phosphorelay plays a major
role in responding to envelope stress in round-cell mutants, acting to repress SPI-
1 and motility genes, as previously discussed. Furthermore, microarray data
demonstrated that both RpoE and CpxA were upregulated in the S. Typhimurium
ΔrodA mutant. RpoS, another alternative sigma factor regulating global stress
responses, was also upregulated ~2-fold in this mutant (98). Aside from global
regulators, a large number of stress-related genes, including heat shock proteins,
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DNA repair genes and envelope stress genes were also among the most highly
upregulated genes in S. Typhimurium ΔrodA (Chapter 6.1.2). The active
expression of SPI-2, Vi capsule production and colanic acid overexpression add
further weight to this prediction, as many of the stress response pathways act to
upregulate genes involved in intracellular or stationary phase survival in ‘stressful’
environmental situations, including SPI-2, Vi capsule and biofilm/colanic acid-
associated genes (118, 318, 98, 397).
Furthermore, ftsZ is known to be overexpressed in round-cell mutants, helping to
prevent cell lysis (130). ftsZ expression is regulated both directly and indirectly by
the global stress response pathways, including RpoE, CpxAR, RcsCDB (211, 321,
322). Expression of ftsZ is also induced by the alarmone ppGpp, which itself is the
regulator of RpoE (337, 338, 485, 486). The upregulation of ftsZ in round-cell
mutants may be caused directly by the upregulation of upstream stress response
pathways.
Previous studies have suggested that round-cell mutants displayed increased
sensitivity to various forms of environmental stress, something which would be in
line with the proposed activation of global stress response pathways (211, 214).
Similarly, the sensitivity of round-cell mutants to cold-shock, along with the
tendency to lyse, and the dependency of these mutants upon magnesium/calcium
for growth, also point towards significant cell envelope defects and thus a likely
upregulation of general and envelope stress response pathways. In addition, the
overexpression of capsular polysaccharides and possibly the Vi capsule in S.
Typhi, the formation of inner membrane vesicles as previously noted (130),
upregulation of certain outer membrane proteins, and possible changes in LPS
expression tend to suggest that the bacterial envelope as a whole is significantly
affected in ΔpbpA and ΔrodA mutants.
However, the observation that the oxidative stress sensitivity of ΔpbpA and ΔrodA
mutants was not significantly increased, along with the ability of these cells to
assemble functional multi-protein wall-spanning complexes, and the generally
retained structural integrity of the LPS layer, all may suggest that defects in the
cell wall/envelope structure of ΔpbpA or ΔrodA mutants are not as severe as
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originally proposed. Alternatively, it may be that the perturbations to the cell wall
integrity in these mutants are counteracted by the upregulation of stress defence
mechanisms, which are highly effective in restoring barrier function in these cells.
However, more comprehensive studies are necessary to fully characterise cell wall
defects in round-cell mutants.
In conclusion, these results reveal a situation whereby the inactivation of pbpA or
rodA, and associated downstream peptidoglycan structural defects, are thought to
bring about the activation of a number of global stress responses, including the
major envelope stress response pathways such as the Rcs phosphorelay. It is the
direct regulation from these responses which may bring about the observed
phenotypes in round-cell mutants, leading to the suppression of SPI-1 and motility
functionality. These pathways may also play a major role in maintaining viability in
round-cell mutants, for instance by upregulating FtsZ to prevent cell lysis, and by
effectively responding to increased stress-sensitivity.
9.6 Further analysis of mrd operon gene function
9.6.1 Physiology of round-cell mutants and clues into pbpA and rodA
function
The observations concerning the upregulation of major stress response pathways
in round-cell ΔpbpA and ΔrodA mutants may provide further clues as to the
precise effects that the inactivation of pbpA or rodA have on cell wall structure,
and hence the roles of these genes. However, the major global stress response
pathways are each highly complex, and able to detect and respond to a number of
factors. Hence, the activation of a particular stress response pathway cannot
necessarily be said to result from the detection of any single feature, be it
compromised peptidoglycan structure or increased sensitivity to certain
environmental factors in the ΔpbpA and ΔrodA mutants. It is therefore difficult to
determine from this study which precise features play a particular role in activating
the stress responses.
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The activation of the Rcs phosphorelay, however, may provide significant insights.
The Rcs phosphorelay is able to detect and respond to peptidoglycan stress
specifically, a property not yet recognised in other envelope stress response
pathways. Activation of the Rcs phosphorelay resulting from perturbations to the
peptidoglycan caused by the inhibition of PBP2, has been shown to involve RcsF,
an outer membrane lipoprotein which induces Rcs phosphorelay signalling (118,
467, 487). The mechanism by which RcsF acts has not been characterised,
although it is thought that in response to perturbations to the outer membrane,
osmotic shock, or treatment with the antibiotic polymyxin B (which also affects the
outer membrane), RcsF activates the Rcs phosphorelay (118, 484, 487, 488). The
nature of the involvement of RcsF in the ΔpbpA and ΔrodA phenotypes has not
been noted within the present study, and future work examining this further may
be useful. However, should RcsF play a significant role, it may highlight important
links between PBP2/RodA-mediated peptidoglycan synthesis and the structure
and integrity of the outer membrane of Salmonella. As such, peptidoglycan
synthesis and outer membrane integrity may be intimately linked. Microarray data
suggested that the makeup of the outer membrane may be significantly affected or
altered in ΔrodA mutants, supporting this hypothesis.
Phenotypic data in this study also supported previous work, showing that both
ΔpbpA and ΔrodA mutants were resistant to A22 (Chapter 4.3.5) (281). The
interdependence of cell shape determinant proteins is not fully understood,
although to clarify this would help with establishing the function of each protein
(131). Studies have also shown that PBP2 localisation was not affected with the
disruption of MreB via A22 treatment of C. crescentus cells (137). In other work,
the localisation of MreB helices was found to be dependent on RodA but not PBP2
(126, 131). These data suggest that the relationship between PBP2 and MreB
differs from that of RodA and MreB in rod-shaped bacteria. As such, it may be
surprising to find that both ΔpbpA and ΔrodA cells possess the same A22-
resistance, perhaps indicating that PBP2 is more closely linked to MreB, along
with RodA, than has been realised. Alternatively, the resistance of these strains to
A22 may simply be due to the fact that since these cells are already round, with
cell wall synthesis defects, the addition of A22 cannot do much to further impede
cell wall growth.
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The majority of studies have shown that the mutant phenotypes are similar, if not
indistinguishable, between different round-cell mrd/mre knockout mutants (130).
This has also been seen in the present study, where on the whole ΔpbpA and
ΔrodA had identical mutant phenotypes. However, minor phenotypic differences
may provide clues into the function of RodA in particular, whose function is
unknown. As well as the different localisation dependencies already mentioned,
data from this study highlighted significant differences in the virulence of
ΔpbpA/ΔrodA and ΔmreCD mutants of S. Typhimurium. SPI-2 expression is active
in ΔpbpA, ΔrodA and ΔmreCD mutants of S. Typhimurium. However, ΔmreCD
mutants remained virulent in vivo when injected intravenously into mice (previous
work of this lab) (368), whereas in vivo assays of ΔpbpA and ΔrodA mutants
showed that these mutants were attenuated. This result may highlight hitherto
unrecognised properties of PBP2 and RodA, such that mutants have a more
marked effect on cell wall integrity, affecting virulence to a greater extent.
In addition, minor differences were seen in the level of flhDC repression between
ΔpbpA and ΔrodA mutant cells. The greater suppression seen in ΔpbpA mutants
may result from increased activation of regulatory pathways such as the Rcs
phosphorelay, resulting from heightened damage to the cell wall. If this is the case,
it may highlight the importance of PBP2 above RodA, in particular.
9.6.2 Further insights into ybeB, ybeA, and rlpA function
Experimental analyses conducted in this work sought to further describe the
functions of ybeB, ybeA and rlpA, as well as pbpA and rodA, determining whether
any functional relationships existed between the former and latter genes.
Phenotypic assays of the ΔybeB, ΔybeA and ΔrlpA mutants showed that these
strains generally behaved as wild-type, particularly in terms of virulence factor
functionality. However, a number of observations were made, hinting towards the
function of these genes.
ybeB and ybeA
Comparison of the Salmonella YbeB protein sequence with that of the Salmonella
S12 ribosomal protein showed some significant similarities within a short region,
312
which in S12 mapped to the conserved ‘PGVRY’ loop of S12 (Chapter 4.3.6). This
loop is implicated in streptomycin resistance and is important for tRNA recognition
(290). S12 is also the target of streptomycin, which causes mis-reading of tRNA
codons and ultimately a stalling of protein synthesis (288, 289). The YbeB protein
is highly conserved even among distantly related species, suggesting that its
function is important. The finding of this study may indicate that YbeB functions in
a similar manner to S12 in Salmonella. However, the lack of a distinguishing
phenotype for ΔybeB mutants may point towards some redundancy of function.
Furthermore, streptomycin sensitivity was not altered in ΔybeB mutants,
suggesting that this antibiotic does not target YbeB in addition to S12.
To date, a functional relationship between pbpA/rodA and the remaining mrd
operon genes has not been established. Several portions of data from this study
suggest that the 5 genes may not be completely unrelated. Transcriptional
luciferase reporter assays from this study have confirmed hypotheses that ybeB
and ybeA, at least, are co-transcribed along with pbpA and rodA. In addition,
significant mecillinam resistance of both ΔybeB and ΔybeA mutants may be
indicative of a functional relationship. The observation that ΔybeA mutants were
generally shorter in length than wild-type cells was suggestive of FtsZ
overproduction, as previously discussed. Knowing that FtsZ production is also
increased in round-cell mutants, this may present further evidence of a functional
relationship whereby the inactivation of ybeA has some of the same effects on cell
physiology as the inactivation of pbpA or rodA, if less severe.
Any functional link between the ybe genes and pbpA and rodA may also be related
to the localisation of ribosomes, protein synthesis and RNA processing sites; in B.
subtilis ribosomes were shown to localise to the cell periphery and the cell poles
(230, 231). Whilst the localisation of ribosomes to the cell periphery, which is
presumably important for protein synthesis, may occur independently, it is possible
that the bacterial cytoskeleton and associated proteins are involved in directing
ribosome localisation. The close proximity of bacterial ribosomes to the cell
membrane may also indicate a link between active protein synthesis complexes
and the cell wall synthetic complexes.
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Expression of a major T3SS in Shigella sonnei is regulated post-transcriptionally
through regulation of invE mRNA stability, so that in adverse conditions such as
low temperature InvE is not expressed; InvE encodes the transcriptional regulator
of the T3SS structural genes. invE mRNA is thus stable at 37°C but not at 30°C or
low osmotic pressure. Mitobe et al. recently found that the cell shape determinant
protein RodZ has a secondary function in S. sonnei; in directly binding invE mRNA,
RodZ assists in regulating the stability of this molecule in a CpxA-dependent
manner, directly affecting InvE expression. It was suggested that RodZ may
function as an anchor, directing the localisation of mRNA species, helping
constrain post-transcriptional regulation to regions close to the cell membrane
(168). A number of recent studies also demonstrated that RNase E, a major
component of the RNA degradosome, directly binds the cytoplasmic membrane in
E. coli. RNase E also forms cytoskeletal-like structures which, along with other
members of the degradosome, localises helically around the cell periphery in a
manner reminiscent to MreB (489-492). Taken together, these results suggest that
mRNA processing and perhaps general protein synthesis, are localised specifically
at the cell periphery, and possibly associated with other cytoskeletal elements,
along with the cell wall synthesis machinery.
If this is the case, any functional relationship between ybeB, ybeA and pbpA/rodA
may be linked to the apparent associations between translation/mRNA processing
and the bacterial cytoskeleton. For instance, YbeB and/or YbeA may play roles in
directing the localisation of ribosomes. In its role as a possible ‘checkpoint’
methyltransferase, YbeA may also function to ensure that translation begins not
only when ribosomes are correctly assembled, but also when they are correctly
localised. However, YFP-fusion proteins of both YbeB and YbeA appeared to be
spread diffusely through the cytoplasm in S. Typhi cells (Chapter 4.1.6). Assuming
these protein fusions remained functional, this suggests that YbeB and YbeA do
not play a role in ribosome localisation.
Whatever their role, ybeB and ybeA are co-regulated along with pbpA and rodA,
suggesting that important links exist between the regulation of cell wall synthesis
and ribosome assembly or protein synthesis. Given the conserved nature of these
proteins, it is also clear that their function is important (189, 194). The putative
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links between translation and the cytoskeletal proteins, or the cell wall synthesis
machinery, warrant further investigation.
rlpA
Similarly to previous studies, an obvious phenotype for ΔrlpA mutants was also
hard to find. However, some evidence suggests that it may be functionally related
to pbpA and rodA. Both previous work of this lab and the work of Gerding et al.
demonstrated that in certain situations RlpA localised in distinct helical-like foci
along the lateral cell wall, reminiscent of PBP2 and RodA, as well as at the cell
septum. The SPOR domain-containing RlpA protein is also known to bind
peptidoglycan and may play a role in cell division, due to its septal localisation
(163, 179, 201).
RlpA may play a significant role in directing associations between peptidoglycan
and the outer membrane. The distinct localisation patterns of RlpA could indicate
that such a role is specifically important during the course of both septal and
lateral cell wall synthesis (201). Observations of the present study may support
this. Several ΔrlpA mutant cells were noted with distinct surface features, similar to
those seen with polymyxin B treatment (Chapter 4.2). If significant, the observed
surface protrusions may result from significant dissociation of the outer membrane
from the peptidoglycan layer as previously discussed. Alternatively the surface
protrusions also may result from the production of excess outer membrane in
ΔrlpA mutant cells. In round cell mrd mutants, it was noted that cells were unable
to adjust the rate of cytoplasmic membrane synthesis, resulting in excess inner
membrane production (130). In a similar manner, ΔrlpA mutants may be unable to
regulate outer membrane production – speculatively, RlpA may play a role in
helping cells to coordinate outer membrane growth according to rates of
peptidoglycan synthesis and cell wall growth. The disruption of rlpA would, as such,
interfere with this regulation, possibly leading to constitutive overproduction of
outer membrane.
Additional work is needed both to verify these observations and to further
investigate the function of RlpA. Also, the role of RlpA may be masked by
functional redundancy, since several outer membrane lipoproteins are already
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known to play crucial roles in linking the outer membrane to the peptidoglycan
layer in Gram-negative bacteria, including Lpp and Pal, the latter of which is
important in cell division (201, 202). Hypothetically, RlpA may play a temporary
role, being important for maintaining peptidoglycan-outer membrane binding
particularly during the breaking of old peptidoglycan strands and the incorporation
of new peptidoglycan strands into the cell wall, before the more major and
permanent Lpp and Pal proteins come into play.
It was previously noticed that the Rcs phosphorelay is induced by polymyxin B
treatment (118, 488). It would be interesting to determine whether this stress
response pathway is also induced in ΔrlpA mutants.
9.7 Comparisons between S. Typhi and S. Typhimurium mrd mutant
phenotypes
Analyses of S. Typhi and S. Typhimurium mrd operon mutants from both this study
and a previous study (163) showed that the phenotypes of ΔpbpA and ΔrodA
mutants were largely indistinguishable between the two serovars, in terms of both
growth and morphological defects, and virulence factor functionality. S. Typhi
round-cell mutants, however, showed a more stringent requirement for MgCl2 or
CaCl2 supplementation for survival and growth.
However, later results suggested that the regulation of the virulence phenotypes in
response to pbpA/rodA inactivation may differ between the two serovars. Motility
and SPI-1 functionality were recovered in S. Typhimurium round-cell mutants with
restoration of flhDC and hilD expression respectively. The introduction of the
pBAD-hilD expression vector into S. Typhi round-cell mutants, however, did not
bring about a recovery of SPI-1 expression (Chapter 7.3.2). In this instance, it was
thought that hilD expression from the pBAD vector may have been prevented in
the S. Typhi strain, through either an inherent toxicity of this strain to arabinose, or
an inability to express the pBAD-encoded proteins, particularly as SPI-1
expression levels were not increased in the wild-type strain expressing pBAD-hilD.
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A possible role for both RcsC and PagN in the regulation of SPI-1 and motility was
established in S. Typhimurium, but not S. Typhi round-cell mutants, where neither
SPI-1 or flagella expression was recovered with the inactivation of rcsC or pagN. It
is possible that in these strains expression of the SPI-1 and motility genes was
recovered but protein expression or functionality remained suppressed, as
transcription of SPI-1 and flagella genes was not assessed in S. Typhi round-cell
ΔrcsC/ΔpagN cells. RcsC and PagN were identified as putative regulators from the
recovery of flagella gene transcription in S. Typhimurium ΔrodA in rcsC::Tn10d(Tc)
and pagN::Tn10d(Tc) transposon mutants. RcsC and PagN may play similar roles
in both Typhi and Typhimurium round-cell mutants, but other factors may also be
involved in S. Typhi, which prevent the downstream functionality of the motility or
SPI-1 systems. It is also possible that the global regulation is significantly different
between Typhi and Typhimurium. Whilst additional work is needed to establish at
what level SPI-1 and motility defects are regulated in S. Typhi mutants, the
reasons for the observed differences may be discussed. These may arise as a
result of differences between the two serovars or from attenuations specific to the
S. Typhi vaccine strain BRD948, for instance.
9.7.1 The nature of the BRD948 S. Typhi strain and the associated ΔhtrA
mutation
The BRD948 strain of S. Typhi harbours specific attenuating mutations in the aroC,
aroD and htrA genes, making it suitable for use as a vaccine strain. Of these
mutations, the ΔhtrA mutation could be highly significant, affecting the phenotypes
of mrd operon mutants in this study. HtrA (DegP) is a periplasmic protease which
degrades mis-folded envelope proteins and is required for protection against
oxidative stress and intracellular survival in Salmonella. HtrA expression is
regulated by both the Cpx and rpoE envelope stress response pathways (216,
493-495). Interestingly, in Yersinia htrA expression was induced from
overproduction of the outer membrane protein OmpX-like protein through the
CpxAR pathway. However, in E. coli, which is more closely related to Salmonella,
htrA activation through overproduction of outer membrane proteins was shown to
occur through RpoE (494).
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At least one envelope stress response pathway is thought to be significantly
involved in the regulation of virulence in ΔpbpA and ΔrodA mutants. As such, and
knowing the importance of HtrA in the stress response pathways, it is likely that
HtrA is ordinarily overexpressed in ΔpbpA and ΔrodA mutants. This is supported
by the observed upregulation of OmpX-like protein in S. Typhimurium ΔrodA cells,
which would likely lead to htrA overexpression. Microarray data also showed that
htrA itself was upregulated ~7-fold in S. Typhimurium ΔrodA. The absence of HtrA
from S. Typhi may therefore have important consequences for the health of ΔpbpA
and ΔrodA mutant cells. Any resulting perturbation to the health and general
physiology of S. Typhi ΔpbpA or ΔrodA cells may affect their ability to express
functional flagella or SPI-1 needles. It is also possible that the lack of HtrA
significantly alters the envelope stress responses, and therefore influences flhDC
and hilD expression in these mutants.
9.7.2 The S. Typhi serovar specific transcriptional regulator, TviA
TviA is a major SPI-7-encoded transcriptional regulator which is absent from the
genome of S. Typhimurium. It is responsible for the expression of the Typhi-
specific Vi capsule, but also regulates virulence genes outside of SPI-7. In
conjunction with RcsB, TviA negatively regulates both motility and SPI-1 genes.
This additional level of complexity of virulence gene regulation in S. Typhi, which is
also related to the envelope stress response, may be at least partially responsible
for the differences in phenotype seen in S. Typhi ΔpbpA and ΔrodA mutants (116).
The inactivation of rcsC is known to not completely suppress the Rcs
phosphorelay. Hence residual RcsB activation, combined with the action of TviA,
may lead to the continued SPI-1 and motility repression seen in S. Typhi
ΔpbpA/ΔrodA ΔrcsC double mutants (466, 467).
It is likely that both TviA and HtrA play considerable roles in establishing the
observed phenotypes in S. Typhi round-cell mrd mutants, though further work will
be needed in order to assess this. In terms of TviA, this would be made possible
through the combined inactivation of both tviA and the Rcs phosphorelay, for
instance, or through the inactivation of other members of the Rcs phosphorelay.
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The phenotypic analysis of ΔpbpA and ΔrodA mutants generated from a wild-type
S. Typhi strain, would also permit study into the effects of the htrA mutation.
9.8 Conclusions
A number of significant conclusions can be drawn from the results of this study. A
considerable range of questions have also been raised through the course of this
study, which form the basis of plans for future work.
From the outset, this study sought to better characterise the roles of the mrd
operon genes in Salmonella Typhi. It was therefore important to initially
characterise the mrd operon. Results of this study have shown that the mrd
operon consists at least of ybeB, ybeA, pbpA and rodA in Salmonella, these genes
being co-transcribed and co-regulated from a strong promoter located upstream of
ybeB. rlpA may also be expressed under the control of the mrd operon promoter,
as well as potentially from its own promoter, located inside the rodA gene.
In terms of gene function, the results of this study support those of previous
studies, showing that pbpA and rodA, but not ybeB, ybeA and rlpA, are directly
involved in cell shape determination. Several portions of evidence suggest that
rlpA in particular may also play a role during cell wall synthesis, along with pbpA
and rodA. A clear indisputable relationship between cell wall synthesis and cell
shape, and the ybe genes has not yet been established, these genes appearing to
play a major role in ribosome assembly and stability. However, the co-regulation of
these genes with pbpA and rodA, along with a number of observations from this
study and putative physical links between protein synthesis and cell wall synthetic
machinery in the literature, permitted tentative hypotheses to be made concerning
such a relationship. These therefore require further study.
The results of this study provide valuable information concerning the physiology
and pathogenicity of round-cell ΔpbpA and ΔrodA mutants of Salmonella Typhi. It
was firstly conclusively demonstrated that invasion-associated virulence factors
are almost completely repressed in these mutants, at the level of transcription. The
lack of repression of virulence factors required for intracellular survival, including
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SPI-2, along with the ability to restore SPI-1 and motility expression through either
recovery of hilD or flhDC expression, or the inactivation of upstream global stress
response pathways, subsequently highlighted a number of important features of
round-cell mutants, particularly concerning the regulation of the mrd mutant
phenotypes:
 Round-cell mrd operon mutants retain their ability to assemble functional
cell-wall spanning multi-protein organelles such as flagella, despite the
apparent cell wall defects inherent in these mutants.
 The assembly, functionality and physical localisation of the T3SS and
flagella organelles is not dependent upon bacterial cytoskeletal elements
such as MreB, whose localisation is disrupted in ΔrodA mutants at least
(131).
 SPI-1 and motility virulence factors are downregulated in ΔpbpA and ΔrodA
mutants in response to the activation of a number of global stress response
pathways, including envelope stress response pathways such as the Rcs
phosphorelay, which in particular is thought to play a major role in virulence
gene regulation in these mutants.
 The regulatory pathways activated in round-cell mutants result in a
physiological state whereby invasion genes are repressed and genes
required for intracellular survival and survival in adverse environmental
conditions (e.g. stationary phase-activated genes) are upregulated. As such,
the SPI-2 T3SS, the Vi antigen capsule and the cellulose and colanic acid
capsular polysaccharides are all actively expressed or produced. These
factors are thought to permit survival and growth/cell division of the round-
cell mutants, and also are indicative of the effects that the inactivation of
pbpA or rodA has on the cell envelope structure in particular.
 Although recovery of flhDC and hilD expression in round-cell mutants is
sufficient to restore some motility and SPI-1 functionality to these mutants,
full virulence is not restored. It is likely that a number of factors are involved
in the complex regulation of virulence in response to the inactivation of
pbpA and rodA. This regulation is also likely to occur at a number of levels.
A potentially significant role for c-di-GMP in the post-transcriptional
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regulation of motility and SPI-1 in round-cell mutants has also been
established.
 A possible novel role for the outer membrane adhesin PagN in the
regulation of virulence in round-cell mutants has been highlighted.
 Unlike studies with an ΔmreCD mutant, in vivo studies show that ΔpbpA
and ΔrodA mutants remain attenuated despite the putative functionality of
virulence factors required for intracellular survival. This result highlights the
first instance of a significant phenotypic difference between different round-
cell mutants.
Together these results enhance understanding of both the roles of each individual
mrd operon gene in Salmonella, and the general physiology of round-cell mrd
operon mutants. They also have provided important insights into the relationships
between cell shape determination and virulence in Salmonella.
9.9 Outstanding questions and future work
In conclusion to this study, a number of outstanding questions remain unanswered,
which future work aims to address. In addition, a number of hypotheses have been
formulated from the results of this work which also require testing through further
experimental analyses.
In terms of investigating the mrd operon as a unit, it would be useful to definitively
map the ybeB promoter position, and also to clarify whether rlpA forms part of the
operon, determining whether it is expressed predominantly under the control of its
own promoter or from the mrd operon promoter upstream of ybeB. To test these
points, northern blot or primer extension analyses would be useful, enabling a
better definition of the full cohort of co-transcribed genes within the mrd operon. In
addition, expression levels of rlpA could be investigated under the control of the
putative rlpA promoter, by cloning the rlpA gene complete with upstream promoter
sequences, or ybeB promoter sequences, into a promoter-less expression vector
containing sequences encoding a 3’ epitope tag, such that an easily traceable
epitope-tagged RlpA protein would be expressed under the control of either
promoter. This would enable comparisons of rlpA expression levels under the
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control of either promoter, and also help determine the optimum conditions for rlpA
expression with each promoter.
It would also be useful to investigate regulation of the mrd operon genes, by
determining the conditions under which mrd operon genes are activated or
suppressed. This would provide further information on the function of each gene
and the operon as a whole.
Microarray analysis from this study provided extensive valuable insights into the
gene expression profile of the ΔrodA mutant of S. Typhimurium. Whilst the large
number of experimental analyses carried out alongside the microarrays helped to
verify the microarray results, additional quantitative real-time RT-PCR (qPCR)
experiments may be useful to fully verify these results. Initial qPCR analyses were
attempted, but were not informative due to high levels of variation in the results,
possibly due to experimental error. It may also be useful to conduct further
microarrays in S. Typhi round-cell mutants, to provide important insights into the
differences, particularly in the physiology and active regulatory pathways, between
S. Typhi and S. Typhimurium round-cell mutants.
An important aspect of future work would be to investigate in more detail the
regulatory mechanisms involved in the control of the virulence phenotypes of
ΔpbpA and ΔrodA mutants. In particular, further work is needed to characterise the
role of the Rcs phosphorelay in ΔpbpA and ΔrodA mutants, looking both at the
expression levels of the major Rcs proteins in these mutants, and the extent to
which they are responsible for SPI-1/motility repression, in both Typhi and
Typhimurium mutants. Additional experiments are also needed to identify factors
involved in the activation of the Rcs phosphorelay, upstream of RcsC or RcsB.
RcsF constitutes a likely factor involved in the activation of the Rcs phosphorelay
in response to peptidoglycan stress, although till now no evidence from this work
has supported this hypothesis. To identify upstream regulatory signals would also
help to define more precisely what effects the inactivation of pbpA of rodA have on
the cell, and which features of the mutants cause the upregulation of such stress
response pathways. Specifically, experimental work could focus on the systematic
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generation and characterisation of knockout mutants of the major members of the
Rcs phosphorelay in round-cell mutants.
The role of other major stress response pathways, and particularly those involved
in the envelope stress response, also warrants further study, particularly as
evidence suggests that cpxA, rpoE and rpoS at least were upregulated in round-
cell mutants. It is likely that the regulatory pathways activated in round-cell
mutants are complex, involving a large number of interacting factors. In particular
the role of TviA in the regulation of virulence in round-cell S. Typhi mutants
requires investigation. It would be interesting to test whether motility or SPI-1
functionality can be restored in ΔpbpA/ΔrodA ΔtviA double mutants.
Preliminary results of this study highlighted a role for c-di-GMP in the post-
transcriptional regulation of virulence in round-cell mutants. In order to
characterise the role of c-di-GMP further, it would be useful to repeat and refine
the c-di-GMP LC/MS/MS assays, enabling the direct quantification of c-di-GMP in
round-cell mutants. A number of EAL and GGDEF domain proteins which play a
major role in the regulation of c-di-GMP levels, including AdrA, YciR, YhjH, and
t3302 (stm3388) (95, 403, 451), have been cloned into the pBAD24 expression
vector. These will be introduced into round-cell mutants of both S. Typhi and S.
Typhimurium and induced, to determine the extent to which variation of c-di-GMP
levels can affect motility/SPI-1 functionality in these mutants. Work is also needed
to determine the mechanism by which c-di-GMP acts in round-cell mutants, and if
its role is connected to that of the Rcs phosphorelay. Ultimately it would be useful
to determine if SPI-1 and motility functionality can be fully restored in round-cell
mutants, as well as virulence in vivo.
Additional experimental analyses are needed to further characterise the possible
novel role of PagN in virulence gene regulation in round-cell mutants, be it direct
or indirect. This could be done by the selective mutagenesis of short regions of the
pagN gene to determine the downstream effects on virulence gene functionality, or
by analysis of the transcriptional profile in ΔpagN mutants to identify regulatory
pathways affected which may alter virulence gene expression, for example.
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In global transposon mutagenesis screens a total of around 7000 individual
colonies were assayed for recovery of motility gene expression. It may be useful to
continue this screen, to be sure of more complete coverage of the Salmonella
genome, enabling the identification of additional putative motility gene regulators.
Further phenotypic characterisation of the ΔpbpA and ΔrodA mutants may also be
necessary to better describe the effects that these mutations have upon
Salmonella biology and pathogenicity. For example, several assays conducted in
this study highlighted significant alterations to the cell envelope structure in
particular. Further work is needed to define the effects of mrd mutations on the
outer membrane structure, through further analysing both LPS structure and the
outer membrane protein profiles in these mutants. This is also applicable for the
ΔrlpA mutant, in which possible major effects on the outer membrane structure
were isolated.
In terms of ybeB, ybeA and rlpA, extensive further work is needed to better
characterise the functions of these genes. In addition to examining the outer
membrane in ΔrlpA mutants, it would be interesting to investigate expression of
the Rcs phosphorelay in these mutants, along with other envelope stress response
pathways which respond to perturbations in the outer membrane. This is
particularly relevant since polymyxin B treatment is known to induce the Rcs
phosphorelay, and would help to verify the surface phenotype observed in ΔrlpA
mutants.
The putative links between protein synthesis and cell wall synthesis or the
bacterial cytoskeleton also require investigation. The results of this study
suggested that YbeB and YbeA are cytoplasmic proteins, with no particular pattern
of localisation. However, it requires further analysis to ensure that the YFP-fusion
proteins constructs of these genes are functional. It could also be interesting to
determine whether the localisation of these proteins, along with other ribosome-
associated proteins and proteins involved in translation, varies with cell growth, or
as a consequence of ΔpbpA/ΔrodA mutations. This would help establish whether
links exist between these elements and the cell shape determinant proteins.
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The short-cell phenotype of ΔybeA mutant cells was thought to result from the
possible overexpression of ftsZ in these cells. This would need to be established
experimentally through transcriptional reporter assays to analyse ftsZ expression,
for example. Further work is also needed to investigate the reason for the short-
cell phenotype of these cells. In addition, a possible link between cell size and
motility/SPI-1 functionality in round-cell mutants was observed, which deserves
further consideration, to determine whether motility functionality is directly related
to cell size, or whether these two features are both independent consequences of
upstream factors.
Finally, further assessment of the regulation of virulence in S. Typhi is required, to
determine whether motility and SPI-1 functionality can be restored in ΔpbpA and
ΔrodA mutants, as well as if and how regulation differs between the Typhimurium
and Typhi serovars. In addition to examining TviA, the role of HtrA in contributing
to the observed phenotypes in Typhi mutants should be assessed. As an
extension to this study it may be useful to examine mrd gene function in a wild-
type S. Typhi strain.
It is clear that the work of this study could be extended beyond the areas already
discussed, and a large number of additional minor questions may also remain to
be investigated. The cumulative results from this study, as well as future work, will
no doubt provide extensive solid evidence and important insights into the roles of
the mrd operon genes in both the biology and pathogenicity of Salmonella, the
relationships between mrd operon genes, and the activity of global regulatory
pathways. Ultimately this work provides useful insights into the biology of an
important clinically relevant pathogen, particularly in terms of cell surface features
which constitute important targets for future therapeutics. Much of this work is also
applicable to related Gram-negative pathogens.
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